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INTRODUZIONE
La diversità genetica gioca un ruolo importante nella sopravvivenza e nei processi
adattativi di tutte le specie. Quando l'ambiente cambia (es: condizioni climatiche,
agenti patogeni, disponibilità di cibo), la popolazione è soggetta ad una pressione
selettiva: col passare del tempo, i tratti variabili più vantaggiosi per l'adattamento
vengono selezionati mediante processi di selezione naturale e trasmessi da una
generazione alla successiva.
La diversità genetica è generata dalla combinazione di differenti processi evolutivi,
che  includono  le  mutazioni,  la  deriva  genetica,  le  migrazioni  e  la  selezione
naturale.
La selezione naturale  lascia  una traccia  molecolare caratteristica  all'interno dei
genomi,  che  può  essere  rilevata  con  l'applicazione  di  diversi  metodi  evolutivi.
Questi  metodi  possono  essere  suddivisi  in  due  categorie:  test  che  ricercano
segnali  di  selezione  inter-specie  (mediante  il  confronto  tra  individui  di  specie
diverse), e test che, invece, si focalizzano su confronti intra-specie (cioè all'interno
della stessa specie). 
Durante  il  periodo  di  dottorato  ho  condotto  studi  evolutivi  su  geni  soggetti  a
differenti pressioni selettive. 
In  un  primo  studio  ho  analizzato  la  storia  evolutiva  di  geni  coinvolti
nell'adattamento alla dieta. I cambiamenti nella disponibilità di cibo e nella dieta
avvenuti  nel  corso  della  storia,  hanno  creato  forti  pressioni  selettive  in  diversi
processi  biologici.  Ad  esempio,  nell'uomo,  la  rivoluzione  agricola  ha  favorito  il
consumo di carboidrati. 
Sfruttando la disponibilità di sequenze genomiche di organismi diversi, ho eseguito
un'analisi  evolutiva  su  geni  che  sono  coinvolti  in  diverse  fasi  dell'
assorbimento e della digestione dei carboidrati nell'orletto a spazzola della mucosa
intestinale e ho usato dei dati di risequenziamento di campioni di DNA antichi per
determinare quando si sono sviluppati gli alleli adattativi. 
In  una  seconda serie  di  studi,  invece,  ho  effettuato  delle  analisi  evolutive  per
studiare l'interazione tra le proteine dell’ospite e quelle patogene.
Le  molecole  che  partecipano  alla  risposta  immunitaria  sono  coinvolte  in  una
costante “corsa alle armi” contro i patogeni e contengono le tracce molecolari di
questo  conflitto.  Ho  quindi  analizzato  la  storia  evolutiva  dei  geni  della  difesa
immunitaria (ad esempio geni di rilevamento antivirale, di induzione della risposta
a  interferone  ed  effettori  antivirali),  del  sistema  del  complemento  (che  è  un
effettore  dell’immunità  innata)  e  di  proteine  batteriche  che  interagiscono con  il
complemento. 
Tuttavia,  i  conflitti  genetici  con  i  patogeni  non  coinvolgono  solo  geni  con  una
specifica  funzione  nella  difesa  immunitaria,  ma  anche  molecole  implicate  in
processi omeostatici cruciali. 
Tra queste ci  sono: (i)  il  trasportatore degli  steroli,  NPC1, utilizzato dai filovirus
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come recettore per l’ingresso nella cellula dell'ospite; (ii) la basigina, una proteina
multifunzionale  con  un  ruolo  nel  funzionamento  dei  trofoblasti  e  nella
spermatogenesi  che  viene  utilizzata  dal  Plasmodium falciparum per  l’invasione
eritrocitaria. 
Ho quindi  studiato la storia evolutiva di questi geni e dei loro interattori virali  e
microbici.
SCOPO DEL LAVORO
Lo scopo del mio progetto è quello di utilizzare analisi evolutive per indagare e
descrivere eventi adattativi in geni soggetti  a diverse pressioni selettive, sia nei
mammiferi sia in virus, protozoi e batteri. In particolare, ho condotto analisi inter-
specie  e  analisi  di  genetica  di  popolazione-filogenetiche,  con  l'obiettivo  di
individuare la selezione positiva che ha agito per lunghi tempi evolutivi.
MATERIALI E METODI
Le sequenze di cDNA dei geni di interesse di numerose specie di mammiferi e
patogeni sono state ottenute da banche dati pubbliche (NCBI, UCSC o ENSEMBL)
oppure mediante sequenziamento diretto. 
Le  analisi  condotte  sui  DNA  antichi  sono  state  possibili  grazie  a  recenti
pubblicazioni di dati relativi al sequenziamento del genoma di ominidi tra cui un
uomo di Neanderthal,  un uomo di Denisova, un cacciatore-raccoglitore europeo
del Mesolitico proveniente dalla Spagna e un ominide siberiano del Paleolitico.
Le sequenze sono state allineate con software specifici (es: RevTrans 2.0, PRANK
e GUIDANCE).
Dato che la ricombinazione genica può essere scambiata per selezione positiva,
tutti gli allineamenti sono stati sottoposti a screening per la ricerca di breakpoints di
ricombinazione utilizzando un software specifico (GARD). 
I segnali di selezione positiva sono stati determinati con il software codeml; inoltre i
siti  selezionati positivamente sono stati identificati  con due programmi differenti:
BEB e MEME. Per valutare eventi di selezione episodica su specifici rami della
filogenia sono stati utilizzati Bs-Rel e branch-site test del software codeml.
Le analisi evolutive nell’uomo, nello scimpanzé e nel gorilla sono state eseguite
utilizzando un  approccio  di  genetica  di  popolazione-filogenetico.  Per  valutare  il
significato  funzionale  dei  residui  selezionati  positivamente,  sono  state  condotte
analisi di strutture 3D.
Grazie  a  modelli  statistici  di  regressione  logistica,  sono  stati  condotti  studi  di
associazione  genetica  tra  le  varianti  alleliche  selezionate  ed  il  fenotipo  di
resistenza all'infezione da HIV ed è stata valutata l'espressione genica in risposta
alla  stimolazione  con  interferone  alpha  (IFN-α).  In  particolare  sono  state
selezionate tre coorti europee di individui sieronegativi esposti a HIV-1 (HESN) che
differiscono per origine geografica ed esposizione al virus. Le varianti di interesse
sono  state  genotipizzate  mediante  sequenziamento  diretto  del  DNA di  questi
soggetti.
I risultati ottenuti per ciascuna delle tre casistiche analizzate, sono stati combinati
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mediante tecniche di meta-analisi con PLINK.
Il  saggio  di  infezione  da  HIV  è  stato  condotto  separando  in  coltura  le  cellule
mononucleari  del  sangue  periferico  (PBMC)  dei  soggetti  HESN.  Dopo  averne
valutato la vitalità, è stato fornito l'input virale HIV-1Ba-L p24. La titolazione virale è
stata  effettuata  saggiando l'antigene virale  p24 nel  terreno di  coltura,  rilasciato
dopo 7 giorni di incubazione, mediante saggio ELISA. 
Per  la  stimolazione  con  IFN-α,  le  PBMC  isolate  da  controlli  sani  sono  state
piastrate in terreno di coltura con o senza l'aggiunta di IFN-α. Dopodichè, l'RNA è
stato estratto dalle cellule e retro-trascritto in cDNA. La quantificazione del cDNA è
stata  eseguita  tramite  Real-Time  PCR  e  i  risultati  sono  stati  espressi  come
rapporto tra il gene di interesse e un gene housekeeping (GAPDH).
RISULTATI
Le analisi evolutive possono fornire informazioni estremamente rilevanti non solo
sulla storia evolutiva del nostro genoma, ma anche riguardanti la presenza e la
localizzazione di varianti genetiche funzionali legate alla diversità fenotipica e alla
salute umana. 
Nello  studio  sui  geni  dell'orletto  a  spazzola  della  mucosa  intestinale,  i  risultati
indicano che la pressione evolutiva data dall'adattamento a diete specializzate ha
portato ad una selezione positiva diffusa nei mammiferi e nelle popolazioni umane.
Inoltre, ho osservato che gli alleli moderni che sono stati selezionati positivamente,
sono insorti prima dell'avvento dell'agricoltura. 
Nella seconda serie di analisi ho dimostrato che anche la risposta immunitaria ha
esercitato  una  forte  pressione  evolutiva:  infatti  ho  trovato  tracce  di  selezione
positiva pervasiva in residui e regioni proteiche che esercitano un ruolo funzionale
(ad  esempio  porzioni  regolatorie  o  che  conferiscono  attività  antivirale).  È
interessante notare che spesso la selezione naturale ha come target dei residui
che si trovano nella stessa posizione spaziale in proteine diverse. Questo vale ad
esempio  per  i  siti  trovati  in  OAS1,  OAS2  e  MB21D1,  che  hanno  mostrato
un’evoluzione in parallelo.
Nelle analisi di proteine virali e microbiche e dei loro interattori nelle cellule ospite,
la maggior parte dei siti selezionati positivamente si trova all'interno della regione
all'interfaccia tra ospite e patogeno. Questo rispecchia l'aspettativa di uno scenario
di  conflitto  genetico,  per  cui  i  geni  dell’ospite  e  del  patogeno si  evolvono  per
tentare di evitare l'interazione nel primo caso, e di rafforzarla nel secondo. Alcuni
dei  siti  selezionati  positivamente  all'interfaccia  di  interazione  hanno  un  ruolo
nell’affinità  di  legame  tra  ospite  e  patogeno,  altri  molto  probabilmente  hanno
contribuito al cambiamento di tropismo dell'ospite. Alcuni residui virali, invece, si
trovano  in  determinanti  antigenici.  Dato  che  le  strategie  di  trattamento
farmacologico più promettenti  comprendono quelle basate sulle combinazioni di
anticorpi, questi risultati dovrebbero far riflettere sulle problematiche relative alla
loro efficacia a lungo termine.
CONCLUSIONI
Questi  lavori  evidenziano  l'importanza  delle  analisi  evolutive.  In  particolare,  ho
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mostrato che gli studi evolutivi possono: (i) fornire informazioni riguardo agli eventi
adattativi  che  hanno  plasmato  i  tratti  specifici  umani,  (ii)  identificare  regioni
funzionali e siti che evolvono sotto selezione positiva, (iii) prevedere superfici di
interazione  ospite-patogeno  a  livello  del  singolo  aminoacido,  (iv)  fornire
informazioni sulle determinanti  molecolari alla base della specie-specificità della
suscettibilità alle infezioni e chiarire la risposta differenziale a molecole naturali o
sintetiche,  (v)  contribuire  a  individuare  i  serbatoi  più  probabili  per  i  patogeni
zoonotici,  (vi)  spiegare  le  variazioni  di  tropismo  del  patogeno  e  (vii)  fornire
informazioni su possibili bersagli terapeutici (che riguardano ad esempio l'efficacia
dei trattamenti a lungo termine basati sulle combinazioni di anticorpi).
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SUMMARY
INTRODUCTION
Genetic  diversity  plays  an important  role  in  the  survival  and  adaptability  of  all
species.  When  a  population  environment  (meaning,  for  instance,  climatic
conditions, pathogens, and food availability) changes, the population is subject to a
selective pressure. Variation in the population gene pool provides variable traits
which can be selected for, via natural selection, leading to an adaptive change to
survive. Genetic diversity is generated by a combination of different evolutionary
processes such as mutation, genetic drift, migration and natural selection. 
Natural  selection  leaves  a  distinctive  molecular  signature  in  genomes.  Such
molecular signatures can be detected with evolutionary tests that can be divided
into those that search for selection at the inter-species level (e.g., human versus
primates and mammals) and those that focus on within-species data (e.g., among
human populations).  In  my work,  I  used evolutionary studies to analyze genes
under different selective pressures.
In a first study, I investigate the evolutionary history of genes possibly involved in
diet adaptation. Changes in food availability and diet likely created strong selective
pressures on multiple biological processes. In humans, the agricultural revolution
favored carbohydrate consumption. I exploit the availability of genome sequences
from different organisms, together with resequencing data of ancient DNA samples
to  perform  a  comprehensive  evolutionary  analysis  of  genes  involved  in  sugar
absorption/digestion at the brush-border and to test when adaptive alleles arose.
In a second set of studies, I use evolutionary analyses to investigate the interaction
between host  proteins  and viral/protozoan/bacterial  protein  products.  Molecules
that participate in immune response are expected to be engaged in a constant
arms-race  with  pathogens  and  to  harbour  the  molecular  signatures  of  such  a
conflict.  I  thus investigate the evolutionary history of genes involved in immune
defense, such as antiviral  sensing proteins, genes with IFN-inducible properties
and antiviral effectors. I also investigate the evolutionary history of the complement
system,  an  innate  immunity  effector,  and  of  bacterial-encoded  complement-
interacting proteins.
Nevertheless, not only genes with specific defense function, but also molecules
involved in central homeostatic processes may be engaged in genetic conflicts with
pathogens. This is exemplified by (i) the sterol transporter NPC1, used as receptor
for  filoviruses  entry  and  (ii)  basigin,  a  multifunctional  protein  with  a  role  in
trophoblast function and in spermatogenesis which is used for erythrocyte invasion
by  Plasmodium falciparum.  I  therefore  study  the  evolutionary  history  of  these
genes and of their viral/microbial interactors. 
AIM OF THE WORK
The  purpose  of  my  project  is  to  use  evolutionary  analyses to  investigate  and
describe  adaptive  events  at  candidate  genes  subject  to  different  selective
pressures,  in  species  ranging  from  mammals  to  viruses/protozoa/bacteria.  In
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particular, I focus on inter-species and population genetics-phylogenetics analyses,
with the aim to detect positive selection acting over long evolutionary timescales.
MATERIALS AND METHODS
Mammalian  and  pathogen  coding  gene  sequences were retrieved from public
databases (Ensembl, UCSC and NCBI) or obtained by direct sequencing.
Information from the Neandertal and Denisova high-coverage genomes, as well as
from a hunter-gatherer Mesolithic European from Spain and a Paleolithic Siberian
was derived from previous works. 
Sequences were aligned using RevTrans 2.0 utility, PRANK, and unreliably aligned
codons were then filtered using GUIDANCE. Since recombination can be mistaken
as  positive  selection,  all  alignments  were  screened  for  the  presence  of
recombination breakpoints using a specific software (GARD). To detect selection,
codeml models were fitted to the data using different models of equilibrium codon
frequencies. Sites under selection were identified using BEB and MEME. Branches
and sites subject to episodic positive selection were identified using Bs-Rel or  the
branch-site tests from the codeml software. 
Evolutionary  analysis  in  the  human,  chimpanzee  and  gorilla lineages  was
performed using a population genetics-phylogenetics approach. 
Analysis of 3D structures was used to infer the functional significance of positively
selected sites.
In  order  to  assess  the  role  of  selected  variants  in  HIV-1  susceptibility,  and  to
evaluate  gene  expression  in  response  to  interferon  alpha  (IFN-α),  genetic
association analyses,  in vitro HIV-1 infection and IFN-α stimulation assays were
also performed. 
Genotyping  was  carried  out  on  three  independent  European  cohorts  of  HIV-1
exposed  seronegative  individuals  (HESN)  with  different  geographic  origin  and
distinct  exposure  route.  Variants  were  genotyped  through  direct  sequencing.
Genetic association analyses were performed by logistic regression and results
from the three cohorts were combined using a random-effect  meta-analysis;  all
analyses were performed using PLINK.
For  the  HIV  infection  assay,  PBMC  from  HESN  subjects  were  separated  on
lymphocyte separation medium. After viability assessment, they were resuspended
in a medium containing HIV-1Ba-L  p24 viral input. After 7 days, supernatants were
collected  for  p24  antigen  ELISA  analyses  and  absolute  levels  of  p24  were
measured.
For IFN-α stimulation, freshly isolated PBMC from healthy controls were incubated
with medium alone or with IFN-α. Cultured PBMC RNA was extracted and then
reverse transcribed into first-strand cDNA. cDNA quantification was performed by a
Real-Time PCR strategy.  Results  were presented  as  ratios between the  target
gene and the GAPDH housekeeping mRNA.
RESULTS
Evolutionary analysis can provide extremely relevant information not only on the
evolutionary  history  of  our  genome,  but  also  on  the  presence  and  location  of
functional  genetic  variants  especially  in  relation  to  phenotypic  diversity  and,
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ultimately, human health. 
In the study of the brush border genes, results indicated pervasive selection in
mammals  and  human  populations,  reflecting  specific  adaptation  to  specialized
diets.  Furthermore,  I  found  that  positively  selected  modern  alleles  predate  the
emergence of agriculture. 
In the second set of analyses I found that pervasive positive selection is driven by
pressure  related  to  immune response.  Selection  acted  on  functionally  relevant
protein regions (e.g.: regulatory regions, regions which confer antiviral activity) and
residues.  Interestingly,  natural  selection  often  targeted  residues  located  in  the
same spatial position in different proteins. This is for example the case of sites
detected in OAS1, OAS2 and MB21D1, which revealed parallel evolution. 
In the analyses of  viral/protozoan/bacterial  proteins and their  host  interactors,  I
found most of the positively selected sites within the region at the host-pathogen
interface.  These  results  epitomize  the  expectation  under  a  genetic  conflict
scenario,  whereby  the  host  and  the  pathogen  genes  evolve  within  binding
avoidance-binding  seeking  dynamics.  Part  of  these  sites  had  a  role  in  host-
pathogen binding affinity, some other adaptive changes most likely contributed to
the shift to human hosts, and still other residues found to evolve under positive
selection  in  viruses  reside  in  antigenic  determinants.  Because  antibody
combinations are the most promising treatment strategies, these findings should
pose a serious concern to their effectiveness in the long-term.
CONCLUSIONS
These works highlight the importance of evolutionary analysis. Specifically, I show
that evolutionary studies can (i) provide information on the past adaptive events
that shaped human-specific traits, (ii) identify functional regions and sites evolving
under  positive  selection,  (iii)  predict  host-pathogen  interaction  surfaces  at  the
single  amino acid  resolution,  (iv)provide valuable  information on the molecular
determinant  underlying  species-specific  infection  susceptibility  and  clarify  the
differential response to natural or synthetic molecules, (v) help identify the most
likely reservoirs for zoonotic pathogens, (vi) explain changes in pathogen tropism
and (vii) provide information on possible therapeutic targets (e.g. effectiveness of
long-term treatment based on antibody combinations).
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1. INTRODUCTION
1.1 Genetic variability and evolution
As humans and other organisms moved to inhabit every part of the world,
they  were  exposed  to  new  environments,  including  different  climatic
conditions, pathogen species and food sources, to which they were forced
to adapt  [1,  2].  Variation is  essential  to species survival  and adaptation
during evolution: if  the environment changes, species that have a higher
genetic variability will be better able to evolve to adapt. Variants that confer
an advantage for a species will be selected for by natural selection.
Selection  operates  at  the  level  of  the  phenotype.  Within  and  between
species, there are multiple potential sources of phenotypic variation, and
each of these sources reflects a different underlying cause. The particular
source of phenotypic variation determines whether that trait has the ability
to  respond  to  environmental  changes.  Researchers  are  therefore  highly
interested in determining the relative importance of both the genetic and the
environmental factors that lead to particular traits for several reasons: 1)
current  genetic  diversity  contains  information  about  the  size  and
movements of past populations (referred to as groups of organisms of one
species),  and on the history of  adaptation to environmental changes;  2)
information can be used to predict the evolutionary dynamics of an entire
population  with respect  to  the specific  trait  [3-5];  3)  this  knowledge has
biomedical  and  therapeutic  implications,  since  it  may be  translated  into
novel  treatment  strategies  in  term  of  molecular  targets  or  drug
development.
Genetic  diversity  is  shaped  by  a  number  of  different  processes  which
include  mutation,  recombination,  genetic  drift,  migration  and  natural
selection.
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1.1.1 Mutation and recombination
Mutation  is  the  only  process  generating  new alleles,  providing  the  raw
material on which evolution can act. A mutation is a heritable change in the
DNA sequence. If a mutation occurs in reproductive cells, it may also be
passed  from  parent  to  offspring.  Mutations  are  essential  factors  in
evolution, as they provide the variation that enables organisms to change
and adapt to their environment when selective pressure is applied. Based
on their effects on the ability of the individual to survive and reproduce,
mutations  can  be  divided  into  three  broad  categories:  deleterious,  that
decrease this ability, neutral, that do not have an effect and are fixed or lost
by drift,  and advantageous,  that  increase the ability  of  the  organism to
survive and reproduce [6].
New combinations of mutations may then arise through recombination in
meiosis: they occur as a part of sexual reproduction and enhance the ability
of  organisms to adapt  to  their  environment  by combining advantageous
alleles at different loci. Nevertheless, recombination can also generate new
combinations of alleles on the same DNA molecule, known as haplotype,
and in this way increase haplotype diversity. Consequently, recombination
is also capable of breaking up advantageous allelic combinations.
1.1.2 Genetic drift and migrations
Genetic  drift  is  a  process  in  which  allele  frequencies  within  a  species
change by chance alone as a result of different possible scenarios. These
changes are not driven by environmental or adaptive pressures and can
either increase or decrease over time. Typically, genetic drift occurs in small
populations, where infrequently occurring alleles face a greater chance of
being  lost.  Common  examples  of  genetic  drift  are  bottlenecks  and  the
founder effect. A population bottleneck arises when a significant number of
individuals in a population dies or is otherwise prevented from breeding,
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resulting in a drastic decrease in the size of the population, whereby the
level of genetic variation is extremely limited. The founder effect, instead,
involves migration, where a small group of organisms may migrate from a
large continental population and establish a colony in a new location. In any
case, the final effect of genetic drift  is to reduce genetic variation within
populations and increase divergence among populations [7].
Migration is the movement of individuals of the same population from one
geographic location to another. Gene flow is the outcome of a migration,
which is the exchange of genes between populations. Genetic variation is
added  to  new populations  and  increases  genetic  differences  within  the
recipient  population. At  the same time, migration prevents subpopulation
from  becoming  too  different:  in  the  absence  of  migration  there  will  be
differing frequencies of common alleles among local populations and some
local  populations  will  posses  certain  rare  alleles  not  found  in  others;
migration  leads to mixing of  the  gene pool.  Hence,  migration  increases
genetic  variation  within  population  and  reduces  divergence  between
populations.
1.1.2.1 Modern human evolutionary history
Anatomically modern humans appeared in East  Africa about  200k years
ago, spread out from sub-Saharan Africa approximately 100k years ago,
and subsequently colonized Europe and East Asia. 
A  study  of  Cann  and  colleagues  [8]  indicated  that  there  is  a  strong
correlation between geographic distance among populations and genetic
variability within population; indeed populations closer to Africa show more
variability  than  population  further  from  Africa,  reflecting  the  route  of
migrations of ancient humans. The allele pool of populations reflects this
geographic scenario: in fact, most of the alleles/haplotypes of non-African
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populations are a subset of the African ones. This observation is crucial in
order to identify genetic adaptation, because it must be considered when
evaluating whether a specific variant is influenced by the action of natural
selection. Demographic events influence variability in all genes in the same
way,  whereas selection specifically targets defined regions;  so deviation
from the general behavior of genetic variation can be an indication of the
action of natural selection. It should also be considered that, during their
evolutionary history,  humans have adapted to the environment,  and this
adaptation  is  driven  by  different  forces,  with  major  effects  generally
ascribed to pathogens, climate and diet. 
1.1.3 Natural selection
Another process that generates variability is natural selection, which is the
tendency for traits to increase or decrease in frequency in a population,
depending on the reproductive success (fitness) they confer [9]. Traits with
a greater level of fitness contribute more to the gene pool of subsequent
generations. Selection represents the action of environmental factors on a
particular  phenotype and genotype through selective pressures and can
occur at any stage, from the formation of the genotype at fertilization to the
end of the reproductive period.
There  are  three  major  forms  of  natural  selection:  purifying  or  negative
selection, positive or adaptive Darwinian selection and balancing selection.
Purifying selection is the most pervasive form of natural selection acting on
genomes. It  reduces the frequency of deleterious alleles in a population.
New  mutations  often  have  detrimental  effect  on  biological  fitness  and
purifying selection reduces the number of new mutation in the gene pool.
The main consequence of negative selection is a local reduction of diversity
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and an increase of  rare  alleles  when selection  is  not  strong enough to
completely eliminate deleterious variants from the population (that is, weak
negative selection) [10] (Fig 1A).
Balancing selection is a form of natural selection whereby multiple alleles
are  maintained  at  an  appreciable  frequency  within  the  gene  pool.  It
principally  acts  by  two  mechanisms:  heterozygote  advantage  (or
overdominance) and frequency-dependent selection. The first  refers to a
situation  in  which  heterozygotes  show  a  higher  level  of  fitness  than
homozygotes. This leads to the maintenance of two or multiple alleles in a
population at a given locus (Fig 1B). Frequency-dependent selection occurs
when the fitness of a genetically-determined phenotype is dependent on its
frequency relative to other phenotypes in a given population. For example,
in  negative  frequency-dependent  selection,  the  fitness  of  a  phenotype
decreases  as  it  becomes  more  common.  Whatever  the  mechanisms,
balancing selection leads to an excess of intermediate-frequency variants,
which will results in increased levels of diversity. Finally, positive Darwinian
selection refers to selection acting upon newly advantageous mutations.
Under  positive  selection,  advantageous  alleles  rapidly  achieve  high
frequencies within the population. This occurs at a rate much faster than
that  of  a  neutral  allele.  When  an  advantageous  mutation  increases  in
frequency in the population as a result of positive selection, linked neutral
variation  will  be  dragged  along  with  it  in  a  process  known  as  genetic
hitchhiking.  As a  consequence,  variation  that  is  not  associated with  the
selected allele is eliminated, resulting in a selective sweep that leads to an
overall  reduction  of  genetic  diversity  around  the  selected  site  (Fig  1C).
Additional features include a skew in the distribution of allele frequencies
towards  an  excess  of  rare  and  high-frequency  derived  alleles,  and  a
transitory increase in the strength of linkage disequilibrium associated with
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the selected allele.
Figure 1: Rows A, B and C illustrate three patterns of natural selection. The columns represent three generations: the
first column shows the starting group of four individuals looking at the same chromosome in each; the second column
shows the first generation with mutations, and the third column shows the final outcome for the chromosomes in three
different  patterns  of  natural  selection.  Each  circle  represent  a  polymorphism,  within  a  haplotype.  White  circles
represent mutations under neutrality, black circle deleterious mutations and gray circles indicate advantageous ones.
Pattern A illustrates genetic polymorphisms under negative selection. Deleterious mutations arise (black dot) and they
can be removed immediately (if severely deleterious, e.g. line 3 in column 3) or kept at low frequencies (if weakly
deleterious, e.g., line 2 in column 3). Linked neutral polymorphism will also disappear (or be kept at low frequencies,
e.g. line 3 in column 3). Pattern B illustrates balancing selection. Two new alleles are shown (shaded and black circles)
and, if they confer advantage in the heterozygous state, they will increase to intermediate frequencies. Linked neutral
polymorphism will also increase to intermediate frequencies. Pattern C illustrates genetic polymorphism under positive
selection. When a new advantageous mutation arises (shaded circle in line 2, column 2), the allele increases in
frequency (in the population) along with linked neutral polymorphisms (lines 3 and 4 in column 3, which now resemble
line 2, column 2) (Image adapted from [11]).
Much research in recent years has focused on the development of genomic
methods to identify positive selection: this is because positive selection is
considered to be the primary mechanism of adaptation, so understanding
the  traits  (and  genes  underlying  them)  that  have  undergone  positive
selection  during evolution  can provide  insight  into  the events  that  have
shaped the genomic variability of the species, as well as into the diseases
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that continue to plague today.
1.2 Detection of natural selection
Based on types of data they utilize, the timescale they focused on and the
type of selective signature they identify, methods to detect natural selection
in the genome may be distinguished into inter- and intra-species analyses. 
Inter-species analysis are used to identify selective events that took place
within the deep past and that reﬂect macroevolutionary trends that occur as
a result of selection between species. They are based on the comparison of
homologous traits of DNA sequences among related species. Inter-specific
analysis are based on few important intuitions: (i) closely related organisms
share a very similar gene pool, which they have inherited from a common
ancestor; conserved sequences between species indicate that a particular
sequence may have been maintained by evolution,  more likely for  their
basic role in proteins function and stability. Mutations in a highly conserved
region usually lead to a non-viable life form of the protein and are therefore
quickly removed from the gene pool. Mutations that confer an advantage
for organism survival in a particular environment are instead maintained in
the genome. Indeed, inter-specific analysis search for rare variable regions
among huge conserved ones (ii)  traits  that  are conserved across  many
clades of a phylogeny but that show extreme differentiation in one or a few
lineages are thought to be candidates for selection. 
Intra-species analysis, instead, are used to identify more recent selective
events  (e.g.  lineage specific  selection  in  human populations)  comparing
genetic variation within sequences of the same species. These analyses
search  for  genes/gene  regions  subject  to  different  form  of  selection:
positive selection, which refers to the case in which DNA variants has a
selective advantage over others, and consequently rises in frequency; and
balancing selection, which refers to selective regimes that increase genetic
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variation  within  a  species.  These  two  kind  of  selection  leave  different
signatures on genomic regions. These signatures can be searched for and
exploited to identify selected variants: (i) in a selective sweep, a genetic
variant reaches high frequencies together with nearby linked variants (the
result  is  a  high  frequency  derived  allele).  From  this  homogenous
background, new alleles arise but are initially at low frequency (surplus of
rare alleles); (ii) selective sweeps bring a genetic region to high frequencies
in  a  population,  including  the  causal  variant  and  its  neighbors.  The
associations between these alleles deﬁne a haplotype, which persists in the
population until  recombination breaks these associations (the result  is  a
long unbreak haplotype); (iii) selection acting on an allele in one population
but  not  in  another  creates a marked difference in  the frequency of  that
allele between the two populations. This effect of differentiation stands out
against the differentiation between populations with respect to neutral (i.e.,
non selected) alleles [1].
1.2.1 Detection of natural selection at the inter-species level 
Each form of natural selection leaves distinctive “signatures” or patterns of
genetic  variation in  DNA sequences.  Methods to detect  selection at  the
inter-species level typically rely on the comparison of homologous traits or
sequence among related species. These approaches take as an input the
alignment and the site-by-site analysis of orthologous coding sequences.
For each site it will be determined which among all substitution would lead
to  an  amino-acid  replacement  (non-synonymous  substitution)  or  not
(synonymous substitution). The number of nonsynonymous differences per
nonsynonymous site (dN) and the number of synonymous differences per
synonymous site (dS) are then calculated. Under neutral evolution, the rate
at  which  aminoacid  replacements  accumulate  is  expected  to  be
comparable to the rate of synonymous changes and, therefore, dN/dS (ω)
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should be equal  to  1.  Nonetheless,  in  most  species  the majority of  the
aminoacid  replacements  are  deleterious  and  eliminated  by  negative
selection: in this case dN/dS<1. Conversely, a specific selective pressure
may favor aminoacid replacements: in this case dN/dS will be higher than
1, a hallmark of positive selection (Fig 2). 
Figure 2: Example of a site-by-site analysis of 14 orthologous coding sequences (sp = species). The first one is a
nucleotide alignment, the second one represents its amino acid translation. Image adapted from Sironi and colleagues
review [12]..
1.2.2 Detection of selection at a specific site
The most widely used models to detect selection at specific sites are the
sites models implemented in the PAML (phylogenetic Analysis by Maximum
Likelihood) package [13], which are used to infer positive selection and to
identify sites under selection. These models allow dN/dS to vary from site to
site, assuming a constant rate at synonymous sites. The analysis is based
on  fitting  the  data  (multi-species  alignment  and  phylogenetic  tree)  to
different  models  that  allow  (positive  models)  or  do  not  allow  (neutral
models) a class of codons to evolve with  dN/dS>1. To determine whether
the neutral model can be rejected in favor of the positive selection model,
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likelihood ratio tests (LTR) are then applied. If neutral models are rejected
in favor of positive selection ones, the gene can be declared to be positively
selected. Only in this case, a Bayes Empirical Bayes approach (BEB) can
be used to detect specific sites targeted by selection [14]. In particular, BEB
calculates the posterior probability that each site belongs to the class of
codons with dN/dS >1) [15].
The PAML approach assumes that  the strength and direction  of  natural
selection is uniform across all lineages. Because this is often not the case,
different  approaches  can  be  applied.  For  instance,  MEME  (the  Mixed
Effects  Model  of  Evolution),  developed  by  Murrell  and  co-workers  [16],
allows the distribution of dN/dS to vary from site to site and from branch to
branch.  The  method  has  therefore  greater  power  to  detect  episodic
selection,  a  selective  pressure  acting  on  a  limited  number  of  lineages,
especially if it is confined to a small subset of branches in the phylogeny.
1.2.3 Detection of selection of lineages under positive selection and 
lineages-specific sites
Often positive selection is focused on few sites with specific roles in the
function or stability in an otherwise selective constrained protein. 
To  detect  selection  along  specific  branches,  PAML  also  implements
methods  called  “branch-site”  models  [17].  These  models  require  the
phylogeny to be divided into two classes: “foreground” and “background”
branches. An LTR is then applied to compare a model that allows positive
selection on a class of  codons only for  the foreground branches with a
model  that  does  not  allow  such  selection  [17].  Designation  of  the
foreground  branches  needs  a  priori information,  possibly  based  on
biological evidence. If this information is not available, it is still possible to
run the analysis by designating each branch of the tree as “foreground”.
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Different methods can then detect selection at specific lineages without  a
priori branch  partition.  One  of  these  is  the  branch  site-random  effects
likelihood (Bs-Rel)  method.  Bs-Rel  simulates  three different  evolutionary
scenarios (purifying, neutral, and diversifying selection) for all branches in a
given tree, and each branch is considered independently from the others; in
this way the algorithm applies sequential  likelihood ratio tests to identify
branches that are influenced by positive selection [18].
1.2.4 Detection of positive selection using a population genetics-
phylogenetics approach
Rather  than  comparing  the  amount  of  change  at  synonymous  and
nonsynonymous sites between two or more species,  there are methods
that exploit the availability of an ever increasing number of sequences for
the  same species  to  improve  power  and  resolution  in  detecting  natural
selection.  An  example  is  the  population  genetic-phylogenetic  method
developed  by  Wilson and colleagues  [19],  which jointly  compares intra-
species variation and inter-specific divergence to estimate the distribution
of selection coefficients (γ) along coding regions. gammaMap estimates the
frequency of codons at which non-synonymous mutations fall into one of
twelve categories, that range from strongly beneficial (γ = 100) to inviable   
(γ = −500), with γ equal to 0 indicating neutrality.     This method allow also to
identify specific codons evolving under positive selection in each lineage.
1.2.5 Detection of positive selection in human populations
The complex patterns  of  genetic  diversity in  human populations are the
product of many levels of demographic and evolutionary events acting on
different  timescales,  including  colonizations, migrations,  population
expansions,  mutation,  genetic  drift  and selection.  Several  recent  studies
have indicated that human demographic history (i.e. the pattern of human
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migrations  throughout  the  world  with  subsequent  expansions  and
bottlenecks)  explains  a  large  part  of  neutral  genetic  diversity  among
populations, and they strongly support an African origin for modern humans
[20,  21].  Therefore,  population  genetic  analyses must  take into  account
demographic history. This is achieved mainly by using an outlier approach:
genes/variants are considered candidate selection targets if they represent
outliers in an empirical distribution.
To search for polymorphisms that have been targeted by natural selection
in  human  populations,  a  set  of  tests  are  applied.  Briefly,  the  following
tests/parameters are calculated:
-  nucleotide diversity:  both θW  [22],  an estimate of the expected per site
heterozigosity,  and π [23],  defined as the average number of nucleotide
differences per site between two DNA sequences, are extimated; these are
increased under balancing selection, decreased under purifying selection or
selective sweeps.
-Tajima's D [24]: this statistic takes into account both SNP frequency and
allele  spectra.  It  is  close to  0  under  the standard hypothesis  of  neutral
evolution; positive values indicate balancing selection while negative values
are suggestive of purifying selection or selective sweep.
-Fst: it is a measure of population genetic differentiation. Lower Fst values
are  expected  at  loci  under  balancing  selection  compared  to  neutrally
evolving ones [25]; high values are suggestive of positive selection.
-DIND test [26]: the rationale behind the DIND test is that a derived allele
under positive selection will display lower levels of nucleotide diversity at
linked sites than expected from its frequency in the population. Thus,  the
ratio  of  intra-allelic  diversity  associated  with  the  ancestral  and  derived
alleles  (iπA/iπD)  is  analyzed against  the  frequency  of  the  derived  allele
(DAF);  given  a  DAF interval,  a  high  value  of  iπA/iπD indicates  that  the
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neutral  diversity associated with the derived allele is  limited,  suggesting
positive selection.
-  Fay and  Wu's  H  (DH):  the  test  is  based  on  the  idea  that  directional
selection at one site may drive linked mutations to high frequency; this is
also  applied  to  derived  alleles  (which  usually  display  lower  frequency).
Negative values indicate an excess of high frequency derived alleles and
represent a signature of selective sweeps.
1.3 Drivers of natural selection
Migration and colonization of new habitats are a major component of the
species history. Such processes lead to sharp changes in environmental
conditions  (water  and  food  availability,  climate,  pathogens  richness  and
diversity) experienced by organisms. Changes in environmental conditions
can lead to shifts in selective pressures which in turn alter the phenotypic
composition of species [27].
Detecting how natural selection has affected genome variability has proven
to be a powerful  tool  to delineate genes and biological functions having
played  a  key  role  in  species  adaptation  [28].  This  holds  true  for  both
mammal and pathogen evolutionary history.
1.3.1 Adaptation to dietary pressure
Selective pressures related to diet have varied over geographic space, as
species  adapted  to  different  ecological  niches  and  to  use  dietary
components available in those environments. In addition, human diets have
changed over time including the recent past (the last 100000 years) with
the agricultural revolution and the consequent domestication of plants and
animals  [29].  Changes  in  food  availability  and  diet  composition  during
evolution,  likely created strong selective pressures on multiple biological
processes. The identification of the genetic loci that were targeted by these
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diet-related selected pressures may provide insight  into the evolutionary
history of the species as well as into the biological pathways that mediate
the effect of dietary risk factors for common diseases, such as diabetes,
hypertension and cancer [30].
1.3.1.1 Candidate genes of natural selection under dietary-driven 
selective pressures
Among the biological processes that may have adapted to dietary-driven
selective pressures I mention:
-Metabolism:  the process of  building molecular  structures  from nutrients
and breaking them down for energy production. Although many metabolic
pathways  play  an  important  role  under  all  dietary  regimes,  specific
pathways and reactions may become critical when species specialize on
particular  dietary  components.  For  this  reason,  initial  efforts  to  identify
genetic adaptation to dietary specializations have focused on enzymes that
have a well-characterized and a highly specific functional role in nutrient
metabolism [29].
-Sensory perception: feeding is a multisensorial experience; before being
tested, food is seen, touched and smelled. Processing of food in the mouth
leads  to  the  release  of  additional  molecules  that  stimulate  taste  and
olfaction, as well as to the production of sounds that stimulate auditions.
The  five  senses  are  developed  to  different  degrees  across  species,
reflecting their feeding habits and needs, as well as to the whole complex of
interactions with the surrounding environment. Many studies have sought to
understand the evolution of olfaction, vision and taste in human and non-
human primates, with important implications for understanding adaptations
to dietary changes. A special focus of evolutionary analyses has been on
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the taste receptors (in particular bitter taste receptors because of their role
in preventing the ingestion of poisonous foods) and olfactory receptors, and
on the broader category of genes involved in chemosensory perception [26,
31-33].
-Appetite control: appetite includes various aspect of eating patterns, such
as frequency and size of eating episodes, choice high-fat or low-fat foods,
energy content and diversity of food consumed. The regulation of appetite
is a biological process tightly connected to the environmental availability of
food  and  to  lifestyle.  Therefore  genes  involved  in  appetite  control  are
potential  candidates  as  target  selective  pressure  when  species  faced
different dietary challenges [33, 34].
-Morphological  development  of  the  digestive  system:  is  likely  to  have
adapted  to  dietary  shifts.  An  example  is  dental  enamel  thickness,  a
phenotypic trait of particular interest, as it may reflect adaptation to variable
fracture-resistence properties of food items. Enamelin peptides are thought
to be involved in the formation and elongation of enamel crystallites during
tooth  development  genes  and  for  these  processes  were  identified  as
targets of recent positive selection [35-37].
1.3.2 Adaptation to pathogens
Infectious  diseases  and  epidemics  have  always  accompanied  and
characterized the history of most species, representing a major cause of
death. 
Migration  and  cultural  changes  during  the  recent  human  evolutionary
history  (the  past  10000  years)  exposed  populations  to  dangerous
pathogens as they colonized new environments, increased in population
density and had closer contact with animal disease vectors, including both
domesticated  animals  (dog,  cattle  and  sheep)  and  those  exploiting
permanent human settlements (rodents and sparrows) [9].
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Even today, despite progress in sanitation and medical research, infection
are estimated to account for about 15% of deaths in the world's population,
reaching  about  41%  in  Africa  (WHO  2008,  http://www.who.int/en).  In a
recent report (September 2016), the WHO estimated that in 2015 about 5.9
million  children  under  the  age  of   five  died  of  infection  (preterm  birth
complications, pneumonia, birth asphyxia, diarrhoea and malaria). 
Data  on  human  forager-farmers  traditionalists  with  limited  access  to
modern medicine also show infections as a main cause of death (72%) [38]
and longitudinal studies of the Gombe chimpanzees [39] identify infection in
the majority of deaths (67%) for all ages [40]. 
It is not surprising so the idea whereby pathogens have been acting as a
powerful selective pressure. 
1.3.2.1 Zoonotic diseases
Mammals display different susceptibility to distinct pathogens, and, nearly
two-thirds  (61%)  of  human  diseases  originate  through  a  zoonotic
transmission from a reservoir animal host [41]. For instance, bats have long
been known to harbour and disseminate a wide range of viruses that are
likely  pathogenic  for  humans,  among  which  Ebola  and  Middle  East
Respiratory  Syndrome  (MERS-CoV)  viruses  [42];  the  same  for  rodents,
which  are  known to  harbour  Lassa  virus  [43],  responsible  for  a  severe
hemorrhagic fever. The etiological agent of AIDS, human immunodeficiency
virus  type  1  and  2,  are  retroviruses  that  must  likely  originated  in
chimpanzees and in sooty mangabey monkeys, respectively;  Plasmodium
falciparum,  the causative agent  of  malaria,  originated from gorillas;  high
concentrated  poultry  and  pig  farming  provided  optimal  condition  for
increased mutation, reassortment and recombination of influenza viruses
[41]. 
Thus,  domestic  and  wild  mammalian  (and  non-mammalian)  species
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represent natural reservoirs of human pathogens and/or may provide the
adaptive  environment  for  pathogen  spillover.  Because  host  reservoir
species  and  their  pathogens  often  co-evolved  for  millions  of  years,
evolutionary analyses may help to explain host adaptive events associated
with  low susceptibility  and mild  disease outcome,  as well  as  to provide
valuable information on the differential susceptibility to infection within and
among species [12].
1.3.2.2 “Red Queen” scenario
Interactions of pathogens with their hosts result in a situation that is defined
as  an  “arms-race”,  in  which  continuous  selective  pressure  on  the  host
occurs to generate resistance against pathogens, and, at the same time, on
pathogens, which try to develop new strategies to evade host defenses for
a successful infection. Evolutionary fit pathogens, which are able to survive,
replicate, and spread effectively within the host, have an improved chance
of passing their genes on to the next generation. Similarly, host genotypes
are more likely to persist within the population if those particular individuals
are more capable of controlling or resisting infection. Co-evolution between
hosts and pathogens naturally occurs as a result of these interactions. The
result is a genetic conflict referred to as a “Red Queen” scenario, from the
character in Lewis Carrol's novel who says: “It takes all the running you can
do, to keep in the same place”. This conflict shapes genetic diversity both in
the  host  and  in  the  pathogens  genomes,  determining  fast  evolutionary
rates.  Protein  regions directly  involved in  host-pathogen interactions are
expected to evolve under the strongest diversifying (positive) selection [12].
Moreover, natural host defenses, which take much longer to evolve than
their  pathogen  counter-parts,  have  been  supplemented  by  man-made
developments,  such  as  vaccines,  antibiotics  and  modern  medical
interventions, which place added pressures on pathogens to adapt. Host
17
innate and adaptive immune responses and modern medical interventions
are all selective pressures that contribute to pathogen evolution within the
host [44].
Integrating evolutionary analyses of host and pathogen interacting partners
into  a  common  framework  therefore  hold  the  promise  to  improve  the
understanding of the strategies used by both hosts and pathogens to adapt
and counter-adapt.  In  turn,  this  knowledge has possible biomedical  and
therapeutic implications, given the ability of different pathogens or distinct
strains of the same infectious agent to elude not only natural host defenses
but also drugs and vaccination strategies.
1.3.2.3 Candidate genes under pathogen-driven selective pressures
It's common opinion that protein regions at the host-pathogen interface are
targeted by the strongest selective pressure.  Among the candidate genes
with high rates of adaptation I mention:
- innate immune genes that are devoted to antiviral/ antimicrobial response:
the mammalian immune system is endowed with a repertoire of molecular
sensors  called  pattern-recognition  receptors  (PRRs).  These  molecules
detect  pathogen-associated  molecular  patterns  (PAMPs)  and  initiate  a
downstream  signaling  cascade  that  culminates  in  the  production  of
cytokines and antimicrobial factors. In the host-pathogen arms-race, these
molecules represent one of the foremost detection-defence system.
Host  restriction  factors  are  other  important  components  of  the  innate
immune  response  to  infection:  they  generate  potent,  widely  expressed
intracellular  blocks  to  viral  replication  and  for  these  reasons  represent
obvious targets in host-pathogen arms-races. Specifically, genetic conflicts
between host  restriction  factors  and  viral  components  often  play  out  in
terms of binding-seeking dynamics (e.g. the host factor adapts to bind the
viral component) and binding-avoidance dynamics (e.g. the virus counter-
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adapts to avoid binding and restriction by the host factors).
Consistently, several studies have reported adaptive evolution at proteins
with a specialized role in antiviral defense [45-51];
- antigen presentation, T cell activation and immunoglobulin G receptors:
antigen  presentation  and  T  cell  activation  are  central  processes  in
mammalian  cell-mediated  immune  response.  Therefore,  a  convenient
strategy  for  pathogens  to  elude  immune  surveillance  is  to  hijack  the
molecular pathways responsible for these processes [52, 53]. In line with
the arms-race scenario, there is evidence of positive selection at several
mammalian genes involved in antigen presentation and in the regulation of
T cell activation [54, 55];
- other than immune effectors: despite the relevance of adaptive immunity
for  host  defense,  host-pathogen  interactions  are  not  limited  to  immune
system components. Host gene products that engage in genetic conflicts
include those that participate in the coagulation cascade and the contact
system,  which  are  commonly  used  by  bacterial  pathogens  to  promote
tissue invasion or to elude detection by immune cells. Moreover, incidental
receptors are often represented by the products of housekeeping genes,
which,  from  the  viral  perspective,  have  two  advantages:  first  they  are
expressed at high levels in multiple cell types, and second they are highly
conserved  because  most  amino  acid  replacements  cause  a  substantial
reduction in fitness (this means that the sequence space available to the
host for adaptive change is limited) [12].
As  far  as  pathogens are  concerned,  protein  under  host-driven selective
pressure could be all proteins that mediate the initial and essential steps of
host  infection via host  cell  binding and entry and those represent  major
targets for immune responses influencing antigenic selection. 
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1.4 Aim of my thesis
The purpose of my project is to use evolutionary analyses to investigate
and  describe  adaptive  events  at  genes  subject  to  different  selective
pressures. One aim is to gain a deeper understanding into the evolutionary
history of the species. Another important driver for the research is based on
the observation whereby natural selection acts on phenotypes and these, in
turn, derive from functional variants. Therefore, the identification of natural
selection  signatures  implies  the  identification  of  genes/gene  regions
carrying polymorphic functional variants. This is particularly relevant when
the  genes  being  analyzed  have  been  involved  in  human  diseases  or
phenotypic  traits  of  medical  relevance.  Moreover,  the  selective pressure
underlying  species  adaptations  are  often  environment-driven;  therefore
evolutionary analysis approaches can provide information on how human
and  other  organisms  have  adapted  to  their  environment  and  how
environment shifts (as those carried along by agriculture and pathogens)
may have resulted in disease susceptibility. 
Here I show two sets of studies.
In the first study, I analyze genes subject to dietary pressures: in particular,
I  exploit  the  availability  of  an  ever  increasing  number  of  mammal
sequences  to  analyze  the  evolutionary  history  of  genes  that  encode
intestinal brush-border proteins involved in carbohydrate metabolism. This
decision was based on the concept that the availability of food resources is
a driver of pivotal importance in specie evolution and that the introduction of
agriculture resulted in a dietary shift in terms of carbohydrate intake. The
availability of ancient DNA made it possible to also test when (if  after or
before the agricultural revolution) adaptive alleles arose. The identification
of dietary adaptation signals may shed light not only on the evolutionary
history of our species, but also on the mechanisms that underlie common
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metabolic diseases in modern human populations.
In the second set  of  studies,  I  use evolutionary large-scale  analyses to
investigate  genes  involved  in  host-pathogen  interactions,  both  in
virus/pathogen strains and in primate/mammalian species. 
On one hand, I analyze the evolutionary history of molecules most likely
involved  in  this  interaction,  as  engaged  at  different  levels  in  immune
response: antiviral sensing proteins, genes with IFN-inducible properties,
and antiviral effectors. This is because molecules that participate in immune
response  are  expected  to  be  engaged  in  a  constant  arms-race  with
pathogens and to harbour the molecular signature of such a conflict.
On the other hand, I study the interaction between pathogens and proteins
not  directly  involved in  immune response but  known to be engaged by
pathogens to invade host  cells.  That  is  because not  only  genes with  a
specific  defense  function,  but  also  molecules  involved  in  central
homeostatic  processes  may  be  engaged  in  genetic  conflicts  with
pathogens. 
The idea is that evolutionary analyses can pinpoint regions and residues
directly  involved  in  host-pathogen  interaction,  and  validate  the  idea
whereby protein regions at host-pathogen interfaces are the major target of
positive selection. This is ultimately expected to result in the identification of
variants in the host or the pathogen that (i) modulate infection susceptibility
or  virulence  and  can  be  prioritized  in  screening  for  association  with
autoimmune  diseases  and  infections;  (ii)  help  to  explain  changes  in
pathogen tropism; (iii) explain species-specificity of infections; (iv) provide
information on suitable vaccine targets and on treatment option such as the
effectiveness of long-term treatments based on antibody combinations.
These  works  highlight  the  importance  of  evolutionary  analysis.  The
methods I used have previously been described; yet, I combined multiple
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methodologies to assure that results are conservative. 
Large-scale  evolutionary  analyses  in  mammals  have  mostly  described
general patterns rather than focused on the specific interaction with one or
more  pathogens.  In  the  context  of  virology,  genome-wide  analyses  of
positive selection during speciation are lacking. These works are innovative
because they integrate analysis of the host's and the pathogen's interacting
partners into a common framework, to define the molecular determinants of
host-range and virulence. The experimental design I used may therefore
serve as a model for the analysis of other host-pathogen interactions. 
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2. METHODS
2.1 Evolutionary analyses
Algorithms, programs, and tests applied for all evolutionary analyses are 
summarized in Table 1.
2.1.1 Mammalian sequences and samples
Coding  sequences  were  retrieved  from  the  NCBI  database
(http://www.ncbi.nlm.nih.gov/),  from  the  Ensemble  website
(http://www.ensembl.org/index.html)  and  from  UCSC  server
(http://genome.ucsc.edu/).  Information  for  the  Neandertal  and  Denisova
high-coverage genomes [56, 57], as well as for a hunter-gatherer Mesolithic
European from Spain [58] and a Paleolithic Siberian [59] was obtained by
previous works.
To  increase  the  number  of  sequences  or  to  assess  the  presence  of
sequence  errors  or  rare  variants  in  the  reference  genome  assemblies,
primates sequences were in some cases obtained by direct sequencing. In
particular,  coding  sequencing  information  for  Gorilla  gorilla,  Aotus
trivirgatus,  Saguinus  oedipus and  Chlorocebus  aethiops and  3  Pan
troglodytes was  obtained  by  direct  sequencing  of  cDNA derived  from
EB(JC),  OMK,  EBV  B95  UK,  COS1  and  EB176(JC)  cells,  respectively
(obtained  by  the  European  Collection  of  Cell  Cultures,  ECACC).  The
genomic  DNA of   Colobus  guereza,  Ateles  fusciceps,  Pithecia  pithecia,
Lagothrix lagothricia amd 9  Pan troglodytes,  was kindly provided by the
Gene  Bank  of  Primates,  Primate  Genetics  (Germany)  and  used  as  a
template for gene amplification and sequencing. 
The list of species analyzed for each genes varies depending on availability
and other factors (e.g.  gene loss,  reliability of  orthology).  For all  human
genes,  I  checked  whether  primate  genes  represented  1-to-1  orthologs
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using the Ensembl Compara GeneTrees database [60]. Species for which
this  information was not  available,  a BLAST search of  the gene coding
sequences against the genome of these species was performed using the
NCBI  BLAST utility.  Single  primate genes for  which BLAST or  Ensembl
Compara GeneTrees hits were not consistent with the presence of a single
orthologs were removed. 
2.1.1.1 Sequencing analysis
For  the  primate  sequences  obtained  through  direct  sequencing,  the
cDNAs/DNAs were amplified by PCR and treated with ExoSAP-IT (USB
Corporation,  Cleveland  OH,  USA).  Purified  PCR  products  were  directly
sequenced on both strands with a Big Dye Terminator sequencing Kit (v3.1
Thermo Fisher Scientific), and run on a Thermo Fisher Scientific  ABI 3130
XL  Genetic  Analyzer.  Sequences  were  assembled  using  DNA  Baser
Sequence Assembler version 4.10.
2.1.2 Viral/protoza/ bacteria sequences
Ebolavirus and Marburgvirus GP sequences were retrieved from the NCBI
database.
Sequences  for  Neisseria  gonorrhoeae  Por1A  and  Por1B  were  obtained
from a previous work [61]. Streptococcus pneumoniae PspC  sequences
were retrieved from Iannelli et al. [62]; Borrelia burgdorferi OspE sequences
were  obtained from the NCBI  database,  with  the exclusion of  antigenic
variants  arising  during  infection;  Borrelia  burgdorferi  CspZ  sequences
derive from human clinical isolates as reported in Rogers et al. [63].
RH5 and  EBA175 Plasmodium sequences were retrieved from the NCBI
database or derived from previous works [64-66].
2.1.3 Alignments and gene trees
One  of  the  most  common  problems  in  evolutionary  analyses  is
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reconstructing  reliable  alignments:  alignment  errors  can  generate  false
positive  results  due  to  the  incorrect  evaluation  of  the  number  of
nonsynonymous and synonymous substitutions.  For  sequences showing
limited  divergence,  alignments  were  generated  using  softwares  that
maintain the codon reading frame. In particular the RevTrans 2.0 utility
(http://www.cbs.dtu.dk/services/RevTrans/, MAFFT  v6.240  as  an  aligner)
[67] was used, which uses the protein sequence alignment as a scaffold for
constructing  the  corresponding  DNA multiple  alignment.  This  latter  was
checked  and  edited  using  TrimAl  (automated1  mode) [68] and  manual
editing was used to correct few misalignments in proximity of small gaps
(http://phylemon.bioinfo.cipf.es/utilities.html). 
Viral  sequences show a stronger  sequence divergence due to the high
mutation rate.  Multiple sequence alignment were therefore generated by
PRANK,  based  on  a  specific  algorithm  that  takes  into  account  the
evolutionary  distances  between  sequences.  Unreliably  aligned  codons
were  then  filtered  using  GUIDANCE  [69],  an  open  access  tool  for  the
identification of unreliably aligned regions (codons with a score <0.90 were
masked as suggested by Privman and colleagues [70]). 
The  unrecognized  action  of  recombination  is  another  source  of  false
positive results when tests of  positive selection are applied [71].  This is
because most  methods used to infer  positive selection assume that  the
phylogenetic tree and branch lengths are constant across all sites in the
alignment,  a  tenet  that  is  invalid  in  the  presence  of  recombination.  All
alignments  were  thus  screened  for  the  presence  of  recombination
breakpoints  (and,  if  necessary,  split  on  the  basis  of  these  ones)  using
GARD  (genetic  Algorithm  Recombination  Detection)  [72],  a  genetic
algorithm implemented in the HYPHY suite [73]  which uses phylogenetic
incongruence among fragments to detect recombination events.
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Gene trees were generated using phyML [74], a General Time Reversible
(GTR)  model  plus  gamma-distributed  rates  and  4  substitution  rate
categories.  
2.1.4 Detection of natural selection acting on all lineages of a tree
To  detect  sites  targeted  by  negative  selection,  the  Single  Likelihood
Ancestor Counting (SLAC) or the Fixed Effects Likelihood (FEL) methods
implemented in the HYPHY package were used.
Evidence of positive selection was instead assessed by the codon-based
codeml program  implemented  in  the  PAML  (Phylogenetic  Analysis  by
Maximum Likelihood) suite [13, 75], which was developed to infer positive
selection and to identify positively selected sites.
This  tool  analyzes  gene  alignment  to  evaluate  the  nonsynonymous/
synonymous rate ratio,  considering the dN/dS ratio for any codon in the
gene as a random variable from a statistical distribution, thus allowing ω to
vary from site to site, assuming a constant rate at synonymous sites. 
To test for selection, site models that allow (M2a, M8) or disallow (M1a, M7
and M8a) a class of sites to evolve with ω >1 were fitted to the data using
two different codon frequency models: the F3x4 and the F61 models, which
weight in different ways the frequency of each codon in the data analyzed.
The nested models  (M1a vs  M2,  M7 and  M8a vs  M8)  were  compared
through  likelihood-ratio  tests  (degrees  of  freedom=  2  except  for  the
comparison between M8a and M8 which has degree of  freedom= 1)  to
asses statistical significance. Positively selected sites were identified using
the Bayes Empirical  Bayes (BEB) analysis  (with a cut-off  of  0.90).  BEB
calculates the posterior probability that each codon is from the site class of
positive selection (under model M8) [15]. For the identification of specific
positively selected sites the Mixed Effect Model of Evolution (MEME) from
HYPHY (with the cutoff  of  0.1 [16]) was also applied. MEME allows the
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distribution of ω to vary from site to site and from branch to branch at a site,
therefore  allowing  the detection  of  both  pervasive  and episodic  positive
selection.  The REL (Random Effects  Likelihood)  [76]  and FEL (with the
default cutoff of 0.1) tools  were also applied to identify positively selected
sites.  REL models  variation  in  nonsynonymous  and  synonymous  rates
across  sites  according  to  a  predefined  distribution,  with  the  selective
pressure at an individual site inferred using an empirical Bayes approach;
FEL directly estimates nonsynonymous and synonymous substitution rates
at each site [76]. 
SLAC, FEL, MEME and REL analyses were performed either through the
DataMonkey server (http://www.datamonkey.org) [77] or run locally (through
HYPHY). 
2.1.5 Detection of episodic selection
Positive selection can act  on all  lineages in a tree,  but  also on specific
branches.  To  explore  possible  variations  in  selective  pressure  among
different lineages, other models from the PAML package were used, the so
called free-ratio models. The M0 model assumes all branches to have the
same ω,  whereas M1 allows each branch to have its  own ω [75].  The
models  are  compared  through  likelihood-ratio  tests  (LRT)  (degree  of
freedom=total number of branches -1). In order to identify specific branches
with a proportion of sites evolving with dN/dS>1, the Branch Site-Random
Effects Likelihood (Bs-Rel) was used. This method implements branch-site
models that simultaneously allow ω variation across branches and sites.
One advantage of Bs-Rel is that it requires no prior knowledge about which
lineages are of  interest  (i.e.,  are more likely have experienced episodic
diversifying selection). 
To cross-validate branches identified using this approach or to analyze the
presence of  episodic positive selection on specific branches,  branch-site
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LRTs from codeml (the so-called modified model A and model MA1, “test 2”)
[17] were used. In this test, branches are divided  a priori into foreground
(those to be analyzed for positive selection) and background lineages. The
test  is  based  on  the  comparison  between  the  MA model,  that  allows
positive selection on the foreground lineages, with model MA1 that does
not allow such positive selection. A false discovery rate (FDR) correction
was applied to account for multiple hypothesis testing (i.e., correcting for
the number of  tested lineages),  as suggested [78].  To identify sites that
evolve under positive selection on specific lineages, the MEME and BEB
analysis  from MA (with a cutoff  of  0.90)  [17]  and BUSTED (Branch-site
Unrestricted  Statistical  Test  for  Episodic  Diversification,  [16])  were  used
[17]. BUSTED is a test designed to detect the action of episodic positive
selection  that  is  acting  on  a  subset  of  branches  in  the  phylogeny at  a
proportion of  sites within the alignment.  To detect  selection at  individual
sites, twice the difference of likelihood for the alternative and the null model
is compared to a  χ2 distribution with one degree of freedom. A site was
considered as positively selected if it showed a p value <0.05.
Bs-Rel, BUSTED and MEME analyses were performed either through the
DataMonkey server (http://www.datamonkey.org) [77] or run locally (through
HYPHY). 
2.1.6 Detection of positive selection in bacteria
Because recombination rates in bacterial genomes can be very high [79],
analysis of positive selection in bacteria was performed using omegaMap, a
Bayesian  method  that  simultaneously  estimates  recombination  and
selection  (inferred  through  ω estimation)  [80].  The  program  performs
Bayesian inferences of ω and ρ (recombination parameter), allowing both
parameters to vary along the sequence. An average block length of 10 and
30 codons was used to estimate ω and ρ, respectively. To determine the
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influence  of  the  choice  of  priors  on  the  posteriors,  the  analyses  were
repeated  with  two  alternative  sets  of  priors.  For  each  alignment,  three
independent omegaMap runs, each with 500,000 iterations and a 50,000
iteration burn-in,  were compared to assess convergence and merged to
obtain the posterior probabilities.
2.1.7 Detection of co-evolving sites
In order to analyze the presence of co-evolving sites, two different methods
were applied: BGM (Bayesian Graphical Model)-Spidermonkey [81] and the
Mutual  Information  Server  To  Infer  Coevolution  (MISTIC)  [82].  BGM-
Spidermonkey  identifies  co-evolving  sites  from  coding  sequences;  a
Bayesian  Graphical  Model  is  used  to  evaluate  the  connection  among
codons  in  the  alignment  (represented  by  the  nodes  of  the  network).
Significant  statistical  associations  between  nodes  are  indicated  by  the
edges  of  the  network,  suggesting  functional  or  structural  interactions
between  codons.  BGM-Spidermonkey  is  implemented  in  the  HYPHY
package.
MISTIC  estimates  the  relationship  between  two  or  more  alignment
positions.  The  co-evolutionary  association  is  evaluated  by  Mutual
Information (MI), estimating whether the information from the amino acid at
the  first  position  can  help  to  predict  the  amino  acid  information  at  the
second position.
For BGM-Spidermonkey sites were filtered based on a minimum count of 4
substitutions  across  the  phylogeny  and  each  site  was  conditionally
dependent on one other site. To be conservative, a pair of residues was
considered as co-evolving only if it  showed a posterior probability >0.95.
Likewise, MISTIC site pairs were required to display an MI rank higher that
the 95th percentile calculated using all MI scores from the alignment. Pairs
of sites exceeding the threshold for both methods were declared to be co-
29
evolving.
2.1.8 Detection of positive selection in Homininae
The action of positive selection in the Homininae lineages was analyzed
using gammaMap, a population genetics-phylogenetics method developed
by  Wilson  and  colleagues  [19].  This  method  compares  intra-species
variation  and  inter-specific  divergence  to  estimate  the  distribution  of
selection coefficients  (γ)  along coding regions.  In  particular,  gammaMap
assigns the selection coefficient  γ to  12 different  categories of  selective
effects, ranging from strongly beneficial (γ=100) to effectively unviable (γ =-
500),  with  γ  equal  to  0  indicating  neutrality.  For  gammaMap  analyses,
genotype  data  from  the  phase  1  of  the  1000  Genomes  Project  were
retrieved from the dedicated website [83]; in particular SNP information for
three human populations were retrieved: African (YRI), European (CEU),
and Chinese (CHB). For chimpanzees and gorillas, genotype information
were  retrieved  from  a  previous  work  [84]  for  25  and  27  individuals,
respectively.
Ancestral  sequences were reconstructed by parsimony from the human,
chimpanzee, orangutan and macaque sequences or using the ASR utility
from  Datamonkey.  ASR  implements  three  different  methods  based  on
maximum-likelihood or Bayesian inference [76].
gammaMap analysis was performed assuming θ (neutral mutation rate per
site),  k  (transitions/transversions  ratio),  and  T  (branch  length)  to  vary
among genes following log-normal distributions. 
For  P (the probability that  adjacent  codons share  the same population-
scaled selection coefficient), a value of 0.02 was assumed and the neutral
frequency of  non-STOP codons  was  set  to  1/61.  For  population-scaled
selection coefficients,  a uniform Dirichlet  distribution with the same prior
weight for each selection class was considered. For each gene, two Markov
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chain Monte Carlo runs of 100000 iteration each were run with a thinning
interval of 10 iterations. Runs were compared for convergence and merged
for the analyses. To be conservative, a codon was declared to be targeted
by positive selection when the cumulative posterior probability of γ ≥ 1 was
greater than 0.75, as suggested [85]. 
2.1.9 Human population genetic analysis
A set of programs was developed to retrieved genotypes from the 1000
Genomes  Pilot  Project  MySQL  database  [86]  and  to  analyze  them
according  to  selected  regions/populations.  These  programs  were
developed  in  C++  using  the  GeCo++  [87]  and  the  Libsequence  [88]
libraries. Genotype information for the genes of interest were obtained and,
in  particular,  three  human  populations  with  different  ancestry  were
analyzed: Europeans (CEU), Africans (Yoruba ,YRI), and East Asians (Han
Chinese in Bejing, CHB). In order to obtain a control set of approximately
1000 genes to use as a reference set, 1200 genes were initially selected by
random sampling of  those included in  the RefSeq list.  For  these genes
orthologous  regions  were  retrieved  in  the  chimpanzee,  orangutan  or
macaque genomes (outgroups) using the LiftOver tool. Genes showing less
than 80% human-outgroup aligning bases were discarded. This originated
a final set of 987 genes, referred to as control set. These data were used to
calculate θ W [22], π [89] as well as Tajima's D [24] over each entire gene
regions. Normalized Fay and Wu's H (DH) was also calculated in 500bp
sliding windows moving with step of 500bp [90, 91].
The  pairwise  FST [92]  and  the  DIND  (Derived  Intra-allelic  Nucleotide
Diversity) [93] test were calculated for all SNPs mapping to the analyzed
genes, as well as for SNPs mapping to the control set. FST values are not
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independent from allele frequencies, so variants were binned in 50 classes
based  on  the  minor  allele  frequency  (MAF)  and  the  FST empirical
distribution was calculated for each MAF class using the control data set.
The same procedure was applied for the DIND test; statistical significance
was thus calculated by obtaining an empirical distribution of DIND values
for variants located within control genes; in particular, the DIND test was
calculated using a constant number of 40 flanking variants (20 upstream
and 20 downstream), as described [54]. DIND values for the three human
populations were binned in 100 derived allele frequency (DAF) classes, and
for  each  class  the  distributions  were  calculated.  As  suggested  [93],  for
values of iπD=0 the DIND value was set to the maximum obtained over the
corresponding class plus 20. 
As a confirmatory signature of positive selection in human population, DH
was also calculated.  Sliding window analyses have an inherent  multiple
testing problem that is difficult to correct because of the non-indipendence
of windows. In order to partially account for this limitation, DH was also
calculated for the control gene set, and the distribution of the statistic was
obtained for the corresponding windows. 
Table 1. Summary of algorithms, programs, and tests used for bioinformatics analysis.
Computational resources/ statistics Description References
Evolutionary analisis inter-species
Databases
NCBI (National Center for Biotechnology
Information) database
The National Center for Biotechnology Information
database  provides  access  to  biomedical  and
genomic information.
Ensembl It is a genome browser for vertebrate genomes that
supports  research  in  comparative  genomics,
evolution,  sequence  variation  and  transcriptional
regulation.
Server
DataMonkey sever Web  server  for  HyPhy,  a  computational
phylogenetics  software  package  developed  to
[77]
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perform  maximum  likelihood  analyses  of  genetic
sequence  data  and  equipped  with  tools  to  test
various statistical hypotheses.
MISTIC (Mutual Information Server To 
Infer Coevolution)
Web  tool  that  aims  to  estimate  the  mutual
coevolutionary relationship between two residues in
a protein family using corrected Mutual Information
(MI).  
[82]
Utilities
EnsemblCompara GeneTrees The  database  allows  performing  cross-species
analyses to  infer gene orthology and paralogy by
using  phylogenic  gene  trees  generated  by
maximum likelihood.
[60]
RevTrans 2.0 utility It virtually translates a set of DNA sequences, aligns
the peptide sequences, and uses this as a scaffold
to  construct  the  corresponding  DNA  multiple
alignment.
[67]
TrimAl This tool allows the automated removal of spurious
sequences or poorly aligned regions from a multiple
sequence alignment.
[68]
GARD (Genetic Algorithm Recombination
Detection) 
It  is  a  genetic  algorithm  of  the  Hyphy  package
developed to search for recombination breakpoints
in  multiple  sequence  alignments  and  to  identify
putative recombinant sequences.
[72]
SLAC (Single Likelihood Ancestor 
Counting)
A tool from the Hyphy package for the estimation of
the  average  dN/dS  ratio;  it  uses  likelihood-based
branch lengths,  nucleotide and codon substitution
parameters  and  ancestral  sequence
reconstructions.
[76]
PhyML This  software  estimates  maximum  likelihood
phylogenies from alignments of nucleotide or amino
acid sequences.
[94].
codeml This  software  is  from  the  PAML  package  and
applies likelihood ratio tests to compare models of
gene  evolution  that  allow  or  disallow  a  class  of
codons to evolve with dN/dS >1 
 [13]
BEB (Bayes Empirical Bayes analysis) This method is used to identify positively selected
sites; it calculates the posterior probability that each
codon is from the site class with dN/dS >1 (under
models allowing dN/dS>1).
[14, 15] 
MEME (Mixed Effects Model of Evolution) This methods identifies positively selected sites by
allowing the distribution of dN/dS to vary from site to
site  and  from  branch  to  branch  at  a  site,  thus
detecting  both  pervasive  and  episodic  positive
selection. It is included in the HyPhy package
[16]
BSREL (Branch-site REL) This  tool  performs  a  series  of  LRT  tests  to  find
lineages on which a proportion of sites evolve with
dN/dS > 1, without making any a priori assumptions.
[18]
BGM (Bayesian Graphical Model)-
Spidermonkey 
A tool  implemented  in  the  HYPHY package  that
identifies co-evolving sites from coding sequences.
[81]
Population genetics-phylogenetics analysis
Utilities
gammaMap This program is based on a  combined population
genetics-phylogenetics  model  of  selection.  It
estimates  the distribution of  selection coefficients,
[19]
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and  allows  localization  of  the  signal  of  selection
using  a  Bayesian  sliding  window  approach.  The
signature of selection is detected from the contrast
in the dN/dS ratio within and between species.
ASR (Ancestral Sequence 
Reconstruction)
This is a utility from Datamonkey that reconstructs
ancestral  sequences  using  three  likelihood-based
methods. 
[76]
Population genetics analysis
Database
1000 Genomes This  database  collects  information  about  human
genetic variation
[86]
Browser
UCSC table browser Provides access to information about location and
annotation of genomic regions.
[95]
C++ libraries
GeCo++ This  library  allows  to  manage  genomic  element
annotation,  sequences,  and  positional  genomic
features; it provides users with tools to keep track of
genomic variations.
[87]
libsequence This library facilitates writing and implementation of
evolutionary  genetics  applications;  it  is  mainly
dedicated to the analysis of SNP data.
[88]
Statistics
θW This parameter estimates of the expected per site
heterozigosity.
[22]
π It  is  defined as the average number of nucleotide
differences per site between two DNA sequences.
[89]
Tajima's D This test is based on the allele frequency spectrum
(i.e.  the  distribution  of  allele  frequencies  at
polymorphic  sites);  low  negative  values  of  D
indicate an excess of rare alleles and suggest either
purifying or positive selection.
[24]
DH The  test  is  based  on  the  idea  that  directional
selection at one site may drive linked mutations to
high frequency; this also applies to derived alleles
(which usually  display lower  frequency).  Negative
values indicate an excess of high frequency derived
alleles  and  represent  a  signature  of  selective
sweeps.
[90, 91]
FST This  parameter,  also  known  as  fixation  index,
measures variations in the allele frequency between
two  populations.  FST largely  depends  on
demographic history (which affects all loci equally)
but natural selection may drive allele frequencies to
differ  more or less than expected on the basis of
demography  alone.  Specifically,  local  adaptation
may cause an allele to increase in frequency in one
population  and  therefore  result  in  high  FST (high
differentiation with another population)
[92]
DIND test (Derived Intra-allelic Nucleotide
Diversity)
The DIND test evaluates haplotype homozygosity. It
is  based  on  the  difference  of  nucleotide  diversity
between  haplotypes  carrying  the  derived  and  the
ancestral  alleles  It  has  higher  power  to  detect
recent  selective  events  compared  with  the
[93]
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commonly used sequence-based neutrality tests.
Utilities
omegaMap This  is  a  Bayesian  method  that  simultaneously
estimates  recombination  and  selection  (inferred
through ω estimation).
[80]
LiftOver tool This  tool,  available  from  the  UCSC  genome
browser, converts a given genome position from a
genome assembly to the corresponding position in
another assembly.
[96]
2.2 Protein 3D structures, in silico mutagenesis, and protein-protein 
docking
For the  in silico mutagenesis and the protein-protein docking I worked in
association with a group at the University of Milan Bicocca. 
Protein 3D structures were derived from the Protein Data Bank (PDB) or
predicted  using  three  different  methods:  MODELLER  [97]  with  loop
refinement,  I-TASSER  [98,  99]  with  a  defined  template,  or  I-TASSER
without any template. The quality of each model was assessed with VADAR
(Volume, Area, Dihedral Angle Reporter), which uses several algorithms to
calculate  different  parameters  for  individual  residues  and  for  the  entire
protein   [100].  The  overall  quality  was  estimated  with  respect  to  its
geometry  and  energy  (packaging  defects,  free  energy  of  folding,  core
hydrophobic and charged residues). Secondary structures were validated
through the use of PSIPRED [101] server. According to these criteria, the
best among the three models was used for our analysis. 
Protein-protein  interaction  analyses  were  performed  using  PIC  (Protein
Interaction Calculator) [102]. 
Protein-protein  docking analysis  was performed using ClusPro [103].  To
validate  the  method,  a  first  run  of  docking  was  carried  out  using  the
interacting partners to verify that the output was comparable to the three-
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dimensional  structure  of  the  PDB file.  After  mutagenesis,  a  new run  of
docking was performed. The 10 best cluster structures were analyzed to
verify  whether  the  ‘native  protein-protein  conformation’  could  be  found
among them. Because the sampling on the conformation is very extensive
(109 combinations), if the ‘native conformation’ is not found in the clusters, it
is  safe to assume that  this  type of  binding is  no longer  stable  and the
mutation results in a perturbation of the native binding.
In  silico mutations  were  generated  with  the  FoldX  tool  run-muta  [104].
Specific mutation were performed 5 times to ensure convergence. Images
were  created  using  PyMOL (The  PyMOL Molecular  Graphics  System,
Version 1.5.0.2 Schrödinger, LLC).
2.3 Haplotype Association with HIV-1 Infection Susceptibility 
2.3.1 Human subjects, genotyping and statistical analysis
191  males  exposed  to  HIV-1  infection  by  injection  drug  use  (IDU)  and
enrolled  in  prospective  cohort  studies in  Spain (Valme Hospital,  Sevilla)
who had shared needles for >3 months were recruited. Concurrent markers
of HCV infection were present in 100% of IDU subjects. Eighty-five of these
subjects  were  HIV-1  negative  (IDU-HESN  (HIV-1  exposed  seronegative
individuals)) and 106 were HIV-1 positive (IDU-controls (CTR)). 
Thirty-eight  Spanish  HESN  exposed  to  the  virus  through  unprotected
sexual intercourse (Sexual Exposed (SexExp)-HESN) were also recruited.
These  subjects  are  female  partners  of  HIV-1  positive  patients  (without
treatment and viremic, mean number of unprotected sexual intercourse per
year:  110,  mean  number  of  years  as  sexual  partners:  5,  range  3–17).
Healthy Controls (HCs) (n = 180) that were anonymous blood donors from
Jaen Hospital were also enrolled. All these individuals were seronegative
for both HIV-1 and HCV. All subjects were Spanish of Caucasian origin. The
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study was designed and performed according to the Helsinki declaration
and was approved by the Ethics Committee of the participating hospitals
and the University of Jaen. All patients and healthy blood donors provided
written informed consent to participate in this study. 
As for  Italian SexExp-HESN, inclusion criteria  were a history of  multiple
unprotected  sexual  episodes  for  more  than  4  years  at  the  time  of
enrolment,  with  at  least  three  episodes  of  at-risk  intercourse  within  4
months  prior  to  study  entry  and  an  average  of  30 (range,  18 to  >100)
reported unprotected sexual contacts per year [105].  SexExp-HESN and
188 HCs were recruited at the S. M. Annunziata Hospital, Florence; all of
them  were  Italian  of  Caucasian  origin.  The  study  was  reviewed  and
approved by the institutional review board of the S. M. Annunziata Hospital,
Florence. Written informed consent was obtained from all subjects. 
Variants hypothesized to be associated with HIV-1 infection susceptibility
were genotyped through PCR amplification and direct  sequencing.  PCR
products were treated with ExoSAP-IT (USB Corporation, Cleveland OH),
directly sequenced on both strands with a Big Dye Terminator sequencing
Kit  version 3.1  (Thermo Fisher  Scientific),  and run on a Thermo Fisher
Scientific  ABI  3130  XL  Genetic  Analyzer  (Thermo  Fisher  Scientific).
Sequences  were  assembled  using  DNA  Baser  Sequence  Assembler
version 4.10,  and inspected manually by two distinct  operators.  Genetic
association  analyses  were  performed  by  logistic  regression  and  results
from the three cohorts were combined using a random-effect metaanalysis;
all analyses were performed using PLINK [106]. 
2.3.2 HIV Infection Assay
This part was performed in association with a group at the Department of
Biomedical and Clinical Science “L. Sacco” of the University of Milan.
PBMCs from 50 HESN subjects were separated on lymphocyte separation
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medium (Organon Teknica, Malvern, PA); 10 × 106 cells/mL were cultured
for 2 days at 37 °C and 5% CO2 in RPMI 1640 containing FBS (20%),
phytohemagglutinin (7.5 μg/mL), and interleukin-2 (IL-2) (15 ng/mL). After
viability  assessment,  2.5  ×  106 cells  were  resuspended  in  medium
containing 1 ng of HIV-1Ba-L p24 viral input/106 PBMC and incubated for 3 h
at 37 °C. Cells were then washed and resuspended in 3 mL of complete
medium with IL-2 (15 ng/mL). Cells were plated in 24-well tissue culture
plates and incubated at 37 °C and 5% CO2. After 7 days supernatants were
collected  for  p24  antigen  enzyme-linked  immunosorbent  assay  (ELISA)
analyses. Absolute levels of p24 were measured using the Alliance HIV-1
p24 ELISA Kit  (PerkinElmer).  The HIV-infection assay was performed in
triplicate.  To account for  minor differences in virus titer,  p24 levels were
normalized  within  experiment.  HIV-1Ba-L was  provided  through  the  EU
programme EVA centre for AIDS Reagents NIBSC, UK. 
2.3.3 IFN-α Stimulation and Transcript Quantification 
This part was performed in association with a group at the Department of
Biomedical  and  Clinical  Science  “L.  Sacco”  of  the  University  of  Milan.
Whole blood was collected from 45 HCs by venupuncture in Vacutainer
tubes  containing  EDTA  (Becton  Dickinson,  NJ),  and  PBMCs  were
separated on lymphocyte separation medium (Organon Teknica, Malvern,
PA). Based on data derived from a kinetic study, 5 × 105 freshly isolated
PBMCs were  incubated  for  3  h  with  medium alone  or  400  U/ml  IFN-α
(Sigma Aldrich). RNA was extracted from cultured PBMC by using the acid
guanidium  thiocyanate–phenol–chloroform  method.  The  RNA  was
dissolved in RNase-free water, and purified from genomic DNA with RNase-
free  DNase  (RQ1  DNase;  Promega,  Madison,  WI).  1  µg  of  RNA was
reverse transcribed into first-strand cDNA in a 20µl final volume containing
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1 µM random hexanucleotide primers, 1 µM oligo dT, and 200 U Moloney
murine  leukemia  virus  reverse  transcriptase  (Clontech,  Palo  Alto,  CA).
cDNA quantification for the genes of interest and  GAPDH was performed
by  a  real-time  PCR  strategy  (DNA Engine  Opticon  2;  MJ  Research,
Ramsey, MN). Reactions were performed using a SYBR Green PCR mix (5
Prime, Gaithersburg, MD). Results were expressed as ΔΔCt and presented
as ratios between the target gene and the GAPDH housekeeping mRNA.
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3. RESULTS AND DISCUSSION
3.1 Adaptation to dietary selective pressure
3.1.1  Natural  selection  at  the  brush-border:  adaptations  to
carbohydrate diets in humans and other mammals  
The  ever-increasing  availability  of  genome  sequences  from  different
organisms and from multiple individuals of the same species, together with
resequencing  data  of  ancient  DNA  samples,  now  allows  to  perform
comprehensive  evolutionary  analyses  of  biological  pathways.  Herein  I
exploited this wealth of information to investigate the evolutionary history of
genes that encode intestinal brush-border proteins involved in carbohydrate
metabolism. This decision was based on the well-accepted concept that the
availability  of  food  resources  is  a  driver  of  pivotal  importance  in  the
evolution  in  mammals  and  by  the  fact  that  one  of  the  most  important
turning-points of human history, the introduction of agriculture, resulted in a
dietary shift in terms of carbohydrate intake. In this respect, the availability
of  human DNA samples  of  pre-agricultural  populations  allows  testing  of
specific hypotheses as to when adaptive alleles at genes involved in sugar
metabolism arose. The text-book examples of positive selection at the LCT
(lactase)  locus in  pastoralism [107],  as well  as the increase in  amylase
gene copy number in  human populations that  consume starch-rich diets
[108, 109], were the starting point for the work, which focuses on 9 genes
encoding apical brush-border proteins involved in carbohydrate digestion
and absorption. Specifically, I analyzed MGAM (maltase-glucomylase), SI
(sucrase-isomaltase),  LCT  and  TREH  (trehalase),  which  break  down
complex sugar into monosaccharides; SLC2A2, SLC5A1 and SLC2A5, that
are  specialized molecules  located at  the apical  brush-border  membrane
and  transport  monosaccharides  to  enterocytes;  TAS1R2  and  TAS1R3,
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sweet  receptors  at  the  intestinal  brush-border  apical  membrane,  which
probably activate gut hormone secretion through glucose sensing. 
I  performed an  in-depth  analysis  of  the  evolutionary  history  of  these  9
genes encoding apical brush-border proteins in 40 mammalian species. 
Our  results  indicated  pervasive  selection  in  mammals  and  human
populations  at  genes  coding  for  brush-border  carbohydrate  metabolism
genes.  Episodic  positive  selection  was  also  detected  for  several
mammalian  lineages.  For  TREH,  for  instance,  two  positively  selected
lineages (microbat and platypus) have a diet that includes trehalose. I also
detected  positive  selection  at  SI  in  both  bat  species  (megabat  is
frugivorous,  microbat  insectivore),  with  microbat  also  showing  selection
signatures at  MGAM and TREH. As an adaptation to flight, bats generally
display a reduced small intestinal nominal surface area compared to non-
flying mammals,  and resort  to higher sugar paracellular absorption as a
compensation [110].  Positive selection at  individual  mammalian lineages
might therefore reflect specific adaptations to flight (bats) and to specialized
diets (insects, crustaceans). 
Several positive selected sites lend themselves to further exploration by
means of biochemical and molecular biology tools. This will be particularly
interesting for sites that involve the catalytic sites or show parallel evolution
in MGAM and SI, as well as for those flanking missense mutations. 
As  for  humans,  SLC5A1 (the  major  transporter  of  dietary  glucose)
displayed several positively selected codons in the human but not in the
chimpanzee lineage. However, the selective pressure predated agriculture.
Indeed, this was the case for most non-coding positively selected variants
identified in human populations. Some of these are “modern alleles” when
Neandertals  and  Denisovans  are  taken  as  a  comparison,  but  not  as
modern as to unequivocally support their agriculture-driven spread. Indeed,
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based on the sequencing of a Denisova and a Neandertal individual, and
on allele frequency in extant human populations, Prufer and colleagues [56]
compiled a list  of  modern-human-specific-alleles,  suggested to represent
changes that were most important during the recent evolutionary history of
our species. Results herein indicate that modern alleles at SLC5A1 and SI
were  indeed  driven  to  high  frequency  by  natural  selection  in  human
populations. Nevertheless, most of these positively selected modern alleles
were  already  present  in  the  Mesolithic  and  Paleolithic  and,  therefore,
predate  the  emergence  of  agriculture.  Whether  the  onset  of  selection
occurred  before  the  Paleolithic  or  these  alleles  segregated  as  neutral
standing  variation  in  these  early  populations  remains  to  be  evaluated,
possibly  through  the  sequencing  of  additional  ancient  samples.  Early
hominins exploited underground storage organs (USOs, rich in starch) and
plant food rich in fermentable carbohydrates (acorns and nuts) [111, 112].
Thus,  the  introduction  of  agriculture  might  have  spurred  the  frequency
increase of variants that were already weakly adaptive in hunter-gatherers,
resulting in a continuum rather than an abrupt onset of selective events. A
similar concept has been proposed for traits unrelated to diet [58]. Clearly,
these data have a relevance in explaining the high prevalence of diabetes
and obesity seen in modern populations. 
Some of the selective events I identified open many interesting research
avenues. As an example, I detected positive selection at SLC2A5 (fructose
transporter)  in  Europeans.  Reminiscent  of  lactose  intolerance,  some
degree of fructose intolerance, associated with gastrointestinal symptoms,
is quite common in humans [113, 114] and fructose absorption is reduced
by the presence of sorbitol [114]. Thus, selection at  SLC2A5 might have
been  driven  by  the  domestication  and  widespread  consumption  in
temperate areas of fruit crops (e.g. apples and pears) that contain excess
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fructose plus sorbitol [114]. It will be extremely interesting to test whether
the positively selected variant I identified herein (and which is in LD with an
eQTL), modulates fructose absorptive capacity.
The  analyses  provides  also  valuable  informations  concerning  the
susceptibility  of  human  populations  to  metabolic  diseases;  e.g.  the
selection targets at  SLC2A2 are in  phase with the risk allele for  fasting
glucose levels and with the non-risk allele for gamma-glutamyl transferase
levels.
Personal contribution to the work: I particularly focused on the evolutionary analysis in
mammals and on the lineage-specific selection analysis. I also produced figures and tables
for the manuscript.
43
Natural selection at the brush-border: adaptations to 
carbohydrate diets in humans and other mammals
Chiara Pontremoli,1* Alessandra Mozzi,1* Diego Forni,1* Rachele Cagliani,1 
Uberto Pozzoli,1 Giorgia Menozzi,1 Jacopo Vertemara,1 Nereo Bresolin,1,2 Mario 
Clerici,3,4 Manuela Sironi1
1 Bioinformatics, Scientific Institute IRCCS E.MEDEA, 23842 Bosisio Parini, Italy.
2 Dino Ferrari Centre, Department of Physiopathology and Transplantation, University of Milan, Fondazione Ca' Granda IRCCS 
Ospedale Maggiore Policlinico, 20122 Milan, Italy. 
3 Department of Physiopathology and Transplantation, University of Milan, 20090 Milan, Italy.
4 Don C. Gnocchi Foundation ONLUS, IRCCS, 20148 Milan, Italy.
* these authors equally contributed to this work
Corresponding author: Manuela Sironi, PhD, Bioinformatics - Scientific Institute IRCCS E.MEDEA, 23842 Bosisio Parini, Italy.
Tel: +39-031877915; Fax:+39-031877499; e-mail: manuela.sironi@bp.lnf.it
Abstract
Dietary shifts can drive molecular evolution in mammals and a major transition in human history,
the agricultural revolution, favored carbohydrate consumption. We investigated the evolutionary
history of 9 genes encoding brush-border proteins involved in carbohydrate digestion/absorption.
Results  indicated  widespread  adaptive  evolution  in  mammals,  with  several  branches
experiencing episodic selection, particularly strong in bats. Many positively selected sites map to
functional protein regions (e.g. within glucosidase catalytic crevices), with parallel evolution at
SI and  MGAM. In human populations five genes were targeted by positive selection acting on
non-coding variants within regulatory elements. Analysis of ancient DNA samples indicated that
most  derived  alleles  were  already  present  in  the  Paleolithic.  Positively  selected  variants  at
SLC2A5 (fructose  transporter)  were  an  exception  and  possibly  spread  following  the
domestication of specific fruit crops. We conclude that agriculture determined no major selective
event  at  carbohydrate  metabolism  genes  in  humans,  with  implications  for  susceptibility  to
metabolic disorders.
Keywords: MGAM; SI; LCT; TREH; SLC2A2; natural selection.
Introduction
Diet  played  an  extremely  important  role  in  the
evolution  of  mammals  and  pathways  that  allow
nutrient  breakdown  and  absorption,  as  well  as
taste perception, evolved in response to changes in
trophic  strategies  (Karasov  et  al.  2011).  In
particular, simple and complex sugars account for
a different proportion of energy intake in diverse
species  and  a  positive  relationship  is  observed
between the dietary intake of carbohydrates  and
the  presence  of  gut  enzymes  and  transporters
necessary  for  their  digestion  and  absorption
(Karasov et al. 2011). 
In  humans,  culture  has  paralleled  and  often
affected  genetic  evolution;  in  particular,  the
domestication of plant and animals  determined
dramatic  dietary shifts  during the  evolution  of
our species. One of the most prominent signals
of positive selection in the genome of European
populations  is  observed  at  the  LCT gene,
encoding a small intestine brush-border enzyme
that  catalyzes  the  hydrolysis  of  lactose  into
monosaccharides that can be absorbed (Fig. 1A)
(Tishkoff et  al.  2007).  Variants that allow  LCT
expression  after  weaning  are  strongly  selected
for  in  populations  that  historically  relied  on
animal  husbandry  (Tishkoff  et  al.  2007).
Likewise, the development of agriculture 
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Figure 1. Analyzed genes, protein domain structure, and dog gene analysis. (A) The image is modified from KEGG (hsa04967) and
gene products are color-coded with enzymes in orange, transporters in blue, and taste receptors in green. Amylases (not included in this
study) are shown in red. (B) Domain representation of positively selected genes. Sites selected in whole phylogeny are in red; positively
selected sites in the human, chimpanzee, and gorilla lineage are in cyan, orange, and violet, respectively. Asterisks denote lineage-specific
sites that are also selected in whole phylogeny. Positions refer to the human sequence. (C) MGAM and SLC5A1 phylogenetic tree for
Laurasiatheria. Aminoacid status at positions 797 and 1001, as well as at the 7 C-terminal positions is shown for MGAM. Gray shading
indicates identity with the dog sequence. Position 244 is reported for SLC5A1. 
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resulted in starch being an increasingly abundant
component  in  human  diets.  In  our  species,
duplication  of  the  pancreatic  AMY2 gene
originated  the  salivary  amylase  gene  (AMY1),
which  shows  extensive  copy  number
variation(Perry et al. 2007). The number of AMY1
copies is higher in populations that consume high-
starch  diets,  indicating  selection  for  increasing
starch  digestion  capacity  (Perry  et  al.  2007).
Analysis  of  dog  genomes  also  revealed
polymorphic increase in AMY2B (pancreatic) copy
number  during  domestication,  suggesting  that
these animals adapted to a diet rich in agricultural
refuse  (Axelsson  et  al.  2013;  Freedman  et  al.
2014).In  most  mammals  amylases  catalyze  the
first step in the digestion of starch; the following
reactions  occur  in  the  small  intestine  where,  in
addition  to  LCT,  three  brush-border  enzymes,
trehalase  (TREH),  maltase-glucoamylase
(MGAM),  and  sucrase-isomaltase  (SI)  break
down complex sugars into monosaccharides (Fig.
1A, Table 1). These latter are then transported to
enterocytes  by  specialized  molecules  (SLC5A1,
SLC2A2,  and  SLC2A5),  located  at  the  apical
brush-border membrane (Fig. 1A, Table 1). 
In  addition  to  enzymes  and  transporters,  sweet
taste receptors (TAS1R2 and TAS1R3) have also
been observed at the intestinal brush-border apical
membrane  in  different  mammals,  where  they
probably activate gut  hormone secretion through
glucose sensing (Fig. 1A, Table 1).
In line with the central role of starch metabolism
in humans  and other  mammals,  the  MGAM and
SLC5A1 loci were targeted by natural selection in
dogs (Axelsson et al. 2013). In humans, signals of
selection at genes involved in starch and sucrose
metabolism  have  been  detected  for  populations
that  rely  on  roots  and  tubers  as  staple  foods
(Hancock  et  al.  2010).  Nonetheless,  the
evolution  of  brush-border  carbohydrate
metabolic  genes  has  never  been  analyzed  in
detail.  Herein  we  use  both  inter-  and  intra-
species comparisons to analyze the evolution of
these  9  genes  in  mammals  and  human
populations.  For  the  inter-species  analyses,  we
focused on coding regions by applying different
methods  to  assess  whether  brush-border
carbohydrate  metabolic  genes  were  targets  of
either pervasive or episodic positive selection. In
this  context,  positive  selection  is  defined  by a
faster  rate  of  accumulation  of  nonsynonymous
(aminoacid-replacing) compared to synonymous
(non-aminoacid  replacing)  substitutions,  a
pattern that may involve only a limited number
of  sites  in  a  protein.  If  the  selective  pressure
acted  on  a  limited  number  of  lineages  in  a
phylogeny,  it  is  said  to  be  “episodic”.  As  for
intra-species  analyses,  we  focused  on  human
populations  and  integrated  information
concerning  archaic  hominins:  this  allowed
testing  of  specific  hypotheses  as  to  when
adaptive  alleles  at  genes  involved  in  sugar
metabolism  arose  or  spread.  In  this  case,  we
analyzed  both  coding  and  non-coding  regions
and we define positive selection as the frequency
increase  in  a  population  of  a  beneficial
variant/haplotype  (also  referred  to  as  selective
sweep). The general underlying premise for this
study is that natural selection acts on functional
genetic  variants  with  a  phenotypic  effect.
Therefore,  evolutionary  analysis  can  provide
information  on  the  location  and  nature  of
adaptive  changes  that  modulate  phenotypic
diversity in humans and other mammals. 
Materials and Methods
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Algorithms,  programs,  and  tests  applied  for  all
analyses are summarized in Supplementary Table
S1, Supplementary Material online.
Evolutionary analysis in mammals
Mammalian sequences genes were retrieved from
the  NCBI  database  (as  of  January  7th,  2015)
(Supplementary Table S2, Supplementary Material
online).  Mammalian  orthologs  of  human  brush-
border  genes  were  included  only  if  they
represented  1-to-1  orthologs  as  reported  in  the
EnsemblCompara GeneTrees (Vilella et al. 2009).
The  MGAM gene  may  have  undergone  domain
duplications  in  some mammals  (Naumov 2007).
Although  all  the  sequences  we  obtained  from
NCBI  were  comparable  in  size  to  the  human
sequence,  we  cannot  exclude  annotation  errors
and, therefore, aligning of paralogous domains. 
However,  we  note  that,  even  in  this  case,  our
results would not be significantly affected because
the methods we used to detect positive selection
are  equally  applicable  to  paralogous  and
orthologous regions (Bielawski and Yang 2003).  
DNA  alignments  were  performed  using  the
RevTrans  2.0  utility  (Wernersson  and  Pedersen
2003), which uses the protein sequence alignment
as  a  scaffold  for  constructing the  corresponding
DNA multiple alignment. Alignment uncertainties
were  removed  using  trimAl  (automated1  mode)
(Capella-Gutierrez et al.  2009). Alignments were
checked by hand before running selection tests. 
Recombination  may  yield  false  positive  results
when  tests  of  positive  selection  are  applied
(Anisimova  et  al.  2003).  This  is  because  most
methods used to  infer  positive selection assume
that the phylogenetic tree and branch lengths are
constant across all sites in the alignment, a tenet
that is invalid in the presence of recombination.
We thus screened all alignments for the presence
of recombination breakpoints (the locations where
recombination  events  occur  in  the  alignments)
using GARD (Genetic Algorithm Recombination
Detection)  (Kosakovsky  Pond  et  al.  2006).  No
evidence of recombination was detected for  LCT,
SLC2A2, and  TAS1R2, whereas breakpoints were
detected for the remaining genes. 
SLAC  (Single  Likelihood  Ancestor  Counting)
was  applied  to  calculate  the  average  non-
synonymous   substitution/synonymous
substitution  rate  (dN/dS)  for  the  9  genes
(Kosakovsky  Pond  and  Frost  2005).  To  detect
positive  selection  we  used  the  site  models
implemented in PAML (Yang 1997; Yang 2007);
NSsite models that allow (M2a, M8,) or disallow
(M1a, M7) sites to evolve with dN/dS >1 were
fitted to the data with two models of equilibrium
codon  frequencies:  the  F3x4  model  (codon
frequencies  estimated  from  the  nucleotide
frequencies in the data at each codon site) and
the  F61 model  (frequencies  of  each  of  the  61
non-stop  codons  estimated  from  the  data)
(Supplementary  Tables  S3,  Supplementary
Material online). These analyses were performed
either  for  whole  gene  alignments  or
independently  for  sub-regions  defined  in
accordance with the recombination breakpoints.
In  these  latter  cases  Bonferroni  correction  for
multiple  tests  was  applied  to  the  maximum-
likelihood  ratio  tests  (LRT)   p values
(Supplementaty  Tables  S3,  Supplementary
Material  online).  Trees  were  generated  by
maximum-likelihood using the program PhyML
(Guindon  et  al.  2009).  Whenever  maximum-
likelihood  trees  showed  differences  (always
minor)  from  the  accepted  mammalian
phylogeny,  analyses  were  repeated  using  the
accepted tree, and the same results were obtained
in  all  cases  (not  shown).  Sites  under  selection
with the M8 model were identified using Bayes
Empirical  Bayes  (BEB)  analysis  with  a
significance  cutoff  of  0.90  (Anisimova  et  al.
2002;  Yang  et  al.  2005).  For  MEME  (Mixed
Effects Model of Evolution) (Murrell et al. 2012)
the  default  cutoff  of  0.10  was  used.  
To  explore  possible  variations  in  selective
pressure among different mammals for the five
positively  selected  genes,  we  tested  whether
models that allow dN/dS to vary along branches
had significant better fit to the data than models
that  assume one same dN/dS across  the entire
phylogeny  (Yang  and  Nielsen  1998).  This
condition  was  verified  for  all  genes
(Supplementary  Table  S4,  Supplementary
Material online). 
To identify specific branches with a proportion
of  sites  evolving  with  dN/dS>1,  we  used  BS-
REL  (Kosakovsky  Pond  et  al.  2011).  This
method  implements  branch-site  models  that
simultaneously  allow  dN/dS  variation  across
branches and sites. One advantage of BS-REL is
that it requires no prior knowledge about which
lineages are of interest (i.e. are more likely have
experienced  episodic  diversifying  selection).
Branches  identified  using  this  approach  were
cross-validated using the branch-site likelihood
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ratio  tests  from codeml  (the  so-called  modified
model A and model MA1, “test 2”) (Zhang et al.
2005). In this test, branches are divided  a priori
into foreground (those to be analyzed for positive
selection)  and  background  lineages,  and  a
likelihood ratio test is applied to compare a model
that  allows  positive  selection on the foreground
lineages with  a  model  that  does not  allow such
positive  selection.  A  false  discovery  rate
correction  was  applied  to  account  for  multiple
hypothesis  testing  (i.e.  we  corrected  for  the
number  of  tested  lineages),  as  suggested
(Anisimova  and  Yang  2007).  MEME  and  BEB
analysis  from MA (with  a  cutoff  of  0.90)  were
used to  identify sites  that  evolve  under  positive
selection  on  specific  lineages  (Supplementary
Table  S5,  Supplementary  Fig.  S1  and  S2,
Supplementary Material online). 
Ancestral  site  reconstruction  was  obtained
through  the  DataMonkey  sever  by  ASR  utility,
which  implements  three  different  methods
(Delport et al. 2010) .
GARD,  MEME,  SLAC,  and  BS-REL analyses
were  performed either  through the  DataMonkey
server (Delport et al. 2010) or run locally (through
HyPhy) (Supplementary Table S1, Supplementary
Material online).
Population genetics-phylogenetics analysis
Data from the Pilot 1 phase of the 1000 Genomes
Project were retrieved from the dedicated website
(1000 Genomes Project Consortium et al. 2010).
SNP  genotype  information  for  25  unrelated
chimpanzees  and  27  unrelated  gorillas  were
retrieved  from  (Prado-Martinez  et  al.  2013).
Coding sequence information was obtained for the
9  genes  and  the  ancestral  sequence  was
reconstructed  by  parsimony  from  the  human,
chimpanzee,  orangutan  and  macaque  sequences.
Analyses  were  performed  with  gammaMap
(Wilson et al. 2011).
For gammaMap analysis, we assumed θ (neutral
mutation rate per site), k (transitions/transversions
ratio), and T (branch length) to vary among genes
following log-normal distributions. For each gene
we  set  the  neutral  frequencies  of  non-STOP
codons  (1/61)  and  the  probability  that  adjacent
codons  share  the  same  selection  coefficient
(p=0.02). For selection coefficients we considered
a  uniform  Dirichlet  distribution  with  the  same
prior  weight  for  each  selection  class.  For  each
gene  we  run  10,000  iterations  with  thinning
interval of 10 iterations.
Population genetics analyses
A set  of  programs  was  developed  to  retrieve
genotypes from the 1000 Genomes Pilot Project
MySQL  database  (1000  Genomes  Project
Consortium  et  al.  2010)  and  to  analyse  them
according to selected regions/populations. These
programs  were  developed  in  C++  using  the
GeCo++  (Cereda  et  al.  2011)  and  the
libsequence (Thornton 2003) libraries. Genotype
information was obtained for the 9 brush-border
genes. In order to obtain a control set of ~1,000
genes  to  use  as  a  reference  set,  we  initially
selected  1,200  genes  by  random  sampling  of
those included in the RefSeq list. For these genes
we  retrieved  orthologous  regions  in  the
chimpanzee,  orangutan  or  macaque  genomes
(outgroups)  using  the  LiftOver  tool;  genes
showing less than 80% human-outgroup aligning
bases were discarded. This originated a final set
of 987 genes, hereafter referred to as control set.
Compared  to  the  control  set,  no  brush-border
gene was exceptional in terms of recombination
rate  and  none  (with  the  exclusion  of  TAS1R3,
which  displayed  no  selection  signature)  had
unusually  high  GC  content,  which  may  bias
selection inference (Pollard et al. 2006) (Fig. S3,
Supplementary  Material  online).
Nucleotide  diversity  over  whole  gene  regions
was measured as  π  (Nei  and Li  1979) and θW
(Watterson 1975). DH (Fay and Wu 2000; Zeng
et al.  2006) was also calculated in 5kb sliding
windows moving with a step of 500 bp.  Sliding
window  analyses  have  an  inherent  multiple
testing  problem  that  is  difficult  to  correct
because of the non-independence of windows. In
order to partially account for this limitation, we
applied the same procedure to the control gene
set, and the distribution of DH was obtained for
the  corresponding  windows.  This  allowed
calculation of the 5th  percentile and visualization
of regions below this threshold.
FST (Wright 1950) and the DIND (Derived Intra-
allelic Nucleotide Diversity)  test (Barreiro et al.
2009) were calculated for all SNPs mapping to
the control and brush-border gene sets. Because
FST values  are  not  independent  from  allele
frequencies,  we  binned  variants  based on  their
MAF (Minor Allele Frequency, 50 classes) and
alculated the percentiles distributions for each 
48
Figure 2. 3D mapping of selected sites.  Surface representation of MGAM maltase domain (PDB: 3L4V) in complex with kotalanol (blue
stick) (A) and SI isomaltase domain (PDB: 3LPP) (B). Catalytic crevices are shown in the enlargements; color codes as follows: red,
positively selected sites in the whole phylogeny; yellow, lineage-specific sites; orange and cyan, positively selected sites in the chimpanzee
and human lineages, respectively; green, catalytic residues; blue, aminoacids involved in ligand binding (Sim et al. 2010). (C) Mapping of
positively selected sites onto the TREH structure; color codes are as above; violet: positively selected residues in gorilla. (D) Multiple
alignment of MGAM and SI trefoil domains for a few of representative mammalian species; positively selected sites (whole phylogeny) are
in red. Asterisks indicate conserved cysteine residues. The structural superimposition of trefoil domains of MGAM (orange) (PDB code:
3TON) and SI (light blue) (Protein Model Portal code: P14410, Model 2) is also shown. Positively selected sites on whole phylogeny are
represented as sticks, green for SI and red for MGAM.
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MAF class. As for the DIND test,  we calculated
statistical  significance by obtaining an empirical
distribution  of  DIND-DAF  (Derived  Allele
Frequency) value pairs for variants located within
control  genes.  Specifically,  DIND  values  were
calculated for all SNPs using a constant number of
40  flanking  variants  (20  up-  and  down-stream).
The distributions of DIND-DAF pairs for Yoruba
(YRI),  Europeans  (CEU),  and  Chinese  plus
Japanese (CHBJPT) was binned in DAF intervals
(100  classes)  and  for  each  class  the  percentiles
distributions  were  calculated.  As  suggested
previously  (Barreiro  et  al.  2009),  for  values  of
iπD= 0 we set the DIND value to the maximum
obtained over the whole dataset plus 20.  Due to
the  nature  of  low-coverage  data,  for  low  DAF
values most iπD  resulted equal to 0 (i.e. the 95 th
percentile could not be calculated);  thus, we did
not  calculated  DIND  in  these  ranges  and  we
consequently cannot detect selection acting on low
frequency derived alleles.   
For  the  DIND  test,  an  approach  based  on
coalescent simulations was also applied to assess
statistical  significance.   In  particular,  coalescent
simulations  were  performed  using  the  cosi
package  (Schaffner  et  al.  2005)  with  2000
iterations.  Simulations  were  conditioned  on
mutation and recombination rates, and on a region
length of 20,000 bp.  We simulated demographic
patterns using parameters for YRI, CEU and AS as
described in (Grossman et al.  2010) with a data
thinning  procedure  that  improves  fitting  to  the
1000  Genomes  empirical  data  (Engelken  et  al.
2014). Estimates of the population recombination
rate parameter ρ were obtained from UCSC table
browser. 
Results
Most  brush-border  carbohydrate
digestion/absorption genes evolve adaptively in
mammals.
We  analyzed  the  evolutionary  history  of  genes
involved in carbohydrate metabolism. These were
selected  on  the  basis  of  KEGG  pathway
“Carbohydrate  digestion  and  absorption”
(hsa04973)  with  the  inclusion  of  brush-border
proteins  only  and  the  addition  of  TREH
(GO:0044245, polysaccharide digestion) (Fig. 1A,
Table  1).  We  obtained  coding  sequence
information  from  public  databases.  Except  for
TAS1R3, at least 39 species were available for
each gene (Table 1, Supplementary Table S2,
Supplementary  material  online).  We  first
calculated  the  average  non-synonymous
substitution/synonymous  substitution  rate
(dN/dS) for the 9 genes: in all cases dN/dS was
lower than 1 (Table 1), indicating a major role
for  purifying  selection  in  shaping  genetic
diversity.  Although  constraints  on  protein
function and structure often result in purifying
selection being the primary force  that  shapes
diversity  at  coding  sequences,  diversifying
selection  might  involve  specific  sites  or
domains.  To  test  this  possibility,  we  applied
maximum-likelihood  ratio  tests  (LRT)
implemented  in  the  codeml  program  (Yang
2007)  after  accounting  for  the  presence  of
recombination.  Specifically,  we  compared
models  of  gene  evolution  that  allow (NSsite
models  M2a  and  M8,  positive  selection
models) or disallow (NSsite models M1a and
M7, null models) a class of codons to evolve
with dN/dS >1. To assure reliability, different
codon  substitution  models  were  used
(Supplementary  Table  S3,  Supplementary
Material  online).  Results  indicated  that  five
brush-border  genes  were  targeted by positive
selection in mammals (Fig. 1B, Supplementary
Table  S3,  Supplementary Material  online).  In
order  to  identify  specific  sites  subject  to
positive  selection,  we  applied  the  Bayes
Empirical  Bayes  (BEB) analysis  (Yang et  al.
2005),  which  calculates  the  posterior
probability  that  each  codon  is  from  the  site
class of positive selection (under model M8).
An  additional  method,  the  Mixed  Effects
Model  of  Evolution  (MEME)  (Murrell  et  al.
2012)  was  also  applied.  MEME  allows  the
distribution of dN/dS to vary from site to site
and from branch to branch at a site, therefore
allowing  the  detection of  both pervasive  and
episodic  positive  selection;  the  method  has
been shown to have more power than methods
that  assume  constant  dN/dS  across  lineages
(Murrell et al. 2012). To be conservative, only
sites  detected  using  both  BEB  and  MEME
were  considered  targets  of  positive  selection
(Fig.  1B);  their  functional  implications  are
analyzed below. 
Different selective pressure among lineages
We  next  explored  possible  variations  in
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selective pressure  among different  mammals  for
the  five  positively  selected  genes  (Fig.  1B,
Supplementary Table  S4 and S5,  Supplementary
Fig. S1 and S2, Supplementary Material online). 
SI showed  the  strongest  evidence  of  episodic
selection:  several  positively  selected  residues
were identified for rodents and bats, with microbat
also  showing  positive  selection  at  MGAM
(Supplementary Table S5, Supplementary Fig. S2,
Supplementary  Material  online).  Interestingly,
microbat and platypus, the only two lineages that
experienced  episodic  selection  at  TREH
(Supplementary Table S5, Supplementary Fig. S1,
Supplementary Material  online)  have a  diet  that
includes  trehalose,  as  these  animals  feed  on
insects and crustaceans, respectively.
It  was  recently  suggested  that  MGAM and
SLC5A1 were  positively  selected  in  dog.  The
putative  adaptive  coding  changes  are  present  in
the  dog  reference  genome  (a  boxer)  and  are
accounted for by position M797 and V1001 (dog
residues)  in  MGAM,  where  a  2  aminoacid  C-
terminal extension was also noted (Axelsson et al.
2013).  Although  we  did  not  find  evidence  of
positive selection for any of the analyzed genes in
dog (Supplementary Table S5, Supplementary Fig.
S1  and  S2,  Supplementary Material  online),  we
analyzed these residues by taking into account the
known phylogeny of mammals  and by ancestral
state reconstruction at internal nodes (this was not
feasible for the C-terminal extension). As shown
in  Figure  1C,  dogs  share  the M797 and  V1001
residues  with  several  related  species  and  these
aminoacids  represent  the ancestral  state  at  most
nodes. Inference on the C-terminal extension was
more difficult, due to extensive variability in this
region;  dog  shares  the  2  aminoacids  extension
with  cat,  cow,  and  alpaca,  although  with  minor
differences in these two latter species (Fig. 1C). A
similar  analysis  for  the  SLC5A1 putatively
selected  site  (V244)  (Axelsson  et  al.  2013)
indicated  frequent  substitutions  at  this  position,
with valine being shared by dog, ferret, and other
species  (Fig.  1C).  Calculation of dN/dS for  this
position in the whole phylogeny indicated a value
of 1.19, close to selective neutrality. 
Several  positively  selected  sites  impinge  on
functional protein regions
We  detected  one  positively  selected  site  in  the
maltase  domain  of  MGAM  (A662,  Fig.  1B),
which is in close spatial proximity to the active
site (Sim et al.  2010) (Fig. 2A). Similarly,  in
the SI isomaltase subunit some lineage-specific
positively  selected  sites  were  found  to  be
located  in  nearby  the  substrate-binding  and
active sites (Fig. 2B, Supplementary Table S5,
Supplementary  Material  online)  (Sim  et  al.
2010). As for TREH, two of the selected sites
we  identified,  E159  (whole  phylogeny)  and
P287  (microbat)  are  also  in  proximity  to
residues involved in substrate binding (Fig. 2C,
Supplementary  Table  S5,  Supplementary
Material online). 
A part from these sites, most selected residues
in  MGAM and  SI  are  surface-exposed,  with
some  of  them  defining  continuous  surface
patches  (Supplementary  Fig.  S4,
Supplementary  Material  online).  Moreover,  a
considerable  proportion of  positively selected
sites maps to the trefoil or P domains (PD, Fig.
1B).  The  superimposition  of  the  two  PDs
revealed that the two positively selected sites
of MGAM (T979, A987) correspond to T956
and T964, which are positively selected in SI
(Fig. 2D). 
Although four  glycosyl-hydrolase domains of
SI and MGAM share limited sequence identity,
their  3D  structure  is  remarkably  similar.
Structural  superimposition  indicated  that,  in
addition  to  the  trefoil  domain,  other
corresponding  regions  were  targeted  by
selection (Fig. 3B and C). 
In  SI,  missense  mutations  responsible  for
congenital  sucrase-isomaltase  deficiency
(CSID)  or  identified  in  chronic  lymphocytic
leukemia patients (CLL) have been shown to
alter the cellular trafficking of the protein, its
folding,  membrane  turnover  and  localization
(Spodsberg et al. 2001; Rodriguez et al. 2013).
We  noted  that  mutations  R91T  (CLL,
endoplasmic  reticulum  accumulation)  and
Q117R  (CSID,  mis-sorting  to  the  basolateral
membrane) (Spodsberg et al. 2001; Rodriguez
et  al.  2013)  immediately  flank  positively
selected  sites  (Fig.  3A).  3D  mapping  and
structural  comparisons  indicated  that  CSID
mutations  Q1098P,  C1229Y,  and  W1493C
(Propsting  et  al.  2003;  Alfalah  et  al.  2009;
Rodriguez  et  al.  2013)  are  located  in  close
spatial proximity to positively selected sites in
either SI or MGAM (Fig. 3B and C). 
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Parallel  and  divergent  evolution  of  brush-
border proteins in humans,  chimpanzees,  and
gorillas
We  next  applied  a  population  genetics-
phylogenetics approach to study the evolution of
brush-border  genes  in  the  human,  chimpanzee,
and  gorilla  lineages.  Specifically,  we  used
gammaMap (Wilson et al. 2011) that jointly uses
intra-specific variation and inter-specific diversity
to  estimate  the  distribution  of  selection
coefficients (γ) along coding regions. gammaMap
envisages 12 classes of γ, ranging from strongly
beneficial  (γ=100) to  inviable  (γ  =-500),  with γ
equal to 0 indicating neutrality.
We observed a general preponderance of codons
evolving under  negative  selection (γ  < 0)  in  all
genes  and  in  all  species.  The  most  striking
difference  was  observed  for  SLC5A1,  which
showed a preponderance of negative γ values in
chimpanzee and to a lesser extent in gorilla, but
not in our species, where an appreciable fraction
of  codons  showed  γ  values  higher  than  5  (Fig.
3D). We thus used gammaMap to identify specific
codons  evolving  under  positive  selection
(cumulative  probability  >0.80  of  γ  ≥  1)
(Supplementary  Table  S6,  Supplementary
Material online). Seven positively selected codons
were identified for SLC5A1 in humans, none in
chimpanzees  or  gorillas.  Whereas  two  of  these
(A411 and H615) might  have hitchhiked with a
regulatory  variant  (see  below),  analysis  of  the
remaining  sites  indicated  that  E341  and  G312
flank  one  of  the  transmembrane  helices
composing  the  so-called  “sugar  bundle”,  which
forms  extensive  contacts  with  carbohydrate
molecules  (Sala-Rabanal  et  al.  2012)  (Fig.  3E).
One  additional  site  (L645)  is  in  the  immediate
vicinity of a C-terminal luminal region that acts as
a  stereo-specific  sugar  binding  region  (Fig.  3E)
(Wimmer et al. 2009).
The  location  relative  to  3D  structures  of  other
positively selected sites (Supplementary Table S6,
Supplementary  Material  online)  are  shown  in
Figures 1B, 3B, 3C, and Supplementary S4. 
Pre-agricultural  origin  of  most  positively
selected alleles 
We finally investigated whether natural selection
acted  on  genes  involved  in  carbohydrate
digestion/absorption  during  the  recent
evolutionary history of human populations. We
excluded  LCT from  this  analysis,  as  its
selection pattern has been described in  detail
(Tishkoff et al. 2007). Natural selection leaves
signatures  that  can  be  detected  using
appropriate tests.
For  instance,  the  increase  in  frequency  of  a
selected haplotype (selective sweep) may result
in a temporary reduction in the level of genetic
variability (measured by θW  (Watterson 1975)
and π (Nei and Li 1979))  and in a shift of the
site  frequency  spectrum,  leading  to  a
deficiency  of  intermediate  frequency  alleles
(indicated  by  negative  values  of  Tajima's  D
(Tajima  1989)).  Also,  a  selective  sweep  may
determine an excess of high frequency derived
alleles  (which  can  be  assessed  with  the
normalized Fay and Wu's H (DH) test (Zeng et
al.  2006))  and  low  nucleotide  diversity
associated with the derived allele (Barreiro et
al.  2009).  This  latter  feature  can be searched
for  using  the  DIND  (Derived  Intra-allelic
Nucleotide  Diversity)  test  (Barreiro  et  al.
2009).  Thus,  using  the  1000  Genomes  Pilot
Project  data  (1000  Genomes  Project
Consortium  et  al.  2010)  for  Yoruba  (YRI),
Europeans (CEU), and Chinese plus Japanese
(CHBJPT),  we  estimated  nucleotide  diversity
and Tajima's D (Tajima 1989) over whole gene
regions.  We  also  calculated  pairwise  FST,  an
estimate  of  population genetic  differentiation,
and  performed  the  DIND  test  for  all  SNPs
mapping  to  these  genes  and  in  their  50  kb
flanks  (25  kb  up-  and  down-stream). For  all
tests  statistical  significance  (in  terms  of
percentile  rank)  was  obtained  by  deriving
empirical distributions; coalescent simulations
were  also  performed  for  the  DIND  test.  We
considered genes as positive selection targets if
significant results were obtained for the same
population  in  at  least  two statistics  based on
different  features;  we  also  considered  SNPs
with a significant DIND test in all populations
or with extremely high DIND ranks (>0.999).
Moreover, we obtained normalized values for
Fay and Wu's  H (DH) (Zeng et  al.  2006), in
sliding windows along the analyzed  genomic
regions;  DH  was  used  as  a  confirmatory
signature  but  not  in  the  initial  detection  of
selection  targets  (Supplementary  Table  S1,
Supplementary Material online). 
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Figure  3.  Parallel  evolution at  MGAM and SI,  and lineage-specific selection.  (A)  Multiple alignment  of  SI  aminoacids  78-130 for  a few of  representative
mammalian species. The location of mutations R91T and Q117R is shown. (B and C) Superimposition of the structure of the sucrase domain (SI, Protein Model Portal
code: P14410 Model 2, blue) with glucoamylase (MGAM, PDB code: 3TON, red) (B) and with isomaltase (SI, PDB code: 3LPP , pale blue) (C). Enlargements highlight
positively selected sites or residues subjected to pathological mutation located in the corresponding regions of the two different domains. Color codes are as in figure
2A-C. Human missense mutations affecting the protein sorting are reported in magenta. (D) Violin plot of selection coefficients (median, white dot; interquartile range,
black bar). Selection coefficients (γ) are classified as strongly beneficial (100, 50), moderately beneficial (10, 5), weakly beneficial (1), neutral (0), weakly deleterious
(−1), moderately deleterious (−5, −10), strongly deleterious (−50, −100), and inviable (−500). (E) Topological  representation of SLC5A1; transmembrane helices
forming the sugar- and hush-bundle are represented in yellow and green, respectively. The location of the stereo-specific and non-stereo-specific binding motifs is
shown in magenta and orange, respectively. Positively selected sites in the human lineage are in cyan. Residues in black are involved in sugar or Na + binding.
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In  SI,  the  DIND  test  detected  2  outlier  linked
variants in YRI, which also had unusually high FST
(Table 2); rs6788812 represented a DIND outlier
in CHBJPT, as well,  and was located in a local
valley of DH for this population (in line with DH
having  maximum  power  for  high-frequency
sweeps  (Zeng  et  al.  2006))  (Fig.  4A,  Table  2).
These  results  suggest  that  a  common  selective
sweep determined the frequency increase of these
variants  in  Asia  and Africa.  No selection signal
was detected in CEU and analysis of ancient DNA
samples   indicated  that  the  Denisova  and  Altai
Neandertal (Meyer et al. 2012; Prufer et al. 2014)
carry  the  ancestral  allele,  whereas  a  Mesolithic
European individual from the La Brana-Arintero
site (Olalde et al. 2014) harbors the derived allele
at rs6788812 (Table 2, Fig. 5). 
In  YRI  another  variant  (rs11919067)  had  an
extremely  high  DIND  rank  and  a  linked  SNP
(rs112446029)  represented  a  DIND  outlier,
although with lower rank (Table 2); both variants
have high DAF (derived allele frequency) in YRI,
whereas the derived allele is fixed outside Africa
(Table 2). Sliding-window analysis of DH in YRI
detected  a  local  valley  where  rs11919067  is
located (Fig.  4A).  Overall,  these results  suggest
that  a  selective  sweep  drove  the  frequency
increase of these variants  in all  populations and
that  the  process  is  complete  in  non-Africans.
Interestingly,  rs11919067 and rs112446029 have
been  cataloged  in  a  list  of  “modern-human-
specific sites”- i.e. positions where the Denisova
or  Altai  Neandertal  sequences  display  the
ancestral  allele,  whereas  most  modern  humans
carry the derived allele (Prufer et al. 2014) (Table
2,  Fig.  5). The  catalog also includes rs9917722
(T1802S), which we identified in the gammaMap
analysis  (Table  2,  Supplementary  Table  S6,
Supplementary  Material  online).  Analysis  of  all
modern-human-specific  sites  in  SI (Fig.  4A)
indicated that they mainly cluster in two regions,
one where rs9917722 and rs6788812 are located,
and  the  other  encompassing  rs11919067  and
rs112446029. In YRI rs9917722 shows no linkage
disequilibrium  (LD)  with  rs11919067  and
rs6788812  (r2=0.003  and  0.085,  respectively).
Overall, these data suggest that distinct selective
events,  have  occurred  at  SI  after  the  modern-
human  lineage  split  from the  common  ancestor
with  Denisovans  and  Neandertals.  Interestingly,
analysis  of  an  Upper  Paleolithic  sample  from
Siberia (Raghavan et al. 2014) indicated that this
individual  carried  the  derived  allele  at
rs11919067, rs112446029, and rs9917722 (Fig.
5). 
Signals of positive selection in all populations
were  also  detected  at  another  brush-border
enzyme,  TREH.  Indeed,  the  same  TREH
variant  (rs527619)  was  identified  as  a  DIND
outlier in all three populations, although with
different DAF (Table 2, Fig. 4B). 
As for  transporters,  SLC5A1 showed reduced
nucleotide  diversity  in  CHBJPT  and  low
Tajima's  D  in  CEU  and  CHBJPT
(Supplementary  Table  S7,  Supplementary
Material online). The DIND test detected five
linked outlier variants in CEU with a DAF of
0.94; the derived allele is fixed in YRI and AS
(Table 2). The SNPs are in a local valley of DH
in  Europeans,  and  a  very  local  and  limited
reduction in DH was also observed in YRI (DH
loses power at sweep completion) (Fig. 4C).
Four of the five SLC5A1 SNPs we detected are
listed  in  the  modern-human-specific  site
catalog,  which  also  includes  rs17683430
(A411T,  detected  by  gammaMap)  (Table  2,
Supplementary  Table  S6,  Supplementary
Material  online).  Analysis  of  modern-human-
specific sites along the SLC5A1 gene indicated
that they are scattered across a relatively large
region  with  a  clustering  around  the  five
variants detected (Fig. 4C); in Europeans these
are  in  tight  LD  with  rs17683430  and  with
rs33954001  (also  detected  by  gammaMap,
Supplementary  Table  S6,  Supplementary
Material  online)  (r2>0.86),  suggesting  these
SNPs hitchhiked to high frequency due to LD
with one of the DIND outlier variants. Analysis
of  the  Mesolithic  and  Paleolithic  samples
(Olalde  et  al.  2014;  Raghavan  et  al.  2014)
revealed  that  the  derived  allele  was  already
present at all selected variants (Fig. 5) . 
SLC2A2 also showed low Tajima's D values in
CHBJPT  (Supplementary  Table  S7,
Supplementary Material online). Four variants
were DIND outliers in CHBJPT and displayed
unusually  high  FST in  the  YRI/CHBJPT
comparison.  The  variants  have  high  DAF in
CHBJPT (Table 2) and are located in a local
DH valley, strongly supporting selective sweep
has  occurred  in  Asian  populations  (Fig.  4D).
Interestingly,  in CEU the four variants are in
tight  LD  (r2>0.9)  with  two  GWAS  SNPs
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(rs11920090  and  rs10513686)  associated  with
fasting glucose-related traits and gamma-glutamyl
transferase  (GGT)  levels  (Dupuis  et  al.  2010;
Chambers et al. 2011; Manning et al. 2012). Both
the Mesolithic and the Paleolithic samples carried
the derived allele at most SNPs (Fig. 5). Thus, in
analogy  to  the  SLC5A1 and  SI variants,  the
selected haplotype was present in the Paleolithic
(Fig. 5).
In  SLC2A2,  the  DIND  test  also  detected  six
outliers in YRI, which also display high FST values
(Table 2). These variants have a DAF of 0.90 in
YRI and fall in a DH valley (Fig. 4D); the derived
allele  is  fixed  or  almost  fixed  in  non-Africans,
suggesting  a  complete  sweep  that  predated  the
split  of  modern  humans  from  Neandertal  and
Denisovans,  as  these  hominins  also  carry  the
derived alleles (Fig. 5). 
Finally, in  SLC2A5 two DIND outlier variants in
CEU also displayed a high FST ranks (Table  2),
suggesting that a selective sweep has occurred in
Europeans. The two variants are in LD (r2= 0.76)
with  rs113568511,  identified  as  an  eQTL
(expression quantitative trait locus) for SLC2A5 in
lymphoblastoid  cell  lines  (Lappalainen  et  al.
2013). 
Several selected variants we detected map within
ENCODE functional  elements  (Fig.  4).  Overall,
we analyzed 8 genes (LCT was omitted) and we
found one  with  a  significant  DIND test  for  the
same  variant  in  three  populations  (TREH)  and
three  with  at  least  two variants  showing outlier
values both for the DIND and FST tests (SLC2A2,
SI, and SLC2A5) (Table 2). To obtain an estimate
of whether these findings are unusual and of the
incidence  of  false  positives,  we  adopted  a
resampling approach.  Specifically,  we  drew 100
samples  of  8  randomly  selected  genes  and  we
calculated the DIND tests and FST for all variants
mapping  to  these  genes.  For  each  sample  we
counted the number of positively selected genes,
defined as those carrying at least one variant with
significant  DIND test  in three populations or  at
least two variants showing outlier values both for
the DIND and FST tests  in the same population.
Results indicated that the probability of drawing a
set of genes showing the same or a higher number
of selected genes as those in the brush-border set
is 0.02.
Discussion
Adaptive evolution in mammals 
We explored the evolutionary history of genes
encoding  brush-border  proteins  involved  in
carbohydrate  digestion  and  absorption.  This
decision  was  based  on  the  well-accepted
concept that the availability of food resources
is a driver of pivotal importance in evolution in
mammals  and  that  individual  mammalian
lineages  might  have  adapted  to  specialized
diets  (e.g.  insects,  crustaceans)  or  lifestyles
(e.g. flight). 
We found evidence of positive selection at the
four brush-border enzymes, indicating stronger
selective pressure compared to transporters and
taste receptors. Episodic positive selection was
also detected for several mammalian lineages.
Whereas  for  TREH two  positively  selected
lineages  (microbat and platypus) have a diet
that  includes  trehalose,  mammals  showing
evidence of positive selection at MGAM and SI
display  different  food  habits.  Thus,  as
previously  reported  for  TAS1R2 (Zhao  et  al.
2010;  Jiang  et  al.  2012),  inference  of  the
underlying  selective  pressures  remains
uncertain.  Nonetheless,  we  detected  positive
selection at  SI in both bat species (megabat is
frugivorous,  microbat  insectivore),  with
microbat also showing selection signatures at 
MGAM and  TREH. As an adaptation to flight,
bats  generally  display  a  reduced  small
intestinal  nominal  surface  area  compared  to
non-flying mammals, and resort to higher sugar
paracellular  absorption  as  a  compensation
(Caviedes-Vidal  et  al.  2007).  Because
polysaccharides  require  digestion  before  they
can be metabolized, fast and efficient digestion
of  complex  sugars  would  be strongly
advantageous  in  these  species,  which  daily
ingest  large  amounts  of  food  (up  to  50% of
their  body  weight)  to  meet  energy
requirements. Whether positive selection at  SI
and MGAM is part of a more general adaptation
to flight in these animals remains an interesting
possibility worth further investigation.
Positively selected sites in enzyme encoding
genes
The rate  of  starch-generated glucose depends
on the activity of MGAM and SI, which have
complementary substrate specificity in humans 
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Figure  4.  Location  of  the  most  likely  selection  targets.  Candidate  targets  in  human  populations  and  their  genomic  locations
(GRCh37/hg19) are shown for SI (A), TREH (B), SLC5A1 (C), SLC2A2 (D), SLC2A5 (E) within the UCSC Genome Browser view. Relevant
ENCODE annotation tracks are shown as gray horizontal shading or colored peaks in case of histone marks. Candidate selection targets
falling in putative regulatory regions are indicated with cyan vertical lines. For SI, SLC5A1, and SLC2A2 a sliding-window analysis of DH is
also shown in green (YRI), red (CHBJPT) or blue (CEU). The gray horizontal line represents the 5th percentile of DH. Variants in blue, red
and green represent selection targets in CEU, CHBJPT, and YRI, respectively. The location of variants cataloged as modern-human-
specific sites are shown in orange. Additional color codes are as follows: cyan, positively selected sites in the human lineage detected by
gammaMap; violet, GWAS SNPs; magenta, eQTL.
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(Sim et al. 2010). In a few instances we found the
corresponding residues of  MGAM and SI to  be
targeted by selection, indicating an important role
for  these  sites.  An interesting possibility is  that
some selected sites in SI and MGAM evolved to
hone  the  folding,  cellular  trafficking,  and
membrane turnover of these enzymes, depending
on  specific  molecular  (e.g.  interaction  with
chaperones)  or  physiological  (e.g.  body
temperature) features of distinct mammals. In fact,
some of the identified selected sites are located in
close spatial proximity to SI missense mutations
that  affect  the  enzyme's  post-translational  fate,
sometimes showing temperature-sensitive  effects
(Propsting  et  al.  2003;  Alfalah  et  al.  2009;
Rodriguez  et  al.  2013).  In  analogy,  an  LCT
missense  mutation  associated  with  congenital
lactase deficiency (G1363S),  has been shown to
alter  protein  trafficking  and  folding,  partially
depending on temperature (Behrendt et al. 2009). 
Adaptive  events  in  primates  and  human
populations
Our study was also motivated by the observation
that one of the most important turning-points of
human  history,  the  introduction  of  agriculture,
resulted in a dietary shift in terms of carbohydrate
intake. In this respect, the availability of genetic
information  for  other  primates  and  for  pre-
agricultural  human  populations  allows  the
opportunity  to  address  the  tempo  and  mode  of
evolution  for  genes  involved  in  carbohydrate
digestion and absorption.
A notable observation is the different evolutionary
fate of  SLC5A1 in humans vs.  chimpanzees and
gorillas.  Still,  we  note  that,  whereas  some sites
positively selected in the human SLC5A1 gene are
likely  involved  in  sugar  binding,  the  signal  we
detected is partially accounted for by hitchhiking
of  coding  variants  with  the  intronic  positive
selection target(s), as population genetic analysis
indicated. 
Integration  of  different  tests  can  improve  the
power to detect selective sweeps and, importantly,
allows  identification  of  the  causal  variant(s)
(Grossman et al. 2013). Our approach includes the
DIND test, which is powerful in most DAF ranges
(Barreiro et al. 2009; Fagny et al. 2014) and less
sensitive than iHS to low genotype quality or low
coverage (i.e. it is well suited for the 1000G data)
(Fagny  et  al.  2014).  DIND  results  were
combined  with  pairwise  FST analyses  and
nucleotide diversity or Tajima's D, whereas DH
(Zeng et  al.  2006) was  calculated in  sliding-
windows to account  for  local events  and,  for
this reason, used as an a posteriori validation.
These  analyses  indicated that  five  out  of  the
nine genes we analyzed have been targeted by
selection  during  the  history  of  human
populations,  with  SI and  SLC2A2 having
experienced distinct  events  targeting different
variants. The majority of sweeps we detected
occurred in all analyzed populations, although
in  some  instances  they  have  reached
completion  (e.g.  SI and  SLC2A2 in  non-
Africans  and  SLC5A1 in  non-Europeans)  or
proceeded  with  different  timing/strength  (e.g.
TREH). 
The  availability  of  an  increasing  number  of
ancient  DNA  sequences  allows  the
unprecedented opportunity to define the time in
human history when selection operated, in turn
providing information on the possible selective
pressures.  Based  on  the  sequencing  of  a
Denisova and a Neandertal individual, and on
allele frequency in extant human populations,
Prufer et al (Prufer et al. 2014) compiled a list
of modern-human-specific-alleles, suggested to
represent  changes  that  were  most  important
during the  recent  evolutionary history of  our
species.  Results  herein  indicate  that  modern
alleles at SLC5A1 and SI were indeed driven to
high frequency by natural selection in human
populations.  Nevertheless,  most  of  these
positively selected modern alleles were already
present in the Mesolithic and Paleolithic and,
therefore, predate the emergence of agriculture.
Whether the onset of selection occurred before
the  Paleolithic  or  these  alleles  segregated  as
neutral  standing  variation  in  these  early
populations remains to be evaluated,  possibly
through  the  sequencing  of  additional  ancient
samples.  Although  with  uncertainty  due  to
possible gene conversions, the initial expansion
of the  AMY1 copy number was dated around
200,000  years  ago,  a  time  frame  that  might
coincide  with  the  introduction  of  starch-rich
underground  storage  organs  (USOs)  as  food
sources  in  hominin  diet  (Perry  et  al.  2007).
USOs are thought to have played an important 
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Figure 5. Positively selected variants in human populations. Genotype data are shown for a Neandertal, a Denisova, an Upper Paleolithic Siberian, 
and a Mesolithic hunter-gatherer; allele frequencies are shown for modern human populations (pie-charts). Only one allele is reported when coverage 
was not sufficient for genotype inference. Blue and red colors indicate ancestral and derived alleles, respectively. A temporal line with the approximate 
ages of the individuals is also reported (kya: thousands of years ago). 
role  in  human evolution  (Laden and Wrangham
2005).  Thus,  agriculture  might  have spurred the
frequency increase of variants  that  were already
weakly adaptive in hunter-gatherers, resulting in a
continuum rather than an abrupt onset of selective
events. A similar concept has been proposed for
traits  unrelated  to  diet  (Olalde  et  al.  2014).  
As for the more recent selective event at SLC2A5,
it is worth noting that some degree of fructose
intolerance  is  widespread  in  humans,  and
fructose  absorption  is  increased  by  the  co-
ingestion  of  glucose  and  is  reduced  by  the
presence  of  sorbitol  (Skoog  and  Bharucha
2004). Thus, selection at  SLC2A5 might have
been driven by the domestication in temperate
areas of fruit crops (e.g. apples and pears) that
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contain excess fructose plus sorbitol (Skoog and
Bharucha 2004).  Clearly,  it  would  be extremely
interesting  to  test  whether  the  positively  select
variant identified herein (and which is in LD with
an eQTL), modulates fructose absorptive capacity.
Selection targets in regulatory regions 
In analogy to the well-known selection targets at
the LCT locus (Tishkoff et al. 2007), the selection
signatures we identified in human populations tar-
get  non-coding  polymorphisms,  supporting  the
view that most adaptive changes affect regulatory
elements (Grossman et al. 2013). We suggest that
regulatory variants may also represent the selec-
tion target at the dog MGAM and SLC5A1 genes.
Although  the  analyses  we  performed  were  not
specifically devised to search for recent selective
events in dogs, and surely lack power in this re-
spect,  the candidate coding variants  Axelsson et
al.  (Axelsson et  al.  2013) proposed can be ana-
lyzed within the framework of the known mam-
malian phylogeny. Overall, these analyses suggest
that coding variants are not likely selection targets
in the canine  MGAM and  SLC5A1 genes, in line
with  the  observation  that  the  expression  of
MGAM is  higher  in  dogs  compared  to  wolves
(Axelsson et al. 2013).
Deeper  understanding  of  the  evolutionary  pro-
cesses associated with human dietary shifts is ex-
pected to provide valuable information concerning
the susceptibility of human populations to meta-
bolic diseases.  Data herein indicate that the selec-
tion targets at  SLC2A2 are in phase with the risk
allele for fasting glucose levels and with the non-
risk allele for GGT levels. This opens the question
as to whether the disease alleles hitchhiked with
the selected variant, or might be accounted for by
the  selected  haplotype.  In  either  case,  further
analyses will be required to determine which phe-
notype selection acted upon. 
Acknowledgments
CP is supported by a fellowship of the Doctorate
School  of  Molecular  Medicine,  University  of
Milan. 
References
1000 Genomes Project Consortium, et al. 2010. A
map of human genome variation from population-
scale sequencing. Nature 467:1061-1073.
Alfalah M., M. Keiser, T. Leeb, K. P. Zimmer,
and  H.  Y.  Naim.  2009.  Compound
heterozygous  mutations  affect  protein  folding
and  function  in  patients  with  congenital
sucrase-isomaltase  deficiency.
Gastroenterology 136:883-892.
Anisimova  M.,  and  Z.  Yang.  2007.  Multiple
hypothesis  testing  to  detect  lineages  under
positive selection that affects only a few sites.
Mol. Biol. Evol. 24:1219-1228.
Anisimova M., R. Nielsen, and Z. Yang. 2003.
Effect of recombination on the accuracy of the
likelihood  method  for  detecting  positive
selection  at  amino  acid  sites.  Genetics
164:1229-1236.
Anisimova M.,  J.  P.  Bielawski,  and Z.  Yang.
2002. Accuracy and power of bayes prediction
of  amino  acid  sites  under  positive  selection.
Mol. Biol. Evol. 19:950-958.
Axelsson  E.,  et  al.  2013.  The  genomic
signature  of  dog  domestication  reveals
adaptation  to  a  starch-rich  diet.  Nature
495:360-364.
Barreiro  L.  B.,  et  al.  2009.  Evolutionary
dynamics  of  human  Toll-like  receptors  and
their  different  contributions  to  host  defense.
PLoS Genet. 5:e1000562.
Behrendt M., M. Keiser, M. Hoch, and H. Y.
Naim.  2009.  Impaired  trafficking  and
subcellular  localization  of  a  mutant  lactase
associated  with  congenital  lactase  deficiency.
Gastroenterology 136:2295-2303.
Bielawski J. P., and Z. Yang. 2003. Maximum
likelihood  methods  for  detecting  adaptive
evolution  after  gene  duplication.  J.  Struct.
Funct. Genomics 3:201-212.
Capella-Gutierrez S., J. M. Silla-Martinez, and
T.  Gabaldon.  2009.  trimAl:  a  tool  for
automated  alignment  trimming  in  large-scale
phylogenetic  analyses.  Bioinformatics
25:1972-1973.
Caviedes-Vidal  E.,  et  al.  2007.  The  digestive
adaptation of flying vertebrates: high intestinal
60
paracellular  absorption  compensates  for  smaller
guts. Proc. Natl. Acad. Sci. U. S. A. 104:19132-
19137.
Cereda  M.,  M.  Sironi,  M.  Cavalleri,  and  U.
Pozzoli.  2011.  GeCo++:  a  C++  library  for
genomic features  computation  and annotation in
the presence of variants. Bioinformatics 27:1313-
1315.
Chambers  J.  C.,  et  al.  2011.  Genome-wide
association  study  identifies  loci  influencing
concentrations of  liver  enzymes  in  plasma.  Nat.
Genet. 43:1131-1138.
Delport  W.,  A.  F.  Poon,  S.  D.  Frost,  and  S.  L.
Kosakovsky  Pond.  2010.  Datamonkey  2010:  a
suite  of  phylogenetic  analysis  tools  for
evolutionary  biology.  Bioinformatics  26:2455-
2457.
Dupuis J., et al. 2010. New genetic loci implicated
in fasting glucose homeostasis and their impact on
type 2 diabetes risk. Nat. Genet. 42:105-116.
Engelken  J.,  et  al.  2014.  Extreme  population
differences  in  the  human  zinc  transporter  ZIP4
(SLC39A4) are explained by positive selection in
Sub-Saharan Africa. PLoS Genet. 10:e1004128.
Fagny M., et al. 2014. Exploring the occurrence of
classic selective sweeps in humans using whole-
genome  sequencing  data  sets.  Mol.  Biol.  Evol.
31:1850-1868.
Fay J. C., and C. I. Wu. 2000. Hitchhiking under
positive Darwinian selection. Genetics 155:1405-
1413.
Freedman A. H., et al. 2014. Genome sequencing
highlights  the  dynamic  early  history  of  dogs.
PLoS Genet. 10:e1004016.
Grossman  S.  R.,  et  al.  2010.  A composite  of
multiple  signals  distinguishes  causal  variants  in
regions  of  positive  selection.  Science  327:883-
886.
Grossman  S.  R.,  et  al.  2013.  Identifying  recent
adaptations  in  large-scale  genomic  data.  Cell
152:703-713.
Guindon S., F. Delsuc, J. F. Dufayard, and O.
Gascuel.  2009.  Estimating  maximum
likelihood phylogenies with PhyML. Methods
Mol. Biol. 537:113-137.
Hancock A. M., et al. 2010. Colloquium paper:
human  adaptations  to  diet,  subsistence,  and
ecoregion  are  due  to  subtle  shifts  in  allele
frequency. Proc. Natl. Acad. Sci. U. S. A. 107
Suppl 2:8924-8930.
Jiang  P.,  et  al.  2012.  Major  taste  loss  in
carnivorous  mammals.  Proc.  Natl.  Acad.  Sci.
U. S. A. 109:4956-4961.
Karasov W.  H.,  C.  Martinez del  Rio,  and E.
Caviedes-Vidal.  2011.  Ecological  physiology
of  diet  and  digestive  systems.  Annu.  Rev.
Physiol. 73:69-93.
Kosakovsky  Pond  S.  L.,  D.  Posada,  M.  B.
Gravenor, C. H. Woelk, and S. D. Frost. 2006.
Automated  phylogenetic  detection  of
recombination using a genetic algorithm. Mol.
Biol. Evol. 23:1891-1901.
Kosakovsky Pond S. L., and S. D. Frost. 2005.
Not  so  different  after  all:  a  comparison  of
methods for  detecting amino acid sites  under
selection. Mol. Biol. Evol. 22:1208-1222.
Kosakovsky Pond S. L., et al. 2011. A random
effects branch-site model for detecting episodic
diversifying  selection.  Mol.  Biol.  Evol.
28:3033-3043.
Laden G., and R. Wrangham. 2005. The rise of
the hominids as  an adaptive  shift  in  fallback
foods:  plant  underground  storage  organs
(USOs) and australopith origins. J. Hum. Evol.
49:482-498.
Lappalainen T., et al. 2013. Transcriptome and
genome  sequencing  uncovers  functional
variation in humans. Nature 501:506-511.
Manning A.  K.,  et  al.  2012.  A genome-wide
approach  accounting  for  body  mass  index
identifies  genetic  variants  influencing  fasting
glycemic  traits  and  insulin  resistance.  Nat.
61
Genet. 44:659-669.
Meyer M., et al.  2012. A high-coverage genome
sequence from an archaic  Denisovan individual.
Science 338:222-226.
Murrell B., et al. 2012. Detecting individual sites
subject  to  episodic  diversifying  selection.  PLoS
Genet. 8:e1002764.
Naumov D. G. 2007.  Structure and evolution of
mammalian  maltase-glucoamylase  and  sucrase-
isomaltase  genes.  Mol.  Biol.  (Mosk)  41:1056-
1068.
Nei M., and W. H. Li. 1979. Mathematical model
for  studying  genetic  variation  in  terms  of
restriction  endonucleases.  Proc.  Natl.  Acad.  Sci.
U. S. A. 76:5269-5273.
Olalde  I.,  et  al.  2014.  Derived  immune  and
ancestral pigmentation alleles in a 7,000-year-old
Mesolithic European. Nature 507:225-228.
Perry G. H., et al. 2007. Diet and the evolution of
human amylase gene copy number variation. Nat.
Genet. 39:1256-1260.
Pollard  K.  S.,  et  al.  2006.  Forces  shaping  the
fastest  evolving  regions  in  the  human  genome.
PLoS Genet. 2:e168.
Prado-Martinez J., et al. 2013. Great ape genetic
diversity and population history. Nature 499:471-
475.
Propsting M. J., R. Jacob, and H. Y. Naim. 2003.
A glutamine  to  proline  exchange  at  amino  acid
residue  1098  in  sucrase  causes  a  temperature-
sensitive  arrest  of  sucrase-isomaltase  in  the
endoplasmic  reticulum  and  cis-Golgi.  J.  Biol.
Chem. 278:16310-16314.
Prufer  K.,  et  al.  2014.  The  complete  genome
sequence  of  a  Neanderthal  from  the  Altai
Mountains. Nature 505:43-49.
Raghavan  M.,  et  al.  2014.  Upper  Palaeolithic
Siberian genome reveals dual ancestry of Native
Americans. Nature 505:87-91.
Rodriguez D., et al. 2013. Functional analysis of
sucrase-isomaltase  mutations  from  chronic
lymphocytic  leukemia  patients.  Hum.  Mol.
Genet. 22:2273-2282.
Sala-Rabanal M., et al. 2012. Bridging the gap
between  structure  and  kinetics  of  human
SGLT1.  Am.  J.  Physiol.  Cell.  Physiol.
302:C1293-305.
Schaffner  S.  F.,  et  al.  2005.  Calibrating  a
coalescent  simulation  of  human  genome
sequence  variation.  Genome  Res.  15:1576-
1583.
Sim  L.,  et  al.  2010.  Structural  basis  for
substrate  selectivity  in  human  maltase-
glucoamylase  and  sucrase-isomaltase  N-
terminal  domains.  J.  Biol.  Chem.  285:17763-
17770.
Skoog  S.  M.,  and  A.  E.  Bharucha.  2004.
Dietary  fructose  and  gastrointestinal
symptoms:  a  review.  Am.  J.  Gastroenterol.
99:2046-2050.
Spodsberg  N.,  R.  Jacob,  M.  Alfalah,  K.  P.
Zimmer,  and  H.  Y.  Naim.  2001.  Molecular
basis of aberrant apical protein transport in an
intestinal  enzyme  disorder.  J.  Biol.  Chem.
276:23506-23510.
Tajima F.  1989.  Statistical  method for  testing
the  neutral  mutation  hypothesis  by  DNA
polymorphism. Genetics 123:585-595.
Thornton K.  2003.  Libsequence:  a C++ class
library  for  evolutionary  genetic  analysis.
Bioinformatics 19:2325-2327.
Tishkoff  S.  A.,  et  al.  2007.  Convergent
adaptation  of  human  lactase  persistence  in
Africa and Europe. Nat. Genet. 39:31-40.
Vilella  A.  J.,  et  al.  2009.  EnsemblCompara
GeneTrees:  Complete,  duplication-aware
phylogenetic trees in vertebrates. Genome Res.
19:327-335.
Watterson  G.  A.  1975.  On  the  number  of
segregating  sites  in  genetical  models  without
recombination. Theor. Popul. Biol. 7:256-276.
62
Wernersson  R.,  and  A.  G.  Pedersen.  2003.
RevTrans:  Multiple  alignment  of  coding  DNA
from aligned amino acid sequences. Nucleic Acids
Res. 31:3537-3539.
Wilson D. J., R. D. Hernandez, P. Andolfatto, and
M.  Przeworski.  2011.  A  population  genetics-
phylogenetics  approach  to  inferring  natural
selection  in  coding  sequences.  PLoS  Genet.
7:e1002395.
Wimmer  B.,  M.  Raja,  P.  Hinterdorfer,  H.  J.
Gruber, and R. K. Kinne. 2009. C-terminal loop
13 of Na+/glucose cotransporter 1 contains both
stereospecific  and  non-stereospecific  sugar
interaction sites. J. Biol. Chem. 284:983-991.
Wright  S.  1950.  Genetical  structure  of
populations. Nature 166:247-249.
Yang Z. 2007. PAML 4: phylogenetic analysis by
maximum likelihood.  Mol.  Biol.  Evol.  24:1586-
1591.
Yang  Z.  1997.  PAML:  a  program  package  for
phylogenetic  analysis  by  maximum  likelihood.
Comput. Appl. Biosci. 13:555-556.
Yang Z.,  and  R.  Nielsen.  1998.  Synonymous
and nonsynonymous  rate  variation  in  nuclear
genes of mammals. J. Mol. Evol. 46:409-418.
Yang Z.,  W.  S.  Wong,  and R.  Nielsen.  2005.
Bayes empirical bayes inference of amino acid
sites under positive selection. Mol. Biol. Evol.
22:1107-1118.
Zeng K., Y. X. Fu, S. Shi, and C. I. Wu. 2006.
Statistical tests for detecting positive selection
by utilizing high-frequency variants.  Genetics
174:1431-1439.
Zhang  J.,  R.  Nielsen,  and  Z.  Yang.  2005.
Evaluation  of  an  improved  branch-site
likelihood  method  for  detecting  positive
selection  at  the  molecular  level.  Mol.  Biol.
Evol. 22:2472-2479.
Zhao H.,  et  al.  2010.  Evolution  of the sweet
taste receptor gene Tas1r2 in bats. Mol. Biol.
Evol. 27:2642-2650.
63
3.2 Adaptations to pathogens
3.2.1 Adaptation of genes involved in the immune response
3.2.1.1 OASes and STING: adaptive evolution in concert
In this work I analyzed the evolutionary history of the MB21D1-TMEM173
and  OAS-RNASEL axes.  OAS  (2'-5'-oligoadenylate  synthases)  proteins
and cyclic GMP-AMP synthase (cGAS, gene symbol:  MB21D1) patrol the
cytoplasm  for  the  presence  of  foreign  nucleic  acids  (based  on  their
similarities, cGAS and OAS proteins may be considered as a novel family
of pattern-recognition receptors, PRRs). Upon binding to dsRNA or dsDNA,
OAS  proteins  and  cGAS  produce  nucleotide  second  messengers  to
activate RNase L and STING (stimulator of interferon genes, gene symbol:
TMEM173),  respectively,  and initiate antiviral  programs. Therefore, these
molecules  represent  central  elements  of  the  innate  antiviral  immune
response. Indeed, all  of them are constantly involved in genetic conflicts
with  pathogens  and,  as  a  consequence,  are  commonly  thought  to  be
targeted by positive selection.
Species-specific differences in the function of PRRs or of their downstream
effectors may be common. In the case of  TLRs, for  instance,  the same
receptor in  distinct  species may recognize different  ligands or the same
ligand with different affinity [115]. Therefore, studying the pattern of inter-
species  evolution  may  provide  valuable  information  on  the  differential
susceptibility to infection within and among species. Primates, for example,
show marked differences in the susceptibility and severity of several viral
infections  including those caused by HIV/SIV,  HCV,  HBV,  and Varicella-
zoster virus [116, 117]. Moreover, several emerging and re-emerging viral
diseases affecting humans originate through the zoonotic transmission from
a reservoir  animal  host  [118].  Bats  (Chiroptera),  as instance,  have long
been known to harbor and disseminate a wide range of viruses that are
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highly pathogenic for humans. On the one hand, this observation suggests
that  bats  have been  co-evolving  with  viruses  for  a  long  time and have
adapted to high viral exposure. On the other hand, the wide variety of viral
families hosted by bats indicates that adaptation most likely involved genes
with a role in immune response, rather than molecules acting as incidental
viral  receptors (as different  viruses use distinct  strategies  to  invade the
host). Thus, innate immunity genes that are devoted to antiviral response
represent excellent candidates as adaptive selection targets in Chiroptera.
I therefore performed an in-depth analysis of the evolutionary history of 7
genes (OAS1-3,  OASL,  MB21D1,  TMEM173,  and  RNASEL)  in  primates
and bats. I applied conservative maximum-likelihood models [13, 71, 75]
and  identified  sites  and  lineages  subject  to  positive  selection  by  the
intersection  of  different  methods,  to  assure  reliability  [14-16].  Positively
selected sites were mapped onto 3D structures in order to understand their
functional significance. Furthermore, I performed an evolutionary analysis
in  the  human,  chimpanzee,  and  gorilla  lineages  using  a  population
genetics-phylogenetics approach [19]. 
Results  indicated  widespread  evidence  of  adaptive  evolution  in  both
primates and bats, with several genes targeted by positive selection in both
mammalian  orders.  In  Chiroptera  selective  pressure  was  comparatively
stronger  for  STING and RNase L than for  pattern recognition  receptors
(OASes and  cGAS).  Several  positively  selected  sites  were found  to  be
located in functionally relevant protein regions. As an example, position 230
in  STING,  a  major  determinant  of  response  to  natural  ligands  and  to
mimetic drugs (e.g. DMXAA), was found to be positively selected in both
the primate  and  bat  phylogenies.  Several  positively  selected sites  were
found to be located in functionally relevant protein regions. For instance,
T181 immediately flanks the second ER (endoplasmic reticulum) retention
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signal in the protein sequence (Fig 3A-B). Also, position 230 in TMEM173
was  found  to  be  positively  selected  in  both  the  primate  and  bat
phylogenies. This site lies in the flexible loop that acts as a lid above the
cyclic dinucleotide binding pocket of the receptor. Substitutions at this site
greatly affect the response to natural ligands and to mimetic drugs, such as
DMXAA  [119-121]  (Fig  3).  In  humans,  positions  230  and  232  are
polymorphic  (G230A and  H232R).  Different  alleles  at  these  sites  affect
STING binding specificity for different substrates, including the canonical 3'-
5'  cyclic  dinucleotides,  known  to  be  synthesized  by  bacteria,  and  the
noncanonical [G(2'-5')pA(3'-5')p] cyclic dinucleotide, that contains a single
2'-5' phosphodiester bond and is produced by mammalian cGAS (Fig 3B-C)
[122-125].
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Figure  3: A.  Positively  selected  sites  mapped  onto  the  human  STING  dimeric  structure  in  complex  with
[G(2',5')pA(3',5')p]  (green)  (PDB code:  4LOH).  The  two  monomers  are  colored  in  dark  and  light  gray.  Positively
selected sites in both orders are in red. B. Multiple alignment of cGAS amino acids 176-240 for a few of representative
primate and bat species. Positively selected in primates and/or bats are in red; position 232 is boxed in blue. C.
Superimposition of the structure of the wt STING monomer (dark grey) in complex with [G(2',5')pA(3',5')p] ) (green)
(PDB code: 4LOH) and the STING double mutant (G230I, H232R) (pale cyan) in complex with DMXAA (magenta)
(PDB  code:  4QXP).  The  different  conformation  of  the  loop  covering  the  dNTPs  binding  site  is  enlarged.
[G(2',5')pA(3',5')p] and DMXAA are represented as sticks.
In  OAS1,  OAS2,  and  cGAS  analysis  of  positively  selected  sites  and
superimpostion  of  3D  structures  revealed  parallel  evolution,  with  the
corresponding residues selected in different genes (Fig 4). 
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Figure 4: Superimposition of the structure of the cGAS (PDB code: 4O67, light grey) and OAS1 (PDB code: 4IG8,
black).  Enlargements  highlight  positively  selected  sites  located  in  the  corresponding  regions  of  the  two  different
enzymes.  Color  codes  are  as  follows:  red,  positively  selected  sites  in  the  primate  phylogeny;  orange,  positively
selected sites in the bat phylogeny; yellow, lineage-specific sites; cyan, positively selected sites in the chimpanzee
lineage; blue, positively selected sites in the gorilla lineage; green, positively selected sites in more than one lineage
among human, chimpanzee and gorilla.
Because  this  cannot  result  from  gene  conversion,  it  is  suggested  that
selective pressure acting on OAS and MB21D1 genes is related to nucleic
acid recognition and to the specific mechanism of enzyme activation, which
requires a conformational change.
As for RNASEL, I extended a previous analysis [126] with the inclusion of
additional  primate  sequences  and  by  incorporating  information  on  the
protein  3D  structure  [127].  Interestingly,  in  primates  and  bats  selection
targeted an α-helix/loop element in RNase L that modulates the enzyme
preference for ssRNA versus stem loops. 
Finally, using a population genetics-phylogenetics approach I analyzed the
distribution  of  selective  coefficients  along the whole  gene regions and I
detected positively  selected sites in  the human,  chimpanzee and gorilla
lineages.  Several  interesting  findings  emerged.  For  instance,  the  long-
standing balancing selection event  that  was previously  described at  the
OAS1 locus in chimpanzees [128] was detected. In fact, I identified shared
selected  sites  in  the  three  species,  with  some  of  them  polymorphic  in
chimpanzees,  but  fixed in  humans and gorillas.  This  observation makes
perfect sense if, as shown by Ferguson et al. [128], two or more haplotypes
originated  before  the  split  of  great  apes  and  were  driven  to  fixation  or
maintained in the population as a result of selective forces. I also detected
fixed  positively  selected  sites  shared  between  gorillas  and  humans  in
MB21D1, possibly suggesting a similar scenario as in OAS1.
In summary, this work represents a comprehensive analysis of the selective
events acting  on the MB21D1-TMEM173 and OAS-RNASEL systems in
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primates and bats. Because evolutionary studies can provide information
on  the  location  and  nature  of  adaptive  changes,  thus  highlighting  the
presence of functional variation, these data provide information about sites
and domains that determine species-specific infection susceptibility. Also, it
has previously been suggested that, by generating diversity, selection may
induce  species-specific  differences  in  the  response  to  pharmacological
compounds,  suggesting  caution  when  extrapolating  results  obtained  in
model  organisms [55,  115].  I  provide  direct  proof  of  this  hypothesis  by
showing that a major determinant of the species-specific differences in the
induction of the interferon gene expression in response to DMXAA was a
target of positive selection. This mimetic drug showed promising antitumor
effects in mice, but failed in human clinical trials. These results suggest that
binding affinity for natural ligands drove the evolution of the STING binding
crevice and eventually resulted in species-specific response to a synthetic
compound.  This  observation  is  relevant  for  the  design  of  DMXAA
derivatives  for  the  development  of  human  antitumor  and  antiviral
applications, as well as for the use of STING-stimulating cyclic nucleotides
as vaccine adjuvants [129].
Personal contribution to the work: I performed evolutionary analyses and I analyzed data.
I also produced figures and tables for the manuscript.
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Abstract
OAS (2'-5'-oligoadenylate  synthases)  proteins  and cyclic  GMP-AMP synthase (cGAS,  gene
symbol: MB21D1) patrol the cytoplasm for the presence of foreign nucleic acids. Upon binding
to  dsRNA or  dsDNA,  OAS proteins  and  cGAS produce  nucleotide  second  messengers  to
activate  RNase  L  and  STING  (stimulator  of  interferon  genes,  gene  symbol:  TMEM173),
respectively; this leads to the initiation of antiviral responses. We analyzed the evolutionary
history of the  MB21D1-TMEM173 and  OAS-RNASEL axes in  primates and bats and found
evidence of widespread positive selection in both orders. In  TMEM173, residue 230, a major
determinant of response to natural ligands and to mimetic drugs (e.g. DMXAA), was positively
selected  in  Primates  and  Chiroptera.  In  both  orders  selection  also  targeted  an  α-helix/loop
element in RNase L that modulates the enzyme preference for ssRNA vs. stem loops. Analysis
of positively selected sites in OAS1,  OAS2, and MB21D1 revealed parallel evolution, with the
corresponding  residues  being  selected  in  different  genes.  As  this  cannot  result  from  gene
conversion, these data suggest that selective pressure acting on  OAS and  MB21D1 genes is
related to nucleic acid recognition and to the specific mechanism of enzyme activation, which
requires  a  conformational  change.  Finally,  a  population  genetics-phylogenetics analysis  in
humans, chimpanzees, and gorillas detected several positively selected sites in most genes. Data
herein shed light into species-specific differences in infection susceptibility and in response to
synthetic  compounds,  with  relevance  for  the  design  of  synthetic  compounds  as  vaccine
adjuvants.
Key words : OAS, cGAS, STING, RNase L, positive selection
Introduction
The  innate  immune  system recognizes  invading
infectious  agents  through  an  array  of  so-called
pattern-recognition  receptors  (PRRs).  These
molecules  detect  pathogen-associated  molecular
patterns  (PAMPs)  and  initiate  a  downstream
signaling  cascade  that  ultimately  triggers
antiviral/antimicrobial programs. PRRs belong to
diverse  molecular  families  including  Toll-like
receptors  (TLRs),  Nod-like  receptors  (NLRs),
RIG-I-like  receptors  (RLRs),  and  AIM2-like
receptors (ALRs). 
Recently,  a  cytosolic  cyclic  GMP-AMP
synthase  (cGAS,  official  gene  symbol:
MB21D1) was found to act as an antiviral DNA
sensor (Sun et al. 2013). Upon binding to DNA,
cGAS catalyzes the synthesis of cyclic GMP-
AMP (cGAMP), which functions as a second
messenger  and  binds  the  stimulator  of
interferon genes (STING, official gene symbol:
TMEM173).  STING,  which  is  located  in  the
endoplasmic  reticulum  (ER),  can  also  sense
cyclic dinucleotides of prokaryotic origin and is
targeted by different viruses, including hepatitis
C virus (HCV) and Dengue virus. 
cGAS can detect a wide range of viruses and
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shares  structural  and  functional  features  with
OAS1 (2'-5'-oligoadenylate synthase 1). Although
they are not phylogenetically related,  OAS1 and
cGAS display similar structural fold and activation
mechanisms, and both enzymes produce atypical
nucleotide second messengers. In fact, OAS1 and
its  paralogs,  OAS2  and  OAS3,  have  long  been
known to bind viral  dsRNA and to catalyze the
synthesis  of  2'-5'  oligoadenylates,  which
specifically activate  the latent  form of RNase L
(Hovanessian et al. 1977; Kerr and Brown 1978).
Inhibition  of  viral  propagation  is  eventually
achieved by RNase L through RNA degradation
and induction of apoptosis. 
Based  on  their  similarities,  cGAS  and  OAS
proteins may be considered as a novel family of
PRRs (Civril et al. 2013; Kranzusch et al. 2013),
although  they  impinge  on  different  effector
molecules. 
Because of their direct role in PAMP recognition,
PRRs  and  their  downstream  effectors  are
constantly  involved  in  genetic  conflicts  with
pathogens and, as a consequence, are commonly
targeted  by  positive  selection  (Wlasiuk  and
Nachman 2010; Areal et al. 2011; Cagliani et al.
2014a;  Cagliani  et  al.  2014b;  Tenthorey  et  al.
2014). RNase L, for example, evolved adaptively
in  Primates,  with  most  positively  selected  sites
located  in  protein  domains  that  directly  contact
the viral genetic material (Jin et al. 2012). This is
in line with the host-pathogen arms race scenario,
whereby protein regions directly involved in the
recognition  and  binding  of  pathogen-derived
components  should  evolve  under  the  strongest
selective  pressure.  This  implies  that  species-
specific differences in the function of PRRs or of
their  downstream effectors  may be  common.  In
the case of TLRs, for instance, the same receptor
in distinct species may recognize different ligands
or the same ligand with different affinity (Werling
et  al.  2009).  Therefore,  studying  the  pattern  of
inter-species  evolution  may  provide  valuable
information  on  the  differential  susceptibility  to
infection within and among species. Primates, for
example,  show  marked  differences  in  the
susceptibility  and  severity  of  several  viral
infections  including  those  caused  by  HIV/SIV,
HCV,  HBV,  and  Varicella-zoster  virus  (Varki
2000;  Willer  et  al.  2012).  Moreover,  several
emerging and re-emerging viral diseases affecting
humans  originate  through  the  zoonotic
transmission from a reservoir animal host (Jones
et  al.  2008).  Recent  examples  of  pathogen
spillover events include the Ebola and Middle
East  respiratory  syndrome  (MERS-CoV)
viruses:  both  originated  in  bats  and
subsequently spread to humans either directly
or  through an intermediate  host  (Wang et  al.
2011;  Cotten  et  al.  2013).  Indeed,  bats
(Chiroptera) have long been known to harbor
and disseminate  a  wide range  of viruses  that
are highly pathogenic for humans. In addition
to  Ebola  virus  and  MERS-CoV,  notable
examples  include  henipavirueses  (e.g.  Nipah
and  Hendra  viruses),  which  cause  a  high
fatality  rate  in  humans  and  other  mammals,
hepaciviruses, influenza A viruses, as well as a
range of paramyxoviruses (Calisher et al. 2006;
Drexler et al. 2012; Tong et al. 2012; Quan et
al. 2013). With the exception of lyssavirus (e.g.
rabies virus), bats are symptomless carriers of
these human viral pathogens (Field et al. 1999).
On  the  one  hand,  the  observation  whereby
several  Chiroptera  families  harbor  a range of
viral species suggests that bats have been co-
evolving with viruses for a long time and have
adapted  to  high  viral  exposure.  On the  other
hand, the wide variety of viral families hosted
by bats  indicates  that  adaptation  most  likely
involved  genes  with  a  role  in  immune
response,  rather  than  molecules  acting  as
incidental  viral  receptors (as different  viruses
use distinct strategies to invade the host). Thus,
innate  immunity  genes  that  are  devoted  to
antiviral  response  represent  excellent
candidates  as  adaptive  selection  targets  in
Chiroptera.  A recent  comparison  of  two  bat
genomes (Pteropus alecto and  Myotis davidii)
reported  adaptive  evolution  at  such  genes,
including TLR7 and TBK1, this latter encoding
an  interactor  of  STING (Zhang et  al.  2013).
Nonetheless, fast evolutionary rates at immune
response  loci  are  a  common  feature  of
mammalian  genomes  and  surely  do  not
represent  a  bat-specific  trait  (Barreiro  and
Quintana-Murci 2010; Zhang et al. 2013).
Also, an unexpected finding emerged from the
analysis  of  the  two  bat  genomes,  as  both
species  were  found  to  have  lost  the  entire
cluster  of  ALR genes  (Zhang  et  al.  2013).
Overall, as noted elsewhere (Wynne and Wang
2013),  the  adaptive  strategies  underlying  bat
ability  to  asymptomatically  maintain  viruses
remain elusive. Possibly, detailed analyses of 
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specific  antiviral  systems may help address  this
issue. Starting from this premise, we analyzed the
evolutionary  history  of  the  OAS-RNASEL and
MB21D1-TMEM173 axes in primates and bats. 
Materials and Methods
Gorilla sample and sequencing
The  genomic  DNA of  one  Gorilla  gorilla  was
obtained  from  the  European  Collection  of  Cell
Cultures (ECACC). MB21D1 exons 3 and 5 were
PCR-amplified from genomic DNA and directly
sequenced using primers 
5'-GCCTGAACATATAACATTAAC-3' (exon 3) 
and 
5'-AGGGTGACTCTAGTTCTTAGA -3'(exon  5)
as forward and 
5'-TTATTTCCCCTGTATTTCCAG  -3'(exon  3)
and 5'-GCTATGAGATGCCTAAAATCC-3' (exon
5)  as  reverse.  PCR products  were  treated  with
ExoSAP-IT (USB Corporation  Cleveland  Ohio,
USA), directly sequenced on both strands with a
Big Dye Terminator sequencing Kit (v3.1 Applied
Biosystems), and run on an Applied Biosystems
ABI  3130  XL  Genetic  Analyzer  (Life
Technologies).  Sequences were assembled using
AutoAssembler  version  1.4.0  (Applied
Biosystems),  and  manually  inspected.  The
obtained  sequences  have  been  submitted  to  the
NCBI database.
Evolutionary  analyses  in  primates  and  bats
Primate and bat sequences were retrieved from the
NCBI database (http://www.ncbi.nlm.nih.gov,  last
accessed October 31, 2014).  The tree shrew and
the horse sequences were also included in primate
and bat alignments, respectively. A list of species
is  reported  in  supplementary  table  S1.  DNA
alignments  were  performed  using  the  RevTrans
2.0  utility
(http://www.cbs.dtu.dk/services/RevTrans/, last
accesed  October  31,  2014)  (Wernersson  and
Pedersen 2003), which uses the protein sequence
alignment  as  a  scaffold  to  construct  the
corresponding  DNA  multiple  alignment.  This
latter  was  checked  and  edited  by  TrimAl  to
remove alignment uncertainties
(http://phylemon.bioinfo.cipf.es/utilities.html, last
accessed October 31, 2014) (Capella-Gutierrez et
al.  2009).  Gene  trees  were  generated  by
maximum-likelihood  using  the  program phyML
(Guindon et al. 2009).
Positive  selection  was  detected  using  PAML
(Phylogenetic  Analysis  by  Maximum
Likelihood)  analyses  (Yang  2007).  The  site
models implemented in PAML were developed
to detect positive selection affecting only a few
aminoacid  residues  in  a  protein:  positive
selection  is  characterized  by  a  non-
synonymous  substitution/synonymous
substitution rate (dN/dS, also referred to as ω)
ratio >1. To detect selection, site models that
allow  (M2a,  M8)  or  disallow  (M1a,  M7)  a
class of sites to evolve with ω >1 were fitted to
the  data  using  the  F3x4  model  (codon
frequencies  estimated  from  the  nucleotide
frequencies in the data at each codon site) and
the F61 model (frequencies of each of the 61
non-stop codons estimated from the data).
Positively selected sites  were identified  using
two  different  methods:  the  Bayes  Empirical
Bayes (BEB) analysis (with a cut-off of 0.90),
which calculates the posterior probability that
each  codon is  from the site  class  of  positive
selection (under model M8) (Anisimova et al.
2002),  and  the  Mixed  Effects  Model  of
Evolution (MEME) (with the default cutoff of
0.1)  (Murrell  et  al.  2012),  which  allows  the
distribution of ω to vary from site to site and
from  branch  to  branch  at  a  site.  Only  sites
detected using both methods were  considered
positively selected.
To explore also possible variations in selective
pressure among different lineages, we applied
the free-ratio models implemented in the PAML
package: the M0 model assumes all branches to
have  the  same  ω,  whereas  M1  allows  each
branch  to  have  its  own  ω  (Yang 1997).  The
models  are  compared  through likelihood-ratio
tests  (degree  of  freedom=  total  number  of
branches  -1).  In  order  to  identify  specific
branches  with  a  proportion  of  sites  evolving
with ω>1, we used BS-REL (Kosakovsky Pond
et al.  2011). This method implements branch-
site  models  that  simultaneously  allow  ω
variation  across  branches  and  sites.  BS-REL
requires  no  prior  knowledge  about  which
lineages  are  more  likely  have  experienced
episodic  diversifying  selection.  Branches
identified  using  this  approach  were  cross-
validated with the branch-site  likelihood ratio
tests from PAML (the so-called modified model
A and  model  MA1,  “test  2”)  (Zhang  et  al.
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2005).  A false  discovery  rate  (FDR)  correction
was  applied  to  account  for  multiple  hypothesis
testing (i.e. we corrected for the number of tested
lineages),  as  suggested  (Anisimova  and  Yang
2007). MEME and BEB analysis from MA (with a
cut-off  of  0.90)  were  used  to  identify sites  that
evolve  under  positive  selection  on  specific
lineages (Zhang et al. 2005).  
GARD  (Kosakovsky  Pond  et  al.  2006),  SLAC
(Kosakovsky  Pond  and  Frost  2005),  MEME
(Murrell et al. 2012) and BS-REL analyses were
performed  through  the  DataMonkey  server
(http://www.datamonkey.org, last  accessed
October  31,  2014) (Delport  et  al.  2010)  or  run
locally (through HyPhy).
Population genetics-phylogenetics analysis
Data from the Pilot 1 phase of the 1000 Genomes
Project  (1000G)  were  retrieved  from  the
dedicated  website
(http://www.1000genomes.org/,  last  accessed
October  31,  2014)  (1000  Genomes  Project
Consortium  et  al.  2010).  SNP  genotype
information for 25 unrelated chimpanzees and
27  unrelated  gorillas  were  retrieved  from
(Prado-Martinez et al. 2013). Coding sequence
information  was  obtained  for  each  gene  and
the  ancestral  sequence  was  reconstructed  by
parsimony  from  the  human,  chimpanzee,
orangutan  and  macaque  sequences.  Analyses
were  performed  with  gammaMap  (Wilson  et
al. 2011). 
For  gammaMap  analysis,  we  assumed  θ
(neutral  mutation  rate  per  site),  k
(transitions/transversions ratio), and T (branch
length)  to  vary  among  genes  following  log-
normal distributions. For each gene we set the
neutral frequencies of non-STOP codons (1/61)
and the probability that adjacent codons share
the  same  selection  coefficient  (p=0.02).  For
selection coefficients we considered a uniform
Dirichlet  distribution  with  the  same  prior
weight for each selection class. For each gene
we  run  100,000  iterations  with  thinning
interval of 10 iterations.
To be conservative, we declared a codon to be
targeted  by  positive  selection  when  the
cumulative posterior probability of γ ≥ 1 was >
0.75, as suggested (Quach et al. 2013).
Three-dimensional structure analysis
Protein 3D structures for human OAS1 (PDB
code:  4IG8)  (Donovan  et  al.  2013),  cGAS
(PDB codes: 4O67 and  4KM5) (Zhang et  al.
2014; Kranzusch et al.  2013), RNase L (PDB
code:  4OAV)  (Han  et  al.  2014)  and  STING
(PDB codes: 4LOH, 4QXP, and 4KSY) (Gao et
al. 2013b; Gao et al. 2014; Zhang et al. 2013)
were  derived  from  the  Protein  Data  Bank
(PDB)  (http://www.pdb.org, last  accessed
October  31,  2014);  the  human  OAS2  model
was  obtained  from  the  Protein  Model  Portal
(code: P29728). Structure superimposition and
sites  mapping  were  performed using  PyMOL
(The  PyMOL  Molecular  Graphics  System,
Version 1.5.0.2 Schrödinger, LLC). 
Results
Adaptive evolution in Primates
We analyzed the evolutionary history of  OAS
genes  (including  the  enzymatically  inactive
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OASL),  MB21D1,  and  TMEM173 in  Primates
(supplementary table S1). Although Jin et al. (Jin
et  al.  2012)  previously  described  adaptive
evolution of RNASEL in Primates, we included the
gene to allow comparison with bats and mapping
of selected sites  on the 3 dimensional  structure,
which  has  recently  been  solved  (see  below).
Coding  sequences  for  available  primate  species
were  retrieved  from  public  databases;  the  tree
shrew sequence was also included as an outgroup
(supplementary  table  S2).  Direct  sequencing  of
Gorilla gorilla DNA was used to fill-in gaps in the
coding sequence of MB21D1. 
DNA alignments were generated using RevTrans
(Wernersson and Pedersen 2003) and screened for
the  presence  of  recombination  using  GARD
(genetic  algorithm  recombination  detection)
(Kosakovsky  Pond  et  al.  2006).  No  breakpoint
was detected for any gene. 
The average
nonsynonymous/synonymous  substitution  rate
ratio (dN/dS, also referred to as ω) was calculated
using  the  single-likelihood  ancestor  counting
(SLAC)  method  (Kosakovsky  Pond  and  Frost
2005).  In  analogy  to  most  mammalian  genes
(Lindblad-Toh  et  al.  2011),  dN/dS  was  always
lower than 1 
Figure 1. Plot of dN/dS values (with 95% confidence intervals) calculated
for OAS family genes, MB21D1, RNASEL, and TMEM173 in primates and
bats.
Figure  1),  indicating  purifying  selection  as  the
major  force  shaping  diversity  at  these  genes  in
Primates.  This  finding  does  not  exclude  that
localized positive selection acts on specific sites
or  domains.  To  test  this  possibility  we applied
likelihood  ratio  tests  (LRT)  implemented  in  the
codeml program (Yang 1997; Yang 2007). 
Under  different  codon  frequency models,  two
nected in  favor  of the positive selection models
(M2a  and  M8)  for  OAS1,  OAS2,  MB21D1,
TMEM173, and  RNASEL (Table 1). No evidence
of  positive  selection  was  detected  for  OAS3
and  OASL. We  next  applied  the  Bayes
Empirical Bayes (BEB) analysis (Anisimova et
al.  2002;  Yang  et  al.  2005)  and  the  Mixed
Effects Model of Evolution (MEME) (Murrell
et al. 2012) to identify specific sites targeted by
positive
(selection  in  these  genes;  only sites  detected
using both methods were considered (Figure 2,
Table 1).
 
Finally,  we  extended  our  analysis  to  explore
possible variations in selective pressure across
primate  lineages.  To  this  aim,  we  tested
whether models that allow dN/dS to vary along
branches had significant better fit than models
that assume one same dN/dS across the entire
phylogeny  (Yang  and  Nielsen  1998).  This
hypothesis  was  verified  for  OAS1,  MB21D1,
and  RNASEL  (supplementary  table  S3).  We
thus  used  the  branch  site-random  effects
likelihood  (BS-REL)  method  (Kosakovsky
Pond et  al.  2011)  to  analyze  selection  along
specific  lineages.  BS-REL  identified  two
branches for OAS1, three for MB21D1 and two
for  RNASEL  (Figure  2,  supplementary  table
S3). These were  cross-validated using codeml
(branch-site LRT models) (Zhang et al. 2005),
with application of false discovery rate (FDR)
correction, as suggested (Anisimova and Yang
2007). The analysis did not confirm the OAS1
branches detected by BS-REL. Conversely for
the MD21D1 gene all the three branches were
validated  and  positively  selected  sites  were
identified  for  the  Hominidae  and  Homininae
lineages (Figure 3A, supplementary table S3).
Finally, for RNASEL only the Tibetan macaque
branch  was  confirmed  but  no  positively
selected sites were found (supplementary fig.
S1).
Positive selection in primate lineages
To gain insight into the more recent selective
events  in  Primates,  we  applied  a  population
genetics-phylogenetics approach  to  study  the
evolution of OAS genes, MB21D1, TMEM173,
and  RNASEL in the human, chimpanzee,  and
gorilla  lineages.  Specifically,  we  applied
gammaMap  (Wilson  et  al.  2011)  that  jointly
uses  intra-species  variation  and  inter-specific
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diversity to estimate the distribution of selection
coefficients (γ) along coding regions. For humans
we exploited data from the 1000 Genomes Pilot
Project  (1000G)  for  Europeans  (CEU),  Yoruba
(YRI),  and  Chinese  plus  Japanese  (CHBJPT)
(1000 Genomes Project Consortium et al. 2010).
For  chimpanzees  and  gorillas,  we  used  SNP
information  from  25  and  27  individuals,
respectively (Prado-Martinez et al. 2013).We also
used  gammaMap  to  identify  specific  codons
evolving  under  positive  selection  (defined  as
those having a cumulative probability >0.75 of γ
≥ 1) in each lineage. 
Results  indicated that in the three species,  most
genes evolved under different degrees of purifying
selection,  with  the  exclusion  of  OAS1,  which
showed a preponderance of sites with γ values in
the  5  to  10  range  (i.e.  moderately  beneficial)
(Figure  3B).  The  distribution  of  γ  values   for
OAS1 was similar  in humans,  chimpanzees,  and
gorillas.  In  general,  γ  distributions  at  the  seven
genes were comparable in the three species with
the exclusion of OAS2 in humans and TMEM173
in  chimpanzees,  which  showed  stronger
constraint  compared  to  the  other  two species
(Figure 3B).  We also detected sites targeted by
positive selection at most genes. In OAS1 some
positively selected sites were shared by two or
even  three  (codon  54)  species  (Table  2).
nterestingly,  most  of  these  OAS1 sites  were
previously  shown  to  define  two  major
haplotype clades that segregate in chimpanzees
and are maintained by long-standing balancing
selection (Ferguson et al. 2012) (Table 2). The
most  recent  common  ancestor  of  the  two
haplotype I clades was estimated to predate the
human/chimpanzee/gorilla  split  (Ferguson  et
al.  2012).  Because  the  ancient  balanced
haplotypes  carry  several  coding  variants  and
because some of  these were  also detected as
positively selected sites  in  the BEB analyses
(Table 2),  we re-ran the  PAML site models
after  masking  these  sites  in  the  human,
chimpanzee, and gorilla sequences.
Figure 2. Schematic representation of the domain structure of OASs family members, cGAS, RNase L and STING. Domains are color-coded as
reported in the legend (left). The position of positively selected sites is shown and colour-coded as follows: red, positively selected sites in the primate or
bat phylogenies; blue, lineage-specific positively selected sites; black, positively selected sites in the human, chimpanzee or gorilla lineages.
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Figure 3.A. Branch-site analysis of positive selection for MB21D1 gene (cGAS) in Primates and Chiroptera. Branch lengths are scaled to the expected
number of substitutions per nucleotide, and branch colors indicate the strength of selection (ω). Red, positive selection (ω > 5); blue, purifying selection
(ω = 0); gray, neutral evolution (ω = 1). The proportion of each color represents the fraction of the sequence undergoing the corresponding positive class
of selection. Thick branches indicate statistical support for evolution under episodic diversifying selection as determined by BS-REL. Red dots denote
branches that were also detected to be under selection using the PAML branch-site models. B. Violin plot of selection coefficients (median, white dot;
interquartile range, black bar). Selection coefficients (γ) are classified as strongly beneficial (100, 50), moderately beneficial (10, 5), weakly beneficial
(1), neutral (0), weakly deleterious (−1), moderately deleterious (−5, −10), strongly deleterious (−50, −100), and inviable (−500).
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Fully significant results were obtained in all LRTs
(data  not  shown),  indicating  that  the  positive
selection signal at OAS1 is not merely accounted
for by the long-standing balancing selection event
in hominids.Two positively selected sites shared
between humans and gorillas were also detected at
MB21D1 (Figure 2, Table 2).
Positive selection in Chiroptera 
As a comparison to Primates and given the role of
these mammals  as virus  reservoirs,  we analyzed
the evolution of genes in the  OAS-RNASEL and
MB21D1-TMEM173 axes in bats. Specifically, we
obtained  coding  sequences  for  at  least  six  bat
species from public databases and we included the
horse  sequence  as  an  outgroup  (supplementary
table  S2).  As  for  Primates,  the  average  dN/dS
substitution  rate  ratio,  calculated  using  SLAC
(Kosakovsky Pond and Frost  2005),  was in  all
cases  lower  than  1.  Comparison  with  Primates
revealed a good correspondence in dN/dS across
the  seven  genes,  except  forTMEM173 and
RNASEL,  which  showed  comparatively  higher
values  in  bats  than  in  primates  (Figure  1).
Application of the codeml site models  indicated
the  action  of  positive  selection  for  OAS1,
MB21D1,  TMEM173,  and  RNASEL (Table  1).
BEB  and  MEME  analyses  identified  positively
selected sites in the four genes (Figure 2). 
Variations  in  selective  pressure  among  bat
lineages  was  detected  for  OAS1 and  MB21D1
(supplementary table S3); BS-REL identified the
horse  branch  for  OAS1, the  Myotinae  and
Pteropodidae  branches  for  both  genes
(supplementary  fig.  S1A,  Figure  3A,
supplementary  table  S3). With  the  exception  of
Myotinae branch for  OAS1, codeml analysis with
FDR correction confirmed all branches, but BEB
and  MEME  analyses  detected  lineage-specific
positively selected sites in  MB21D1 only (Figure
2, supplementary table S3). 
Parallel evolution at OAS1, OAS2, and cGAS
We identified several  selected sites  in  OAS1;  as
previously  noted  (Ferguson  et  al.  2012),  some
residues (e.g  T24, M28, R47, C54) defining the
two  haplotypes  maintained  by  long-standing
balancing selection are located along the so-called
“spine” helix (helix  α3)(Figure  4).  This  helix  is
central  for  human  OAS1  function:  it  acts  as  a
platform for nucleic acid binding and undergoes a
dsRNA-induced structural switch (Donovan et al.
2013;  Hornung  et  al.  2014).  Additional  sites
(S11 and S50) positively selected in the whole
primate  phylogeny  are  located  on  this  helix
(Figure 4).
Comparison  of  the  OAS1  three-dimensional
structures with the OAS2 model predicted that
OAS1 residue C25 corresponds to A369 in
Positive selection targets functional  sites in
TMEM173 and RNASEL
In  TMEM173 we found six positively selected
sites  in  bats;  these  sites  mainly  localize  in
functional regions of the protein. L23, S65 and
V113 are in the transmembrane regions of the
receptor,  which  are  important  for  protein
dimerization  (Sun  et  al.  2009).  T181
immediately  flanks  the  second  ER  retention
signal  in  the  protein  sequence  (Figure  2).
Interestingly, we also found R78, that is part of
the first RXR retention minimal motif (Sun et
al.  2009),  as  positively  selected  in  the
chimpanzee  lineage.  Other  primates  display
amino  acids  different  from  arginine  at  this
position,  suggesting  variable  localization  of
STING in distinct species (supplementary fig.
S2). 
Position  230  was  identified  as  positively
selected  both  in  the  primate  and  in  the  bat
phylogenies.  This  site  is  also polymorphic  in
human  populations  (G230A,  rs78233829).
Residue 230 is located in a loop forming the lid
region that clamps onto the cyclic di-nucleotide
binding  pocket  of  the  receptor;  mutations  of
this  residue  affect  the  conformation  of  the
protein C-terminal domain and also the binding
to  cyclic  dinucleotides,  as  well  as  to
pharmacological  mimetic  drugs  (Gao  et  al.
2013b;  Yi  et  al.  2013;  Gao  et  al.   2014)
(Figure 6).
Finally,  position  146  (positively  selected  in
bats)  immediately  flanks  a  residue  (V147,
human sequence)  that  was recently shown to
determine  the  constitutive  activation  of
STING,  irrespective  of  cGAMP  stimulation,
when mutated to leucine in humans (Liu et al.
2014). 
The evolutionary history of  RNASEL in 2014)
(Figure 6).
Finally,  position  146  (positively  selected  in
bats)  immediately  flanks  a  residue  (V147,
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human  sequence)  that  was  recently  shown  to
determine  the  constitutive  activation  of  STING,
irrespective of cGAMP stimulation, when mutated
to leucine in humans (Liu et al. 2014). 
The evolutionary history of  RNASEL in Primates
had  previously been  analyzed  (Jin  et  al.  2012).
Herein we confirmed most  sites reported by Jin
and co-workers (Jin et al. 2012) and detected few
more  sites,  possibly  as  a  result  of  increased
species  number.  Most  positively  selected  sites
detected by gammaMap or BEB/MEME localize
to the ankyrin domain, whereas residues 379 and
439  (positively  selected  in  primates  and  bats,
respectively) lie in the ATP binding pocket of the
kinase-like  domain  (Figure  7A).  Although  this
domain  lacks  the  phosphotransfer  activity,
nucleotide binding is maintained and required for
the assembly of a functional RNase dimer (Huang
et  al.  2014).  In  bats  we  also found a  positively
selected site at  position 680,  within a positively
charged residue patch (677KHKKMKLK684, human
sequence) that possibly interacts with the acidic
ankyrin domain (Tanaka et al. 2004) (Figure 7B).
The  interaction  is  thought  to  inhibit  RNase  L
activity  in  absence  of  2'-5'  poliadenylates.  In
Chiroptera  this  position  is  mainly  occupied  by
hydrophobic  residues  such  as  valine  and
tryptophan  (Figure  7B).  Finally,  positively
selected sites were detected in the RNase domain:
most  of these (E638,  C639,  K642,  E649,  R651,
N653) are part  of a α-helix/loop element (HLE)
that creates the substrate-binding pockets (Figure
7B). Deletions in the HLE modulate the substrate
preference of human RNase L (Korennykh et al.
2009; Han et al. 2014).
Discussion
Infections  account  for  about  66%  and  72%  of
deaths among wild chimpanzee and extant human
traditional  societies,  respectively  (Finch  2010);
these  figures  underscore  the  relevance  of
infectious  agents  as  powerful  selective  forces
during the evolutionary history of Primates and,
most  likely,  of  other  mammals.  In  fact,  genetic
data revealed that, among environmental factors,
pathogens  represented  the  strongest  selective
pressure for humans (Fumagalli et al.  2011) and
several  reports  used  inter-  or  intra-species
diversity  data  to  describe  widespread  adaptive
evolution at immune response loci (Barreiro and
Quintana-Murci  2010;  Daugherty  and  Malik
2012; Quintana-Murci and Clark 2013). Specific
selective  events  act  to  increase  the  host
resistance against one or more pathogens and
ample  evidence  indicates  that  the  selective
pressure exerted by past infections contributed
to shaping the susceptibility to present-day 
pathogens  (Kaiser  et  al.  2007;  Emerman and
Malik  2010).  Also,  it  has  previously  been
suggested  that,  by  generating  diversity,
selection  may  induce  species-specific
differences in the response to pharmacological
compounds  (e.g.  vaccine  adjuvants),
suggesting caution when extrapolating results
obtained  in  model  organisms (Werling  et  al.
2009;  Forni  et  al.  2013).  For  these  reasons,
evolutionary  analyses  of  immuneresponse
genes may provide valuable information on the
molecular  determinants  underlying  species-
specific infection susceptibility and may clarify
the differential response to natural or synthetic
molecules. 
Herein we performed evolutionary analysis in
primates and bats.  These latter were included
because  of  the  exceptional  wide  range  of
viruses  they host  without  developing  evident
pathology.  Only six bat  species  are  presently
available for analysis, possibly resulting in low
accuracy and power in positive selection tests
(Anisimova et  al.  2001).  Whereas we limited
the  false  positive rate  by using two different
methods to declare a site as positively selected,
we  may  have  failed  to  detect  some  true
positives.  Indeed,   fewer  selected  sites  were
generally  detected  in  Chiroptera  than  in
Primates.  Taking this  limitation  into account,
we  note  that  several  selected  sites  were
identified in  the bat  TMEM173 and  RNASEL
genes,  suggesting  that  selective  pressure  in
these mammals was comparatively stronger for
downstream  effectors  than  for  PRRs,  in
accordance  with  the  higher  average  dN/dS
values  (Figure  2).  In  line with  the  tenet  that
natural  selection  targets  functionally  relevant
residues, position 230 in TMEM173 was found
to  be  positively selected  in  both  the  primate
and  bat  phylogenies.  This  site  lies  in  the
flexible loop that acts as a lid above the cyclic
di-nucleotide  binding  pocket  of  the  receptor
(Figure  6).  Substitutions  at  this  site  greatly
affect  the  response  to  natural  ligands  and  to
mimetic  drugs,  such  as  DMXAA  (Yi  et  al.
2013;  Gao et  al.  2014).  In  humans,  positions
230 and 232 are polymorphic (G230A and 
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Figure 4.Positively selected sites mapped onto the human OAS1 (PDB code: 4IG8) and OAS2 (model, code: P29728) structures. Color codes are as
follows: yellow, residues involved in dsRNA binding mapped onto OAS1; red, positively selected sites in the whole primate or bat phylogenies; cyan,
positively selected sites in the chimpanzee lineage; blue, positively selected sites in the gorilla lineage; green, positively selected sites in more than one
lineage among human, chimpanzee and gorilla. 
H232R).  Different  alleles  at  these  sites  affect
STING  binding  specificity  for  different
substrates,  including  the  canonical  3'-5'  cyclic
dinucleotides,  known  to  be  synthesized  by
bacteria,  and  the  noncanonical  [G(2'-5')pA(3'-
5')p] cyclic dinucleotide,  that contains a single
2'-5'  phosphodiester  bond  and  is  produced  by
mammalian cGAS (Ablasser et al.  2013; Diner
et al. 2013; Gao et al. 2013a; Zhang et al. 2013).
Whereas  G230  displays  a  substrate  specificity
restricted to the noncanonical dinucleotides, the
G230A substitution enhances signal transduction
at  very  low  concentrations  of  canonical
dinucleotides, because the flexibility of the loop
is  increased  and  favors  the  structural  changes
that occur upon ligand binding (Yi et al. 2013).
Furthermore,  even  though  H232R  was
demonstrated  to  be  critical  for  the
responsiveness  to  canonical  dinucleotides,  the
coupled  substitution  G230A  is  required  to
restore  a  complete  enzyme activation on these
substrates  (Diner  and  Vance  2014).   Different
aminoacid  residues  at  position  230  were  also
shown to be responsible for the species-specific
differences  in  the  induction  of  the  type  I
interferon  pathway in response to  DMXAA in
human and mouse (Gao et al. 2014). Indeed, this
mimetic  drug  showed  promising  antitumor
effects in mice, but failed in human clinical trials
because the human protein does not bind to or
signal in response to DMXAA (Gao et al. 2014).
Functional studies (Gao et al. 2014) nevertheless
demonstrated that the substitution of Gly with Ile
at position 230 results in the gain of function of
human STING for DMXAA recognition. 
These observations suggest that binding affinity
for  natural  ligands  drove  the  evolution  of  the
STING binding crevice and eventually resulted
in  species-specific  response  to  a  synthetic
compound. In this respect, it is worth noting that
the variability of position 230 in primates should
be taken into account in the design of DMXAA
derivatives  for  the  development  of  human
antitumor and antiviral applications. These same
considerations  apply  to  the  proposed  use  of
STING-stimulating cyclic nucleotides as vaccine
adjuvants (Dubensky et al. 2013). 
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Figure 5.A. Positively selected sites mapped onto the human cGAS structure (PDB code: 4O67) . Color codes are as follows: red, positively selected
sites in the primate phylogeny; orange, positively selected sites in the bat phylogeny; yellow, lineage-specific sites; cyan, positively selected sites in the
chimpanzee lineage; blue,  positively selected sites in the gorilla lineage; green, positively selected sites in  more than one lineage among human,
chimpanzee and gorilla. The cGAS-dsDNA complex was obtained by superimposing the human cGAS structure (PDB code: 4O67) with the porcine
cGAS-dsDNA complex. The porcine cGAS structure is omitted. B.  Multiple alignment of cGAS amino acids 377-437 (a portion of the sequence
encompassing the zinc ribbon domain) for a few of representative primates and bats species.  C. Superimposition of the structure of the cGAS (PDB
code: 4O67, light grey) and OAS1 (PDB code: 4IG8, black). Enlargements highlight positively selected sites located in the corresponding regions of the
two different enzymes. Color codes are as in A.
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Figure 6.A. Positively selected sites mapped onto the human STING dimeric structure in complex with [G(2',5')pA(3',5')p] (green) (PDB code: 4LOH).
The two monomers are colored in dark and light gray. Positively selected sites in both orders are in red. B. Multiple alignment of cGAS amino acids 176-
240 for a few of representative primate and bat species.  Positively selected in primates and/or bats are in red; position 232 is boxed in blue.  C.
Superimposition of the structure of the wt STING monomer (dark grey) in complex with [G(2',5')pA(3',5')p] ) (green) (PDB code: 4LOH) and the
STING double mutant (G230I, H232R) (pale cyan) in complex with DMXAA (magenta) (PDB code: 4QXP). The different conformation of the loop
covering the dNTPs binding site is enlarged. [G(2',5')pA(3',5')p] and DMXAA are represented sticks.
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Adding complexity to STING evolution, we also
noted that positive selection in chimpanzee drove
the loss of the N-terminal ER-retention signals in
STING. Although the C-terminal motif (178RIR180)
was shown to be more important for ER retention,
mutagenesis  of  the  N-terminal  signal  (78RYR80)
resulted  in  a  decreased  ER  localization  of  the
protein  (Sun  et  al.  2009).  Analysis  in  primates
revealed that additional species lack the  78RXR80
signal.  In  bats,  with  the  exclusion  of  the  big
brown  bat,  which  has  an  intact  second  motif
(178RIR180),  no  RXR motif  is  present  in  STING,
nor is  any of the other  two motifs  (KKXX and
H/KDEL) usually associated with ER localization
(Sun et al. 2009). The mitochondrial localization
of human STING initially reported by Zhong et al
(Zhong  et  al.  2009)  has  remained  controversial
(Ishikawa and Barber 2008; Burdette and Vance
2013).  Recently,  it  has  been  suggested  that  the
protein  localizes  to  mitochondria-associated
membranes  (MAMs),  where  its  interaction  with
MAVS and RIG-I occurs (Scott 2009; Horner et
al. 2011). It will be interesting to assess whether
species-specific  differences  in  TMEM173
localization  exist  and  how these  affect  immune
response  and  interaction  with  viral-encoded
inhibitors (Burdette and Vance 2013). 
Similarly to TMEM173, positively selected sites
were identified in functional domains of RNase L.
Several  positively  selected  sites  (E638,  K642,
E649, and N653 in Chiroptera; C639 and R651 in
Primates)  localize  to  the  short  HLE  element,
which constitutes the binding-pocket for RNA and
modulates  the  preference  of  the  enzyme  for
ssRNA molecules or stem loops (Korennykh et al.
2009; Han et al. 2014) (Figure 7). Experiments in
cell lines indicated that human RNase L cleaves
HCV  RNA  predominately  at  UA  and  UU
dinucleotides within loops of predicted stem-loop
structures (Han and Barton 2002). More recently,
a phylogenetically conserved RNA structure in the
open reading frame of poliovirus (and other group
C  enteroviruses)  was  found  to  function  as  a
competitive  inhibitor  of  RNase  L  (Han  et  al.
2007). Specific stem loops motifs were found to
be  important  for  the  inhibitory  activity  and  to
account  for  unusual  resistance  of  poliovirus  to
RNase  L-mediated  cleavage  (Townsend  et  al.
2008). Thus, positively selected sites in the HLE
represent  excellent  candidates  as  modulators  of
RNase  L  cleavage  rate  or  susceptibility  to
inhibitors. 
The  RNase  L  ankyrin  repeats  domain  was
strongly  targeted  by selection,  as  well.  Most
selected sites lie in the loop between the two
antiparallel alpha-helices and in the outer helix
of  the  ankyrin  module;  even  though  none  is
directly  involved  in  the  2'-5'  oligoadenylates
binding,  they  could  potentially  mediate  the
dimerization  process  or  the  interaction  with
other proteins. Intriguingly, the ankyrin domain
of murine RNase L is the molecular target of
L*, a protein of Theiler's Virus, a neurotropic
picornavirus. The interaction between RNase L
and  L*  is  strictly  species-specific:  the  viral
protein is  unable  to  inhibit  RNase L of  non-
murine origin (Sorgeloos et al. 2013). Although
our  analysis  did  not  include  rodents,  these
observations  indicate  that  the  ankyrin  repeat
domain  may  be  a  target  of  virus-encoded
inhibitors. 
Overall,  these  data  suggest  that  the  selective
pressure  acting  on  STING  and  RNase  L  is
mainly related to the modulation of molecular
recognition and,  possibly,  to  the escape from
viral  inhibitors.  It  will  be  interesting  to
evaluate  whether  the  positively selected  sites
we  detected  in  bats  contribute  to  the
exceptional  adaptation  of  these  mammals  to
different  viral  pathogens.    Analysis  of  the
PRRs underscored major signatures of adaptive
evolution  for  cGAS  in  both  Chiroptera  and
Primates, whereas OAS1 was strongly targeted
by  selection  in  Primates,  and  much  more
weakly  in  bats.  We  found  several  positively
selected  sites  to  be  located  in  the  relatively
short cGAS-specific zinc ribbon  domain. This
structure is thought to act as a molecular ruler
and to endow cGAS with the ability of binding
the  B-form but  not  A-form of  nucleic  acids,
which is instead recognized by OAS1 (Civril et
al.  2013;  Gao et  al.  2013a;  Kranzusch  et  al.
2013). Thus, positive selection in this domain 
may  act  to  hone  in  the  function  of  this
protruding loop, which is responsible both for
nucleic  acid  recognition  and  for  protein
dimerization,  two  essential  steps  for  full
enzyme activation (Li et al. 2013; Zhang et al.
2014).  Human  cGAS  and  OAS1  recognize
nucleic  acids  through  sequence-independent
interactions  to  the  minor  groove,  mainly
mediated by a positively charged platform on
the protein surface (Hornung et al. 2014).
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Figure 7.A. Positively selected sites mapped onto the human RNase L structure (PDB code: 4OAV).  Enlargements show the ankyrin repeats in complex
with 2-5pppA7 (magenta),  the  ATP binding site  of  theprotein kinase-like domain in complex with AMP-PCP (magenta)  and the  RNase  domain in
complex with RNA (two sugar-phosphate groups and one pyrimidine nucleobase solved, magenta). Color codes are as follows: red, positively selected
sites in the primate phylogeny; orange, positively selected sites in the bat phylogeny; cyan, positively selected sites in the chimpanzee lineage; green,
positively selected sites in the human lineage. The HLE is boxed in black.  B. Multiple alignment of RNase L amino acids 247-684 (a portion of the
sequence encompassing the HLE, black boxed) for a few of representative primates and bats species. Positively selected sites in primates and bats are in
red, the positive selected site in the human lineage is in green.
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 A long alpha helix, called 'spine' helix, opposite
to the active site crevice,  is the major structural
component of the platform (Hornung et al. 2014).
For an efficient activation in vitro, human OAS1
and cGAS require dsRNA molecules >17 bp long
(Donovan et al. 2013) and dsDNA molecules >20
bp  (Kranzusch  et  al.  2013),  respectively.
Intriguingly, we found positively selected sites at
the double ends of the spine helix of both proteins,
as  shown  by  the  superimposition  of  thethree-
dimensional structures. As cGAS and OAS1 use
double-stranded  acid  topology  to  distinguish
between  DNA and  RNA and  for  specific  self-
activation  upon  binding,  domains  directly
involved  in  nucleic  acid  recognition  may  have
evolved adaptively to respond to specific PAMPs
or  to  optimize  enzyme  activation.  A  similar
evolutionary scenario has been recently proposed
for positively selected sites in the pincer region of
RIG-I, another PRR (Lemos de Matos et al. 2013;
Cagliani et al. 2014a; Rawling et al. 2015). Thus,
the selective pressure acting on OAS and MB21D1
genes may be related to PAMP recognition and to
the  specific  mechanism  of  enzyme  activation,
which  envisages  a  conformational  change.  This
hypothesis is strengthened by the observation that
natural selection often targeted residues located in
the same spatial position in different proteins. In
this  respect,  we should add  that  the duplication
events  that  originated  the  OAS gene  family
occurred  before  the  radiation  of  mammalian
lineages,  although  more  recent  expansions
occurred  in  rodents  (Kumar  et  al.  2000).
Consequently,  OAS family  genes  are  quite
divergent in sequence and the possibility that
gene conversion between paralogs contributes
substantially to their evolution has previously
been  dismissed  (Ferguson  et  al.  2012).
Likewise, gene conversion events between the
OAS1 and  MB21D1 coding  regions  are
extremely  unlikely,  as  the  two  genes  display
limited sequence identity, despite the extensive
structural and functional similarities. Thus, the
several  instances  of  corresponding  positions
which  were  targeted  by positive  selection  in
OAS1 and  OAS2,  as  well  as  OAS1 and
MB21D1,  should be regarded  as  independent
events  resulting  from  selection.  
In terms of function and structure, it is worth
noting  that  recent  analyses  (Kranzusch  et  al.
2014; Zhu et al. 2014) indicated that cGAS is
homologous  to  bacterial  enzymes  that
synthesize  3'-5'  cGAMP,  revealing  an
evolutionary  connection  across  distinct
kingdoms.  Based  on  these  structural
similarities  Kranzusch  and  coworkers
(Kranzusch  et  al.  2014)  showed  that  single
aminoacid  replacements  around  the  cGAS
binding  site  alter  the  enzyme's  linkage
specificity.  Whereas  the  selected  sites  in
STING may affect the specificity for products
with  different  phosphodiester  bonds,  we  did
not  detect  positively selected sites  in  or  near
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the  cGAS active site,  suggesting  that  the  major
selective pressure acting on the enzyme was not
related  to  changes  in  STING  ligand  specificity.
Evolutionary analyses  on additional species will
be required, though, to address the potential of co-
evolution  for  cGAS  product  specificity  and
STING  binding  preferences  (Kranzusch  et  al.
2014).
The  combined  analysis  of  intra-species
polymorphism  and  between-species  divergence
allows  detection  of  positive  selection  targets  in
one  species  and  provides  information  on  the
distribution  of  selective  coefficients  along  the
whole gene regions. A previous study of TLR gene
evolution  in  humans  and  great  apes  revealed  a
stronger  effect  of  purifying  selection  in
chimpanzees  and  gorillas  compared  to  humans
(Quach  et  al.  2013).  We  analyzed  these  same
species  and  did  not  detect  a  similar  trend.
Nonetheless,  in  that  previous  work,  the  major
difference  among  species  was  accounted  for  by
TLRs that recognize bacterial PAMPs, whereas the
genes we analyzed herein are mainly devoted to
antiviral  response.  In  general,  the distribution of
selection  coefficients  were  relatively  similar
among  the  three  species,  with  the  exception  of
OAS2 and  TMEM173,  which  showed  a  marked
preponderance  of  selectively constrained  codons
in humans and chimpanzees, respectively. 
An  interesting  observation  emerging  from  the
population genetics-phylogenetics analysis is that
results  were  consistent  with  the   long-standing
balancing selection scenario that  was previously
described  at  the  OAS1  locus  in  hominids
(Ferguson  et  al.  2012).  In  fact,  we  identified
shared  selected  sites  in  the  three  species,  with
some of  them polymorphic  in  chimpanzees,  but
fixed  in  humans  and  gorillas.  This  observation
makes perfect sense if, as shown by Ferguson et
al. (Ferguson et al. 2012), two or more haplotypes
originated before the split of great apes and were
driven to fixation or maintained in the population
as a result  of selective forces.  We also detected
fixed  positively  selected  sites  shared  between
gorillas  and  humans  in  MB21D1,  possibly
suggesting a similar scenario as in OAS1.  
Overall,  our  population  genetics-phylogenetics
analysis  identified  several  sites  which  were
targeted by positive selection in distinct great ape
lineages;  these  represent  extremely  promising
candidates  as  modulators  of  infection
susceptibility in  these species.  Whereas some of
these sites are located in protein regions with
clear  functional  characterization  (e.g.  at  the
nucleic  acid binding interface,  at  intracellular
trafficking  signals),  the  significance  of  other
selected residues remains elusive. As suggested
for  the  balanced  polymorphisms  in  OAS1
(Ferguson  et  al.  2012),  selection  may act  on
regions that play a role in protein folding and
stability.  Also,  it  will  be  interesting  to
investigate  whether  the  diverse  evolutionary
histories for OAS1 and STING in distinct great
ape species resulted from the selective pressure
exerted by of one or more pathogens. 
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3.2.1.2 Diverse selective regimes shape genetic diversity at ADAR 
genes and at their coding targets
Recent  technological  advances  are  providing  an  increasingly  detailed
picture of the extent, regulation and location of A-to-I editing events in the
genome of humans and other species. More than one million A-to-I editing
sites have currently been described in humans and RNA editing has been
implicated in a number of processes and diseases [130-132]. Despite this
wealth of knowledge, evolutionary studies have been lagging behind. 
In  this  work  I  aimed  at  providing  a  comprehensive  overview  of  the
evolutionary history of  the three mammalian genes that  code for  ADAR
family  members  and  which  operate  A-to-I  RNA editing.  I  also  provide
evolutionary analysis at their coding targets. 
To  this  aim  I  used  a  variety  of  datasets  and  applied  state-of-the-art
approaches to analyze the evolution of  ADAR,  ADARB1 and  ADARB2 at
the  inter-  and  intra-species  level.  I  next  used  available  information  on
human editing sites in coding regions, as well as a score of conservation
across mammals (I referred to RADAR database, http://rnaedit.com/ [133],
and Genomic Evolutionary Rate Profiling (GERP) score, respectively),  to
study the evolution of recoding sites.
Results  indicated  that,  over  diverse  time  periods,  diversity  at  the  three
ADAR genes was mainly shaped by purifying selection, as described for
most  mammalian  genes.  Nonetheless,  likelihood  ratio  tests  [13,  75]
revealed that ADAR evolved adaptively in primates, with strongest selection
in  the  unique  N-terminal  domain  of  the  interferon-inducible  isoform
(ADARp150). Positively selected residues in the human lineage were also
detected in the ADAR deaminase domain (adjacent to residues that cause
Aicardi-Goutieres Syndrome when mutated) and in the second RNA binding
domain  of  both  ADARB1 and  ADARB2.  In  particular,  the  corresponding
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residue was independently selected in the two genes.
Population  genetics  analysis  in  humans  revealed  that  the  three  ADAR
family genes were targeted by selection during the recent history of human
populations,  as  well.  By  integrating  different  positive  selection  tests,
ENCODE annotation data, as well as large-scale information on eQTLs, I
show that distinct variants in the three genes increased in frequency as a
result of local selective pressures. Most selected variants are located within
regulatory regions and some are in linkage disequilibrium with eQTLs in
monocytes. 
Data  herein  indicate  that  ADAR family  genes  were  target  by  positive
selection in primates, in the human lineage, and during the recent history of
human populations. These findings and a wealth of previous data suggest a
central role for these enzymes in physiological and pathological processes
[131, 132, 134], a role at least partially mediated by the specific editing of
coding sites. I thus set out to determine the evolutionary history of coding
editing sites.
Recently, a study in macaques indicated that purifying selection is the major
force acting at editing sites and at their flanking positions [135]. In partial
agreement, a previous analysis had suggested that editing sites are less
conserved  across  primates  than their  flanks,  but  that  the  overall  region
carrying the editing site is more conserved than control sequences [136].
Herein, I used a score of conservation across mammals and I focused on
editing  sites  located  in  coding  regions  by  separately  analyzing  editing
events  that  originate  synonymous  and  nonsynonymous  substitution,  to
account  for  underlying  variation  in  sequence  conservation  in  coding
sequences. In contrast  to previous reports,  my findings indicate that  the
editing  site  is  less  conserved  than  its  flanks,  which,  in  turn,  are  more
variable  than  control  positions  randomly  drawn  from  the  edited  coding
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regions.  This  effect  is  observed  at  shared (among mammals)  and non-
shared  nonsynonymous  sites,  as  well  as  at  positions  that  entail
synonymous  substitutions  when  edited.  The  possible  reasons  for  these
discrepancies are manifold. In previously works, the overwhelming majority
of analyzed editing sites was accounted for by non-coding sites. As for the
macaque editome data, the authors analyzed fewer than 30 editing sites in
coding  regions  shared  among  macaques,  chimpanzees  and  humans;
sequence  conservation  was  measured  in  terms  of  human-macaque
percentage identity or dS [135]. Also, the authors did not consider the effect
of editing on the protein sequence (whether or not recoding occurs) and did
not  use a comparison with  control  sequences.  As  suggested,  the lower
conservation I observed at the editing site might reflect fixation of the edited
form in some mammals or correction of G-to-A mutations through editing
[136]. Nonetheless, these possibilities do not explain why flanking positions
are less conserved than control sites. I suggest that most editing events (at
both synonymous and nonsynonymous sites) are slightly deleterious and
are  therefore  counter-selected  within  regions  that  are  poorly  tolerant  to
change. Nevertheless, I show that a minority of recoding events occurs at
highly conserved positions and possibly represents the functional fraction.
These events are enriched in pathways related to HIV-1 infection and to
epidermis/hair  development.  Interestingly,  these processes are related to
ADAR/ADARB1 known functions. In fact, ADAR and ADARB1 have been
involved  in  HIV-1  infection  [137-140].  Also,  mutations  in  ADAR are
responsible  for  dyschromatosis  symmetrica  hereditaria  (DSH),  a
pigmentary skin  disease.  More recently,  hair  anomalies  have also  been
described in  patients  with  DHS [141].  Consistently,  a  conditional  mouse
model that lacks ADAR expression in the epidermis shows fur loss and skin
pathology [142].
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In summary,  these data indicate that  both  ADAR family genes and their
targets evolved under variable selective regimes,  including purifying and
positive selection.  I  suggest  that  pressures related to immune response
were major drivers of evolution for ADAR genes and, possibly, some of their
targets. These analyses do not support the previous suggestion whereby A-
to-I RNA editing contributed to the development of higher brain functions in
humans [143, 144].
Personal contribution to the work: I designed the study with my co-workers, I performed
research and I analyzed data. I also produced tables and figures for the manuscript.
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Abstract
A-to-I RNA editing operated by ADAR enzymes is extremely common in mammals. Several
editing events in coding regions have pivotal  physiological roles and affect protein sequence
(recoding events) or function. We analyzed the evolutionary history of the three ADAR family
genes and of their coding targets. Evolutionary analysis indicated that ADAR evolved adaptively
in primates,  with the strongest  selection in  the unique N-terminal  domain of the interferon-
inducible isoform. Positively selected residues in the human lineage  were also detected in the
ADAR deaminase domain and in the RNA binding domains of ADARB1 and ADARB2. During
the  recent  history  of  human  populations  distinct  variants  in  the  three  genes  increased  in
frequency as  a  result  of  local  selective  pressures.  Most  selected variants  are  located within
regulatory regions  and some are in linkage disequilibrium with eQTLs in monocytes. Finally,
analysis of conservation scores of coding editing sites indicated that editing events are counter-
selected within regions that are poorly tolerant to change. Nevertheless, a minority of recoding
events  occurs  at  highly conserved  positions  and  possibly represents  the  functional  fraction.
These  events  are  enriched  in  pathways  related  to  HIV-1  infection  and  to  epidermis/hair
development. Thus, both ADAR genes and their targets evolved under variable selective regimes,
including  purifying  and  positive  selection.  Pressures  related  to  immune  response  likely
represented major drivers of evolution for ADAR genes. As for their coding targets, we suggest
that  most  editing events  are slightly deleterious,  although a minority may be beneficial  and
contribute to antiviral response and skin homeostasis.
Keywords
ADAR, A-to-I editing, positive selection, ADAR editing sites, evolutionary analysis
Introduction
RNA editing,  defined  as  the  post-transcriptional
modification  of  RNA  molecules  not  including
splicing,  capping,  and  polyadenylation,  is  a
widespread  phenomenon  in  several  living
organisms.  In  metazoans,  the  most  common
RNA editing event is the adenosine to inosine
(A-to-I)  conversion  operated  by  ADAR
(adenosine  deaminases  acting  on  RNA)
enzymes mainly on dsRNA substrates.1 Recent
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estimates suggest that  1.6 million editing sites∼
exist in the human genome.2
Mammalian genomes encode three  ADAR genes:
the catalytically active  ADAR and  ADARB1, plus
ADARB2,  thought  to  be inactive and to  serve a
regulatory  role.3 ADARB2 expression  is  brain-
specific, whereas the other 
two ADAR genes are transcribed in many tissues.1
A unique feature of  ADAR is the presence of an
interferon  (IFN)-inducible  promoter  that  drives
expression  of  a  full-lenght  ADARp150  protein;
the  constitutive,  non  IFN-responsive  promoter
determines the synthesis of a shorter N-terminally
truncated  ADARp110  product.  In  line  with  its
IFN-inducible properties, ADAR was shown play
a role in antiviral responses.4 Mutations in ADAR
are responsible for two different genetic diseases:
Aicardi-Goutières  Syndrome  (AGS)  and
dyschromatosis  symmetrica  hereditaria  (DHS).5
This latter is a pigmentary skin disease, whereas
AGS  is  an  autoinflammatory  conditions  mainly
affecting  the  brain  and  the  skin.  AGS  patients
carrying ADAR mutations display up-regulation of
IFN  stimulated  genes,  suggesting  that  the  gene
acts as a suppressor of IFN responses.6
A-to-I RNA editing is thought to be involved in
several physiological and pathological processes.
Inosine  is  recognized  as  guanosine  by  the
translation  and  splicing  machineries.  Therefore,
editing events can result in a wide range of effects
and may affect protein sequence (recoding events)
and function when they occur in coding regions.
Compared  to  other  mammals,  primates  exhibit
much  higher  levels  of  transcriptome  editing,
mainly as a result of their genome being rich in
Alu sequences,  which  represent  preferential
editing sites by virtue of their propensity to form
double-stranded  RNA  structures.7 Thus,  the
overwhelming majority of editing events occurs in
non-coding  repetitive  sequences.  Nonetheless,
several A-to-I conversions in coding regions have
a pivotal physiological role. Among these, the best
studied  examples  include  brain-specific  ion
channels  and  neurotransmitter  receptors.  For
instance, editing at a single site (known as the Q/R
site) in the ionotropic  glutamate receptor subunit
GLUR2 alters Ca2+ permeability and is essential
for  normal  brain  development.  Indeed,  Adarb1-/-
mice suffer from epileptic seizures and die several
weeks  after  birth.  The  phenotype  is  rescued  by
introduction of a transgene that allows expression
of the Glur2 edited form.8 Whereas the GLUR2
Q/R  editing  event  is  shared  by  humans  and
rodents, conserved mammalian editing sites are
a small minority.9 
In  humans  and  other  primates  most  editing
events  occur  in  the  brain  and,  in  analogy  to
GLUR2,  involve  neuronal  genes.  Paz-Yaacov
and  coworkers  also  indicated  that  human-
specific editable  Alu insertions are enriched in
genes  related  to  neuronal  functions  or
implicated  in  neurological  diseases10.  This
observation,  together  with  the  higher  editing
levels  in  the  brain  of  humans  compared  to
chimpanzees and macaques, led some authors
to suggest that A-to-I RNA editing contributed
to the development of higher brain functions.8,10
From an evolutionary perspective, RNA editing
is  an  extremely  interesting  phenomenon.  In
analogy  to  alternative  splicing,  editing  can
provide transcriptome variability and, as noted,
it  might  allow  variation  at  sites  that  would
otherwise  be  inaccessible  to  mutation,  which
instead  imposes  high  fitness  costs.11
Nevertheless,  recent  data  have  indicated  that
editing  of  coding  sequences  is  generally
nonadaptive in humans, although the presence
of  few  beneficial  recoding  events  was
postulated.12
On  this  basis,  we  set  out  to  perform  an
evolutionary  analysis  of  ADAR family  genes
and of their coding targets. 
Results
ADAR evolved adaptively in primates
To analyze the evolutionary history of  ADAR
genes  (ADAR,  ADARB1,  and  ADARB2)  in
primates,  we  obtained  coding  sequences  for
available species in public databases; the tree
shrew sequence was also included (Table S1).
The  three  DNA  alignments  were  generated
using RevTrans and screened for the presence
of  recombination  breakpoints  using  GARD
(genetic  algorithm  recombination
detection).13,14 No breakpoint was detected for
any gene.
We  next  calculated  the  average
nonsynonymous  substitution/synonymous
substitution rate ratio (dN/dS, also referred to
as  ω)  using  the  single-likelihood  ancestor
counting (SLAC) method.15 In all cases dN/dS
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was lower than 1 (Table 1), indicating purifying
selection  as  the  major  driving  force  in  shaping
diversity at  ADAR genes in primates. This is not
unusual,  as  most  mammalian  genes  display
variable  levels  of  purifying  selection  at  their
coding  regions.16 A  major  effect  of  negative
selection  is  not  incompatible  with  positive
selection acting on  specific sites or domains. To
assess whether positive selection acted on  ADAR
family members, we applied the likelihood ratio
tests  (LRT)  implemented  in  the  codeml
program.17,18 LRTs  compare  models  of  gene
evolution that allow (NSsite models M2a and M8,
positive  selection  models)  or  disallow  (NSsite
models  M1a  and  M7,  null  models)  a  class  of
codons to evolve with dN/dS > 1. In the case of
ADAR,  but  not  of  ADARB1 and  ADARB2,  both
neutral  models  were  rejected  in  favor  of  the
positive  selection  models;  these  results  were
confirmed  using  different  models  of  codon
frequency (Table 2). In order to identify specific
ADAR  sites  targeted  by  positive  selection,  we
applied  the  Bayes  Empirical  Bayes  (BEB)
analysis  and  the  Mixed  Effects  Model  of
Evolution (MEME).19-21 To be conservative, only
sites  detected  using  both  methods  were
considered.  We  identified  a  total  of  eight
positively  selected  sites.  Interestingly,  seven  of
these are located in the additional amino-terminal
portion  of  the  interferon-induced  isoform  of
ADAR  (p150)  (Fig.  1).  One  of  the  positively
selected sites (H129) maps to a nuclear exporting
sequence (NES) (Fig. 1).  The positively selected
L25  residue  immediately  flanks  a  missense
mutation  identified  in  patients  with  DSH  (Fig.
1).5We  next  extended  our  analysis  to  explore
possible  variations  in  selective  pressure  among
primate lineages at ADAR. To this aim, we tested
whether  models  that allow dN/dS to vary along
branches had significant better fit than models that
assume  one  same  dN/dS  across  the  entire
phylogeny.22 Because this hypothesis was verified,
we used the branch site-random effects likelihood
(BS-REL)  method  to  analyze  selection  along
specific  lineages.23 BS-REL  identified  three
branches:  green monkey,  bonobo  and  tree
shrew  (Fig.S1). These  were  cross-validated
using codeml  (branch-site  LRT models),  with
application  of  false  discovery  rate  (FDR)
correction,  as  suggested.24,25 This analysis
confirmed the bonobo branch only (Table S3),
but  detected  no  lineage-specific  positively
selected sites. We note that this is not unusual,
as the simultaneous inference of both the site
and the branch subject to diversifying selection
is difficult;21,24 thus,  BEB analysis is accurate
but has low power in this context.24
Positive selection of  ADAR family genes in
the human lineage
For humans, we exploited data from the 1000
Genomes Pilot Project (1000G) for Europeans
(CEU),  Yoruba  (YRI),  and  Chinese  plus
Japanese  (CHBJPT).26 For  chimpanzees,  we
used  phased  SNP  information  of  10  Pan
troglodytes  verus.27 Ancestral  sequences were
reconstructed by parsimony from the human,
chimpanzee,  orangutan  and  macaque
sequences.  In  line  with  the  results  obtained
above, we observed a general preponderance of
codons evolving under negative selection (γ <
0) for all genes. In particular, in both species
ADAR was found to be less constrained than
ADARB1 and  ADARB2  (Fig.  2).  ene regions.
We thus used gammaMap, a 
We next used gammaMap to identify specific
codons  evolving  under  positive  selection  in
humans  and  chimpanzees.  The  combined
analysis  of  intra-species  polymorphism  and
between-species  divergence  may  allow
increased  power  to  detect  sites  targeted  by
positive  selection  in  one  species.  Moreover,
this  approach  provides  information  on  the
distribution of selective effects along recently
developed  program  that  models  intragenic
variation in selection coefficients (γ), to study
the evolution of ADAR family members in the
human and chimpanzee lineages.
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Figure 1. Adaptive evolution at ADAR genes in primates. Schematic representation of the domain structure of ADAR  family members. Domains are
color-coded: nuclear export signal (NES), yellow; Z-DNA binding domains, cyan; RNA binding motifs (RBD), green; deaminase domain, pink. The
position of positively selected sites is shown together with sequence alignments for a few representative primates. Positively selected sites in primates
and in the human lineage are shown in red and blue, respectively. Some missense mutations associated with AGS and DSH are shown in gray and black,
respectively 5. 
Figure 2. Analysis of selective pressure in the human and chimpanzee
lineages. Violin plot of selection coefficients (median, white dot; interquar-
tile range, black bar). Selection coefficients (γ) are classified as strongly
beneficial (100, 50), moderately beneficial (10, 5), weakly beneficial (1),
neutral  (0),  weakly  deleterious  (−1),  moderately  deleterious  (−5,  −10),
strongly deleterious (−50, −100), and inviable (−500). 
To be conservative, we declared a codon to be
targeted  by  positive  selection  when  the
cumulative posterior probability of γ ≥ 1 was >
0.75,  as  suggested.28  No  positively  selected
codon  was  identified  for  P.  troglodytes.  For
humans,  two  positively  selected  sites  were
identified  in  ADAR;  one  of  these  (I1111)  is
located  within  the  deaminase  domain  and  is
immediately  adjacent  to  two  mutations
(Y1112F  and  D1113H)  responsible  for  AGS
(Fig. 1 and Table S2).5 One selected site was
identified  in  both  ADARB1  and  ADARB2
(Table S2); the selected sites are in the second
dsRNA binding (RBD) domain:  alignment  of
ADARB1  and  ADARB2  indicated  that  the
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corresponding  position  is  targeted  by  selection
(Fig. 1). 
Non-coding  regulatory  variants  represent
targets  of  positive  selection  in  human
populations
We next  investigated whether natural selection
acted on ADAR family members during the recent
evolutionary  history of  human  populations.  The
1000G  data  for  YRI,  CEU,  and  CHBJPT were
used to this purpose. 
Integration  of  different  tests  can  improve  the
power to detect selective sweeps and, importantly,
allows  identification  of  the  causal  adaptive
variant(s).29-31 We  applied  the  DIND  (Derived
Intra-allelic  Nucleotide  Diversity)  test,  which  is
powerful in most derived allele frequency (DAF)
ranges  and  less  sensitive  than  iHS  (Integrated
Haplotype Score) to low genotype quality or low
coverage (i.e.  it  is  well  suited for  the 1000G
data).32,33   DIND results  were  combined  with
pairwise  FST analyses,  whereas  DH  was
calculated  in  sliding-windows  to  account  for
local events and, for this reason, used  as an a
posteriori  validation.34 Statistical  significance
(in terms of percentile rank) for all tests was
obtained  by  deriving  empirical  distributions
from  a  control  set  of  ~1000  genes  (see
Materials and Methods). We declared a variant
to be selected if it displayed both a DIND and
an FST percentile rank >0.95. DH was used to
validate  high-frequency  sweeps,  in  line  with
the power profile of this test.34 
We detected distinct selection signals in ADAR.
In  CEU  and  CHBJPT,  the  same  variant
(rs884618) had unusually high FST (YRI/CEU
and  YRI/CHBJPT  comparisons)  and
represented  a  DIND  outlier  (Table  3).  The
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Figure  3.  Location  of  the
most likely seection targets
in  human  populations.
Candidate  targets are  shown
for ADAR (A), ADARB1 (B),
ADARB2 (C)  within  the
UCSC  Genome  Browser
view.  Relevant  annotation
tracks  are  shown.  For
ADARB2 a  sliding-window
analysis of DH is also shown
in  green  (YRI)  and  blue
(CEU).  The  horizontal
dashed line represents the 5 th
percentile of DH. Variants in
blue, red and green represent
selection  targets  in  CEU,
CHBJPT,  and  YRI,
respectively. Additional color
codes are as follows: yellow
highlight  indicates  SNPs
mapping  to  regulatory
elements;  cyan  indicates
eQTL. 
transcription  factor  binding  sites  have  been
annotated together with histone marks associated
with  regulatory
elements  and
DNase
hypersensitivity
peaks (Fig. 3A). In
CEU and CHBJPT,
rs884618 is  in  full
linkage
disequilibrium
(LD) (r2=1 in both
populations)  with
an  eQTL  SNP
(rs9427108)  in
naive  CD14+
monocytes;35 the
selected  variant
also shows LD (r2=
0.78 and 1 in CEU
and  CHBJPT,
respectively)  with
rs9427114,  which
acts  as  an
interferon-
dependent eQTL in
monocytes  (Fig.
3A and  Table  3).35
As for YRI, several
linked  variants
(r2>0.85)  were
found  to   be
outliers  in  the
DIND test  and FST
distributions (Fig. 3A, Table 3). One of these is
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located  close  to  rs884618  and  falls  within
regulatory elements (Fig. 3A).
Similarly  to  ADAR,  we  detected  one  variant  in
ADARB1 which  represents  the  likely  selection
target in CEU and CHBJPT. Indeed, rs4819027 
represented  a  DIND outlier  in  both  populations
and had very high FST in comparisons with YRI
(Table 3). The SNP is located in the 5' portion of
the first intron, where ENCODE data indicate the
presence  of  regulatory  elements  (Fig.  3B).
Interestingly,  analysis  of  brain  methylation  and
histone  modification  patterns  showed  that
rs4819027  also  maps  to  a  region  where
unmethylated  CpGs  and  H3K4me3  marks  are
located;  these signals  are  associated  with  active
transcription.   Finally,  rs4819027 is in moderate
LD  (r2=  0.73  and  0.80  in  CEU  and  CHBJPT,
respectively)  with  rs2838763,  an  IFN-induced
eQTL  for  ADARB1 in  monocytes.35s  for
ADARB2,  5  different  selection  signals  were
detected.  In  CEU,  two  high-frequency  sweeps
were  detected  at  rs60741147  and
rs10794743/rs4880500 (Table 3).
A rs60741147 and rs10794743/rs4880500 are  in
no LD (r2=0) and in all cases variants mapped to
DH valleys in CEU. rs60741147 is located within
the 3' UTR, in  a region extremely conserved in
mammals (Fig. 3C). Likewise, rs10903528 was in
a DH valley for YRI (Fig. 3C). In this population,
a  second  lower  frequency  event  was  detected,
which  involved  variants
rs2820600/rs2820599/rs2805512 (in  no  LD with
rs10903528).  Finally,  in  CHBJPT  three  nearby
variants  were  found to  represent  DIND and FST
outliers (Table 3 and Fig. 3C). In most instances
selected  variants  were  found  to  map  within
ENCODE regulatory elements (Fig. 3C). 
A minority  of  editing events  occurs at  highly
conserved nonsynonymous sites
We  next  analyzed  the  evolutionary  history  of
ADAR/ADARB1 editing sites  located in human
coding regions.  To this aim, we retrieved A-to-I
editing  sites  from  the  RADAR  database
(http://rnaedit.com/).36 We limited our analysis to
sites within coding regions and located outside of
repetitive elements; editing sites corresponding to
SNP positions (in the dbSNP137 database) were
removed. The remaining sites were divided based
on the change the editing causes (i.e. synonymous
or  nonsynonymous  substitution).  We  also
distinguished  editing  events  based  on  their
conservation  in  mammals.  In  particular,  we
designated  as  “shared”  editing  events  that
occur  in  at  least  one  other  species  (among
chimpanzee,  macaque,  and  mouse;  n  shared
sites=69);  we  refer  to  events  that  have  been
described in humans only as “non-shared” (n
non-shared =664). Due to the small sample size
(n  shared=17),  editing  sites  that  entail
synonymous  substitutions  were  not  separated
based on their being shared or not. 
The  Genomic  Evolutionary  Rate  Profiling
(GERP) score, which measures the base-wise
conservation across mammals, was next used
to  evaluate  sequence  conservation  at  the
editing site and at  flanking synonymous and
nonsynonymous positions (4 codon extension
at  both sides).For  non-shared events,  editing
sites at nonsynonymous positions were found
to be significantly less conserved compared to
flanking  positions  (Fig.  4A);  the  same
occurred  for  editing  sites  at  synonymous
positions  (Fig.  4B),  but  not  at  shared
nonsynonymous  editing  sites  (Fig.  4A,  p
values not shown), possibly due to the small
sample size (n=52). As a further comparison,
1000 positions (reference sites), with flanking
synonymous  and  nonsynonymous  sites  were
randomly  selected  from  the  set  of  genes
harboring  the  editing  events.  Analysis  of
GERP  scores  indicated  that  for  both  the
synonymous  and  nonsynonymous  editing
events,  the  regions  surrounding  editing  sites
were  significantly  less  conserved  than  the
reference  sites;  this  was  observed  at  both
shared  and  non-shared  editing  sites  for
nonsynonymous changes (Wilcoxon rank sum
test, two-tailed, p values = 0.0064 and 2.2x10-
16,  respectively; Fig.  4A) and at  editing sites
that  cause  synonymous  changes  (Wilcoxon
rank  sum  test,  two-tailed,  p  value=  0.0024,
Fig. 4B).
In order to gain further insight, we compared
GERP score  distributions  at  editing  sites  to
those deriving from 100 random samples of the
same  number  of  synonymous  and
nonsynonymous  sites.  In  particular,  site
samples were randomly drawn from the same
set of genes as those where the editing events
occur  (see  Materials  and  Methods).  Results
confirmed  a  general  shift  of  editing  sites
towards  lower  conservation  scores  (Fig.  4C).
Nonetheless,  for  both  shared  and  non-shared
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editing  events  that  cause  nonsynonymous
substitutions,  the  distribution  was  significantly
wider than that of random samples, with a fraction
of  sites  (and  flanking  positions)  showing  very
high  GERP  scores  (Fig.  4C).  This  was  not
observed for editing sites (and flanks) that cause
synonymous changes. 
To  summarize,  the editing site  and its  flanking
positions are significantly less conserved than the
average,  both  when  the  event  causes  a
synonymous  and  a  nonsynonymous  substitution.
Nonetheless,  a  fraction  of  editing  events
determine nonsynonymous  substitution at  highly
conserved positions; this is not the case for events
that  cause  synonymous  changes  and  is  not
depended upon sharing of editing events  among
mammals.  
We  next  used   the  WebGestalt  tool  to  assess
whether nonsynonymous edited sites showing low
and high conservation scores impinge on specific
pathways  or  biological  processes.37 Two  related
pathways,  host  interactions  of  HIV factors/HIV
infection,  were  significantly  enriched  for  genes
that  carry highly conserved  editing sites  (in  the
top 10% of GERP scores) compared to the overall
set of edited genes (i.e. genes that carry at least
one nonsynonymous editing site) (Table 4). In this
same set, GO terms related to hair cycle and hair
follicle/epidermis  development  were  also
enriched. No significant difference was observed
for genes edited at poorly conserved positions. 
Discussion
Recent  technological  advances  are  providing  an
increasingly  detailed  picture  of  the  extent,
regulation and location of A-to-I editing events in
the genome of humans and other  species.  More
than one million editing sites have currently been
described in humans and RNA editing has been
implicated  in  a  number  of  processes  and
diseases.2,5 
Results indicated that over diverse time periods,
diversity  at  the  three  genes  has  been  mainly
shaped  by  purifying  selection.  We  detected
stronger  constraint  at  ADARB1  and  ADARB2
compared  to  ADAR,  although  this  observation
most  probably reflects  our  using  the  long  IFN-
induced isoform of ADAR (encoding ADARp150)
in  both  the  SLAC  and  gammaMap  analyses.
Indeed, we show that ADAR evolved adaptively
in primates and that most positively selected sites
are  located  in  the  Zα domain-containing  N-
terminal  portion  specific  to  ADARp150.  The
Zα domain is functionally active (whereas Zβ
is not) and can bind both dsDNA and dsRNA in
a  Z  conformation.38 Similar  Z-DNA binding
domains  are  generally  found  in  proteins  that
participate in the interferon response pathway
39. In line with its INF-responsiveness, ADAR
has been suggested to play a role during viral
infection, although both antiviral and proviral
effects have been described.4 
The  N-terminal  portion  of  ADARp150  also
carries a NES that overlaps with the Zα domain
and drives ADAR shuffling from the nucleus to
the cytoplasm.40,41  Thus, the N-terminal protein
region widens the activity range of ADAR in
terms  of  substrate  recognition  and  cellular
localization. One of the positively selected sites
we  identified  is  located  within  the  NES,
suggesting that it modulates the level or timing
of  nuclear-cytoplasmic  transport.  In  turn,  the
cytoplasmic localization of ADARp150 might
be relevant  to viral  detection and binding,  as
well  as  to  stress  response,  as  the  protein
localizes  to  stress  granules.  These  structures
form during viral infection or, more generally,
during cell stress conditions, and also contain
other editing enzymes such as APOBEC family
members.42 Thus,  the  variation  pattern  at
ADAR in primates suggests that the selective
pressures acting on the gene are related to its
roles in immune or stress responses.  
Conversely,  the selection signal  identified for
the human lineage was located in the ADAR
deaminase domain and positively selected sites
were  also  detected  for  ADARB1  and
ADARB2We  note  that,although  gammaMap
detected positively selected sites in humans but
non in chimpanzees,  the much larger sample
size  of  human chromosomes  compared  to  P.
troglodytes might  partially  account  for  the
different pattern in the two species.  
The positively selected site in ADAR (I1111)
is  immediately adjacent  to  two positions that
were  found  to  be  mutated  in  AGS  patients
(Y1112F  and  D1113H)  (Fig.  1).6  These
residues  lie  along  the  dsRNA  interaction
surface and the AGS mutations did not alter the
editing of a known  ADAR substrate in an in
vitro assay.6  Thus, the pathogenic substitutions
were hypothesized to act in a substrate- or cell
type-specific  manner.  Clearly,  this  also
represents an attractive possibility for the 
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Figure 4. Conservation at ADAR editing sites. (A) Box plot representation of GERP conservation scores for A-to-I editing events that cause nonsynonymous substitutions. Red and 
orange denote “non-shared” editing sites and their flanking sites, respectively; blue and cyan indicate “shared” editing sites and their flanking sites; dark gray indicates control 
nonsynonymous positions with their flanking codons in light gray (see text). Wilcoxon rank sum test (two-tailed) p values are also reported. (B) Box plot representation of GERP 
conservation scores for A-to-I editing events that cause synonymous substitutions. Dark and light green indicate editing sites and their flanking regions, respectively; dark gray 
indicates control synonymous positions, with light gray indicating their flanking sites. Wilcoxon rank sum test (two-tailed) p values are reported. (C) Distributions of GERP scores at 
editing-sites are reported for “non-shared” and “shared” nonsynonymous editing sites, as well as for synonymous editing sites. Color codes are as in the previous panels, with 100 
random control distributions in gray. Flanking sites are represented with dashed lines.
positively selected site we detected in humans,
as it  might modulate  editing at  human-specific
sites.  nterestingly,  we  found the corresponding
residue  to  be  targeted  by  selection  in  human
ADARB1 and ADARB2. The sites are located at
the C-terminus of the highly conserved α2 helix
structure of the second dsRNA binding domain
(RBD2).  Analysis  of  homologous  domains
indicated that C-terminal extensions of this helix
can  affect  the  RNA binding  capability  of  the
entire RBD domain 43.
I  Furthermore RBD2 is the homologous of the
third ADAR RBD, which was demonstrated to
contribute  to  the  corrected  combination  of  a
nuclear  localization  signal  formed  by  two
flexible fragments flanking the folded domain.44
An  interesting  possibility  is  that  the
corresponding sites in the two proteins evolved
in our species to modulate binding to a common
interactor. 
Population genetics analysis in humans revealed
that  the  three  ADAR genes  were  targeted  by
selection  during  the  most  recent  history  of
human populations,  as  well.  The  approach  we
applied  to  detect  selection  is  based  on  the
integration of two tests,  DIND and  FST,  which
rely  on  distinct  signatures  left  by  selective
sweeps,  namely  haplotype  homozygosity  and
population  genetic  differentiation,  respectively.
As  mentioned  above,  the  combined  use  of
distinct  tests  is  expected  to  afford  higher
resolution  in  detecting  the  causal  variant
underlying the adaptive phenotype and to reduce
the rate of false positive signals.29-31 As for DH,
which has more power than the original Fay and
Wu's H statistic, it was used as a confirmatory
test.34 This  choice  was  motivated  by  the
difficulty of assessing statistical significance in
sliding-window  analyses,  as  multiple  non-
independent  tests  are  performed.  DH has  very
good power for  high-frequency sweeps:indeed,
the three  ADARB2 selected alleles at frequency
>0.75 (rs60741147 and rs10794743 in CEU, and
rs10903528 in YRI) were all located within DH
valleys (Fig. 4C).34
 DH reaches values lower than the 5th percentile
in few relatively small regions along ADARB2 (4
and  5  valleys  in  CEU  and  YRI,  respectively)
(Fig.  4C)  and  is  based  on  a  feature  partially
independent  from  population  genetic
differentiation  and  haplotype  homozygosity.
Thus, the DH results do provide support to the
strategy  we  applied  to  detect  selective  events.
Additional  confirmation  comes  from  the
observation  that  most  selected  variants  are
located within regions with regulatory function,
as  assessed  by ENCODE annotations.45 In  the
case of ADAR and ADARB1 the selection targets
were also found to be in partial or full LD with
previously described eQTLs. Overall, these data
are in agreement with recent analyses indicating
that  regulation  of  gene  expression  is  a  major
determinant  of  phenotypic  variation  in  our
species, as well  as a common target of natural
selection.46,47
In particular, the positively selected variants in
ADAR and  ADARB1,  both shared by CEU and
CHBJPT, are in linkage with eQTLs described in
CD14+  monocytes,  suggesting  that  a  major
selective pressure underlying adaptive evolution
at  these  genes  is  accounted  for  by  infectious
agents.  Interestingly,  the  positively  selected
ADARB1 variant  also  maps  to  a  region  which
likely regulates transcription in the brain. Given
the central role of this enzyme in the editing of
brain-specific genes,  these data warrant  further
analysis  of  the  modulatory  effects  of  the  two
SNP alleles. ADARB2 is also (and preferentially)
expressed in the brain, but its biological role and
regulation  are  poorly  understood.  We  detected
multiple sweep events at this gene, with diverse
variants  targeted  in  the  same  and  in  distinct
populations,  suggesting  strong  selective
pressure. 
Overall,  data herein indicate that  ADAR family
genes  were  targeted  by  positive  selection  in
primates, in the human lineage, and in the recent
history  of  human  populations.  These  findings
and a wealth of previous data suggest a central
role  for  these  enzymes  in  physiological  and
pathological  processes,  a  role  at  least  partially
mediated by the specific editing of coding sites
with well-known effects.3,5,48 These include the
already  cited  GLUR2  Q/R  site,  several
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nonsynonymous  editing  sites  in  HTR2C
(serotonin  receptor),  an  S/G recoding event  in
AZIN1  which  predisposes  to  hepatocellular
carcinoma, and an editing event in NEIL1 that
alters  the enzyme's  specificity.49,50 Beside these
and a few more examples, though, the scenario
of A-to-I editing in coding regions and its overall
significance have remained elusive. We reasoned
that  further  insight  into  this  issue  might  be
gained  through  an  evolutionary  analysis  of
ADAR/ADARB1 coding targets. 
Recently,  a  study  in  macaques  indicated  that
purifying selection is the major force acting at
editing sites and at their flanking positions. 49 In
partial  agreement,  a  previous  analysis  had
suggested  that  editing  sites  are  less  conserved
across  primates  than  their  flanks,  but  that  the
overall  region carrying the editing site is more
conserved  than  control  sequences.51 Herein we
used  a  score  of  conservation  across  mammals
and we focused on editing sites located in coding
regions  by  separately  analyzing  editing  events
that originate synonymous and nonsynonymous
substitution, to account for underlying variation
in sequence conservation in coding sequences. In
contrast to previous reports, our findings indicate
that  the  editing  site  is  less  conserved  than  its
flanks  which,  in  turn,  are  more  variable  than
control  positions  randomly  drawn  from  the
edited coding regions. This effect is observed at
shared and non-shared nonsynonymous sites, as
well  as  at  positions  that  entail  synonymous
substitutions when edited. The possible reasons
for  these  discrepancies  are  manifold.  With
respect  to  Bahn  and  coworkers'  data,  the
overwhelming  majority  of  editing  sites  they
analyzed was accounted for by non-coding sites.
As  for  the  macaque  editome  data,  the  authors
analyzed fewer than 30 editing sites  in coding
regions  shared  among  macaques,  chimpanzees
and  humans;  sequence  conservation  was
measured  in  terms  of  human-macaque
percentage identity or dS.49 Also, the authors did
not consider the effect of editing on the protein
sequence (whether or not recoding occurs) and
did not use a comparison with control sequences.
As  suggested,  the  lower  conservation  we
observed at the editing site might reflect fixation
of  the  edited  form  in  some  mammals  or
correction of G-to-A mutations through editing.51
Nonetheless,  these  possibilities  do  not  explain
why flanking positions are less conserved than
control sites. We suggest that most editing events
are  slightly  deleterious  and  are  therefore
counter-selected within  regions  that  are  poorly
tolerant to change and thus, by definition, highly
conserved.  This  might  be  the  case  for  both
synonymous and nonsynonymous editing events,
with  the  former  excluded  from  regulatory
regions (e.g. in splicing regulatory elements) and
the latter counter-selected in constrained protein
regions. 
These conclusions are in agreement with a recent
work showing that in humans the frequency and
level of editing is lower at nonsynonymous than
at  synonymous  sites,  and  that  recoding events
are rarer in essential genes or in genes subject to
strong  functional  constraint  (measured  as
dN/dS).12 Based on these and other observations
the authors proposed that most recoding events
are deleterious byproducts, although few events
might be functionally relevant and beneficial.12
In  fact,  analysis  of  GERP  score  distributions
revealed that a minority of recoding events does
occur at highly conserved positions. These might
represent the functional fraction. This hypothesis
is  supported  by  the  identification  of  enriched
pathways  and  process  for  genes  that  harbor
recoding  events  at  highly conserved  positions.
We note that the functionally relevant recoding
events  we  mentioned  above  (in  GLUR2,
HTR2C, AZIN1, and NEIL1) all occur at highly
conserved positions (GERP score > 4.5), but are
not included in the enrichment analysis because
they remain below the 90th percentile threshold
(GERP score = 5.7) we set. 
Interestingly,  the  significant  pathways  and
processes  we  detected  are  related  to
ADAR/ADARB1  known  functions.  In  HIV-1
infection both antiviral and proviral effects have
been described for  ADAR.52-55 The three genes
that  contribute  to  the  pathway  (PMSC4,
ANAPC7, and NUPL2) represent host factors for
HIV-1  replication.  Unlike  restriction  factors,
which  are  specifically  devoted  to  antiviral
response  and  often  fast-evolving,  host  factors
carry out central physiological functions and are
exploited by the virus for infection.56 Therefore,
genes  coding  for  host  factors  usually  evolve
under purifying selection. In this respect editing
might represent an advantage on the host side to
allow some level of variability that may affect
the viral  replication process with a low overall
fitness  cost.  It  will  be  interesting  to  evaluate
105
whether editing at these genes can affect HIV-1
infection or replication efficiency. 
Finally,  genes  harboring  recoding  events  are
involved  in  epidermis  development  and  hair
cycle/hair  follicle  development.  As  mentioned
above,  mutations in ADAR are responsible for
dyschromatosis symmetrica hereditaria (DSH), a
pigmentary  skin  disease.  More  recently,  hair
anomalies have also been described in patients
with  DHS.57 Consistently,  a  conditional  mouse
model  that  lacks  ADAR expression  in  the
epidermis shows fur loss and skin pathology. In
particular, epidermal necrosis and abnormal hair
follicles  were  evident  in  these  animals.58 The
pathogenic  mechanism  underlying  DSH  is
poorly understood, but is thought to result from
loss or decreased editing at specific target genes.
Those we identified herein represent promising
candidates. 
In  summary,  our data indicate that both  ADAR
family  genes  and  their  targets  evolved  under
variable  selective  regimes,  including  purifying
and positive selection. We suggest that pressures
related to immune response were major drivers
of evolution for ADAR genes and, possibly, some
of their targets.  These analyses  do not support
nor dismiss the previous suggestion whereby A-
to-I RNA editing contributed to the development
of higher brain functions in humans.8,10 Further
analyses will  be necessary to clarify this issue,
although  result  herein  do  not  reveal
exceptionally fast  evolution  at  ADAR genes  in
humans compared to other primates.
Materials and Methods
Evolutionary analysis in primates
Primate  sequences for  ADAR,  ADARB1  and
ADARB2 were retrieved from the Ensembl and
NCBI  databases
(http://www.ensembl.org/index.html;
http://www.ncbi.nlm.nih.gov/).  All  primate
genes represented 1-to-1 orthologs of the human
genes,  as  reported  in  the  EnsemblCompara
GeneTrees  database  (Tab.  S1).59 This
information  was  not  available  for  Papio
hamadryas,  Macaca  fascicularis,  and  Saimiri
boliviensis.  BLAT  search  of  the  three  ADAR
gene  coding  sequences  against  the  genome  of
these  species  (genome  assemblies:  Pham_1.0,
MacFas_5.0,  and  SaiBol1.0)  was  performed
using the Ensembl BLAST/BLAT utility;  in all
cases hits were consistent with the presence of a
single  ortholog,  with  no  evidence  of  gene
duplication.  
A phylogenetic tree of the three ADAR family
proteins was constructed using phyML with the
best-fitting  model (JTT plus gamma-distributed
rates)  generated  by  ProtTest  3.60,61 The  list  of
species and the phylogenetic tree are reported in
Table S1 and in Figure S2, respectively.
For  the  analysis  of  positive  selection,  DNA
alignments were performed using the RevTrans
2.0  utility,  which  uses  the  protein sequence
alignment  as  a  scaffold  to  construct  the
corresponding  DNA multiple  alignment.13 This
latter was checked and edited by hand to remove
alignment  uncertainties.  Alignments  were  first
screened  for  the  presence  of  recombination
breakpoints  using  GARD  (Genetic  Algorithm
Recombination  Detection);14 the  average
nonsynonymous  substitution/synonymous
substitution rate ratio (dN/dS, also referred to as
ω)  was  calculated  using  the  single-likelihood
ancestor counting (SLAC) method.15
The  site  models  implemented  in  PAML have
been  developed  to  detect  positive  selection
affecting  only  a  few  aminoacid  residues  in  a
protein.  To  detect  selection,  site  models  that
allow (M2a, M8) or disallow (M1a, M7) a class
of sites to evolve with ω >1 were fitted to the
data  using  the  F3x4  and  the  F61  codon
frequency models.  For  these analyses  we  used
trees  generated  by  maximum-likelihood  using
the program PhyML.18,60
Positively selected sites were identified using the
Bayes Empirical Bayes (BEB) analysis (with a
cut-off of 0.90),  which calculates  the posterior
probability that each codon is from the site class
with  ω  >1  (under  model  M8).19 A  second
method, the Mixed Effects Model of Evolution
(MEME) (with the default cutoff of 0.1), which
allows the distribution of ω to vary from site to
site  and  from branch  to  branch  at  a  site,  was
applied.21
To  explore  possible  variations  in  selective
pressure  among  different  lineages,  we  applied
the free-ratio models implemented in the PAML
package: the M0 model assumes all branches to
have  the  same  ω,  whereas  M1  allows  each
branch  to  have  its  own  ω.17 The  models  are
compared through likelihood-ratio tests (degree
of  freedom=  total  number  of  branches  -1).  In
order  to  identify  specific  branches  with  a
proportion of sites evolving with ω>1, we used
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BS-REL  with  the  PhyML-generated  tree.23
Branches  identified  using  this  approach  were
cross-validated  with  the  branch-site  likelihood
ratio  tests  from PAML (the so-called modified
model  A and  model  MA1,  “test  2”).24 A false
discovery rate (FDR) correction was applied to
account for multiple hypothesis testing (i.e. we
corrected for the number of tested lineages), as
suggested.25 BEB analysis from MA (with a cut-
off  of  0.90)  was  used  to  identify  sites  that
evolved  under  positive  selection  on  specific
lineages.24
GARD,  SLAC,  MEME and  BS-REL analyses
were performed through the DataMonkey server
(http://www.datamonkey.org) or  run  locally
(through HyPhy).14,15, 21 ,62
Population genetics-phylogenetics analysis
For  gammaMap  analysis  63,  we  assumed  θ
(neutral  mutation  rate  per  site),  k
(transitions/transversions  ratio),  and  T  (branch
length)  to  vary  among  genes  following  log-
normal distributions.  For each gene we set the
neutral frequencies of non-STOP codons (1/61)
and  the  probability that  adjacent  codons  share
the  same  selection  coefficient  (p=0.02).  For
selection  coefficients  we  considered a  uniform
Dirichlet distribution with the same prior weight
for each selection class. For each gene we run
10,000  iterations  with  thinning  interval  of  10
iterations.
Population genetics analyses
Genotype data from the Pilot 1 phase of the 1000
Genomes  Project  were  retrieved  from  the
dedicated  website,  organized  in  a MySQL
database,  and  analyzed  according  to  selected
regions/populations;  these  analyses  were
performed using the GeCo++and the libsequence
libraries.26, 64,65 
The pairwise FST and the DIND (Derived Intra-
allelic Nucleotide Diversity) test were calculated
for  all  SNPs mapping to  ADAR,  ADARB1 and
ADARB2, as  well  as  for  SNPs  mapping  to  a
control  set  of  ~1,000  genes;  these  latter  were
used as a reference, as previously described.66, 32,
30,31
FST values  are  not  independent  from  allele
frequencies, so we binned variants based on their
minor  allele  frequency (MAF,  50  classes)  and
calculated  FST empirical  distributions  for  each
MAF class. The same procedure was applied for
the  DIND  test;  thus,  we  calculated  statistical
significance  by  obtaining  an  empirical
distribution of DIND values for variants located
within control genes; in particular, the DIND test
was  calculated  using a  constant  number of  20
upstream and downstream  flanking variants, as
previously described.30,31 DIND values for YRI,
CEU  and  AS  were  binned  in  derived  allele
frequency (DAF) intervals (100 classes) and for
each class the distributions were calculated. As
suggested, for values of iπD=0 we set the DIND
value to the maximum obtained over the whole
dataset  plus  20.  Only SNPs with both FST and
DIND  with  a  percentile  rank  >0.95 were
considered as selection targets.32 
DH  was  calculated  in  5kb  sliding  windows
moving  with  a  step  of  500  bp.34,67  Sliding
window  analyses  have  an  inherent  multiple
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testing  problem  that  is  difficult  to  correct
because of the non-independence of windows. In
order to partially account for this limitation, we
calculated DH also for the control gene set, and
the distribution of the statistic was obtained for
the  corresponding  windows.  This  allowed
calculation  of  the  5th   percentile  and  the
identification of regions below this threshold.
LD  was  calculated  through  the  SNAP  utility
(http://www.broadinstitute.org/mpg/snap/). 68
ADAR editing sites analysis
We  retrieved  A-to-I  editing  sites  from  the
RADAR database  (http://rnaedit.com/), limiting
our  search  to  sites  within  coding  regions  and
located  outside  of  repetitive  elements.36
Information concerning the presence of the same
editing  event  in  other  species  (  chimpanzee,
macaque,  and  mouse)  was  also  based  on
RADAR annotations.
The  Genomic  Evolutionary  Rate  Profiling
(GERP)  scorewas  obtained  from UCSC tables
(table  name:  GERP  Scores  for  Mammalian
Alignments) and used to evaluate conservation:
positive scores represent a deficit in substitutions
and  indicate  evolutionary  constraint.69  To
generate  100  comparison  distributions,
nonsynonymous and synonymous positions were
randomly drawn from the same genes harboring
the  editing  events.  In  particular,  distributions
were generated by 100 resamplings of the same
number of positions as the number of non-shared
and  shared  editing  events  for  nonsynonymous
changes (n=443 and n=52, respectively), and for
all  editing  sites  for  synonymous  changes
(n=238). 
GO term and pathway enrichment
To  evaluate  whether  low  and  high  conserved
nonsynonymous  editing  sites  are  involved  in
specific  pathways  or  biological  processes  we
used  the  WEB-based  GEne  SeT  AnaLysis
Toolkit.37 Specifically,  unique  gene  lists  that
carry highly or poorly conserved editing sites (in
the 10% tails of GERP score distributions, Table
S4)  were  used  as  queries;  the  background  list
was  accounted  for  by  the  total  set  of  genes
carrying recoding events. The 87% of recoding
events  occurred  in  distinct  genes  (one
event/gene). When the same gene carried more
that  one  recoding  event,  it  was  counted  only
once in the relative list (for instance, if the same
gene  presented  two  recoding  events  at  highly
conserved positions, it was included only once in
the highly conserved list). The minimum number
of  genes  for  a  category was  set  to  3,  and  we
applied a Benjamini and Hochberg correction for
multiple  testing.  We queried for  enrichment  in
GO  categories,  KEGG  pathways  and  in  the
Pathway Commons database.
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3.2.1.3 Evolutionary analysis identifies an MX2 haplotype associated
with natural resistance to HIV-1 infection
The protein product of the human MX2 (myxovirus resistance 2) gene was
recently shown to act as a post-entry inhibitor of HIV-1 infection [145-147].
MX2  and  its  paralog  MX1  (or  MxA)  belong  to  the  dynamin-like  large
GTPase superfamily. Whereas MX1 can restrict a wide variety of viruses,
MX2 is known to counteract retroviruses only [145-147].  Specifically,  the
human  and  macaque  MX2  proteins  efficiently  restrict  HIV-1  and  other
simian  immunodeficiency  viruses,  but  have  a  modest  effect  against
retroviruses that  infect  non-primate  species  [146,  147].  This  observation
points  to  species-specific  virus-host  interactions  that  may  result  in  an
evolutionary arms races, a scenario previously described for MX1 [148]. 
I  applied a multidisciplinary approach to study the evolutionary history of
MX2,  its  structure,  and  the  relevance  of  its  variants  for  HIV-1  infection
susceptibility in human populations. 
Analysis of the evolutionary history of MX2 in placental mammals unveiled
11 sites subject to pervasive positive selection, most of which localized in a
stalk  domain  loop  (loop  4).  The  corresponding  loop  in  MX1 has  been
previously  shown  to  harbor  positively  selected  sites  in  primates  and  to
confer  antiviral  specificity  [148].  One  of  the  positively  selected  sites
identified in the stalk domain, corresponds to a polymorphic position in the
pig  coding  sequence;  aminoacid  variation  at  this  residue  modulate  the
ability of the porcine MX2 protein to inhibit Vesicular Stomatitis virus (VSV)
replication  [149],  supporting  the hypothesis  that  positively  selected sites
determine antiviral activity.
Application  of  other  statistical  methods  [14-16]  to  study  lineage-specific
selection  and  to  identify  selected  sites  for  specific  branches  in  the
phylogeny indicated episodic selection in the primate and porcine lineages.
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Modeling the 3D structure of MX2 using the known crystal structure of MX1
allowed  further  insight  into  the  functional  role  of  positively  selected
residues. This, and the use of I-TASSER [99], allowed a reliable  ab-initio
prediction of loop 4 structure, which includes two antiparallel alpha-helices
forming a bump protruding from the stalk domain. Analysis of non-loop 4
selected sites in  MX2 and comparison with  MX1 selection  targets [148]
indicated  that  the  same  region  of  the  stalk  domain  carries  residues
positively  selected  in  MX2 and  in  MX1.  Interestingly,  the  MX2  primate-
specific selection target in the GTPase domain is in spatial proximity to a
site subject to diversifying selection in primate MX1 genes. 
I next applied a population genetics-phylogenetics approach to study the
evolution of MX1 and MX2 in the human lineage. A general preponderance
of codons evolving under negative selection was observed for both genes,
with  MX1 showing stronger  constraint.  Thus,  coding variants in  the  two
genes  did  not  represent  positive  selection  targets  during  human
evolutionary history.
The  possible  effect  of  natural  selection  on  genetic  diversity  at  MX2 in
human populations was next analyzed. To this purpose, I used an approach
[55] that integrates information from the Human Genome Diversity Panel
(HGDP) [150] and from the 1000 Genomes Project [86]. By applying tests
based  on  population  genetic  differentiation  (FST)  and  on  haplotype
homozygosity (Derived Intra-Allelic Nucleotide Diversity, DIND test, [93]), I
show that distinct selective events have driven the frequency increase of
two different  haplotypes in  populations of  Asian and European ancestry.
The Asian haplotype carries a susceptibility allele for melanoma [151]; the
European haplotype is tagged by rs2074560, an intronic variant.
Because natural  selection  targets variants  with a phenotypic  effect,  and
given the role of MX2 as a HIV-1 restriction factor, I investigated whether
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the allelic status at rs2074560 modulates susceptibility to HIV-1 infection.
Most  human  subjects  are  susceptible  to  this  virus,  but  a  minority  of
individuals do not seroconvert despite multiple exposures (HIV-1 exposed
seronegative individuals, HESN). I thus genotyped rs2074560 (G/A) in 3
independent  case-control  cohorts:  1)  subjects  from Spain  who  exposed
themselves to the virus through injection drug use (all HCV positive, 106
HIV1-positive,  85  HESN);  2)  italian  heterosexual  subjects  who  have  a
history of unprotected sex with their seropositive partners (88 HESN, 188
healthy  controls,  HC);  3)  a  small  cohort  of  Spanish  sexually-exposed
women  (n=37)  and  188  Spanish  HC.  In  all  cohorts  an  excess  of  GG
homozygotes was observed in HESN compared to controls. The results of
the three association  analyses were combined through a  random effect
meta-analysis,  which  revealed  no  heterogeneity  among  samples
(Cochrane's Q  p value= 0.66, I2= 0) and yielded a  p value of 1.55x10-4.
Overall, these results indicate that the G allele of rs2074560 protects from
HIV-1 with a recessive effect, irrespective of the infection route. 
In line with the results outlined above, in vitro HIV-1 infection of PBMCs
from  50  HESN  subjects  indicated  that  the  G  allele  of  rs2074560  is
associated  with  significantly  lower  viral  replication,  as  assesses  by  p24
antigen quantification (Kruskal-Wallis rank sum test, p= 0.034). 
Finally,  to  assess the functional  role  of  rs2074560 (or  linked variants)  I
analyzed MX2 expression in response to IFN-α. Data from peripheral blood
mononuclear cells from 45 healthy volunteers indicated that the G allele is
associated with a significantly increased MX2 induction in response to IFN-
α (one-way ANOVA, p= 0.015)
In summary, I analyzed the evolutionary history of MX2 in mammals and in
human populations and I exploited this information to identify a haplotype
that  modulates  susceptibility  to  HIV-1  infection  and  transcript  levels  in
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response to IFN-α. Thus,  this work has general implications by showing
that  the  analysis  of  selection  patterns  of  antiviral  response  genes  can
provide valuable information on the allelic determinants of susceptibility to
modern infections. The MX2 variant reported herein represents one of the
few  human  polymorphisms  reliably  associated  with  HIV-1  infection
susceptibility. MX2 should therefore be regarded as an attractive target in
preventative approaches to infection and possibly to favour clearance of
latently HIV-1 infected cells.
Personal contribution to the work: I focused on the evolutionary analysis in mammals.
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Abstract
The  protein  product  of  the  MX2 (myxovirus  resistance  2)  gene  restricts  HIV-1  and  simian
retroviruses.  We  demonstrate  that  MX2 evolved  adaptively  in  mammals  with  distinct  sites
representing selection targets in distinct branches; selection mainly involved residues in loop 4,
previously  shown  to  carry  antiviral  determinants.  Modeling  data  indicated  that  positively
selected sites form a continuous surface on loop 4, which folds into two antiparallel α-helices
protruding from the stalk domain. A population genetics-phylogenetics approach indicated that
the  coding  region  of  MX2 mainly evolved  under  negative  selection  in  the  human  lineage.
Nonetheless, population genetic analyses demonstrated that natural selection operated on  MX2
during the recent history of human populations:  distinct selective events drove the frequency
increase of two haplotypes in populations of Asian and European ancestry. The Asian haplotype
carries a susceptibility allele for melanoma; the European haplotype is tagged by rs2074560, an
intronic variant. Analyses performed on three independent European cohorts of HIV-1 exposed
seronegative individuals with different geographic origin and distinct exposure route showed
that the ancestral (G) allele of rs2074560 protects from HIV-1 infection with a recessive effect
(combined  p value  =  1.55x10-4). The  same  allele  is  associated  with  lower  in  vitro  HIV-1
replication  and  increases  MX2 expression  levels  in  response  to  IFN-α.  Data  herein  exploit
evolutionary information to identify a novel host determinant of HIV-1 infection susceptibility.
Introduction
The  protein  product  of  the  human  MX2
(myxovirus  resistance  2,  also  known  as  MxB)
gene was recently shown to act as an inhibitor of
HIV-1 infection (Goujon et al.  2013; Kane et
al. 2013; Liu et al. 2013b). MX2 blocks HIV-1
replication  at  a  late  post-entry  step  by
decreasing  nuclear  accumulation  and
chromosomal integration of nascent viral DNA
(Goujon et al. 2013; Kane et al. 2013; Liu et al.
2013b). HIV-1 capsid mutations that alter the 
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Figure 1. Adaptive evolution of MX2 in mammals. (A) Schematic representation of the domain structure of MX2 (cyan, bundle signaling element regions; yellow, GTPase domain,
dark green, stalk domain with L4 in light green). The position of positively selected sites is shown together with sequence alignments for a few representative mammals. Positively
selected sites are shown in red (sites identified in the whole phylogeny); primate- and pig-specific sites are in orange and green, respectively. Grey vertical bars below the domain
cartoon denote positively selected sites in MX1 (Mitchell et al. 2012). (B) Branch-site analysis of positive selection. Branch lengths are scaled to the expected number of substitutions
per nucleotide, and branch colors indicate the strength of selection (ω). Red, positive selection (ω > 5); blue, purifying selection (ω = 0); grey, neutral evolution (ω = 1). The proportion
of each color  represents the fraction of the sequence undergoing  the corresponding  class  of selection.  Thick  branches  indicate statistical support  for  evolution under  episodic
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diversifying selection as determined by BS-REL. Red dots denote branches that were also detected to be under positive selection using the PAML branch-site models (after Bonferroni
correction for multiple tests). (C) Structural model of the full-length MX2 protein predicted by I-TASSER. Positively selected sites identified in the whole phylogeny are in red, in
orange and green primate- and pig-specific sites, respectively. Previously identified positively selected sites in the GTPase and stalk domains of MX1 are indicated in magenta. An
enlargement of loop 4 and part of the stalk domain is also shown (with rotation).
nuclear import pathway used by the virus relieve
the  inhibition  operated  by  MX2 (Goujon  et  al.
2013; Kane et al. 2013; Liu et al. 2013b). Thus,
MX2 is thought to target the capsid and to interact
with other cellular proteins such as peptidylprolyl
isomerase  A  (cyclophilin  A)  to  block  HIV-1
nuclear import (Liu et al. 2013b). 
MX2 and its paralog MX1 (or MxA) belong to the
dynamin-like large GTPase superfamily and share
a common structure consisting of an N-terminal
GTPase domain and a C-terminal stalk connected
by a bundle signaling element (Figure 1) (Haller
and Kochs 2011). The protein products of the two
genes display high identity but different cellular
localization and diverse antiviral specificity. MX1
can  restrict  a  wide  variety  of  viruses  including
orthomyxoviruses  (e.g.  influenza  and  Thogoto),
bunyaviruses  (e.g  La  Crosse  and  rift  valley
viruses), and hepatitis B virus (Haller and Kochs
2011).  Conversely,  MX2 is known to counteract
retroviruses only (Goujon et al. 2013; Kane et al.
2013; Liu et al. 2013b), and to exert a weak effect
against vescicular stomatitis virus infection (Liu et
al.  2012).  Specifically,  the  human and  macaque
MX2 proteins efficiently restrict HIV-1 and other
simian  immunodeficiency  viruses,  but  have  a
modest effect against retroviruses that infect non-
primate  species  such as  murine  leukaemia virus
and feline immunodeficiency virus (Goujon et al.
2013; Kane et al. 2013). This observation points
to species-specific virus-host interactions that may
result  from evolutionary arms races (i.e.  genetic
conflicts  between  the  host  and  the  virus),  a
scenario previously described for MX1(Mitchell et
al. 2012). 
Herein  we  analyze  the  evolutionary  history  of
MX2 at the inter-and intra-specific level and use
this  information  to  identify  a  haplotype  that
associates  with  natural  resistance  to  HIV-1
infection in humans.
Results
MX2 evolutionary history in mammals
To  analyze  the  evolutionary  history  of  MX2 in
placental mammals, we obtained coding sequence
information for 29 species from public databases
(Supplementary Tab. S1, Supplementary Material
online). Rodent gene sequences were not included
due to uncertain orthology (they likely arose by
duplication from an ancestral  MX1-like gene)
(Verhelst, Hulpiau, Saelens 2013). The multiple
sequence  alignment  was  screened  for
recombination  using  GARD  (Genetic
Algorithm  Recombination  Detection)
(Kosakovsky Pond et al. 2006), which detected
no  breakpoint.  The  average  non-synonymous
substitution/synonymous  substitution  rate
(dN/dS, also known as ω) for  MX2 amounted
to 0.39 (95% confidence intervals: 0.37, 0.41),
indicating a major role for purifying selection
(which  leads  to  dN/dS values  <1).  However,
whereas  constraints  on  protein  function  and
structure  often  result  in  purifying  selection
being the primary evolutionary force acting on
gene regions, diversifying selection (dN/dS>1)
might  involve  specific  sites  or  domains.
Indeed, this has previously been shown to be
the case for primate MX1 genes (Mitchell et al.
2012).  To  test  this  possibility  we  applied
maximum-likelihood analyses implemented in
the  PAML  (Phylogenetic  Analysis  by
Maximum  Likelihood)  package  (Yang  1997;
Yang 2007). Specifically, we used the codeml
program to compare models of gene evolution
that  allow  (NSsite  models  M2a  and  M8,
positive selection models) or disallow (NSsite
models M1a and M7, null models) a class of
codons to evolve with dN/dS >1. As reported in
table 1, both null models were rejected in favor
of  the  positive  selection  models;  the  same
result  was  obtained  using  different  codon
frequency models  (F3x4 and  F61)  (Table  1).
Thus,  MX2 evolved  adaptively  in  placental
mammals. 
To  identify  specific  sites  subject  to  positive
selection,  we  applied  the  Bayes  Empirical
Bayes (BEB) method (with a cut-off of 0.90)
(Anisimova,  Bielawski,  Yang  2002;  Yang,
Wong,  Nielsen  2005).  Because  this  approach
may  yield  some  false  positives  when  a
relatively  large  number  of  sequences  is
analyzed (Kosakovsky Pond and Frost 2005),
we used the Mixed Effects Model of Evolution
(MEME)  (with  the  default  cutoff  of  0.1)
(Murrell et al. 2012) as a second criterion. To
be  conservative,  only  sites  detected  by  both
methods  were  considered  to  be  positively
selected,  although  this  may  result  in  an
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underestimation of the actual number of selected
sites. These analyses allowed the identification of
11 positively selected sites in MX2 (Figure 1A). 
In order to explore possible variations in selective
pressure among different lineages, we first tested
whether a model that allows dN/dS to vary along
branches (model M1) had significant better fit to
the  data  than  a  model  that  assume  one  same
dN/dS  across  the  entire  phylogeny (model  M0)
(Yang  and  Nielsen  1998).  This  was  indeed  the
case (Table 1), indicating that different mammals
experienced variable levels of selective pressure.
We  thus  used  the  branch  site-random  effects
likelihood (BS-REL) method (Kosakovsky Pond
et al. 2011) to identify lineages on which a subset
of sites have evolved under positive selection. BS-
REL makes no a priori  assumption about which
lineages  are  more  likely  to  represent  selection
targets; the method identified 3 branches (Figure
1B). These were cross-validated using the branch-
site  models  implemented  in  PAML  (Zhang,
Nielsen,  Yang  2005),  which  apply  a  likelihood
ratio  test  to  compare a model  (MA) that  allows
positive  selection  on  one  or  more  lineages
(foreground  lineages)  with  a  model  (MA1)  that
does not allow such positive selection (Table 2).
As  suggested  (Anisimova  and  Yang  2007),  a
Bonferroni  correction  was  applied  to  these  p
values, as multiple hypotheses (3 in this case) are
being tested on the same dataset. PAML analysis
confirmed  the  three  branches  identified  by BS-
REL (Table 2, Figure 1B). The PAML branch-site
models offer the possibility of identifying specific
sites that evolved under positive selection in the
foreground  branches;  this  is  achieved  through
implementation  of  a  BEB  analysis  (Zhang,
Nielsen, Yang 2005).  Notably,  the simultaneous
inference of both the site and the branch subject to
diversifying  selection  is  difficult  (Murrell  et  al.
2012;  Zhang,  Nielsen,  Yang  2005);  thus,  BEB
analysis is accurate but has low power (Zhang,
Nielsen, Yang 2005). Also, because identifying
sites subject to selection is more difficult than
testing whether such sites exist, the branch-site
test may provide statistical support for positive
selection  for  the  foreground  branch(es),  but
BEB may fail  to detect sites with a posterior
probability >0.90 (Zhang, Nielsen, Yang 2005).
This is the case of the alpaca lineage: we found
evidence  of  episodic  selection  (Figure  1B,
Table  2)  but  failed  to  identify  the  selected
site(s). Conversely, BEB detected 1 site in the
primate and 2 sites in the pig 
branches  (Figure  1A).  We  reasoned  that,
because MEME was specifically developed to
detect  episodic  positive  selection (in  addition
to  pervasive  selection),  lineage-specific  BEB
sites should have been identified by the MEME
analysis  we  performed  on  the  whole
phylogeny. Indeed, the three sites identified by
BEB  were  also  detected  by  MEME  (Figure
1A). These sites thus represent lineage-specific
selection targets.
Structural  modeling  and  analysis  of  MX2
selected sites
As  indicated  above,  analyses  allowed
identification  of  11  MX2 sites  subject  to
diversifying selection in the whole phylogeny;
five of these are located in an unstructured loop
(loop 4), where several positively selected sites
were  also  detected  in  primate  MX1 genes
(Mitchell  et  al.  2012)  (Figure  1A).  To  gain
further  insight  into  the  functional  role  of
positively  selected  residues,  we  modeled  the
3D structure of MX2 using the known crystal
structure of MX1 (63% identity at the protein
level)  as  a  template.  The  use  of  I-TASSER
(Roy, Kucukural, Zhang 2010) also allowed a
reliable ab-initio prediction of loop 4 structure
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(Supplementary Fig. S1, Supplementary Material
online),  which  includes  two  antiparallel  alpha-
helices forming a bump protruding from the stalk
domain. Positively selected sites in loop 4 form a
continuous  surface  and  are  mainly  located  on
unstructured  loops  (Figure  1).  Analysis  of  non-
loop 4 selected sites in MX2 and comparison with
MX1  selection  targets  (Mitchell  et  al.  2012)
indicated that the same region of the stalk domain
carries the MX2 460N residue and three selected
sites in MX1; also, the S518 residue is spatially
close to these residues (Figure 1C). Interestingly,
the MX2 primate-specific  selection target  in  the
GTPase domain (364S) is in spatial proximity to a
site  subject  to  diversifying  selection  in  primate
MX1 genes.
Evolution  of  MX1 and  MX2 in  the  human
lineage
We next applied a recently developed  population
genetics-phylogenetics approach  to  study  the
evolution of MX1 and MX2 in the human lineage.
Specifically,  we  ran  the  GammaMap  program
(Wilson et al. 2011) that jointly uses intra-specific
variation  and  inter-specific  diversity  to  estimate
the  distribution  of  fitness  effects  (DFE)  (i.e.
selection coefficients, γ) along coding regions. To
this  aim,  we  exploited  data from the 1000
Genomes Pilot project deriving from the low-
coverage whole genome sequencing of 179
individuals with different ancestry: Europeans
(CEU), Yoruba from Nigeria (YRI), and Chinese
plus Japanese (CHBJPT) (1000 Genomes Project
Consortium et al.  2010).  The ancestral  sequence
was reconstructed by parsimony from the human,
chimpanzee,  orangutan  and  macaque  sequences.
We first applied GammaMap to obtain the overall
distribution  of  selection  coefficients  along  MX1
and  MX2.  A general  preponderance  of  codons
evolving  under  negative  selection  (γ  <  0)  was
observed  for  both  genes,  with  MX1 showing
stronger  constraint  (Figure  2).  GammaMap
allows 
Figure 2. Lineage-specific selection and DFE analysis. Violin plot of
selection coefficients  (DFE)  for  MX1 and  MX2 (median,  white  dot;
interquartile range, black bar). Selection coefficients (γ) are classified
as strongly beneficial (100, 50), moderately beneficial (10, 5), weakly
beneficial  (1),  neutral  (0),  weakly  deleterious  (−1),  moderately
deleterious (−5, −10), strongly deleterious (−50, −100), and inviable
(−500). 
to  identify  specific  codons  evolving  under
positive selection. 
We defined positively selected codons as those
having a cumulative probability >0.80 of γ ≥ 1.
None was found in either MX1 or  MX2. Thus,
coding  variants  in  the  two  genes  did  not
represent  positive  selection  targets  during
human evolutionary history. 
Population  genetic  analysis  of  MX2 in
humans
The results described above indicate that MX2
has  been  a  selection  target  throughout  the
evolutionary history of mammals. In the human
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lineage,  purifying  selection  had  a  major  role  in
shaping  MX2 coding  sequence  diversity.
Inspection  of  the  1000  Genomes  Project  data
indicated that one single non-synonymous variant
in  MX2 segregates  in  human  populations  at  a
frequency  higher  than  1%  (rs56680307).  This
SNP is monomorphic or very rare in non-African
populations,  whereas  it  has  a  minor  allele
frequency (MAF) around 20% in Africa. We thus
investigated  whether  natural  selection  also
affected  genetic  diversity  at  MX2 in  human
populations  acting  either  on  rs56680307  or  on
noncoding variants (as recent data have indicated
that regulatory polymorphisms represent the bulk
of selection targets in human populations (Forni et
al. 2014; Grossman et al. 2013)). To this purpose,
we  initially  exploited  information  from  the
Human Genome Diversity Panel (HGDP), which
consists  of  ~650,000  single  nucleotide
polymorphisms  (SNPs)  genotyped  in  52
populations distributed worldwide (Li et al. 2008).
Using  these  data  we  calculated  FST among
continental groups. 
FST is  a  measure  of  population  genetic
differentiation:  under  selective  neutrality  FST is
mainly  determined  by  demographic  history  and
drift,  but  natural  selection  may  drive  allele
frequencies to differ more than expected. Out of
22 HGDP variants in MX2, three, namely rs45430
(A/G),  rs379839  (A/G),  and  rs2074560  (A/G),
displayed an FST value higher than 
Figure  3.  Population  genetic  differentiation.  FST analysis  of  MX2
variants for YRI-CEU (blue) and YRI-CHBJPT (red) comparisons. Lines
represent the 95th percentiles in each MAF class. Solid squares denote
variants  identified  in  the  HGDP SNP analysis  (bold)  or  SNPs  with  a
significant DIND test. 
the 95th percentile calculated from the distribution
of  HGDP  variants  in  the  same  minor  allele
frequency  (MAF)  class  (see  Materials  and
Methods)  (Figure  3).  Analysis  of  worldwide
variation indicated that ancestral alleles for the
three  SNPs  are  almost  fixed  in  African
populations, whereas derived alleles reach high
frequency  outside  Africa  (Figure  4A).  Thus,
selective  sweeps  may  have  occurred  during
human  colonization  of  Eurasia  and  the
Americas. 
To investigate this possibility further, we used
the 1000 Genomes Pilot Project genotype data.
Selected  variants  were  searched  for  by
integrating  two  approaches:  one  based  on
population genetic differentiation and the other
on haplotype homozygosity. Thus, for all SNPs
in  MX2 we  calculated  YRI-CEU  and  YRI-
CHBJPT FST,  as  well  as  the  Derived Intra-
Allelic  Nucleotide  Diversity  (DIND)  test
(Barreiro  et  al.  2009)  in  CEU and  CHBJPT.
The rationale  behind the DIND test  is  that  a
derived  allele  under  positive  selection  will
rapidly increase in frequency in the population
and will consequently display lower levels of
nucleotide  diversity  at  linked  sites  than
expected.  Thus,  the  ratio  of  intra-allelic
diversity  associated  with  the  ancestral  and
derived  alleles  (iπA/iπD)  is  analyzed  against
the  frequency  of  the  derived  allele  (DAF);
given a DAF interval, a high value of iπA/iπD
indicates that  the neutral diversity associated
with  the  derived  allele  is  limited,  suggesting
positive selection. DIND has higher power than
similar tests in most DAF ranges and is well
suited  for  low-coverage  data  (Barreiro  et  al.
2009;  Fagny  et  al.  2014).  The  statistical
significance  of  both  tests  was  obtained  by
deriving  empirical  distributions  of  the  same
parameters  calculated  for  a  large  number  of
randomly  selected  genes  (see  Materials  and
Methods for details). 
In  CEU  5  SNPs  were  outliers  in  the  FST
comparison  (Figure  3)  and  had  a  significant
DIND test  (DAF:  0.75-0.85,  DIND:  4.9-7.3).
These  variants  include  rs2074560  (derived
allele: A) and, despite the high recombination
rate  in  the  region,  define  a  homogeneous
haplotype that carries derived alleles at several
SNPs  (Figure  4B).  In  CHBJPT,  two  variants
had  a  significantly  high  FST value  and  a
significant DIND test (rs28425 and  rs443099,
DAF:  0.57  and  0.82,  DIND:  7.99  and  7.1,
respectively) (Figure 3). The derived allele of
rs443099 is carried by group of homogeneous
haplotypes, a fraction of which also displays 
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Figure 4. Natural selection at MX2 in human populations. (A) Worldwide allele frequencies of the three HGDP variants showing outlier F ST values.
(B)  Schematic representation of CHBJPT plus YRI (left) and CEU plus YRI (right) haplotypes in the regions surrounding rs443099 and rs2074560,
respectively. Each line represents a haplotype, columns indicate polymorphic positions. Dark grey, derived alleles, light grey, ancestral alleles. The thick
horizontal line separates haplotypes carrying the ancestral (bottom) and derived (top) allele at the selected variants (rs443099 and rs2074560 in the left
and right panels, respectively). (C) Schematic representation of  MX2 within the UCSC Genome Browser view. The location of the selection targets,
recombination rate (Kong et al. 2002), and relevant ENCODE tracks are also shown. SNP colour codes are as in Figure 3. 
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the  derived  allele  for  rs28425 (Figure  4B). The
rs45430 SNP, which we identified as an outlier in
the  initial  FST screen,  has  been  associated  with
melanoma  susceptibility  in  a  genome-wide
association study (GWAS); this variant is in tight
LD (r2=0.95, D'=1) with rs443099,
 suggesting that the derived allele, associated with
increased  melanoma  risk,  has  swept  to  high
frequency outside Africa as a result of selection.
Overall,  these  results  indicate  that  two  distinct
MX2 haplotypes  have  been  targeted  by  natural
selection 
in Asian and European populations. 
Interestingly,  ENCODE  annotations  (ENCODE
Project  Consortium  et  al.  2012)  deriving  from
experiments  in  white  blood  cells  or
lymphoblastoid  lineages  indicated  that  the  CEU
and  CHBJPT selected  variants  are  located  in  a
large  region  extending  downstream  the  MX2
transcription  start  site  where  several  regulatory
motifs  are  located,  as  assessed  by  analysis  of
DNase hypersensitive regions, transcription factor
bindng  sites  and  histone  modifications  (Figure
4C). C
MX2 haplotype  association  with  HIV-1
infection susceptibility
Given the  recently described  role  of  MX2 as  a
restriction  factor  for  HIV-1,  we  investigated
whether  the  positively  selected  European
haplotype  modulates  susceptibility  to  HIV-1
infection. Most human subjects are susceptible to
this  virus,  but  a  minority  of  individuals  do  not
seroconvert  despite  multiple  exposures.  We thus
genotyped  rs2074560 (G/A)  in  a  cohort  of  191
Spanish  individuals  who  were  exposed  to  the
virus  through  injection  drug  use  (IDU).  All  of
them  were  HCV-positive,  but  85  tested  HIV-1
negative  despite  multiple  exposures  through
needle  sharing  (HIV-1  exposed  seronegative,
IDU-HESN); the remaining subjects were HIV-1
positive  (IDU-CTR).  We  observed  a  deviation
from  Hardy-Weinberg  equilibrium  (HWE)  in
IDU-HESN  with  an  excess  of  homozygotes
(HWE p value= 0.0047); IDU-CTR complied to
HWE.  A significant  difference  was  observed  in
the genotypic distribution of rs2074560 in the two
cohorts (Table 3), and the frequency of individuals
homozygous  for  the  G  allele  was  significantly
higher in IDU-HESN (20.0%) compared to IDU-
CTR (7.5%). The odds ratio (OR) for a recessive
model with the GG genotype being protective
against  HIV-1  infection  was  3.06  (95%  IC:
1.25-7.5,  logistic  regression,  p=  0.014).  In
order to replicate this finding a second HESN
population with different geographic origin and
exposed  to  the  virus  through  a  different
infection  route  was  analyzed  as  well.  Thus,
rs2074560  was  genotyped  in  a  well
characterized cohort of 88 heterosexual Italian
subjects who have a history of unprotected sex
with  their  seropositive  partners  (sex-exposed
HESN,  SexExp-HESN).  As  a  control  188
Italian healthy controls (HC) were genotyped;
both  samples  complied  to  HWE.  Again,  a
significant  difference  was  observed  in  the
genotype  distribution  of  rs2074560  (logistic
regression,  p=  0.014)  (Table  3);  similarly  to
what was observed in the Spanish sample, GG
homozygotes  were  significantly  over-
represented  in  HESN  (12.5%)  compared  to
controls  (3.4%).  Thus,  a  recessive  model
yielded  a  significant  association  of  the  GG
genotype  with  HIV-1  protection  (logistic
regression, p value= 0.005, OR: 4.33, 95% IC:
1.55-12.14).  Further  confirmation  was  sought
in a third and smaller population of 37 SexExp-
HESN from Spain. These subjects are women
who  exposed  themselves  repeatedly  through
unprotected  intercourse  with  their  HIV-1
infected partners. A sample of 180 Spanish HC
was also analysed. The genotype proportions of
rs2074560 complied to HWE in both samples.
Again,  GG  homozygotes  were  much  more
abundant among SexExp-HESN (10.8%) than
among  HC  (5.5%),  thus  supporting  results
obtained in the two other case-control cohorts
(Table 3). As expected, the small sample size of
the  HESN  population  resulted  in  a  non-
significant p value due to lack of power. The
results  of the three association analyses  were
combined  through  a  random  effect  meta-
analysis,  which  revealed  no  heterogeneity
among samples (Cochrane's Q p value= 0.66,
I2=  0)  and  yielded  a  p  value  of  1.55x10-4
(Table  3).  Overall,  these  results  strongly
suggest that the G allele of rs2074560 protects
from HIV-1 with a recessive effect, irrespective
of the infection route. 
MX2  haplotype  association  with  in  vitro
viral infection
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To  verify  whether  rs2074560  affects  HIV-1
replication  in  vitro,  we  performed  an  infection
assays.  Specifically,  PBMCs  from  50  Italian
HESN subjects  were  cultured and infected  with
HIV-1Ba-L.  Viral  replication was  assessed after  3
days by measuring viral p24 levels produced by
the  infected  cells.  Results  indicated  that  the  G
allele  is  associated with  significantly lower  p24
antigen levels (Kruskal-Wallis rank sum test,  p=
0.034) (Figure 5).
Figure 5. Box-and-whisker plot of p24 antigen. PBMCs from 50 Italian
HESN subjects were infected with HIV-1Ba-L;  the levels of  viral p24 were
measured after 3 days and normalized within experiments. Data are shown
as a function of  rs2074560  genotype in standard box-and-whisker plot
representation  (thick  line:  median;  box:  quartiles;  whiskers:  1.5  x
interquartile range).
MX2 expression  in  response  to  interferon
treatment
Recent  evidences  have  indicated  that  MX2
expression is increased in response to IFN-α and
that  intra-individual  variability  may exist  in  the
level of induction (Goujon et al. 2013; Kane et al.
2013). Thus, we assessed whether allelic status at
rs2074560 influences MX2 expression levels in
response  to  IFN-α.  To  this  aim,  peripheral
blood  mononuclear  cells  (PBMC)  from  45
healthy volunteers were stimulated with IFN-α
and  MX2 mRNA induction was evaluated by
real-time  PCR.  Results  indicated  that  the  G
allele  of  rs2074560  is  associated  with  a
significantly  increased  MX2 expression  in
response  to  IFN-α (Kruskal-Wallis  rank  sum
test, p= 0.033) (Figure 6).
Discussion
The human MX2 protein has long been thought
to lack antiviral activity and to serve  cellular
functions such as nucleo-cytoplasmic transport
and  cell-cycle  progression  (King,  Raposo,
Lemmon  2004).  Recent  evidences  have
challenged this view by showing that 
Figure 6.  Box-and-whisker plot of  MX2 induction in response to
IFN-α.  Data derive from IFN-α stimulation of PBMCs deriving from
45  healthy  volunteers.  MX2 transcript  levels  are shown  as  log-
transformed  fold-change  expression  from  the  unstimulated  sample.
Data are shown in standard box-and-whisker plot representation, as in
Fig 4..
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MX2 acts as a restriction factor against HIV-1 and
other  simian  retroviruses  (Goujon  et  al.  2013;
Kane  et  al.  2013;  Liu  et  al.  2013b).  Herein  we
follow-up on these observations and demonstrate
that  MX2 evolved adaptively in mammals and in
human  populations  and  that  a  polymorphism in
the  gene  modulates  both  MX2 expression  in
response  to  IFN-α and  HIV-1  infection
susceptibility. 
Antiviral  effectors  are  known  to  represent
common  targets  of  natural  selection  (Daugherty
and Malik 2012), which most likely ensues from
host-pathogen  genetic  conflicts.  Thus,
determinants  of  antiviral  activity  are  often
accounted  for  by  rapidly  evolving  residues.  In
primate MX1 genes most sites targeted by positive
selection  are  located  in  loop  4  and  explain
species-specific  difference  in  antiviral  activity
against  orthomyxoviruses,  although  additional
determinants  of  antiviral  specificity  must  be
accounted for by residues outside loop 4 (Mitchell
et  al.  2012).  The  natural  selection  pattern  we
observed  at  MX2  closely  reflects  the  one
described for MX1, with loop 4 strongly targeted
by natural selection and the same helix surface in
the stalk domain carrying three positively selected
sites  in  MX1  and  the  positively  selected  460
residue  in  MX2  (Mitchell  et  al.  2012).
Interestingly,  one of the positively selected sites
we identified in MX2, S518 in spatial proximity
to the 460 residue, corresponds to a polymorphic
position  in  the  pig  coding  sequence;  aminoacid
variation at this residue modulate the ability of the
porcine  MX2  protein  to  inhibit  vescicular
stomatitis  virus  replication  (Sasaki  et  al.  2014),
supporting the hypothesis that positively selected
sites determine antiviral activity. 
Application  of  two  different  methods  indicated
that  lineage-specific  selective  events  shaped
diversity  at  primate  MX2 genes.  Currently
available  tests  have  limited  power  to
simultaneously  detect  the  sites  and  the  lineages
subject to episodic positive selection (Murrell  et
al.  2012;  Zhang,  Nielsen,  Yang  2005).
Consequently, our analysis cannot be regarded as
comprehensive in this respect, and additional sites
evolving under episodic selection may have gone
undetected.  Indeed,  we  were  unable  to  identify
significant  sites  in  the alpaca lineage,  and more
sites  may represent  selection targets  in  primates
and pigs. Nonetheless, we consider thta the sites
we did identify are supported by robust evidence,
as they were validated by two distinct methods.
Interestingly,  one  site  evolving  adaptively  in
primates  is  located  in  the  MX2  GTPase
domain,  in  spatial  proximity to  an  MX1 site
positively selected in primates (Mitchell et al.
2012). These observations strongly suggest that
the  GTPase  domain  might  play a  role  as  an
antiviral  determinant,  although  its  precise
function  needs  further  experimental  analysis,
as  MX2 mutants unable to bind or hydrolyse
GTP retain their anti-HIV-1 activity (Goujon et
al. 2013; Kane et al. 2013; Liu et al.  2013b).
The  role  of  loop  4  residues  as  antiviral
determinants  is  more  clearly  established,  as
single aminoacid replacements alter the ability
of MX1 to restrict Thogoto virus and influenza
A  virus  (Mitchell  et  al.  2012).  A
crystallographic  study  indicated  that  MX1
forms  ring-shaped  oligomeric  structures,  but
failed to solve the structure of loop 4, that was
however predicted to face the internal surface
of  the  ring (Gao et  al.  2011).  Our  modeling
data indicate that MX2 loop 4 protrudes from
the stalk backbone and, were MX2 to adopt the
same conformation as MX1 oligomers,  might
act  as  the  foremost  contact  surface  with  the
viral substrate (the capsid protein in the case of
HIV-1 (Goujon et al. 2013; Kane et al. 2013;
Liu et al. 2013b)). 
Results  herein  also  indicate  a  continuum  in
selective  pressure  acting  in  mammals  and  in
human  populations,  and  targeting  MX2.
Nonetheless, in line with a large-scale analysis
of  positive  selection,  which  revealed  most
human  selection  targets  to  be  located  in
noncoding  regions  (Grossman  et  al.  2013),
positive selection acted on  MX2 SNPs with a
likely  regulatory  role,  whereas  the  coding
sequence  was  mainly  subject  to  selective
constraint  in  the  human  lineage.  Population
genetic  analyses  indicate  that  two  different
haplotypes  swept  to  high  frequency  in
populations  of  non-African  ancestry;  in  both
cases the result is counter-intuitive as selection
favoured the frequency increase of a melanoma
susceptibility  allele  and  of  a
polymorphism/haplotype  associated  with
decreased  IFN-α induction  and  augmented
HIV-1  infection  susceptibility.  Previous
analyses  have  indicated  that  risk  alleles  for
human diseases may represent selection targets
(Forni  et  al.  2013;  Fumagalli  et  al.  2009;
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Jostins et al. 2012; Raj et al. 2012; Zhernakova et
al. 2010) and this possibly reflects either changes
in environmental  pressures or  pleiotropic effects
of  the  selected  alleles.  Thus,  the  variant  we
analysed may differently affect IFN-α response in
cell types other than PBMCs. Indeed, rs2074560
is  located  in  a  region  which  likely  modulates
transcriptional  activity in different  cell  types,  as
suggested  by  the  presence  of  DNaseI
hypersensitivity  peaks  and  transcription  factor
binding  sites.  An  alternative  explanation  is  that
increased levels of  MX2 induction in response to
IFN-α is  deleterious  to  some  cellular  process
unrelated  to  antiviral  response,  an  hypothesis
previously  proposed  to  explain  the  loss  of
APOBEC3H  activity  in  populations  of  non-
African  ancestry  (OhAinle  et  al.  2008).
Conversely,  our  data  indicate  that  the  stronger
response  to  IFN-α afforded  by  the  rs2074560
ancestral allele confers protection in the context of
HIV-1  infection.  Indeed,  we  analysed  three
populations  of  HESN  subjects  with  different
geographic origin and distinct routes of exposure
to the virus.  Results were consistent in showing
that homozygosity for the G allele at rs2074560
protects  from  infection.  Because  association
results were replicated in the three independents
cohorts,  we  consider  that  evidences  are  strong
enough  to  establish  a  role  for  rs2074560  as  a
determinant  of  HIV-1  infection  susceptibility  in
humans, despite the relatively small sample of the
HESN  populations.  Moreover,  the  association
results  are  supported  by  the  in  vitro infection
assay,  which  indicated  that  the  G  allele
significantly decreases viral replication. Recently,
Lane  and co-workers  performed a  genome-wide
association study of resistance to HIV-1 infection
in  highly  exposed  uninfected  hemophiliacs  and
detected no  genome-wide  significant  association
with the exclusion of the known CCR5Δ32 allele
(Lane et al. 2013); nonetheless, given the average
minor allele frequency of rs2074560 in Europeans
(around  0.25),  its  recessive  effect,  and  the  OR
estimated  herein  (OR:  3.12),  their  study  was
underpowered to reach genome-wide significance
for this variant. 
A recent study of HIV-1-infected and seronegative
subjects  confirmed  that  CCR5Δ32  homozygotes
are  protected  from infection  (OR=0.2),  whereas
no effect was detected for the  HLA-B*57:01 and
*27:05  alleles,  both  associated  with  slow
progression to AIDS (McLaren et al. 2013). The
CCR5Δ32 allele is almost exclusively found in
Europe  and  West  Asia,  where  its  frequency
follows a latitudinal cline (Novembre, Galvani,
Slatkin 2005). In Italy and Spain, the estimated
frequency of CCR5Δ32 homozygotes is around
0.25-0.5% (Novembre, Galvani, Slatkin 2005),
indicating  that  this  allele  makes  a  minor
contribution  to  HIV-1  susceptibility  at  the
population  level.  Additional  polymorphisms
that  modulate  the  susceptibility  to  HIV-1
infection have been identified in recent years;
all of them map to genes involved directly (e.g.
ERAP2,  IRF1,  and  TLR3)  or  indirectly
(FREM1 and  CYP7B1)  in  immune  response
(Ball et al. 2007; Biasin et al. 2013; Limou et
al. 2012; Luo et al. 2012; Sironi et al. 2012).
Some of these loci showed a relatively strong
effect,  comparable  to  that  estimated  for  the
MX2 variants  we  describe herein (Ball  et  al.
2007;  Biasin et  al.  2013;  Limou et  al.  2012;
Luo et  al.  2012).  Nonetheless,  most  of  these
analyses, including those reported in our study,
were performed on relatively small population
samples,  due  to  the  intrinsic  difficulty  in
characterizing  and  recruiting  HESN  cohorts.
Thus,  calculation  of  the  effect  size  on  lager
samples  will  be  necessary  to  provide  more
reliable estimations. 
Another  point  that  will  require  further
investigation is the reason(s) why rs2074560,
which  modulates  expression  levels,  confers
protection  with  a  recessive  effect.  One
possibility is that the cellular amount of MX2
protein is rate-limiting for efficient HIV-1
restriction, so that a threshold  needs  to  be
reached to afford in vivo protection. This model
might  be  appealing  in  light  of  the  proposed
model  for  MX1  antiviral  activity,  whereby
oligomers  enclose  and  sequester  viral
components  (Gao et  al.  2011;  Reichelt  et  al.
2004). Another possibility is that, although in
the association analysis infection susceptibility
was  treated  as  a  dichotomous  variable  (i.e
HESN/non-HESN  status),  it  may  be  a
continuous  trait.  Thus,  the  HESN  status
possibly represents an extreme phenotype and
selection  of  HESN  cohorts  may  result  in
enrichment  for  the most  protective  genotype.
This hypothesis is in line with the results from
the in vitro infection assay, whereby rs2074560
genotype  was  analysed  against  a  continuous
variable  (p24  antigen  levels);  in  this
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experiment  the  effect  of  the  G  allele  was  also
evident in heterozygous subjects, and the limited
the number of GG homozygotes makes it difficult
to determine whether an additive model applies to
these data.
The observation that the MX2 polymorphism that
modulates  susceptibility  to  HIV-1  infection  also
regulates MX2 expression in response to IFN-α is
biologically  interesting.  MX2 is  part  of  the
interferon-regulated  genes,  a  vast  and
heterogeneous family of genes whose expression
is  modulated  by  IFN-α.  Some  of  these  genes,
including  CH25H,  were  recently  shown  to  be
endowed with potent  antiviral  properties (Liu et
al.  2013a).  It  is  thus  tempting  to  envision  a
scenario in which an initial infection with HIV-1
of  target  cells  that  are  GG  homozygous  would
trigger  the  up-regulation  of  MX2;  this  in  turn
would block viral replication and impede nuclear
accumulation  and  chromosomal  integration  of
nascent  viral  DNA.  The  infection  would  be
aborted and the immune response would be able
to clear away the few cells that had been initially
infected, preventing the infection to spread in an
uncontrolled  fashion.  This  could  explain  the
puzzling presence of HIV-specific T helper cells
and CTL in the absence of any detectable ongoing
infection:  a  phenomenon  that  is  observed  in
HESN not only during, but, transiently, also after
cessation of exposure (Miyazawa et al. 2009). 
In  summary,  building on  the  recently described
role  of  MX2  as  HIV-1  restriction  factors,  we
exploited  evolutionary information  to  identify a
variant  that  confers  natural  resistance  to  HIV-1
infection. Results herein establish the role of MX2
as  a  central  element  of  antiviral  response  in
mammalian  species  and  a  possible  target  for
therapeutic  intervention  in  HIV-1  treatment  and
prevention. 
Materials and Methods
Evolutionary analysis in mammals
Mammalian sequences for  MX2 were retrieved
from the Ensembl and  NCBI  databases
(http://www.ensembl.org/index.html;
http://www.ncbi.nlm.nih.gov/). The list of species
is  reported  in  Supplementary  Table  S1,
Supplementary Material online.  DNA alignments
were  performed  using  the  RevTrans  2.0  utility
(Wernersson and Pedersen 2003), which uses the
protein sequence  alignment  as  a  scaffold  to
construct  the  corresponding  DNA  multiple
alignment. This latter was checked and edited
by hand to remove alignment uncertainties. For
PAML analyses  (Yang  2007)  we  used  trees
generated  by  maximum-likelihood  using  the
program PhyML (Guindon et al. 2009).
 The site models implemented in PAML have
been  developed  to  detect  positive  selection
affecting only a  few aminoacid residues in  a
protein.  To  detect  selection,  site  models  that
allow  (M2a,  M8)  or  disallow  (M1a,  M7)  a
class of sites to evolve with ω >1 were fitted to
the  data  using  the  F3x4  and  the  F61  codon
frequency model. Positively selected sites were
identified  using  the  Bayes  Empirical  Bayes
(BEB) analysis (with a cut-off of 0.90), which
calculates  the  posterior  probability  that  each
codon  is  from  the  site  class  of  positive
selection  (under  model  M8)  (Anisimova,
Bielawski, Yang 2002). A second method, the
Mixed  Effects  Model  of  Evolution  (MEME)
(with the default cutoff of 0.1) (Murrell et al.
2012)  was  applied  to  identify  positively
selected sites. MEME allows the distribution of
ω to vary from site to site and from branch to
branch  at  a  site,  therefore  allowing  the
detection  of  both  pervasive  and  episodic
positive  selection  (Murrell  et  al.  2012).  
To  explore  possible  variations  in  selective
pressure among different lineages, we applied
the  free-ratio  models  implemented  in  the
PAML package:  the  M0  model  assumes  all
branches  to  have  the  same  ω,  whereas  M1
allows each branch to  have its  own ω (Yang
and Nielsen 1998). The models are compared
through  likelihood-ratio  tests  (degree  of
freedom=  total  number  of  branches  -1).  In
order  to  identify  specific  branches  with  a
proportion of sites evolving with ω>1, we used
BS-REL (Kosakovsky Pond et  al.  2011) with
the PhyML-generated tree. Branches identified
using this approach were cross-validated with
the  branch-site  likelihood  ratio  tests  from
PAML (the  so-called  modified  model  A and
model  MA1,  “test  2”) (Zhang,  Nielsen,  Yang
2005).  A false  discovery rate  correction  was
applied  to  account  for  multiple  hypothesis
testing  (i.e.  we  corrected  for  the  number  of
tested lineages), as suggested (Anisimova and
Yang 2007).  The advantage of this method is
that  it  also  implements  a  BEB  analysis
analogous to that described above to calculate
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the posterior probabilities that each site belongs to
the  site  class  of  positive  selection  on  the
foreground  lineages.  Thus,  BEB  allows
identification  of  specific  sites  that  evolve  under
positive selection on specific lineages, although it
has  limited  statistical  power  (Zhang,  Nielsen,
Yang  2005).  GARD  (Kosakovsky  Pond  et  al.
2006), MEME (Murrell et al. 2012), and BS-REL
analyses  were  performed  through  the
DataMonkey  server  (Delport  et  al.  2010)
(http://www.datamonkey.org). 
Structural model prediction and validation
Structural models of MX2 were initially predicted
using 3 different methods: MODELLER (Eswar et
al. 2006) with loop refinement, I-TASSER (Roy,
Kucukural,  Zhang  2010;  Zhang  2008)  with  a
defined  template  (MX1,  PDB  structure:  3SZR
(Gao  et  al.  2011))  or  I-TASSER  without  any
template. The quality of each model was assessed
with VADAR (Willard et  al.  2003).  The overall
quality was estimated with respect to its geometry
and  energy  (packaging  defects,  free  energy  of
folding,  core hydrophobic  and charged residues)
(Supplementary Tab. S2, Supplementary Material
online). Secondary structures found in loops were
validated through the use of PSIPRED (McGuffin,
Bryson,  Jones 2000) server  (Supplementary Fig.
S1, Supplementary Material online). According to
these criteria  the model  produced by I-TASSER
with MX1 as template was used for our analysis.
Population genetics-phylogenetics analysis
Data from the Pilot 1 phase of the 1000 Genomes
Project were retrieved from the dedicated website
(1000 Genomes Project Consortium et al. 2010).
Low-coverage SNP genotypes were organized in a
MySQL  database.  A  set  of  programs  was
developed to retrieve genotypes from the database
and  to  analyze  them  according  to  selected
regions/populations.  These  programs  were
developed in C++ using the GeCo++ (Cereda et
al.  2011),  the libsequence (Thornton 2003),  and
the  mysqlpp  libraries.  Coding  sequence
information was obtained for  MX1 and  MX2. To
analyze the DFE we used GammaMap (Wilson et
al. 2011). We assumed θ (neutral mutation rate per
site),  k  (transitions/transversions  ratio),  and  T
(branch  length)  to  vary  among  genes  following
log-normal distributions. For each gene we set the
neutral  frequencies  of  non-STOP codons  (1/61)
and the probability that adjacent codons share the
same  selection  coefficient  (p=0.02).  For
selection coefficients we considered a uniform
Dirichlet  distribution  with  the  same  prior
weight for each selection class. For each gene
we run 10,000 iterations with thinning interval
of 10 iterations.
Population genetic analysis in humans
HGDP genotype  data  derive from a previous
work (Li  et  al.  2008).  Atypical  or  duplicated
samples  and  pairs  of  close  relatives  were
removed  (Rosenberg  2006).  FST among
continental  groups  was  calculated  for  all
HGDP  SNPs.  Because  FST values  are  not
independent  from  allele  frequencies,  variants
were divided in 100 percentile classes based on
MAF and FST distributions were calculated for
each  class;  outliers  were  defined  as  variants
with an FST higher than the 95th percentile in
the  distribution  of  SNPs  in  the  same  MAF
class. 
Data  from  the  Pilot  1  phase  of  the  1000
Genomes  Project  were  retrieved  as  described
above. Genotype information was obtained for
MX2 and for 1,200 randomly selected RefSeq
genes. Orthologous regions in the chimpanzee,
orangutan  or  macaque  genomes  (outgroups)
were  retrieved  using  the  liftOver  tool
(http://hgdownload.cse.ucsc.edu/);  genes
showing  less  than  80%  human-outgroup
aligning bases were discarded. This originated
a  final  set  of  987  genes  (control  set).  FST
(Wright 1950) and the DIND test (Barreiro et
al. 2009) were calculated for all SNPs mapping
to  MX2 and to the control gene sets.  For FST
variants  were binned  variants  based  on  their
MAF (100 classes) and the 95th percentile for
each  MAF  class  was  calculated.  As  for  the
DIND  test,  it  was  originally  developed  for
application  to  Sanger  or  high  coverage
sequencing data (Barreiro et al. 2009), so that
statistical significance can be inferred through
coalescent simulations. This is not the case for
the  1000  Genomes  Project  data;  thus,  we
calculated statistical significance by obtaining
an empirical distribution of DIND-DAF value
pairs for variants located within control genes.
Specifically, DIND values were calculated for
all  SNPs  using  a  constant  number  of  40
flanking  variants  (20  up-  and  down-stream).
The distributions of DIND-DAF pairs for YRI,
CEU  and  CHBJPT  was  binned  in  DAF
intervals (100 classes, bin=0.01) and for each
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class  the  95th  percentile  was  calculated.  As
suggested  (Barreiro  et  al.  2009),  for  values  of
iπD=  0 we set the DIND value to the maximum
obtained over the whole dataset plus 20. 
Subject  cohorts,  genotyping  and  statistical
analysis
We  recruited  191  males  exposed  to  HIV-1
infection by injection drug use (IDU) and enrolled
in  prospective  cohort  studies  in  Spain  (Valme
Hospital, Sevilla) who had shared needles for >3
months. Concurrent markers of hepatitis C virus
(HCV)  infection  were  present  in  100% of  IDU
subjects. Eighty-five of these subjects were HIV-1
negative (IDU-HESN), 106 were HIV-1 positive
(IDU-CTR).  
Thirty-eight Spanish HESN exposed to the virus
through unprotected sexual intercourse (SexExp-
HESN)  were  also  recruited.  These  subjects  are
female  partners  of  HIV-1  positive  patients
(without treatment and viremic, mean number of
unprotected  sexual  intercourse  per  year:  110,
mean number of years as sexual partners: 5, range
3-17).  Healthy  controls  (HC,  n=180)  that  were
anonymous blood donors from The City of Jaen
Hospital were also recruited. All these individuals
were seronegative for both HIV-1 and HCV. All
subjects  were  Spanish  of  Caucasian  origin.  The
study was designed and performed according to
the Helsinki declaration and was approved by the
Ethics  Committee  of  the  participating  hospitals
and  the  University  of  Jaen.  All  patients  and
healthy blood donors  provided written informed
consent to participate in this study.
As  for  Italian  SexExp-HESN,  inclusion  criteria
were  a  history  of  multiple  unprotected  sexual
episodes for more than 4 years at the time of the
enrolment,  with  at  least  3  episodes  of  at-risk
intercourse within 4 months prior to study entry
and an average of 30 (range, 18 to >100) reported
unprotected sexual contacts per year (Miyazawa et
al.  2009).  Sex  Exp-HESN  and  188  healthy
controls  (HC)  were  recruited  at  the  S.  M.
Annunziata Hospital,  Florence; all of them were
Italian  of  Caucasian  origin.  The  study  was
reviewed and approved by the institutional review
board of the S. M. Annunziata Hospital, Florence.
Written informed consent was obtained from all
subjects.
rs2074560  was  genotyped  through  PCR
amplification  and  direct  sequencing  (primer
sequences  are  available  upon  request).  PCR
products  were treated with ExoSAP-IT (USB
Corporation  Cleveland  Ohio,  USA),  directly
sequenced  on  both  strands  with  a  Big  Dye
Terminator  sequencing  Kit  (v3.1  Applied
Biosystems),  and  run  on  an  Applied
Biosystems  ABI  3130  XL Genetic  Analyzer
(Applied  Biosystems).  Sequences  were
assembled using AutoAssembler version 1.4.0
(Applied Biosystems), and inspected manually
by two distinct operators.  Genetic association
analyses were performed by logistic regression
and  results  from  the  three  cohorts  were
combined using a random-effect meta-analysis;
all  analyses  were  performed  using  PLINK
(Purcell et al. 2007).
HIV infection assay
PBMC from 50 HESN subjects were separated
on lymphocyte separation medium (Organon
Teknica, Malvern, Pa);  10×106 cells/mL were
cultured for 2 days at 37°C and 5% CO2 in
RPMI 1640 containing FBS (20%),
phytohemagglutinin (PHA) (7.5 μg/mL), and
interleukin (IL)—2 (15 ng/mL). After viability
assessment, 2.5×106 cells were resuspended in
medium containing 1 ng of HIV-1Ba-L p24 viral
input/106 PBMC and incubated for 3 h at 37°C.
Cells were then washed and resuspended in 3
mL of complete medium with IL-2 (15 ng/mL).
Cells were plated in 24-well tissue culture
plates and incubated at 37°C and 5% CO2.
After 3 days supernatants were collected for
p24 antigen ELISA analyses. Absolute levels
of p24 were measured using the Alliance HIV-
1 p24 ELISA Kit (PerkinElmer). PBMCs from
the 50 subjects were split and infected in three
independent experiments. To account for minor
differences  in  virus  titre,  p24  levels  were
normalized within experiment.   HIV-1Ba-L was
provided through the EU programme EVA
centre for AIDS Reagents NIBSC, UK. 
IFN-α stimulation  and  MX2 transcript
quantification
Whole  blood  was  collected  from  45  healthy
controls  by venupuncture  in  Vacutainer  tubes
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containing EDTA (Becton Dickinson, NJ, USA),
and  PBMC  were  separated  on  lymphocyte
separation  medium  (Organon  Teknica,  Malvern,
Pa). Based on data derived from a kinetic study
(data not shown), 5 x 105 freshly isolated PBMC
were incubated for 3h with medium alone or 400
U/ml IFN-α (Sigma Aldrich).
RNA was extracted from cultured PBMC by using
the  acid  guanidium  thiocyanate–phenol–
chloroform method.  The  RNA was  dissolved  in
RNase-free  water,  and  purified  from  genomic
DNA  with  RNase-free  DNase  (RQ1  DNase,
Promega,  Madison,  Wisconsin,  USA).  One
microgram of RNA was reverse  transcribed into
first-strand  cDNA  in  a  20-µl  final  volume
containing 1 µM random hexanucleotide primers,
1  µM  oligo  dT  and  200  U  Moloney  murine
leukemia  virus  reverse  transcriptase  (Clontech,
Palo Alto, California, USA). cDNA quantification
for  MX2 and  GAPDH was performed by a real-
time PCR strategy (DNA Engine Opticon 2; MJ
Research,  Ramsey,  USA).  Reactions  were
performed  using  a  SYBR  Green  PCR  mix  (5
prime,  Gaithersburg,  USA).  Results  were
expressed  as  ΔΔCt  and  presented  as  ratios
between  the  target  gene  and  the  GAPDH
housekeeping mRNA. 
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3.2.1.4 The complement system as an epitome of host-pathogen 
genetic conflicts
Because the complement system acts as a first line defense and integrates
innate  and  adaptive  immune  responses,  an  extremely  wide  range  of
pathogens  have  developed  complement  evasion  strategies.  Indeed,
pathogenic  organisms  as  diverse  as  helminths  and  viruses  encode
molecules that  inhibit  or  antagonize one or more steps of  the activation
cascade [152-154]. In this respect, the complement system is an epitome
for  the  constant  host-pathogen  conflict  that  contrasts  immune response
with immune evasion [12].
Genetic conflicts have previously been described mainly in the context of
host/virus  interactions  [155,  156],  and  few  studies  have  integrated
evolutionary  analysis  of  both  host  and  pathogen  interacting  partners.
Moreover, the complement system is targeted by pathogens that naturally
infect  humans  but  not  other  primates  (e.g.  Neisseria  meningitidis and
Neisseria gonorrhoeae), offering the opportunity to dissect the evolutionary
events  underlying  host  specificity.  Finally,  microbial  interactors  of
complement system components are often used for vaccine design. 
Thus, the aims of this work were: i) to provide a comprehensive catalog of
sites in complement system genes that were targeted by positive selection
in primates and in the human lineage; ii) to test whether positive selection
acted  on  bacterial  interactors;  iii)  to  integrate  evolutionary  analysis  and
docking  studies  with  previous  biochemical  in  vitro data  to  test  general
hypotheses on host-pathogen interactions.
I analyzed the evolutionary history of 40 complement genes in primates and
in  the  human  lineage  using  conservative  likelihood  ratio  tests  and  a
population genetics-phylogenetics approach [19]. I also applied omegaMap
[80], a Bayesian method that simultaneously estimates recombination rate
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and selection, to study 5 bacterial interactors of complement components. I
finally integrated evolutionary analyses with literature data and performed
protein-protein docking to evaluate the effect of positively selected sites.
Results  show  that  host  components  targeted  by  several  microbial/viral
proteins evolved under the strongest selective pressure in primates; these
include CFH, CD59, C4BPA, and CD55. At such genes, as well as at others
(e.g.  CR2 and  VTN), selection acted on residues that are located at the
interaction interface with microbial/viral components. In CFH, for instance,
the  C-terminal  CCP domains  (19-20),  which  are  bound  by  an  array  of
pathogens,  represented  preferential  selection  targets  (uniform  random
sampling, p<10-5). In particular, three of the sites detected in these domains
were previously shown to be bound by different  pathogens belonging to
distinct  phyla  [157],  indicating  very  strong  and  long-standing  selective
pressures.  One  of  these  sites  also  represents  a  human-specific
determinant  for  the binding of  N. gonorrhoeae,  as is  the case for  three
positively selected sites in C4BPA [158]. Partially because of the resistance
to  human  complement-mediated  killing,  natural  infection  with  N.
gonorrhoeae is restricted to our species [159]. Examples of selection-driven
species-specific susceptibility to infection had previously been reported for
viral pathogens [155, 156], but rarely for bacteria [160]. 
As  for  bacteria,  I  analyzed  five  genes  encoding  complement-interacting
partners:  two  porins  from  N.  gonorrhoeae,  PspC (Steptococcus
pneumoniae),  OspE (Borrelia spp.), and  CspZ (Borrelia spp.). They were
selected because the molecular determinants of the interaction with CFH or
C4BP, the two most common targets, are known. All five genes were found
to have evolved adaptively  and in  all  instances positively  selected sites
were found to be involved in the binding of the host interactor. Theseresults
reflect  the  expectations  under  a  genetic  conflict  scenario  whereby  the
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host’s and the pathogen’s genes evolve within binding avoidance-binding
seeking dynamics. Protein-protein docking analyses supported this view. In
fact,  I  exploited  previous  data  to  validate  an  in  silico mutagenesis  and
docking  strategy  that  was  subsequently  used  to  analyze  the  effect  of
selected  sites.  To  this  aim,  a  subset  of  host-pathogen  protein-protein
interactions  was selected for  the  in  silico  docking studies based on the
availability of the 3D structure of the complex. These analyses revealed that
all  positively  selected  sites  we  analyzed  (both  in  the  host  and  in  the
pathogen interacting partner) modulate binding.
The  pathogens  included  in  this  study  are  extremely  important  from  a
medical  perspective  and account  for  substantial  morbidity  and  mortality.
Bacterial  proteins  that  interact  with  complement  components  have been
regarded as attractive vaccine candidates, because vaccine efficacy may
be enhanced by virulence impairment [161]. The possibility that vaccines
and,  more  generally,  antimicrobial  compounds,  contribute  to  pathogen
evolution  ultimately  resulting  in  cultural-based  arms  race  scenarios  has
previously  been  envisaged  [162,  163].  These  data  support  this  view:
complement-interacting protein surfaces may be more than poised for the
next round of drug-driven selection.
Personal contribution to the work: I performed the evolutionary analysis in primates and I
produced figures and tables.
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Abstract
The complement system is an innate immunity effector mechanism; its action is antagonized
by a wide array of pathogens and complement evasion determines the virulence of several
infections.  We  investigated  the  evolutionary  history  of  the  complement  system  and  of
bacterial-encoded  complement-interacting  proteins.  Complement  components  targeted  by
several pathogens evolved under strong selective pressure in primates, with selection acting
on residues at the contact interface with microbial/viral proteins. Positively selected sites in
CFH  and  C4BPA account  for  the  human  specificity  of  gonococcal  infection.  Bacterial
interactors, evolved adaptively as well, with selected sites located at interaction surfaces with
primate  complement  proteins.  These  results  epitomize  the  expectation  under  a  genetic
conflict  scenario  whereby  the  host’s  and  the  pathogen’s  genes  evolve  within  binding
avoidance-binding  seeking  dynamics.  In  silico mutagenesis  and  protein-protein  docking
analyses supported this by showing that positively selected sites, both in the host's and in the
pathogen's interacting partner, modulate binding.
Keywords:  Complement system; host-pathogen genetic conflict; positive selection; human specific
infections.
Introduction
The  complement  system  is  an  integral  arm  of
innate immunity that plays essential roles in the
clearance  of  pathogenic  invaders,  in  the
maintenance  of  tissue  integrity,  and  in  the
elicitation of inflammatory reactions. This system
consists  of  several  circulating  and  cell-surface-
bound  proteins  that  orchestrate  a  series  of
proteolytic  cascades  (Ricklin  &  Lambris  2013).
Different  triggers  result  in  distinct  pathways  of
complement activation.  The classical pathway is
activated  by  IgM-  and  IgG-  including
immunocomplexes,  but  also  by  endogenous
molecules such as C reactive protein (CRP) or
by  direct  binding  of  C1q  to  pathogen-
associated  molecular  patterns  (Fig.  1).  The
alternative  pathway does  not  require  specific
activation,  but  is  initiated  by  a  spontaneous
hydrolysis of unstable C3 component (Fig. 1).
Finally,  the  lectin  pathway  is  triggered  by
recognition of specific carbohydrate structures
on the surface of foreign cells through ficolins
and mannose-binding lectin (Fig. 1) (Ricklin &
Lambris  2013).  The three pathways converge
on C3 and the first effect of the complement 
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Figure 1. Positive selection at complement system genes  The molecular components of the complement system are shown to provide a general
overview of the extent of positive selection and to highlight the function of positively selected genes. Thus, the figure is not meant to show all molecules
involved in the process or to convey mechanistic insights. Gene products are color-coded as follows: yellow, positive selection in the human lineage (at
least one positively selected site in gammaMap analysis); red symbol, positive selection in primates.
cascade activation is the production of an active
C3  convertase  (Fig.  1).  The  alternative  and  the
classical/lectin  pathways  form  distinct  C3
convertases which cleave C3 into the small  C3a
anaphylatoxinand  C3b.  Anaphylotoxins  act  as
potent  pro-inflammatory  molecules  at  the
systemic and local level and C3b deposited onto
cell  surfaces  acts  as  an  opsonin.  Opsonization
induces  cell  clearance  by  phagocytosis  and
triggers the assembly of C5 convertases. In turn,
C5  cleavage  generates  C5a,  another
anaphylatoxin,  and  the  C5b fragment.  The final
effector mechanism is mediated by the sequential
addition of soluble components C6, C7, C8 and
C9  to  C5b  and  leads  to  the  formation  of  the
membrane  attack  complex  (MAC),  a  lytic  pore
that can cause cell lysis (Ricklin & Lambris 2013)
(Fig. 1). Deregulation of the complement system
can  cause  tissue  damage  and  inflammation
resulting in the development of inflammatory and
autoimmune disorders (Ricklin & Lambris 2013).
Thus, the system is tightly regulated at different
levels: complement regulators act to decrease the
activity  of  the  C3  convertase  (i.e.  CFH  and
C4BP),  to  modulate  the  activity  of  the  C1
complex  (SERPING1),  and/or  to  inhibit  MAC
assembly  (CD59,  vitronectin  and  clusterin)
(Ballanti et al. 2013) (Fig. 1).
An  extremely  wide  range  of  pathogens  have
developed  complement  evasion  strategies.
Indeed,pathogenic  organisms  as  diverse  as
helminths  and  viruses  encode  molecules  that
inhibit or antagonize one or more steps of the
activation  cascade  (Lambris et  al. 2008;
Pangburn et al. 2008; Serruto et al. 2010). The
most commonly used strategies include i) the
recruitment  of  complement  regulators
(especially CFH, C4BP, CD55, and CD59); ii)
the  use  of  proteases  to  degrade  complement
components;  iii)  the  direct  inhibition  of  the
complement cascade; and iv) the secretion of
proteins that mimic complement regulators. On
one hand, the same pathogen may be endowed
with  an  arsenal  of  complement-targeting
molecules;  on  the  other  hand,  the  same
microbial-encoded protein may target multiple
complement components (Lambris et al. 2008;
Pangburn et al. 2008; Serruto et al. 2010). In
this  respect,  the  complement  system  is  an
epitome for the constant host-pathogen conflict
that confronts immune response with immune
evasion.
Because  of  these  considerations,  complement
components and microbial-encoded antagonists
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are  expected  to  engage  in  a  constant  molecular
“arms race” and to be targeted by natural selection
(Red  Queen  hypothesis).  Selective  pressure  is
expected  to  be  strongest  at  protein-protein
interaction  surfaces  and  to  result  in  positive
selection  at  codons  that  encode  such  surfaces
(Sironi et al. 2015). Herein we set out to verify
these predictions.
Genetic conflicts have previously been described
mainly  in  the  context  of  host/virus  interactions
(Sironi et  al. 2015;  Sawyer  &  Elde  2012;
Daugherty & Malik 2012), and few studies have
integrated evolutionary analysis of both host and
pathogen  interacting  partners  (Demogines et  al.
2013;  Barber  &  Elde  2014).  Moreover,  the
complement system is targeted by pathogens that
naturally  infect  humans  but  not  other  primates
(e.g.  Neisseria  meningitidis and  Neisseria
gonorrhoeae),  offering,  as  a  result,  the
opportunity  to  dissect  the  evolutionary  events
underlying  host-specificity.  Thus,  we  performed
an  evolutionary  analysis  of  the  complement
system  and  of  some  microbial  interactors.  We
report extremely widespread positive selection in
primates  and  we  show  that  most  positively
selected sites are located at  interaction surfaces.
This was also true for pathogen-encoded proteins,
with docking analysis supporting role of  selected
sites in the modulation of binding affinities.
Methods
Evolutionary analysis in primates
In  this  study we  considered  44  genes  encoding
complement  proteins  on  the  basis  of  the
Complement  Map  Database  (CMAP)  network
(http://www.complement.us/cmap, “Main  Map-
Direct”,  “Complement  Proteins”).  Among  the
CMAP  “Endogenous  Molecules”,  we  selected
four  more  genes  (CD59,  CLU,  CRP,  and  VNT)
involved  in  the  regulation  of  the  system.
Specifically,  we  focused  on  4  regulators  that
directly  interact  with  complement  proteins  as
previously reported (Ricklin et al. 2010).
Primate coding sequences were retrieved from the
Ensembl  and  NCBI  databases
(http://www.ensembl.org/index.html;
http://www.ncbi.nlm.nih.gov/). 
For all human genes, we checked whether primate
genes  represented  1-to-1  orthologs  using  the
EnsemblCompara GeneTrees database (Vilella
et al. 2009). This information was not available
for  Pan  paniscus,  Macaca  fascicularis,  and
Saimiri  boliviensis; a  BLAST search  of  the
gene coding sequences against the genome of
these  three  species  was  performed  using  the
NCBI  BLAST  utility.  We  removed  single
primate  genes  for  which  BLAST  or
EnsemblCompara hits were not consistent with
the presence of a single ortholog.  Eight genes
(C4A,  C4B,  CFHR1,  CFHR4,  CR1,  CFB,
FCN1,  and  FCN2)  were  not  included  in  the
study due to extensive copy number variation
in humans and to the impossibility of reliably
identifying  orthologs  in  primates.  The  list  of
genes,  species,  and  the  number  of  primate
sequences analyzed for each gene are reported
in  Table  S1  and  Table  S2,  Supporting
Information, respectively. 
DNA  alignments  were  performed  with  the
RevTrans 2.0 utility (MAFFT v6.240 aligner)
(Wernersson  &  Pedersen  2003)  using  the
protein  sequence  alignment  as  a  scaffold  to
construct  the  corresponding  DNA  multiple
alignment.  Alignments  were  checked  and
manual  editing  was  used  to  correct  few
misalignments in proximity of small gaps. We
next  used GUIDANCE (Penn et  al. 2010) to
calculate confidence scores for all columns in
the alignments. Scores were always higher that
0.90, indicating high reliability (Privman et al.
2012).
All alignments were screened for the presence
of  recombination  breakpoints  using  GARD
(Genetic Algorithm Recombination Detection)
(Kosakovsky Pond et al. 2006).
To detect  positive selection,  we used the site
models  implemented  in  PAML (Yang  1997;
Yang  2007) for  whole  gene  alignments  or
independently  for  sub-regions  defined  in
accordance  with  the  recombination
breakpoints. Specifically, we fitted site models
that allow (M2a, M8) or disallow (M1a, M7) a
class of sites to evolve with dN/dS (ω) >1 to
the  data  using  the  F3x4  and  the  F61  codon
frequency models.  Input trees were generated
by  maximum-likelihood  using  the  program
PhyML  (GTR+G  as  nucleotide  substitution
model) (Guindon et al. 2009).
Sites were called as positively selected if they
were detected using both BEB (from model M8
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with a cutoff of 0.90) (Anisimova et al. 2002) and
MEME  (with  a  cutoff  of  0.1)  (Murrell et  al.
2012). We note that, whereas the PAML approach
implicitly assumes that the strength and direction
of natural selection is uniform across all lineages,
MEME allows the distribution of dN/dS to vary
from  site  to  site  and  from  branch  to  branch,
allowing  the  identification  of  sites  targeted  by
episodic  positive  selection.  Thus,  as  expected,
MEME  generally  detects  more  sites  than  BEB
(Table S3, Supporting Information). Because BEB
and MEME have a low but non-negligible  false
positive rate (Anisimova et  al. 2002; Murrell et
al. 2012),  we  applied  the  most  conservative
approach and declared selection at a site only if it
was detected by both methods. 
GARD (Kosakovsky Pond et  al. 2006),  MEME
(Murrell et  al. 2012),  and  SLAC  (Kosakovsky
Pond  &  Frost  2005)  analyses  were  performed
either through the DataMonkey server (Delport et
al. 2010)  (http://www.datamonkey.org)  or  run
locally through HyPhy (Pond et al. 2005).
For  the  population  genetics-phylogenetics
analysis, genotype data from the Pilot 1 phase of
the 1000 Genomes Project were retrieved from the
dedicated  website  (1000  Genomes  Project
Consortium et  al. 2010);  in  particular,  SNP
information were retrieved for individuals of three
human populations: African (Yoruba),  European,
and East Asian (Chinese plus Japanese). Ancestral
sequences were reconstructed by parsimony from
the human, chimpanzee, orangutan and macaque
sequences. 
Analyses  were  performed  with  GammaMap
(Wilson et  al. 2011),  that uses  intra-specific
variation  and  inter-specific  diversity  to  estimate
the  distribution  of  population-scaled  selection
coefficients (γ) along coding regions. gammaMap
classifies γ values into 12 categories, ranging from
strongly beneficial (γ=100) to inviable (γ =-500),
with  γ  equal  to  0  indicating  neutrality.  In  the
analysis, we assumed θ (neutral mutation rate per
site),  k  (transitions/transversions  ratio),  and  T
(branch  length)  to  vary  among  genes  following
log-normal  distributions.  For  p  (the  probability
that  adjacent  codons share  the same  population-
scaled  selection  coefficient)  we  assumed  a
uniform  distribution.  For  each  gene  we  set  the
neutral  frequencies  of  non-STOP codons (pi)  to
1/61.  GammaMap analyses were also performed
with pi estimated from the data for each gene and
results were comparable with the ones obtained
with pi = 1/61. For population-scaled selection
coefficients we considered a uniform Dirichlet
distribution with the same prior weight for each
selection  class.  For  each  gene,  two  Markov
Chain  Monte  Carlo  runs  of  10,000  iterations
each were run with a thinning interval  of 10
iterations.  Runs  were  compared  for
convergence and merged for the analyses.
Uniform  sampling  was  performed  with
100,000  random  samplings  by  assuming  an
equiprobable  distribution  of  selected  sites
along  protein  sequences.  Analyses  were
performed  for  domains  that  interact  with
pathogen-encoded molecules. 
Evolutionary  analysis  of  bacterial-encoded
interactors
Sequences  for  N.  gonorrhoeae Por1A and
Por1B were  obtained  from  a  previous  work
(Posada et al. 2000).
PspC sequences were retrieved from Iannelli et
al. (Iannelli et al. 2002); we included “typical”
sequences belonging  to  allelic  groups  1-3,  5,
and 6 (Iannelli et  al. 2002).  OspE sequences
were obtained from the NCBI database,  with
the  exclusion  of  antigenic  variants  arising
during  infection  (Table  S4,  Supporting
Information).  Finally,  CspZ sequences  derive
from  human  clinical  isolates  as  reported  in
Rogers et al. (Rogers et al. 2009).
Analysis  of  positive  selection  was  performed
using  omegaMap  (Wilson  &  McVean  2006).
The program performs Bayesian inferences of
ω and ρ  (recombination  parameter),  allowing
both parameters to vary along the sequence. An
average block length of 10 and 30 codons was
used  to  estimate  ω  and  ρ,  respectively.  To
determine the influence of the choice of priors
on the posteriors,  the  analyses  were repeated
with two alternative sets  of priors  (Table  S5,
Supporting Information).  For  each alignment,
three independent omegaMap runs,  each with
500,000 iterations and a 50,000 iteration burn-
in, were compared to assess convergence and
merged to obtain the posterior probabilities.
Protein 3D structures,  in silico mutagenesis
and protein-protein docking
The  structure  of  human CFH,  C4BPA,  CR2,
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CD55, CRP , ITGAX, ITGB2, and B. burgdorferi
CspZ were derived from the Protein Data Bank
(PDB  IDs:  2G7I,  2A55,  3OED,  1OJW,  1B09,
3K6S, 1DZI, and 4CBE). The structure of Por1B
of  N.  gonorrhoeae was  obtained  by  homology
modelling  using  the  Por1A (PDB ID:  4AUI_A)
structure  as  a  template;  analysis  was  performed
through the SWISS-MODEL server (Arnold et al.
2006).  The accuracy of the model  was assessed
with  VADAR  (Volume,  Area,  Dihedral  Angle
Reporter),  which  uses  several  algorithms  to
calculate  different  parameters  for  individual
residues and for the entire protein (Willard et al.
2003). We used these parameters to evaluate both
general and residue-specific problems within the
newly determined  protein  structure.  The  protein
model produced had a low number of packaging
defects  and  structural  parameters  (angles,
dihedrals,  buried  charges)  were  in  perfect
agreement with expected values calculated on the
sequence.
Structures  of  the  CFH-OspE,  CFH-FHbp,  and
CD59-ILY  complexes  were  retrieved  from  the
Protein Data Bank (PDB IDs: 4J38,  4AYD, and
4BIK,  respectively).  Protein-protein  interaction
analyses  were  performed  using  PIC  (Protein
Interaction Calculator) (Tina et al. 2007). 
Protein-protein  docking  analysis  was  performed
using  ClusPro  (Comeau et  al. 2004).  To
validate the method, a first run of docking was
carried out using the two interacting partners
(as in the crystal) to verify that the output was
comparable to the three-dimensional structure
of the PDB file. After mutagenesis, a new run
of docking was performed. We analyzed the 10
best  cluster  structures,  to  verify  whether  the
‘native  protein-protein  conformation’ can  be
found among them. Because the sampling on
the  conformation  is  very  extensive  (109
combinations),  if  the ‘native conformation’ is
not found in the clusters, it is safe to assume
that this type of binding is no longer stable and
the  mutation  results  in  a  perturbation  of  the
native binding. 
In  silico  mutations  were  generated  with  the
FoldX  tool  run-muta  (Schymkowitz et  al.
2005).  We performed the specific mutation 5
times  to  ensure  convergence.  Images  were
created using PyMOL (The PyMOL Molecular
Graphics System, Version 1.5.0.2 Schrödinger,
LLC).
Results
Widespread  adaptive  evolution  at  primate
complement system genes
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We  analyzed  the  evolutionary  history  of  40
complement genes in primates (the complete list
of  analyzed  genes  is  shown  in  Table  S1,
Supporting  Information).  DNA  alignments  of
orthologous genes from at least 10 species (Table
S2, Supporting Information)  were generated and
screened  for  the  presence  of  breakpoints  using
GARD  (genetic  algorithm  recombination
detection) (Kosakovsky Pond et  al. 2006).  Only
one  recombination  breakpoint  was  identified  in
ITGAX,  whereas  no  evidence  of  recombination
was  detected  in  any  other  genes.  The  ITGAX
alignment was therefore split into two sub-regions
according to the breakpoint position.
Calculation  of  the  average
nonsynonymous/synonymous  substitution  rate
ratio (dN/dS, also referred to as ω) yielded values
lower than 1 in all  cases,  with the exclusion of
CD59. This result is in line with the notion that
purifying  selection  is  a  major  force  acting  on
primate  coding  regions  (Lindblad-Toh et  al.
2011).  Nonetheless,  positive  selection  may  be
localized and target few specific sites or domains.
To  address  this  possibility,  we  applied  the
likelihood  ratio  tests  (LRT)  implemented  in  the
codeml program (Yang 1997; Yang 2007). For 18
genes  (45%  of  the  total  number  of  genes  we
analyzed),  two neutral  models (site models M1a
and  M7)  were  rejected  in  favor  of  the  positive
selection  models  (M2a  and  M8);  results  were
confirmed using different codon frequency models
(Table S6, Supporting Information). These genes
were therefore considered to be positively selected
(Fig.  1,  Table  1).  We  next  applied  the  Bayes
Empirical Bayes (BEB) analysis (Anisimova et al.
2002;  Yang et  al. 2005)  and  the  Mixed  Effects
Model of Evolution (MEME) method (Murrell et
al. 2012)  to  identify selected codons (Table  S3,
Supporting Information). To be conservative, only
sites detected using both methods were considered
(Table 1). 
Positive selection and selective constraint in the
human lineage
To  perform  an  in-depth  analysis  of  the  more
recent evolution of complement system genes in
the  human  lineage,  we  applied  a  population
genetics-phylogenetics approach. Specifically, we
used  gammaMap  (Wilson et  al. 2011)  that
integrates  intra-specific  variation  and  inter-
specific  diversity  to  estimate  the  distribution  of
population-scaled selection coefficients (γ) along
coding regions. At the gene level we observed
a good correspondence between γ (median over
all  codons) and dN/dS calculated in  primates
(Fig.  2),  suggesting  a  relatively  constant
selective pressure. Notably, some complement
regulators  and  receptors  tended  to  be  more
selectively  constrained  in  humans  than
expected based on dN/dS in primates; the most
extreme example was accounted for by CD59,
which  showed  strong  negative  selection  in
humans  and  the  highest  dN/dS  values  in
primates (Fig. 2).
Despite the general preponderance of negative
values of γ, gammaMap also identified several
codons  evolving  under  positive  selection
(cumulative probability ≥ 0.75 of γ > 0) in the
human  lineage  (Table  S7,  Supporting
Information).
Positive  selection  at  interaction  surfacesTo
investigate the role of sites targeted by positive
selection - either in the primate phylogeny or in
the human lineage  -  we  integrated data  from
previous  experimental  analyses  that  dissected
protein-protein interaction at the single amino
acid  resolution.  In  the  following  section  we
focus  on  host  proteins  that  directly  interact
with pathogen-encoded molecules by detailing
the  location  of  selected  sites  in  terms  of
interaction surfaces. In order to provide some
quantitative  estimation  of  the  strength  of
pathogen-driven  selection,  we  performed
random  uniform  sampling  of  selected  sites
along protein regions.
Figure  2.  Selective  pressure  in  primates  and  humans  dN/dS
(calculated in primates) is plotted against the median of population-
scaled  selection  coefficients  (γ)  in  the  human  lineage  (from
gammaMap) for  all  analyzed complement  genes.  γ are  classified as
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weakly deleterious  (−1),  moderately deleterious  (−5,  −10)  and  strongly
deleterious (−50, −100). Complement receptors and regulators are shown in
blue. 
Specifically, we show that in most cases domains
that  are  known  to  interact  with  pathogens
represent preferential targets of selection. 
CFH, C4BPA, CD55, and CR2 are constituted by
a different number of complement control protein
(CCP) domains.  In  CFH, CCP domains 6-7 and
19-20,  where  most  positively  selected  sites  are
located, are targeted by an extremely wide array
of pathogens (Meri et  al. 2013).  We determined
that the CCP 19-20 domains represent preferential
targets  of  positive  selection:  assuming  an
equiprobable distribution, the likelihood of having
8 selected sites in these regions amounts to 5x10-5;
the  observed/expected  number  of  sites
(enrichment) amounts to 5.0. 
The same calculation yielded a suggestive but non
significant  p  value  of  0.07  for  CCPs  6-7
(enrichment:  2.4).  We  exploited  recent
mutagenesis data (Meri et al. 2013) to analyze the
overlap between positively selected residues and
pathogen binding sites in the CCP 19-20 domain.
Results  showed  that  3  (R1203,  R1206,  and
R1210)  of  the  6  positions  bound  by  at  least  3
distinct pathogens (Meri et al. 2013) are positively
selected (Fig.  3A).  Interestingly,  different  amino
acids at position 1203 are also observed in great
apes (N1203 in chimpanzee and H1203 in gorilla)
and  R1203  represents  a  human-specific
determinant  for  the  binding  of  sialylated  N.
gonorrhoeae (Shaughnessy et al. 2011); indeed, a
single N1203R substitution is sufficient to allow
binding  of  sialylated  gonococci  to  chimpanzee
CFH. 
The molecular details of interaction at CCPs 6-7
are less well characterized, with the exclusion of
N. meningitidis CFH binding proteins (FHbp) (see
below).  Recent  data,  though,  indicated  that
different  residues  at  the  positively  selected  402
site (which is polymorphic in humans, rs1061170)
modulate the binding of  Streptococcus pyogenes
M proteins in a strain-dependent fashion (Nilsson
et al. 2013).
In  C4BPA,  pathogen-interacting  sites  are  less
localized than in CFH, with some preference for
CCPs  1  and  2  (Fig.  3B)  (random  uniform
sampling,  p= 0.074;  enrichment=  1.8)  (Blom &
Ram 2008).  The CCP1 domain is  bound by the
porin  1A  (Por1A)  protein  of  N.  gonorrhoeae.
Por1A can bind C4BPA of human but not of
chimpanzee origin  and the  two proteins  only
differ at 4 positions in CCP1 (Ngampasutadol
et  al. 2005).  These  4  positions  represent  the
species-specific  determinants  for  binding
(Fortin et  al. 2002),  and  three  of  them  are
positively selected (M62, R70, L82). The M62
and  R70  residues  also  flank  the  Por1B
interaction  surface  (Fig.  3B)  (Fortin et  al.
2002). Another positively selected site (Y110)
is located in the linking region between CCP1
and  CCP2,  which  mediates  interaction  with
complement  component  C4b.  This  region  is
also  exploited  by  several  strains  of
Streptococcus pyogenes to interact with C4BP
with  their  M  proteins  (Blom et  al. 2000;
Jenkins et al. 2006). 
In CD55, 11 of the 12 positively selected sites
are  located  in  the  CCP 1-4  domain  (random
uniform  sampling,  p  =  0.045;  enrichment=
1.4).  These  CD55  domains  are  used  as  a
receptor  by  some  picornaviruses,  including
echoviruses 7 and 12, as well as coxsackievirus
B3 (Plevka et al. 2010). These viruses, albeit
related,  have evolved different  CD55 binding
strategies, using distinct CD55 interacting sites
located on the receptor surface. Consistent with
the  arms  race  hypothesis,  we  find  seven
positively selected  sites  on  this  CD55 capsid
binding surface (Fig. 3D).
As for CR2, it displays 15 CCP domains and
most  positively  selected  sites  (6  out  of  11,
random  uniform  sampling,  p  =  9x10-4;
enrichment= 4.4) are located in CCP 1-2; these
two domains form the binding surface for a C3
proteolytic fragment (C3d) and for the gp350
protein of Epstein-Barr virus (EBV). 
Analysis  of  positively selected  sites  unveiled
other  interesting  findings.  Two  positively
selected sites are located on the CRP surface:
one of these, S92,  lies in the phosphocholine
(Pch) binding pocket (Gang et al. 2012) (Fig.
3E).  CRP  binds  Streptococcus  pneumoniae
through Pch residues present in pneumococcal
C-polysaccharide,  and  similar  Pch  molecules
are thought to be important for CRP binding to
other  bacterial  species  and  non-bacterial
parasites  (Weiser et  al. 1998;  Gillespie et  al.
1993; Culley et al. 1996).
Vitronectin  (VTN)  and  CD59  act  as
complement  regulators  and  interact  with
pathogens. In CD59 all positively selected sites
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Figure 3. Positively selected sites in complement system proteinsDomain representation of positively selected genes or/and 3D mapping of selected
sites for CFH (A), C4BPA (B), CR2 (C), CD55 (D), CRP (E), VTN (F), MAC components (G), and C5 (H). Multiple alignments of the VTN N-terminal
portion (F) and C5 anaphylatoxin (H) for representative primate species are reported. Positively selected sites detected by PAML and/or gammaMap
analyses are shown. In structures and alignment, color codes are as follows: blue, residues involved in pathogen binding; green, residues involved in
interactions among complement components; red, positively selected sites; yellow, positively selected sites interacting with a single pathogen; orange,
positively selected sites involved in the binding of more than one pathogen; asterisks denote positively selected sites involved in the interaction among
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complement components. Positively selected sites are reported in black on domain representation. Magenta spheres in the CRP structure (E) represent
phosphocoline molecules. CCP, complement control protein domains (cyan circles); signal peptides (yellow rectangles); SMB, Somatomedin-B domain;
RGD  motif,  integrin  binding  domain;  CR,  connecting  region;  H1-H2,  Haemopexin-like  domains;  HB1-3,  heparin-binding  domains;  TSP,
thrombospondin type 1 repeats; LDLa, low-density lipoprotein receptor domain class A; MACPF, membrane-attack complex/perforin; KAZAL, kazal
type serine protease inhibitors and follistatin-like domain; FIMAC, factor I membrane attack complex domain; TMH1-TMH2, transmembrane helices;
ANATO, anaphylatoxin; C345C, netrin C-terminal domain.
are located in the short region that constitutes the
mature protein (after removal of the signal peptide
and  propeptide)  (random  uniform  sampling,  p=
0.0083; enrichment= 1.7).  A detailed analysis of
selection at CD59 is reported below. As for VTN,
most  interactions  with  pathogens  involve  the
heparin-binding region  3  (HB3),  where  no
positively selected sites are located. In the same
protein,  the  short  “connecting  region”  (CR)
represented a preferential selection target (random
uniform  sampling,  p  =1x10-4;  enrichment=  5.3)
(Fig. 3). The CR is bound by the N. meningitidis
Opc  protein;  in  humans,  Y78  is  a  sulphated
tyrosine  that  directly  interacts  with  Opc  (Sa  E
Cunha et al. 2010) (Fig. 3F).
ITGAX encodes  the  α  subunit  of  integrin  αxβ2,
also called complement  receptor  type 4.  All  the
positively selected sites (Table  1)  are located in
the αI domain, a ~200 amino acid long  structure
that  contains  the  metal  ion-dependent  adhesion
site  (MIDAS)  (random  uniform  sampling,  p  =
7x10-4; enrichment= 6.1). The αI domain of αxβ2
and α2β1 integrins is bound by some rotaviruses
(Fleming et  al. 2011).  By  3D-structure
superimposition,  three  ITGAX  selected  sites
(R238, H241 and Y244) were found to co-localize
with α2β1 integrin residues that are  involved in
collagen  and  rotavirus  binding  (Fleming et  al.
2011) (Fig. S1, Supporting Information).
Although not directly involved in interaction with
pathogens,  positively  selected  sites  were  also
detected  in  the  complement  components
responsible  for  MAC  assembly.  Most  of  them
localize in the membrane attack complex perforin
domain (MACPF) (Fig. 3G), and in particular in
two  functional  regions  that  integrate  into  the
plasma  membrane  (TMH  elements)  (Sonnen  &
Henneke  2014).  In  C9  one  of  these  regions  is
targeted  by  the  paramyosin  of  Schistosoma
mansoni  (Deng et al. 2003); a positively selected
site (A390) in humans is also part of the primary
CD59 recognition site (Huang et al. 2006).
Finally,  we  observed  that  3  out  of  5  positively
selected residues in C5 are within the 73 amino
acid  region  that  constitutes  anaphylatoxin  C5a
(Fig. 3H).
Adaptive  evolution  at  bacterial-encoded
complement regulators
Because host-pathogen  conflicts  are  expected
to shape genetic diversity both in the host’s and
in  the  pathogen’s  genomes,  we  investigated
whether  microbial  genes  that  encode
complement-evasion  molecules  were  targeted
by positive selection. In particular, we focused
on  bacterial  proteins  that  have  been
characterized  to  such  an  extent  that  the
molecular determinants of the interaction with
CFH or C4BP, the two most common targets,
are known. FHbp encoded by  N. meningitidis
were not  analyzed  because their  evolutionary
pattern  has  previously  been  described,  and
positively  selected  sites  localize  outside  the
CFH binding interface (Brehony et al. 2009).
Because  recombination  rates  in  bacterial
genomes  can  be  very  high  (Awadalla  2003),
analyses  were performed using omegaMap, a
Bayesian method that simultaneously estimates
recombination and selection (inferred through
ω estimation) (Wilson & McVean 2006). The
details  of  bacterial  sequences  used  for  these
analyses are reported in the methods section. 
The  porB locus  of  N.  gonorrhoeae was
analyzed  by  separating  Por1A and  Por1B
alleles,  which  form  distinct  monophyletic
groups  (Smith et  al. 1995).  A  previous
evolutionary analysis of Por1A and Por1B had
detected  several  sites  subject  to  positive
selection, but recombination was not accounted
for  (Perez-Losada et  al. 2005).  omegaMap
indicated high recombination at both loci and,
by accounting for this effect, detected positive
selection  at  several  surface-exposed  loop
regions,  some of which are  implicated in  the
binding of CFH or C4BP (Figs 4A and 4B).
Likewise, multiple alleles have been described
for  PspC  (also  known  as  CbpA),  a  major
surface-exposed  protein  of  Streptococcus
pneumoniae.  We  analyzed  "typical"  PspC
sequences only; these have a cholin anchor and
bind  CFH  (Iannelli et  al. 2002).  Positively
selected sites were mainly found to be located
at the N-terminus of PspC and include a short
amino acid stretch which binds CFH (Fig. 4C).
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Finally,  we  analyzed  complement  regulator-
acquiring surface proteins (CRASPs) encoded by
Borrelia species. In CspZ two signals of positive
selection  were  detected  (Fig.  4D);  one  of  these
contains  a  residue  (N51)  involved  in  the
interaction with CFH or CFHR1 (Brangulis et al.
2014).  As  for  OspE,  a  single  signal  of  positive
selection mapping to the CFH binding region was
detected (Bhattacharjee et al. 2013) (Fig. 4E).
The effect of positively selected sites on protein-
protein interactions
To gain further insight into the effect of positive
selection  on  host-pathogen  interactions,  we
applied an integrated approach based on previous
in  vitro experiments,  in  silico  mutagenesis,  and
protein-protein  docking.  Using  this  strategy  we
analyzed  the  interaction  between  CD59  and
intermedilysin  (ILY),  as  well  as  the  binding  of
CFH to OspE and FHbp. We stress that, although
docking results were consistent with in vitro data,
these  analyses  only  provide  qualitative
information on the role of specific sites.
CD59 is  bound by members  of  the  cholesterol-
dependent  cytolysin  family,  including  ILY,
vaginolysin,  and  lectinolysin  (produced  by
Streptococcus  intermedious  and Gardnerella
vaginalis,  respectively)  (Wickham et  al. 2011).
These  proteins  are  thought  to  share  similar
mechanisms  of  binding  to  CD59  and  to  use
residues in this receptor that are also involved in
the  interaction  with  C8α/C9  (Wickham et  al.
2011;  Huang et  al. 2005;  Johnson et  al. 2013).
The  ILY-CD59  interaction  has  been  studied  in
detail  and  occurs  at  two  major  interfaces.  The
primary binding sites in CD59 are involved in the
recruitment of ILY monomers to the host plasma
membrane,  while  the  secondary  binding  sites,
located on the opposite  side of  CD59,  facilitate
intermolecular  interactions  that  drive  the
formation of the ILY prepore ring (Johnson et al.
2013).
Four of the positively selected sites in CD59 are
directly involved in the interaction with ILY. Y87
and D47 are primary and secondary binding sites,
respectively;  R80  forms  a  hydrogen  bond  with
ILY D443,  while  K91  forms  a  salt-bridge  with
ILY D445, these two latter contacts are important
to  stabilize  binding  interfaces  (Johnson et  al.
2013).  3D  structural  mapping  indicated  that
L100 is also located at the primary CD59-ILY
interaction surface (Fig. 5A). In line with the
notion  that  positive  selection  is  pathogen-
driven,  the  in  vitro replacement  of D47 with
different  residues  modulates  CD59  binding
affinity  for  ILY and  affects  cytolytic  activity
(Wickham et  al. 2011).  Likewise,  alanine
mutagenesis of Y87 (Y62 in (Wickham et al.
2011)) was shown to increase the dissociation
constant  of  the  CD59-ILY  interaction.  We
exploited  this  in  vitro experiment  to  assess
whether  in  silico mutagenesis  and  protein-
protein  docking  can  recapitulate  this  result.
Docking  analysis  of  wild-type  human  CD59
and ILY resulted in an interaction pose that is
fully  consistent  with  the  three-dimensional
structure  of  the  solved  complex;  in  silico
mutagenesis  of  Y87  to  alanine  resulted  in  a
displacement  of  the interaction partners  (Fig.
5A),  in  agreement  with  the  in  vitro data
(Wickham et  al. 2011).  We  thus  used  this
strategy  to  address  the  effect  of  amino  acid
replacements  at  positively  selected  sites.
Mutagenesis  was  performed  by replacing  the
human residue with the most common amino
acid observed in primate sequences. Mutations
Y87H,  K91E,  and  L100P  resulted  in  a
complete  misplacement  of  the  interaction,
strongly  suggesting  that  selection-driven
changes  at  these  sites  modulates  CD59-ILY
binding (Fig. 5A). It is worth mentioning that
ILY was not analyzed for selection signatures
because  only 6  sequences  were  available.  In
the  CFH-OspE  interaction  both  partners  are
targeted  by  selection  (Figs  3A and  4E).  In
OspE, two positively selected sites (V120 and
I121)  are  located  at  the  binding  interface
(Bhattacharjee et  al. 2013)  (Fig.  5B);  both
residues interact through hydrogen bonds with
CFH,  pointing  to  their  central  role  in  this
process  (Bhattacharjee et  al. 2013).  n  CFH,
positively selected sites are also located at the
binding interface (e.g. S1196 interacts with S82
in  OspE).  As  above,  we  first  performed  in
silico alanine  mutagenesis  of  a  CFH residue
(K1186)  that,  albeit  being  located  at  the
interaction surface, does not modulate binding
(Meri et al. 2013). In accordance with the in 
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Figure 4. Positive selection at bacterial interactors Plots report the posterior probability of positive selection (dN/dS >1) along coding sequences. The
hatched red lines correspond to a posterior probability of selection equal to 0.95. Positively selected codons or blocks are reported in red. Codons or
blocks that participate in contact with complement proteins are highlighted in yellow. When available, sites were mapped onto 3D structures with the
same color-code as in the plot. Data refer to N. gonorrhoeae Por1A (A) and Por1B (B), S. Pneumoniae PspC (C), B. burgdorferi CspZ (D) and OspE (E).
For PspC a portion of the alignment is shown with color codes as in plots. Codon positions refer to reference strain indicated in each panel.
vitro data  (Meri et  al. 2013),  docking  results
revealed  no  displacement  (Fig.  5B).  We  thus
analyzed  the  effect  on  binding  of  positively
selected sites in OspE and CFH. Mutations V120L
and  I121A  in  OspE,  as  well  as  T1184K  and
S1196P in  CFH,  led  to  a  misplacement  of  the
interactors,  strongly  suggesting  that  they  affect
protein-protein  interaction  (Fig.  5B).  Notably,
variation at  positions 120 and 121 in OspE has
been  proposed  to  contribute  to  complement
resistance in different Borrelia species (Alitalo et
al. 2005).
We  add  that  T1184  was  previously  in  vitro
mutagenized  and  reported  to  decrease  OspE
binding, although not significantly (Meri et al.
2013).  Nonetheless,  the  human  threonine
residue  had  been  replaced  with  a  different
amino acid to the one we introduced and the
effect on binding was much more evident for
the  T1184  mutant  than  for  the  K1186
replacement,  that  we  also  chain/side-chain
interaction between H402 in CFH and H184 in
FHbp. In line with previous reports (Schneider
et al. 2009), mutagenesis of the CFH positively
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Figure 5. In silico mutagenesis and protein-protein docking (A) 3D structure of the CD59-ILY complex (left), docking analysis (middle) and portion of
CD59 multiple alignment (right).  Sites (structure and alignment) are color-coded with positively selected sites in red and positively selected sites
involved in protein-protein interactions at primary binding sites in yellow. Results of docking analysis after mutagenesis of different residues in CD59
are colored in blue, green, magenta, and brown; docking with the un-mutated (human) protein is in grey. (B) 3D structure of the CFH-OspE complex,
docking analysis (middle) and portion of OspE multiple alignment (right). Sites are color-coded as in A.  Residue K1186, which was mutated as a
negative control is in cyan. Protein-protein docking was performed after mutation of CFH (upper panels) or OspE (lower panels) and shown in different
colors. Results with the un-mutated proteins are shown in grey. In the alignment, abbreviations are as follows: B.b., Borrelia burgdorferi; B.g., Borrelia
garinii; B.j.,  Borrelia japonica, B.l.  Borrelia lusitaniae; B.af.,  Borrelia afzelii; B.v.,  Borrelia valaisiana; B.an.,  Borrelia andersonii. In (A) and (B)
asterisks denote mutants used as controls for docking experiments. (C) 3D structure of the CFH-FHbp complex, docking analysis (middle) and portion of
CFH multiple alignment (right). Color codes are as in (A) and (B). Positively selected sites in FHbp derive from a previous work (Brehony et al. 2009). 
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selected site H402 and docking analysis resulted
in no modification of the binding pose (Fig. 5C).
This is probably due to H402 lying at the edge of
the binding surface, with little contribution to the
overall  interaction  energy.  confirmed  as
inconsequential for binding (Meri et al. 2013). 
Finally,  interaction  analysis  of  the  CFH-FHbp
complex  highlighted  the  presence  of  a  main-
chain/side-chain  interaction  between  H402  in
CFH and H184 in FHbp. In line with previous
reports (Schneider et al. 2009), mutagenesis of
the  CFH  positively  selected  site  H402  and
docking analysis resulted in no modification of
the binding pose (Fig. 5C). This is probably due
to H402 lying at the edge of the binding surface,
with little contribution to the overall interaction
energy.
Discussion
This  study was  motivated  by the  observations
that complement components are targeted by an
extremely  wide  range  of  pathogens  and  that
complement  evasion  underlies  the  virulence
and/or outcome of several infections. Thus, the
complement system is extremely important from
a  biomedical  perspective,  its  microbial
interactors are often used for vaccine design, and
the  system  plus  its  interactors  exemplify  how
host-pathogen conflicts play out.
We provide a comprehensive catalog of sites in
complement system genes that were targeted by
positive selection in primates and in the human
lineage,  and  we  report  positive  selection  at
bacterial  interactors.  We  also  integrated
evolutionary analysis  and docking studies with
previous  biochemical  in  vitro data  to  test  the
concept that arms race scenarios mainly involve
host-pathogen interaction surfaces.
Results show that host components targeted by
several  microbial/viral  proteins  evolved  under
the  strongest  selective  pressure  in  primates;
these include CFH, CD59, C4BPA, and CD55.
Selection acted at these genes and at others (e.g.
CR2 and VTN) on residues that are located at the
interaction  interface  with  microbial/viral
components. In CFH, for instance, three sites we
detected were previously shown to be bound by
different  pathogens  belonging to  distinct  phyla
(Meri et  al. 2013),  indicating  very strong  and
long-standing selective
 pressures. One of these sites also represents a
human-specific  determinant  for  the  binding  of
N.  gonorrhoeae,  as  is  the  case  for  three
positively selected sites in C4BPA (Shaughnessy
et al. 2011; Jarva et al. 2007). Partially because
of the resistance to human complement-mediated
killing, natural infectionwith N. gonorrhoeae is
restricted to our species (Ngampasutadol et  al.
2008).  Examples  of  selection-driven  species-
specific  susceptibility  to  infection  have
previously  been  reported  for  viral  pathogens
(Sawyer  &  Elde  2012;  Daugherty  &  Malik
2012),  but  rarely  for  bacteria  (Barber  &  Elde
2014).
Another  member  of  the  Neisseria genus,  N.
meningitidis,  only infects  humans and displays
human-specific binding to CFH (Granoff et al.
2009).  The  only  positively  selected  CFH  site
(H402) at  the interaction surface with FHbp is
not involved in modulating binding. Conversely,
its evolution may be driven by staphylococcal M
proteins,  as  different  residues  at  the  402  site
modulate  the binding affinity of  Streptococcus
pyogenes M proteins  (Nilsson et  al. 2013).  In
line with this finding, positive selection at FHbp
was previously shown to involve regions that do
not  contact  CFH  (Brehony et  al. 2009),
indicating  that  this  latter  and  FHbp  are  not
engaged  in  a  mutual  genetic  conflict.  One
possible  reason  for  this  observation  is  that  N.
meningitidis has  redundant  mechanisms  of
complement evasion and the use of FHbp may
be  recent  and  dispensable;  indeed,  invasive
meningococcal strains that lack FHbp have been
isolated and shown to specifically bind human
CFH (CCPs  6-7)  through PorB2 (Lewis et  al.
2013).
Unlike  FHbp, a  portion  of  positively  selected
sites in the other bacterial proteins we analyzed
were found to be involved in the binding of the
host  interactor.  These  results  reflect  the
expectations  under  a  genetic  conflict  scenario
whereby  the  host’s  and  the  pathogen’s  genes
evolve  within  binding  avoidance-binding
seeking  dynamics  (Sironi et  al. 2015).  We
provide  evidence  in  favor  of  this  possibility
through  protein-protein  docking  analyses.  In
particular, we exploited previous data to validate
an  in  silico mutagenesis  and  docking  strategy
that  was  subsequently  used  to  qualitatively
evaluate the effect of selected sites. To this aim,
a  subset  of  host-pathogen  protein-protein
interactions  was  selected  based  on  the
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availability of the 3D structure of the complex.
These  analyses  revealed  that  most  positively
selected  sites  we  analyzed  modulate  binding
between  interactors.  We  note  that  the  protein-
protein  docking  program  we  used  returns  the
best putative complex between the two protein
structures  given  as  input.  Thus,  the  observed
repositioning  of  the  ligand  after  in  silico
mutagenesis  can  reliably  be  interpreted  as  an
effect on the binding efficiency; the magnitude
of this effect, though, cannot be estimated.
The  host-pathogen  interactions  we  analyzed
herein are necessarily limited to those that have
been reported and characterized in detail. Most
likely, a large number of molecular interactions
that  involve  complement  system  components
and  pathogen-encoded  molecules  remain  to  be
detected  or  characterized;  these  interactions
cannot  therefore  be  analyzed  within  the
framework we applied herein. This represents a
limitation of our study, but the selected sites we
identified may be prioritized in future functional
analyses.  For  instance,  we  detected  several
selected sites in complement factor I (CFI) and
properdin (CFP).  This  latter  is  recruited at  the
surface of Chlamydia pneumoniae, binds fungal
glycans  via  C3,  and  interacts  with  LPS  from
certain  Escherichia  coli strains  (Spitzer et  al.
2007; Agarwal et al. 2011; Cortes et al. 2011).
Likewise,  CFI is  targeted  by important  human
pathogens  such  as  Staphylococcus  aureus and
Prevotella intermedia (Malm et al. 2012; Hair et
al. 2010).  The  protein regions mediating these
interactions  are  unknown,  but  are  expected  to
evolve  under  pathogen-exerted  selective
pressure and possibly involve some of the sites
we describe herein. We note, however, that we
failed to detect positive selection at complement
components  that  do  interact  with  numerous
pathogens. One example is C3;  S. aureus alone
expresses  at  least  three distinct  molecules  that
bind  C3  to  prevent  complement  activation
(Lambris et  al. 2008).  The  lack  of  selection
observed at this gene, as well as at others, may
result either from the conservative approach we
applied  or  from  a  lack  of  power  due  to  the
relatively small number of primate sequences we
included.  Still,  C3  displays  both  a  low dN/dS
(0.25)  and  a  signal  of  purifying  selection  in
humans (median γ =-1). Thus, its central role in
complement activation may impose constraint on
C3  evolution  and  limit  the  sequence  space
accessible for adaptive evolution. In this respect,
it  is  worth  noting  that  several  complement
regulators (e.g CD59, CD55, CD46, CFH) and
receptors  (CR2  and  C3AR1)  tend  to  display
stronger  selective  constraint  in  the  human
lineage  than  expected  on  the  basis  of  their
selective  pattern  in  primates.  The  underlying
selective forces responsible for this observation
remain to be clarified. Infections are believed to
have represented the major cause of mortality in
both early human populations and in great apes
(Finch  2010).  Nonetheless,  human-specific
changes  in  immunological  phenotypes  have
previously  been  described  (O'Bleness et  al.
2012).  Unique  among  hominids,  for  instance,
human  T  cells  express  little  or  no  regulatory
SIGLECs  (sialic  acid-recognizing  Ig-
superfamily lectins), resulting in more vigorous
activation (Nguyen et al. 2006). One interesting
possibility  is  that  shifts  in  selective  pressure
have arisen as a cause of the increased pathogen
load  associated  with  human-specific  features
such  as  large  settlements  and  extensive  inter-
group contacts (O'Bleness et al. 2012).
Finally,  we  note  that  several  pathogens  we
included in this  study are  extremely important
from a clinical perspective and are responsible
for substantial morbidity and mortality. Bacterial
proteins  that  interact  with  complement
components  have  been  regarded  as  attractive
vaccine candidates, because vaccine efficacy is
likely to be enhanced by virulence impairment
(Meri et  al. 2008).  The  N-terminal  domain  of
PspC that interacts with CFH has been tested as
a  possible  vaccine  antigen  in  mice  with
promising  results,  although  protection  was
influenced by the strain used for immunization
and for challenge (Ricci et al. 2011). This effect
was due to the high diversity of PspC molecules
(Ricci et  al. 2011)  that,  as  shown  herein,  is
driven  by  natural  selection.  Deeper
understanding of  the evolutionary dynamics  of
pathogen-encoded  molecules  targeted  by
vaccines or  drugs  may provide  information on
the  most  promising  strategies  for  the
development of novel interventions (Jefferies et
al. 2011; Little et al. 2012).
In summary, in this study we use extensive data
of  inter-  and  intra-specific  genetic  diversity  to
show that complement proteins bound by several
microbial  components  evolved  under  strong
selective  pressure  at  the  host-pathogen
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interaction  interface.  Bacterial  proteins  also
evolved adaptively and positively selected sites
are  involved  in  the  binding  of  the  host
complement  interactor.  These  data  provide
insight into the human-specific susceptibility to
gonorrhea  and  serve  to  validate  more  general
hypotheses on host-pathogen conflicts. 
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3.2.2 Adaptation of genes not involved in immune response
3.2.2.1 Filovirus glycoproteins and their cellular receptor (NPC1) 
evolve under mutual selective pressure
The Filoviridae family (order Mononegavirales) includes the Ebolavirus and
Marburgvirus genera,  which  cause  highly  fatal  hemorrhagic  fevers  in
humans. Recurrent outbreaks of filovirus are likely to have a zoonotic origin
with  subsequent  human-to-human  transmission.  Uncertainty  still  exists
about  the  reservoir  host(s)  for  filoviruses,  and  it  is  presently  unknown
whether the spillover is initiated from a direct contact with the reservoir or
rather from exposure to other wildlife that also contracted the infection from
the reservoir. Moreover, whereas bats are generally asymptomatic carriers
of  Ebolaviruses  and  Marburgviruses,  great  apes,  as  well  as  humans,
represent dead-end hosts due to severe pathology. 
Filovirus infection is mediated by the surface-exposed trimeric glycoprotein
(GP)  and  its  engagement  of  a  cellular  receptor,  the  Niemann-Pick  C1
(NPC1) protein, a housekeeping gene. NPC1 mainly resides in endosomes
and lysosomes where it functions as a cholesterol transporter. 
Interactions  between  viral  molecules  that  mediate  infection  and  host
receptors  are  expected  to  develop  into  genetic  arms-races,  as  the
interacting  partners  are  under  mutual  selective  pressure  within  binding-
seeking/binding-avoiding dynamics (rev. in [12]). This situation may favor
amino acid replacements over silent substitutions, a situation referred to as
positive  (or  diversifying)  selection.  Housekeeping  genes  have  another
characteristic  that  makes  them  appealing  to  viruses:  they  are  highly
conserved  because  most  amino  acid  replacements  cause  a  substantial
reduction  in  fitness.  From  the  viral  perspective,  this  means  that  the
sequence space available to the host for adaptive change is limited. 
Before the molecular details of the interaction between filovirus glycoprotein
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(GP)  and  its  cellular  receptor  (NPC1)  were  known,  Al-Daghri  and  co-
workers [164] analyzed a limited set of mammalian sequences and they
detected three positively selected codons in NPC1; it was suggested that
these sites had evolved in response to filovirus-driven selective pressure.
The recently solved structure of the GP-NPC1 complex [165] indicated that
indeed  these  three  sites  are  located  at  the  interaction  surface,
demonstrating the predictive power of evolutionary inference in the field of
host-pathogen interaction.  Recently,  Ng and co-workers investigated the
evolution of  NPC1 in bats and detected positive selection in the second
GP1-binding loop [166]. Changes at one of these sites (codon 502) indeed
modulate binding to GP1 depending on the status of a single residue in the
viral  protein  (position  141).  Based  on  these  findings,  the  authors
hypothesized that, as expected under an arms-race scenario, codon 141 or
other codons in GP1 may be targeted by positive selection, as well [166]. 
In this work I investigated the evolutionary history of NPC1 in a large set of
mammalian  species  and  I  apply  a  population  genetics-phylogenetic
approach to detect selection in humans and great apes. I then analyzed the
adaptive events in GP during filovirus speciation. I also used state-of-the art
molecular evolution approaches to analyze the interaction of filovirus GP
with NPC1. 
I integrated information on both positively and negatively selected sites to
show that evolution of  NPC1 genes may be severely constrained by the
necessity of maintaining the cellular function. Nevertheless, results indicate
that a minority of residues in mammalian NPC1 proteins evolved adaptively,
with  most  selected  sites  located  within  or  at  the  anchor  points  of  two
protruding  loops  that  directly  interact  with  filovirus  GP  trimers.  More
specifically, the analysis of NPC1 indicated that positive selection drove the
evolution  of  the  receptor  in  all  mammalian  orders/superorders,  from
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Primates to Xenarthra, suggesting that most mammals are or were infected
by filoviruses or related pathogens. In fact, the NPC1 domain that interacts
with  GP represented  a  preferential  selection  target  (empirical  p value=
0.0019). This is in line with the established long-lasting interaction between
these pathogens and their mammalian hosts [164, 166-169]. On the other
side of the race, filovirus  GP was a target of positive selection, with one
selected site  directly contacting NPC1 and some other  residues located
within epitopes for neutralizing antibodies. I detect no evidence of selection
at  GP codon  141  but,  rather,  I  observed  such  selection  to  involve  the
flanking 142 site. Site 142 establishes direct contacts with NPC1, indicating
that  it  may represent  a determinant  of  species tropism and virulence in
specific hosts. Also, these data demonstrate that co-evolution, possibly in
the form of epistasis, acted on GP in Ebolaviruses and in Marburgviruses.
In both genera, one site in a co-evolving pair of residues is located within
an antibody epitope, indicating that the underlying pressure is represented
by the host immune system. Together with the identification of positively
selected residues in Ebolavirus GP that localize to antibody epitopes, these
results point to the host humoral immune response as a major selective
pressure during filovirus speciation.  Interestingly,  residue 484,  which we
detected  as  positively  selected,  falls  within  a  9-amino  acid  long  linear
epitope  recognized  by  the  protective  14G7  antibody  specific  for  EBOV
[170].  Previous  investigation  of  EBOV sequences  from the recent  West
African  outbreak  identified  5  selected  codons  in  the  mucin  domain,
including  sites  479  and  480  [171-174],  within  the  14G7  epitope.
Evolutionary  analysis  of  EBOV  sequences  from  Sierra  Leone  also
suggested that the T485A variant within the 14G7 epitope represents an
escape  mutant  that  originated  during  intra-host  selection  [173].  Thus,
together with previous data, these findings point to the 14G7 epitope as a
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major target of selection in Ebolaviruses.
 
In summary, although the recent analysis of NPC1 evolution in Chiroptera
[166] was motivated by the well-known role of these mammals in MARV
spill-overs and by their possible association with  Ebolavirus transmission,
these data indicate that bats are not the only mammals to be engaged in an
arms-race with filoviruses. I suggest that the reservoir for these viruses may
belong to any mammalian order.  Also,  because one of  the GP selected
sites (S142Q) establishes several atom-to-atom contacts with NPC1-C, I
suggest  that  it  modulates  binding  to  NPC1  in  different  species  and
contributes to determine Ebolavirus host range in the wild. If this were the
case,  EBOV/BDBV (142S)  and SUDV (142Q)  may not  share  the same
reservoir(s).
Moreover, the identification of selected sites and co-evolving sites that map
to  antigenic  determinants  for  neutralizing  antibodies  will  be  extremely
valuable  for  future  efforts  at  developing effective  treatments  for  filovirus
hemorrhagic  fever,  as  most  therapies  are  currently  based  on  antibody
combinations [175].  
Personal contribution to the work: I designed the study with my co-workers, I performed
evolutionary  analyses  and  I  analyzed  data.  I  also  produced  figures  and  tables  and  I
contributed to write the manuscript.
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Abstract
Filovirus infection is mediated by engagement of the surface-exposed glycoprotein (GP) by its
cellular receptor, NPC1 (Niemann-Pick C1). Two loops in the C domain of NPC1 (NPC1-C)
bind  filovirus  GP.   Herein  we  show that  filovirus  GP and  NPC1-C  evolve  under  mutual
selective  pressure.  Analysis  of  a  large  mammalian  phylogeny  indicated  that  strong
functional/structural constraints limit the NPC1 sequence space available for adaptive change
and most sites at the contact interface with GP are under negative selection. These constraints
notwithstanding,  we detected positive selection at  NPC1-C in all  mammalian  orders,  from
Primates to Xenarthra.  Different codons evolved adaptively in distinct mammals,  and most
selected sites are located within the two NPC1-C loops that engage GP, or at  their anchor
points.  In  Homininae,  NPC1-C  was  a  preferential  selection  target,  and  the  T419I  variant
possibly represents a human-specific adaptation to filovirus infection. On the other side of the
arms-race, GP evolved adaptively during filovirus speciation. One of the selected sites (S142Q)
establishes several atom-to-atom contacts with NPC1-C. Additional selected sites are  located
within epitopes recognized by neutralizing antibodies, including the 14G7 epitope, where sites
selected during the recent  EBOV epidemic also map. Finally,  pairs of co-evolving sites in
Marburgviruses and  Ebolaviruses were  found  to  involve  antigenic  determinants.  These
findings suggest that the host humoral immune response was a major selective pressure during
filovirus speciation. The S142Q variant may contribute to determine Ebolavirus host range in
the wild. If this were the case,  EBOV/ BDBV (S142) and  SUDV (Q142) may not share the
same reservoir(s). 
Introduction
Filoviruses  are  negative-sense,  single-stranded
RNA  viruses;  the  Filoviridae family  (order
Mononegavirales)  includes  the  Ebolavirus and
Marburgvirus genera,  which  cause  highly fatal
hemorrhagic  fevers  in  humans.  The  Ebolavirus
genus  consists  of  five  recognized  species:  Tai
Forest  ebolavirus (TAFV),  Reston  ebolavirus
(RESTV),  Sudan  ebolavirus (SUDV),  Zaire
ebolavirus (EBOV), and  Bundibugyo ebolavirus
(BDBV) (Kuhn et al. 2010). The fatality rate
of at least 3 of these viruses (BDBV, EBOV,
and  SUDV)  is  extremely  elevated,  ranging
from~38% for BDBV to ~79% for EBOV (de
La  Vega  et  al.  2015).  TAFV has  only been
associated  with  a  single,  non-fatal  human
infection,  whereas  RESTV is  thought  to  be
non-pathogenic for humans (de La Vega et al.
2015).  The  Marburg genus  only  comprises
one  species  (Marburg  marburgvirus)  which
consists of two major lineages, Marburg virus
(MARV,  also  referred  to  as  Lake  Victoria
Marburg Complex)  and  Ravn virus  (RAVV)
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(Kuhn  et  al.  2010);  both  these  viruses  infect
humans  with  variable  rates  of  mortality
(Brauburger  et  al.  2012).  A third  genus  in  the
Filoviridae family, Cuevavirus, only includes one
species (Lloviu virus, LLOV) isolated from bats
in Northern Spain(Negredo et al. 2011).
Recurrent  outbreaks  of  filovirus  hemorrhagic
fever have been described since 1976 (Messaoudi
et  al.  2015),  the largest  one being the recently
contained  epidemic  in  West  Africa
(http://apps.who.int/ebola/current-
situation/ebola-situation-report-17-february-
2016,  last  accessed  February  2016).  Outbreaks
are  likely  to  have  a  zoonotic  origin  with
subsequent  human-to-human  transmission.
Uncertainty still exists about the reservoir host(s)
for  filoviruses,  and  it  is  presently  unknown
whether  the  spillover  is  initiated  from a  direct
contact  with  the  reservoir  or  rather  from
exposure to other wildlife that also contracted the
infection  from  the  reservoir  (Mari  Saez  et  al.
2014; Olival and Hayman 2014).  Field surveys
have  detected  genome  fragments  or  antibodies
against  EBOV  and  RESTV  in  different  bat
species  from  Africa  and  Asia  (Olival  and
Hayman  2014;  de  La  Vega  et  al.  2015).
Nevertheless, infectious Ebolaviruses have never
been  isolated  from  bats  (Olival  and  Hayman
2014;  de  La  Vega  et  al.  2015).  As  for
MARV/RAVV,  live  viruses  were  isolated  only
once  from  Rousettus  aegypticus bats  in  Kitaka
cave,  Uganda (Towner  et  al.  2009).  These
observations  suggest  that  whereas  bats  are
generally asymptomatic carriers of  Ebolaviruses
and  Marburgviruses,  great  apes,  as  well  as
humans, represent dead-end hosts due to severe
pathology.  Indeed,  Ebolaviruses represent  a
continuing  threat  to  humans  as  well  as  to  the
survival of gorilla and chimpanzee populations in
Central Africa (Walsh et al. 2003).
Filovirus  infection  is  mediated  by  the  surface-
exposed  trimeric  glycoprotein  (GP),  which  is
synthesized as a single peptide and subsequently
cleaved by furin into a receptor-binding subunit
(GP1)  and  a  fusion  subunit  (GP2).  The  two
subunits of each monomer remain linked through
a  disulfide  bond  and  several  non-covalent
interactions (Jeffers et al. 2002; Lee et al. 2008).
After cellular attachment (mediated by GP1) and
endocytosis,  the  virus  is  trafficked  to  the  late
endosomes  where  the  GP trimer  is  primed  by
cysteine  proteases  (Chandran  et  al.  2005;
Schornberg et al. 2006; Kaletsky et al. 2007).
Priming  results  in  exposure  of  the  receptor
binding  domain  (RBD)  and  the  consequent
engagement  of  a  cellular  receptor,  the
Niemann-Pick C1 (NPC1) protein(Miller et al.
2012; Moller-Tank and Maury 2015). A multi-
spanning  membrane  protein,  NPC1  mainly
resides in endosomes and lysosomes where it
functions  as  a  cholesterol  transporter.
Mutations in  NPC1 are responsible for a rare
and fatal lipid storage disorder, Niemann-Pick
disease type C (Garver et al. 2010; Peake and
Vance 2010; Garver 2011). NPC1 is expressed
ubiquitously  and  serves  as  an  indispensable
host  entry  factor  for  all  known  filoviruses
(White  and  Schornberg  2012).  Interaction
with  these  pathogens  involves  the  second
luminal  domain  of  NPC1  (the  so  called
Domain C, NPC1-C), which is bound directly
and  specifically  by  GP;  very  recent
crystallographic  data  indicated  that  two
protruding loops in NPC1-C bind the RBD of
Ebolavirus GP1 (Wang et al. 2016).
Interactions  between  viral  molecules  that
mediate  infection  and  host  receptors  are
expected to develop into genetic arms races,
as  the  interacting  partners  are  under  mutual
selective pressure and cyclical adaptation and
counter-adaptation occur (Sironi et al. 2015).
This  situation  may  favor  amino  acid
replacements  over  silent  substitutions,  a
situation  referred  to  as  positive  (or
diversifying)  selection  (Sironi  et  al.  2015).
Positive selection is expected to be strong at
codons  corresponding  to  residues  that form
the  physical  viral-host  interaction  surfaces
(Sironi et al. 2015). In line with this view, we
have previously analyzed a limited number of
mammalian  species  and  observed  that  three
codons  in  NPC1-C evolved  under  positive
selection  (Al-Daghri  et  al.  2012).  The  three
codons  are  located  in  close  proximity  to  or
within  one  of  the  two  loops  (loop1)  that
engage Ebolavirus GP. More recently, Ng and
coworkers investigated the evolution of NPC1
in bats and detected positive selection in the
second GP1-binding loop  (loop2) (Ng et  al.
2015).  Changes at  one of these sites  (codon
502)  indeed  modulate  binding  to  GP1
depending on the status of a single residue in
the  viral  protein  (position  141).  Based  on
these findings, the authors hypothesized that,
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as expected under an arms-race scenario, codon
141 or other codons in  GP1 may be targeted by
positive selection, as well. 
Herein we investigated the evolutionary history
of NPC1 in a large set of mammalian species and
we show that, despite an overall strong constraint
acting on the protein, positive selection drove the
evolution  of  NPC1-C  by  targeting  different
residues  in  distinct  mammalian  orders.  On the
other  side  of  the  race,  filovirus  GP  evolved
adaptive changes at the RBD, not at site 141 but
at  the flanking  142 position.  Finally,  we  show
that the host humoral immune response exerted a
major pressure during filovirus speciation.
Results
The little sequence space available for adaptive
change in mammalian NPC1 is likely deployed
to respond to filovirus-driven selection 
Filoviruses have represented a selective pressure
for several mammalian species, as witnessed by
the  detection  of  filovirus-derived  endogenous
viral  elements in the genomes of bats,  rodents,
primates,  and  marsupials  (Taylor  et  al.  2010;
Taylor  et  al.  2011;  Ng  et  al.  2015).  Previous
analyses  identified  different  selected  sites  in
NPC1: whereas we detected selection at NPC1-C
loop 1 in a set of 41 mammalian sequences, Ng
et  al  only  analyzed  bats  and  mainly  detected
selection at loop 2 (Al-Daghri et al. 2012; Ng et
al. 2015). Although these differences may simply
reflect  variable  power  to  detect  selection,  they
may also suggest that different sites were target
by  selection  in  distinct  mammals.  To  gain  a
thorough view of  NPC1 evolution and to assess
the  extent  of  filovirus-driven  selection,  we
gathered  a  list  of  80  NPC1 mammalian
sequences  (fig.  S1,  Supplementary  Material
online).  We  first  estimated  the  extent  of
functional constraint acting on NPC1 proteins by
identification  of  sites  under  negative  selection
(total number = 897) using the Single-Likelihood
Ancestor  Counting  (SLAC)  method
(Kosakovsky  Pond  and  Frost  2005).  SLAC
estimates the probability of selection at each site
in an  alignment through  the dN-dS metric (rate
of nonsynonymous changes-rate of synonymous
changes)  (Kosakovsky  Pond  and  Frost  2005).
This is because the conventional dN/dS ratio is
rendered to infinite for dS values equal to 0. The
observation that a large proportion (71%) of sites
shows  evidence  of  negative  selection
indicates that most  amino acid replacements
in  NPC1  are  deleterious.  In  line  with  this
view,  we  observed that codons that carry at
least  one  missense  mutation  responsible  for
Niemann-Pick  disease  type  C  (n  =172)
display significantly lower  dN-dS compared
to sites where no missense mutation has been
described  (Wilcoxon  rank  sum  test,  p=
4.2x10-7)  (fig.  1A).  These  data  suggest  that
adaptive  evolution  at  NPC1 is  restricted  by
functional/structural  constraints  to  maintain
its  cellular  role  as  a  sterol  transporter.  This
also applies  to  residues in  NPC1-C loops 1
and 2: most sites at the contact interface with
GP are under negative selection (7/8 sites in
loop1 and 8/13 in loop2, fig. 1). Consistently,
previous analyses of  NPC1 identified a very
small  proportion  of  positively selected  sites
(Al-Daghri  et  al.  2012;  Ng et  al.  2015).We
next  explored  the  presence  and  extent  of
positive  selection  in  different  mammalian
orders,  superorders  or  clades:  Primates  plus
Scadentia,  Laurasiatheria,  Glires,  and
Xenarthra  plus  Afrotheria.  Screening  of  the
alignments for the presence of recombination
identified  only  one  breakpoint  in  the
Laurasiatheria  alignment  at  position  507;
thus, the initial 169 codons were removed for
evolutionary analysis.
Evidence of  positive selection was  searched
for using the sites models (i.e. these models
allow  dN/dS  to  vary  among  sites  in  the
alignment)  implemented  in  the codeml
program  (Yang  1997;  Yang  2007).  Two
neutral models (M8a and M7) were rejected
in favor of the M8 positive selection model in
all  analyses,  with  the  only  exclusion  of
Primates/Scadentia (Table 1). Conversely, the
M1a  neutral  model  was  never  rejected  in
favor of the M2a positive selection model (all
p values  >0.05).Nonetheless,  simulation
experiments  have  shown  that  the  M1a/M2a
test  has  low power  to  detect  selection even
when  positively selected  sites  truly exist  in
the  data.  This  is  particularly  true  when
relatively few taxa are analyzed and/or if the
proportion of positively selected sites is small
(Wong et al. 2004).
We  thus  identified  positively  selected  sites
through Bayes Empirical Bayes (BEB) 
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Figure 1.  Natural selection at mammalian  NPC1.  (A)  Boxplot representation of dN-dS (see  methods  for  details).  Mammalian  NPC1 codons  carrying  missense
mutations responsible for Niemann-Pick disease type C are compared with sites where no missense mutation has been described. (B) 3D Structure of the GP-NPC1-C complex (PDB
ID: 5F1B). Ebolavirus GP is colored in yellow, with sites under negative selection showed with a darker hue. Human NPC1 is showed in cyan with sites under negative selection in
dark blue. Positively selected sites in the mammalian phylogeny and in Ebolavirus are shown in red, in Homininae are shown in green. Sites denoted with asterisks were previously
detected as positively selected (see text). (C) Schematic representation of NPC1 domains. The three large luminal domains are indicated as A, C, and I; trans-membrane domains are
in purple. Positively selected sites are reported on the NPC1 structure and in the multiple alignment; color and symbol codes are as in panel (B). Few representative mammalian
species are shown in the alignment, and sites under negative selection as detected by SLAC are in blue.  The black head arrow indicates the position (amino acid 169) of the
recombination breakpoint identified in Laurasiatheria. Positions refer to the human sequence (NP_000262).
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 analysis (Anisimova et al. 2002; Yang et al. 2005)
from model M8 (with a posterior probability cut-
off  of  0.95)  and  most  of  them were  located  in
NPC1-C (fig. 1). More precisely, although distinct
codons  were  targeted  by  selection  in  different
mammalian  orders/superorders  or  clades,  most
selected sites (5 out of 7) are within or at the base
of either loop1 or loop2 (fig. 1, table 1). Because
positive  selection  at  NPC1  has  previously  been
demonstrated in Chiroptera (Ng et al.  2015), we
repeated  the  analysis  after  exclusion  of  bat
sequences  from  the  Laurasiatheria  set:  the
likelihood ratio tests remained significant and two
of the three selected sites in NPC1-C were still
detected (table 1). 
We identified a total of 7 positively selected sites
in NPC1, five of them were located in domain C.
To  test  whether  this  number  is  higher  than
expected, we performed random sampling across
NPC1 sites that are not under negative selection
(i.e. we assumed that all sites that are not under
negative  selection  have  the  same  probability  of
being  called  as  positively  selected).  Results
indicated that the likelihood of having 5 selected
sites  in  NPC1-C  amounts  to  0.0019;  thus,  this
domain represents a preferential selection target in
mammals.
Adaptive evolution in humans and great apes
acts on NPC1-C
The failure  to  detect  positively selected sites  in
primate  NPC1 genes may  derive  from  the
relatively  close  relatedness  of  these  species,
resulting in  reduced  power. This  limitation  can
nevertheless  be  bypassed  by  the  availability  of
extensive genetic  diversity data  for  humans and
great apes (1000 Genomes Project Consortium et
al. 2010; Prado-Martinez et al. 2013). This allows
the  application  of  population  genetics-
phylogenetics  approaches  to  analyze  NPC1
evolution in the human, chimpanzee, and gorilla
lineages. Thus, we used gammaMap (Wilson et al.
2011),  a  program  that  jointly  uses  intra-species
variation and inter-specific  diversity,  to  estimate
population-scaled selection coefficients (γ) along
NPC1 and to identify positively selected sites. As
previously suggested based on the distribution of
γ values (Barreiro et al. 2009), we conservatively
declared positively selected sites as those showing
a posterior probability ≥ 0.75 of γ ≥ 1. Whereas no
positively  selected  codons  were  identified  in
chimpanzees, three and two sites were detected in
humans  and  gorillas,  respectively  (table  S1,
Supplementary  Material  online).  All  selected
sites were located in NPC1-C (fig. 1) and the
human selected site I419 is located at the base
of  loop1  (fig.  1).  Site  482  was  found  to  be
selected both in the gorilla and in the human
lineage  (ancestral:  methionine,  human  and
gorilla:  leucine);  the  same  M482L change  is
observed in chimpanzee (although the posterior
probability  in  this  species  did  not  reach  the
significance  cut-off  we  set),  suggesting  that
selection  ensued  in  the  common  ancestor  of
humans  and  great  apes.
Thus, a total of 4 independent selection events
were  detected  and  all  sites  were  located  in
NPC1-C (fig. 1). Again, this finding is unlikely
to  be  due  to  chance  (random  sampling,  p=
0.0007), indicating that domain C represents a
preferential  target  of  positive  selection  in
Homininae, as well. 
Ebolavirus GP proteins evolve in response to
host-driven selection
We next investigated whether positive selection
also  drove  the  evolution  of  Ebolavirus GP
proteins.  Indeed,  we  expect  viral  GP  to  be
under  selective  pressure  both  to  optimize
NPC1 binding and to elude the host immune
system.  In  fact,  GP represents  a  major  target
for antibody response as it is the only protein
exposed  on  the  virus  surface  (Murin  et  al.
2014).
The  genus  Ebolavirus includes  5  distinct
species.  To  investigate  the  evolution  of  GP
during  speciation,  we  obtained  sequence
information for 20 EBOV, 6 BDV, 2 TAFV, 11
SUDV, and 9 RESTV (table S2, Supplementary
Material  online).  Within  each  species,
sequences  were  selected  to  represent  viruses
sampled during distinct outbreaks. In the case
of  the  2014  EBOV  epidemic,  isolates
belonging to the 5 major lineages from Guinea,
Mali, and Sierra Leone were included (Simon-
Loriere  et  al.  2015).  The sequence alignment
was pruned of unreliably aligned codons (see
Material  and  Methods),  a  procedure  that
resulted in the masking of a large portion of the
mucin  domain.  Indeed,  this  region  displays
very little homology among Ebolaviruses. The
pylogenetic tree of  GP obtained with phyML
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was fully consistent with the previously reported
Bayesian phylogeny (Gire et al. 2014). 
A  search  for  codons  under  negative  selection
detected  175  sites,  most  of  them located  in  the
heptad  repeats  and  in  the  fusion  loop  (fig.  S2,
Supplementary Material online). 
The  total  tree  length  for  GP amounted  to  7.22,
indicating that positive selection can be inferred
with high confidence (but low power) using the
codeml branch site tests, which we applied to test
the  internal branches of the phylogeny (fig. 2A).
Statistically  significant  evidence  of  episodic
positive  selection  was  obtained  for  3  branches
(fig. 2A). Selected sites along these branches were
identified using the BEB procedure from model
MA (with a significant posterior probability cut-
off  of  0.95).  A total  of  4  selected  sites  were
detected,  all  of  them located  in  GP1  (fig.  2B).
Among these, residue 142 is in the RBD, at the
direct  contact  interface  with  NPC1-C  (fig.  1B).
Specifically,  the  S142  residue  in  EBOV  GP
establishes  several  atom-to-atom  contacts  with
NPC1-C (Wang et al. 2016). Site 39 (threonine in
SUDV, histidine in EBOV) is located at the base
of the GP trimer, within an epitope bound by the
16F6 antibody that specifically neutralizes SUDV
(fig. 3A) (Bale et al. 2012). Likewise, residue 484
falls  within  a  9-amino  acid  long  linear  epitope
recognized  by  a  protective  antibody  (14G7)
specific  for  EBOV (not  reactive  against  SUDV
and TAFV)  (fig.  3B)  (Wilson  et  al.  2000).  The
fourth selected residue at  position 217 is within
the  so-called  “head”  domain  of  GP1.  A
conservative isoleucine to alanine substitution at
the flanking 218 site results in reduced infectivity
possibly  due  to  alteration  of  GP  structure  and
decreased  incorporation  into  virions
(Manicassamy  et  al.  2005).
Because  epistasis  is  common  in  viruses  and  is
thought to play an important role in the evolution
of immune evasion and host shifts (Bedhomme et
al.  2015),  we  searched  for  evidence  of  co-
evolution  between GP sites.  To  this  aim,  we
applied BGM-Spidermonkey (Poon et al. 2007)
and  MISTIC  (Simonetti  et  al.  2013)  (see
Material and Methods for details). One pair of
co-evolving sites (309 and 509) was detected
by  both  methods  with  high  confidence  (fig.
3C).  Residue  509  (in  GP2)  is  at  the  direct
contact  interface  with  the  KZ52  antibody
isolated  from  a  human  survivor  of  EBOV
infection (fig.  3C) (Lee et  al.  2008),  whereas
residue 309 is located in the glycan cap. This
region is also bound by neutralizing antibodies,
but the precise epitopes are not fully resolved
(Murin et al. 2014). Interestingly, residue 509
(G509  in  SUDV  and  P509  in  EBOV)
represents the anchor point of the N-terminal
portion  of  GP2  to  the  GP  core;  the
conformation  of  the  GP2  N-terminus  differs
between SUDV and EBOV and is expected to
result in different mobility of this portion (Bale
et  al.  2012).  Finally,  it  is  worth  noting  that
mutations at the flanking 508 residue affect the
binding  of  three  different  antibodies  against
EBOV  GP,  and  Q508R  escape  mutants  are
associated  with  lethality  in  monkeys  treated
with a combination of three neutralizing mAbs
(ZMAb)  (Qiu  et  al.  2013).  Site  508  showed
evidence  of  positive  selection  on  the  branch
separating  SUDV from  EBOV/TAFV/BDBV,
although  the  posterior  probability  (0.94)  did
not reach the threshold we set for significance. 
Evolution of Marburgvirus GP
Finally, we investigated the evolution of GP in
Marburg marburgvirus. The analysis included
representative  sequences  for  the  MARV  and
RAVV lineages, selected on the basis of their
association with distinct outbreaks or isolation
years (table  S3,Supplementary Material 
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Figure 2. Branch-site analysis of positive selection for Ebolavirus GP. (A) Analyses of episodic positive selection are shown in the box and selected
sites are reported. -2ΔlnL is twice the difference of the natural logs of the maximum likelihood of the models being compared (see text for details).
Numbers in the tree identify the corresponding tested branches. Ebolavirus species are highlighted by triangles. The darker blue triangle in the EBOV
phylogeny denotes isolates from 2014 West  Africa  epidemic.  (B) Mapping of  co-evolving and positively selected sites onto the  Zaire  ebolavirus
glycoprotein structure. The dashed portion of the structure corresponds to the alignment region masked by GUIDANCE. Positively s elected sites are in
red, co-evolving sites are denoted with a star.
online).  The  GP gene  tree  was  consistent  with
previously reported phylogenies  based on whole
genome sequences (Carroll et al. 2013).
MARV and RAVV belong to the same species and
the  GP phylogeny  is  much  shallower  (tree
length=1.75)  compared  to  that  of  Ebolaviruses.
Therefore, we tested for positive selection using
both the codeml site models (M7 vs M8 and M8a
vs M8) and the branch-site models (MA1 vs MA).
These latter models were used to test selection on
the internal branch of the phylogeny. Evidence of
positive selection was obtained using all tests (fig.
4A),  although  no  positively  selected  sites  were
detected. Co-evolution analysis identified one pair
of  sites  (fig.  4B):  the  267  residue,  co-evolving
with codon 279, is located within the epitope for
the 7G8 protective antibody (fig. 4C)(Hevey et
al. 2003).
Discussion
In this study we show that mammalian NPC1
proteins evolved adaptively, with most selected
sites  located  at  the  base  of  two  protruding
loops  that  directly  interact  with  filovirus  GP
trimers.  In  turn,  filovirus  GP was a  target  of
positive  selection,  with  one  selected  site
directly  contacting  NPC1  and  some  other
residues  located  within  epitopes  for
neutralizing  antibodies.  We  detected  positive
selection  at  NPC1-C  in  all  mammalian
orders/superorders, from Primates to 
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Figure 3. Selection at antibody binding interfaces.  GP alignments for  Ebolavirus species  is shown along with the interaction surface with the
protective 16F6 (PDB ID: 3VE0) (A) 14G7 (PDBID: 2Y6S) (B), and KZ52 (PDB ID: 3CSY) (C) antibodies. In the alignments, positively selected sites
are framed in red, GP residues involved in antibody binding are in bold. GP position 508 (see text) is in blue. In the structures, the epitope region is
shown in stick representation with color codes as in Figure 1.
Xenarthra, suggesting that most mammals are   or
were infected by filoviruses or related pathogens.
Together with previous results (Al-Daghri et al.
2012; Ng et al. 2015), these data strongly suggest
that filoviruses and their mammalian hosts have
been engaged in long-lasting genetic conflict.
Indeed,  based  on  the  synteny  of  filovirus-
derived  endogenous  viral  elements,  recent
works  indicated  that  these  pathogens  have
infected bats and rodents for at least 25 MY
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and  18  MY,  respectively  (Taylor  et  al.  2010;
Taylor et al. 2011; Taylor et al. 2014).
The  use  of  housekeeping  proteins  as  cellular
receptors  is  a  common  strategy  employed  by
viruses to infect the host (Sironi et al. 2015). From
a viral  standpoint,  housekeeping genes have the
advantage  of  being  expressed  at  high  levels  in
multiple  cell  types.  A notorious  example  of  a
housekeeping protein functioning as a viral entry
gate is the transferrin receptor (TfR), which is also
a target of positive selection in mammals (Kaelber
et  al.  2012;  Demogines  et  al.  2013).  TfR  is
exploited  by  some  New  World  arenaviruses,
parvoviruses,  and  retroviruses.  These  pathogens
interact  with  the  same  domain  of  TfR  and  the
binding  surfaces  are  contiguous  with  small
overlaps (Demogines et al. 2013). By analogy, we
cannot exclude that the selected sites we detected
in  NPC1-C  evolved  in  response  to  pathogens
other  than  filoviruses,  as  several  enveloped
viruses  are  trafficked  to  endolysosomal
compartments  after  endocytosis  (Jae  and
Brummelkamp  2015).  Nonetheless, current
observations  indicate  that  whereas  all  extant
filoviruses are dependent on NPC1 for infection,
there  is  no  evidence  that  other  viruses  use  this
receptor.  Housekeeping  genes  have  another
characteristic  that  makes  them  appealing  to
viruses:  they are highly conserved because most
amino  acid  replacements  cause  a  substantial
reduction  in  fitness.  From the  viral  perspective,
this means that the sequence space available to the
host for adaptive change is limited. In NPC1, the
majority of sites at the contact interface with GP
are under negative selection and cannot therefore
evolve  to  avoid  viral  binding.  Indeed,
replacements  at  highly  conserved  positions  are
likely to  result  in  Niemann-Pick disease,  as  the
analysis of reported mutations demonstrates. Only
few sites within loop 1 and loop2 are not targeted
by purifying selection. Among these, residue 502
was  previously detected  as  a  selection  target  in
bats (Ng et al. 2015), whereas we had previously
described  codon  421  as  positively  selected  in
mammals (Al-Daghri et al. 2012). This latter site
was also detected in this study, but it did not reach
the  threshold  for  statistical  significance  we  set
(Xenarthra/Afrotheria  set;  BEB,  posterior
probability  =  0.902  ).  Clearly,  this  does  not
exclude  the  possibility  that  it  represents  a
selection  target  and  that  it  modulates  filovirus
infection;  indeed,  residue  421  is  located  at  the
direct  contact  interface with GP (Wang et al.
2016). As for site 502, it did not show evidence
of dN/dS >1 in our analyses, suggesting that it
represents a selection target in bats only. This is
consistent  with  the fact  that  distinct  sites  are
selected in different mammalian orders. 
Most  of  the  selected  sites  we  detected  are
located  within  the  two  NPC1-C  loops  that
engage  GP or  at  their  anchor  points.  In  the
complex structure, none of them was reported
to  establish  atom-to-atom  contacts  with  GP.
Nonetheless,  loop structures are known to be
highly flexible and mobile, suggesting that the
selected  residues  might  modulate  loop
conformation  and,  consequently,  GP  binding
affinity.  The  I419  site,  which  is  positively
selected  in  the  human  lineage,  immediately
flanks the contact interface with GP, possibly
representing  a  human-specific  adaptation  to
filovirus infection. Additional sites targeted by
positive selection in primates were found to be
located in NPC1-C regions distant from the GP
binding  interface.  Whether  these  variants
modulate binding via long-range interactions or
alteration of protein structure/stability remains
to  be  evaluated.  However,  positive  selection
preferentially  targeted  NPC1-C  in  all
mammalian  orders.  Enrichment  of  positively
selected sites in this domain is unlikely to be
accounted for by lower functional constraints;
in  fact,  we  performed  random  sampling
allowing positively selected sites to only occur
at  sites  that  are not under negative selection.
We  thus  suggest  that  the  selective  pressure
acting  on  NPC1 is  mainly  exerted  by
filoviruses  or  other  pathogens  that  infect  the
host via endolysosomal trafficking. 
In  line  with  the  arms  race  scenario,  we  also
detected positively selected sites in Ebolavirus
GP proteins.  Notably,  the branch-site  test  we
used  to  detect  positive  selection  during
Ebolavirus speciation  is  robust  to  saturation
issues  and  has  a  minimal  false  positive  rate.
Also, the test is largely insensitive to violations
of the assumption of neutral evolution on the
background  branches  (Zhang  et  al.  2005;
Anisimova  and  Yang 2007). Nonetheless,  for
sequences as divergent as those from the five
Ebolavirus species,  the  test  lacks  power
(Gharib  and  Robinson-Rechavi  2013),
indicating that several selected sites may have
remained undetected. 
169
One of the selected sites we identified (S/Q142) is
located at the direct contact interface with NPC1-
C and establishes several  atom-to-atom contacts
with  the  receptor  (Wang  et  al.  2016).  Ng  and
coworkers showed that a conservative change at
the  flanking  141  site  (V141A)  modulates  the
binding  of  GP  to  NPC1-C  from  Africa  straw-
colored fruit bats. The NPC1 molecule from these
bats  is  a  poor  ligand  for  EBOV GP due to  the
positively  selected  D502F  change  (Ng  et  al.
2015).  Because  V141A is  a  naturally  occurring
variant  in  Ebolaviruses,  the  authors  speculated
that  it  may  represent  an  adaptive  change  to
broaden host  tropism.  Our results  are  consistent
with  this  possibility,  although  we  detect  no
evidence of selection at codon 141 but, rather, we
observed  such  selection  to  involve  the  flanking
142 site.  Interestingly,  analysis  of EBOV GP in
complex with NPC1-C (which was not available
when Ng and  co-workers  published  their  work)
indicated  that  residue  141  in  EBOV  GP
establishes no direct contact with the 502 residue
in  NPC1.  Nevertheless,  the  V141A substitution
restores GP binding to NPC1 molecules carrying
the  D502F  substitution.  This  observation
substantiates  the  view that  changes  within  loop
positions  or  in  their  flanks  may  affect  loop
structure  and,  consequently,  binding  properties.
This is also in line with the view that loops are
highly mobile and can exists  as an ensemble of
conformations  (Shehu  and  Kavraki  2012),
complicating  the  prediction  of  the  functional
effects of amino acid replacements. Experimental
studies will be required to address the role of the
S142Q  variant  in  modulating  host  tropism  or
virulence in specific hosts. Clearly, this variant (as
well  as  the  V141A substitution)  is  unlikely  to
represent  a  major  determinant  of  virulence  in
humans,  as  viruses  causing  a  high  fatality  rate
share  the same amino acid with  non-pathogenic
species  (i.e.  RESTV).  Nevertheless,  the  S142Q
variant  may  contribute  to  determine  Ebolavirus
host  range  in  wild  animals  (see  also  (Ng et  al.
2015)).  If  this  were  the  case,  EBOV/BDBV
(S142) and SUDV (Q142) may not share the same
reservoir(s). Previous studies of positive selection
in  Ebolaviruses were  based  on  intra-species
analyses and consequently detected sites that are
different from those reported herein (Li and Chen
2014; Azarian et al. 2015; Ladner et al. 2015; Park
et  al.  2015).  Besides  the  fact  that  different
evolutionary  time  frames  are  investigated
compared to inter-species studies, intra-species
analyses  allow  the  assessment  of  protein
regions  that  are  poorly  conserved  among
species,  such  as  the  mucin  domain.
Conversely,  due  to  unreliable  alignments,
which  in  turn  are  known  to  originate  false
positive results, we filtered a large portion of
codons in the mucin domain. This very domain
was  previously  found  to  represent  a
preferential target of selection in EBOV (Walsh
et  al.  2005;  Ladner  et  al.  2015;  Park  et  al.
2015).  For  instance,  an  early  study  with
relatively few EBOV sequences detected one
single positively selected site (position 370) in
the mucin domain (Walsh et  al.  2005).  More
recently,  investigation  of  EBOV  sequences
from the latest West African outbreak identified
5  selected  codons  in  the  mucin  domain,
including  sites  479  and  480  (Ladner  et  al.
2015). As the 484 site we detected herein, these
residues  are  within  the epitope for  the 14G7
antibody. Also, evolutionary analysis of EBOV
sequences from Sierra Leone suggested that the
T485A  variant  within  the  14G7  epitope
represents  an  escape  mutant  that  originated
during intra-host selection (Park et  al.  2015).
These results  point  to  the 14G7 epitope as  a
major target of selection in Ebolaviruses. More
generally, analysis of EBOV from Sierra Leone
indicated  an  enrichment  of  nonsynonymous
substitutions  within  B cell  epitopes,  and  two
out of four positively selected sites we detected
in  Ebolavirus GP are located within antibody
epitopes  (sites  39  and 484).  Recent  evidence
indicates  that  epistasis  in  viral  proteins  may
play an important role in the development of
immune  escape  and  drug  resistance
(Kryazhimskiy et al. 2011). This is particularly
true for  viral  surface-exposed molecules.  The
co-evolving sites we detected in Ebolavirus GP
are  not  located  in  spatial  proximity  in  the
folded protein structure.
 This  is  not  unexpected,  though,  as  previous
studies  indicated  that  epistatic  sites  in  the
surface  proteins  of  human  influenza  A virus
(HAV)  are  not  in  physical  proximity
(Kryazhimskiy et al. 2011). This in confirmed
also by experimental data showing that a HAV
oseltamivir-resistant  mutant  carrying  the
H274Y substitution has decreased viral fitness,
which can be restored by second-site mutations
in residues that are in no close contact with 
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Figure 4. Marburgvirus GP adaptive evolution. (A) Phylogenetic tree of GP sequences from Marburgviruses.  The tested branch is indicated on the
phylogenetic tree by the corresponding number. - 2ΔlnL is twice the difference of the natural logs of the maximum likelihood of the models being
compared (see methods for details).  (B) Schematic representation of the domain structure of MARV glycoprotein. Co-evolving sites are shown in red
with a star. (C) Alignment of the GP positions surrounding co-evolving sites for a few representative Marburgvirus strains; color codes are as in panel A;
co-evolving sites are boxed in red and denoted with a star.
H274 in the neuraminidase structure (Bloom et
al.  2010). In the context of HAV, epistatic sites
were found to be common in hemagglutinin sites
responsible  for  antigenic  shifts  (Neverov  et  al.
2015).  Likewise,  the  fixation  of  destabilizing
mutations  in  antigenic  regions  of  the  HAV
nucleoprotein was found to be dependent on the
acquisition  of  enabling  substitutions. Again,
nucleoprotein  epistatic  mutations  involve
residues  in  no  physical  contact,  and  their
effect  is  mainly  explained  by  a  change  in
protein  stability,  with  escape  mutations
determining  a  decrease  in  stability  that  is
tolerated only in  the presence of second-site
stabilizing  substitutions  (Gong  et  al.  2013).
For  both  Ebolavirus and  Marburgvirus GP,
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one  site  in  a  co-evolving  pair  of  residues  is
located  within  an  antibody  epitope,  suggesting
that  the  underlying  pressure  driving  their
evolution  is  represented  by  the  host  immune
system.  Together  with  the  identification  of
positive selected residues in  Ebolavirus GP that
localize to antibody epitopes, these results point
to the host humoral immune response as a major
selective  pressure  during  filovirus  speciation.
Because the most promising treatment strategies
for  filovirus  hemorrhagic  fever  are  based  on
antibody  combinations  (Murin  et  al.  2014;
Casadevall  and  Pirofski  2015),  antigenic
variability should pose a serious concern to their
effectiveness in the long-term. 
In  summary,  data  herein  indicate  that  positive
selection has been driving the molecular evolution
at the host-filovirus interaction surface, acting on
the the cellular  receptor  NPC1 and on the viral
glycoprotein. If the hypothesis of filovirus-driven
positive selection at mammalian NPC1 is correct,
our  findings  suggest  that  most  mammals  are  or
were  infected  by  these  pathogens;  the  filovirus
reservoir(s)  may thus belong to any mammalian
order.
Materials and Methods
Sequences, alignments, and gene trees
Viral  sequences  were  retrieved  from  the  NCBI
database  and  a  list  of  accession  numbers  is
provided  as  tables  S2  and  S3,  Supplementary
Material online. Available mammalian sequences
for NPC1 were  also  retrieved  from  the  NCBI
database  (http://www.ncbi.nlm.nih.gov/,  last
accessed  February  2016).  A  list  of  species  is
available  as  fig.  S1,  Supplementary  Material
online.
Alignment  errors  are  common  when  divergent
sequences  are  analyzed  and  can  affect
evolutionary  inference.  Thus,  we  used  PRANK
(Loytynoja  and  Goldman  2005)  to  generate
multiple  sequence  alignments  and  GUIDANCE
(Penn et al. 2010) for filtering unreliably aligned
codons (we masked codons with a score <0.90), as
suggested (Privman et al.  2012). Several codons
in  Ebolavirus GP mucin domain were filtered by
GUIDANCE, whereas no codons were filtered in
Marburgvirus and mammalian alignments.
All alignments were screened for the presence of
recombination  using  GARD (Genetic  Algorithm
Recombination  Detection)  (Kosakovsky Pond
et al. 2006), a Genetic Algorithm implemented
in the HYPHY suite (Pond et al. 2005).
After running a codon model selection analysis
in HYPHY, gene trees were generated using the
program  phyML with  a  maximum-likelihood
approach,  gamma-distributed  rates,  4
substitution rate categories,  and estimation of
transition/transversion ratio  and proportion of
invariable sites (Guindon et al. 2010). 
NPC1 mutations
The list of Niemann-Pick type C mutations was
obtained  from  the  Human  Gene  Mutation
Database  (HGMD,
http://www.hgmd.cf.ac.uk/ac/,  last  accessed
February 2016).  From a  total  of  225  unique
missense and nonsense mutations, we retained
missense  substitutions  only (n  = 200).  These
occurred in 172 unique codons.
Evolutionary analyses
The SLAC tool (Kosakovsky Pond and Frost
2005) from the HYPHY package was used to
identify sites  under negative selection and for
calculating  dN-dS  (rate  of  nonsynonymous
changes-rate of synonymous changes) at each
site  (Kosakovsky  Pond  and  Frost  2005).
Because  SLAC  is  very  conservative
(Kosakovsky  Pond  and  Frost  2005)  a
significance cut-off= 0.1 was used. An  NPC1
alignment with 80 species (including Eutheria,
Metatheria  and  Monothremata,  fig.  S1,
Supplementary Material online).
Evidence of positive selection was searched for
using  the  codon-based codeml program
implemented  in  the  PAML  (Phylogenetic
Analysis by Maximum Likelihood) suite (Yang
2007).  This  tool  analyzes gene  alignments  to
evaluate the nonsynonymous/synonymous rate
ratio  (dN/dS,  also  referred  as  ω);  positive
selection can be defined when ω is higher than
1.
We  applied  different  random  site  (NSsite)
models  with a F3x4 codon frequency model.
M1a is a nearly neutral model that assumes one
dN/dS (ω) class between 0 and 1, and one class
with  ω=1;  M2a  (positive  selection  model)  is
the same as M1a plus an extra class of ω >1.
M7 is a null  model that assumes that 0<ω<1
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and  is  beta  distributed  among  sites;  M8  is  a
positive selection model: it is the same as M7 but
also includes an additional category of sites in the
alignment  with  ω>1;  M8a  is  the  same  as  M8,
except that does not allow positive selection, but
only  neutral  evolution. To  assess  statistical
significance twice the difference of the likelihood
(ΔlnL)  for the models (M1a vs M2a, M7 vs M8
and M8a vs M8) is compared to a  χ2 distribution
(2 degrees of freedom for  the M1a vs M2a and
M7 vs M8 comparisons, 1 degree of freedom for
M8a  vs  M8).  Positively  selected  sites  were
identified using the Bayes Empirical Bayes (BEB)
analysis, which calculates the posterior probability
that each codon is from the site class of positive
selection  (under  model  M8)  (Anisimova  et  al.
2002).  To  be  conservative,  we  considered  a
posterior probability ≥ 0.95.
To  analyze  the  presence  of  episodic  positive
selection we applied the branch-site test (Zhang et
al. 2005) from the PAML suite (Yang 2007). The
test  is  based  on  the  comparison  between  two
nested models: a model (MA) that allows positive
selection  on  one  or  more  lineages  (called
foreground  lineages),  and  a  model  (MA1)  that
does not allow such positive selection. The  ΔlnL
for  the  two  models  is  then  compared  to  a  χ2
distribution with one degree of freedom (Zhang et
al.  2005).  A false  discovery rate  correction  was
applied to take into account a multiple hypothesis
issue generated by analyzing different branches on
the same phylogeny (Anisimova and Yang 2007).
When the likelihood ratio test suggested the action
of positive selection, the Bayes Empirical Bayes
(BEB) analysis was used to evaluate the posterior
probability  (with  a  cut-off  of  0.95)  that  each
codon  belongs  to  the  site  class  of  positive
selection on the foreground branch.
Detection of co-evolving sites
In  order  to  analyze  the presence of co-evolving
sites  in  Filovirus  GP,  we  applied  two  different
methods:  BGM  (Bayesian  Graphical  Model)-
Spidermonkey (Poon et al. 2007) and the Mutual
Information  Server  To  Infer  Coevolution
(MISTIC)  (Simonetti  et  al.  2013).  BGM-
Spidermonkey  identifies  co-evolving  sites  from
coding sequences; a Bayesian Graphical Model is
used to evaluate the connection among codons in
the  alignment  (represented  by  the  nodes  of  the
network).  Significant  statistical  associations
between nodes are  indicated by the edges of
the network, suggesting functional or structural
interactions  between  codons.  BGM-
Spidermonkey is implemented in the HYPHY
package.
MISTIC  estimates  the  relationship  between
two  or  more  alignment  positions.  The  co-
evolutionary  association  is  evaluated  by
Mutual  Information  (MI),  estimating  whether
the information from the amino acid at the first
position  can  help  to  predict  the  amino  acid
information at the second position.
For  BGM-Spidermonkey  sites  were  filtered
based on a minimum count of 4 substitutions
across  the  phylogeny  and  each  site  was
conditionally dependent on one other site.  To
be  conservative,  we  considered  a  pair  of
residues  as  co-evolving  if  they  showed  a
posterior  probability  >0.95.  Likewise,  for
MISTIC site pairs were required to display a
MI  rank  higher  that  the  95th percentile
calculated  using  all  MI  scores  from  the
alignment.  Pairs  of  sites  exceeding  the
threshold for both methods were declared to be
co-evolving.
Positive selection in Homininae
For gammaMap (Wilson et al. 2011) analysis,
genotype  data  from the phase 1 of  the 1000
Genomes  Project  were  retrieved  from  the
dedicated  website  (1000  Genomes  Project
Consortium  et  al.  2012);  we  retrieved  SNP
information  for  the  three  human populations:
African (Yoruba), European, and Chinese. For
the chimpanzee and gorilla analyses, genotype
information  were  retrieved  from  (Prado-
Martinez et al. 2013) for 25 and 27 individuals,
respectively.
The ancestral sequence was reconstructed from
the  human,  chimpanzee,  orangutan  and
macaque  sequences.  Ancestral  sequence
reconstruction  (ASR)  was  performed  through
the  DataMonkey sever  (Delport  et  al.  2010)
using the ASR utility, which implements three
different  methods  based  on  maximum-
likelihood or  Bayesian inference  (Kosakovsky
Pond  and  Frost  2005).  The  three  methods
yieleded consistent results at all positions.  
GammaMap applies  a  population  genetics-
phylogenetics  approach  using intra-specific
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variation  and  inter-specific  diversity  to  estimate
the  distribution  of  population-scaled  selection
coefficients (γ) along coding regions. γ values are
classified into 12 categories, from inviable (γ =-
500) to strongly beneficial (γ=100), with γ equal
to  0  indicating  neutrality.  In  the  analysis,  we
assumed θ (neutral mutation rate per site) and k
(transitions/transversions ratio) to vary following
log-normal distributions; for T (branch length) a
normal  distribution  was  adopted.  For  p  (the
probability that  adjacent  codons  share  the  same
population-scaled  selection  coefficient)  we
assumed  a value  of  0.02.  We  set  the  neutral
frequencies of non-STOP codons (pi) to 1/61. For
population-scaled  selection  coefficients  we
considered  a  uniform Dirichlet  distribution with
the  same  prior  weight  for  each  selection  class.
Two Markov Chain Monte Carlo runs of 100,000
iterations each were run with a thinning interval of
10  iterations.  Runs  were  compared  for
convergence and merged for the analyses.
3D structure mapping and rendering 
Protein 3D structure of NPC1-GP complex (PDB
ID: 5F1B) (Wang et al. 2016),  Sudan ebolavirus
glycoprotein  bound  to  16F6 (PDB  ID:  3VE0)
(Bale et al.  2012),  Zaire ebolavirus glycoprotein
bound to 14G7 (PDBID: 2Y6S) (Olal et al. 2012)
and to KZ52 (PDB ID: 3CSY) (Lee et al. 2008)
were derived from the Protein Data Bank (PDB).
Sites were mapped onto structures using PyMOL
(The  PyMOL  Molecular  Graphics  System,
Version 1.5.0.2 Schrödinger, LLC).
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3.2.2.2 Adaptive evolution underlies the species-specific binding of P. 
falciparum RH5 to human basigin
Plasmodium falciparum, the causative agent of most malaria-related deaths
in humans, is a member of the Laverania subgenus, which includes ape-
infecting  Plasmodium  protozoa.  Although  P.  falciparum infection  is  now
restricted to humans, phylogenetic reconstruction of  Laverania sequences
suggested that all extant P. falciparum strains resulted from a single gorilla
to human cross-species transmission event [176]. 
Host shifts are often mediated by adaptive evolution at genes that encode
host-pathogen interacting partners, and evolutionary analysis can provide
valuable insight into the molecular determinants of zoonotic transmission
events and spillovers [12]. I thus analyzed the evolutionary history of two
parasite ligand-host receptor pairs that were suggested to determine the
species tropism of  P. falciparum.  In particular,  recent  evidence indicated
that  binding of  Reticulocyte-binding protein  Homolog 5 (RH5)  to  human
basigin (BSG) is a major determinant of species-specificity; a less important
role was ascribed to the interaction between Erythrocyte Binding Antigen-
175  (EBA-175)  and  human  glycophorin  A  (GYPA).  Basigin  is  a
multifunctional  protein  with  a  role  in  trophoblast  function  and  in
spermatogenesis.  This  is  therefore  another  example  showing  that  host-
pathogen interactions are not limited to the immune system components.
By sequencing of  BSG genes from Old and New World monkeys, I show
that BSG evolved adaptively in primates with selection targeting two sites
(F27 and H102) that were previously shown to modulated PfRH5 binding
[65].  A population-genetic  phylogentics  approach  detected  the  strongest
selection for the gorilla lineage; in both gorilla and chimpanzee, selection
targeted residues that affect the binding specificity of PfRH5, as previously
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demonstrated in binding assays [65].
On  the  parasite  side,  natural  selection  also  operated.  Using  different
methods to detect episodic positive selection we show that the RH5 gene
evolved adaptively on the  P. falciparum branch; one of the two positively
selected sites we detected (W447) is known to stabilize the interaction with
human basigin.
As  for  the  EBA175 gene,  we  detect  no  selection  in  the  P.  falciparum
lineage. Its host receptor, GYPA, shows evidence of positive selection in all
hominid lineages; selected codons include glycosylation sites that modulate
PfEBA175 binding affinity.  
Data herein suggest that  BSG-binding  Plasmodium parasites have been
circulating for a long time among wild primate populations and support the
notion  that  adaptive  changes  in  the  BSG-RH5  interacting  partners
contribute to host shifts. With respect to the more recent events that led to
the  emergence  of  P.  falciparum as  a  human pathogen,  these  analyses
implicate that its gorilla-infecting ancestor encoded a functional  RH5 gene
and exerted a strong selective pressure on BSG. Adaptive changes in the
gorilla  BSG and in the parasite  RH5 genes most likely contributed to the
shift to human hosts. 
Conversely, these results suggest that variation at PfEBA175 had no major
role in the emergence of P. falciparum as a human pathogen. Clearly, this
observation does not imply that interaction between GYPA and EBA-175 is
unimportant for erythrocyte invasion, but supports the notion that it is not a
determinant of host tropism [65].
In summary, these data provide an evolutionary explanation for species-
specific binding of the PfRH5-BSG ligand-receptor pair and supports the
role of adaptive evolution at these genes as a determinant of the host shift
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that  gave  rise  to  P.  falciparum  as a  major  human pathogen.  This  work
exemplifies how evolutionary information can provide insight into infectious
disease emergence and zoonotic transmission.
Personal contribution to the work: I performed the analyses and I analyzed data. I also
produced figures and tables for the manuscript.
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Abstract
Plasmodium falciparum, the causative agent of the deadliest form of malaria, is a member of the
Laverania subgenus,  which includes ape-infecting parasites.  P. falciparum is  thought  to have
originated in gorillas, although infection is now restricted to humans. Laverania parasites display
remarkable  host-specificity,  which  is  partially  mediated  by  the  interaction  between  parasite
ligands and host receptors. We analyze the evolution of BSG (basigin) and GYPA (glycophorin A)
in primates/hominins, as well as of their  Plasmodium-encoded ligands, PfRH5 and PfEBA175.
We show that, in primates, positive selection targeted two sites in  BSG (F27 and H102), both
involved in PfRH5 binding. A population-genetic phylogentics approach detected the strongest
selection for the gorilla lineage: one of the positively selected sites (K191) is a major determinant
of  PfRH5  binding  affinity.   Analysis  of  RH5 genes  indicated  episodic  selection  on  the  P.
falciparum branch; the positively selected W447 site is known to stabilize the interaction with
human basigin. Conversely, we detect no selection in the receptor binding region of EBA175 in
the  P. falciparum lineage. Its host receptor,  GYPA, shows evidence of positive selection in all
hominid lineages;  selected codons include glycosylation sites that modulate PfEBA175 binding
affinity.   Data  herein provide an evolutionary explanation for  species-specific  binding of the
PfRH5-BSG ligand-receptor pair and support the hypothesis that positive selection at these genes
drove the host shift leading to the emergence of P. falciparum as a human pathogen. 
Introduction
Plasmodium  falciparum,  the  causative  agent  of
most  malaria-related  deaths  in  humans,  is  a
member  of  the  Laverania subgenus,  which
includes  ape-infecting  Plasmodium protozoa.
Analysis  of  African  wild-ape  populations
indicated  that  Laverania parasites  have
remarkable host-specificity and revealed a gorilla
origin for P. falciparum (Liu et al. 2010). Indeed,
phylogenetic  reconstruction  of  Laverania
sequences suggested that all extant  P. falciparum
strains  resulted  from  a  single  gorilla  to  human
cross-species  transmission  event  (Liu et  al.
2010).  Despite  its  origin,  field  studies  have
found no evidence of P. falciparum infection in
gorillas, suggesting that the parasite is unable
to  cross  back  the  species  barrier  (Liu et  al.
2010). 
The  molecular  determinants  underlying  the
species-specificity  of  Laverania parasites  are
only beginning to be elucidated.  An essential
step  for  Plasmodium infection  is  erythrocyte
invasion. This requires a sequential cascade of
events  that  involve  multiple  interactions
between merozoite ligands and host receptors.
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Erythrocyte  Binding  Antigen-175  (PfEBA175)
was the first  P. falciparum invasion ligand to be
identified (Orlandi et al. 1990; Sim et al. 1994); it
interacts  with  glycophorin-A (GYPA),  a  highly
abundant  erythrocyte  surface  sialoglycoprotein.
Specifically,  PfEBA175  binding  requires  sialic
acid  residues  displayed  on  GYPA.  This
observation, together with the notion that humans
lack  a  functional  cytidine  monophosphate-N-
acetylneuraminic acid hydroxylase (CMAH) gene
and  therefore  display  different  glycosylation
patterns  compared  to  other  apes,  led  to  the
suggestion that the interaction between GYPA and
PfEBA175  played  a  major  role  as  a  species-
specific  determinant  (Martin et  al. 2005).  This
view was recently challenged by in vitro binding
assays  showing  that  PfEBA175  orthologs  from
chimpanzee-infecting parasites (P. reichenowi and
P. billcollinsi) can bind human GYPA in a sialic
acid-dependent manner (Wanaguru et al. 2013b).
Conversely,  species-specific  interactions  were
reported  for  another  pair  of  ligand-receptor
partners:  the  P.  falciparum reticulocyte-binding
protein homologue 5 (PfRH5) and basigin (BSG),
its erythrocyte cell-surface receptor (Wanaguru et
al. 2013b;  Crosnier et  al. 2011).  In  particular,
Wanaguru and coworkers showed that PfRH5 can
bind  chimpanzee  BSG,  but  with  lower  affinity
compared to the human protein, and it is unable to
bind  BSG  of  gorilla  origin  (Wanaguru et  al.
2013b).  PfRH5  belongs  to  the  reticulocyte
binding-like (RBL) family of  Laverania proteins
that includes different numbers of active paralogs
in  distinct  species  (Otto et  al. 2014).  PfRH5
polymorphisms  in  laboratory-adapted  P.
falciparum strains  allow  invasion  of  red  blood
cells  from  New  World  primates  and  rodents,
substantiating the role of PfRH5 as an important
determinant of host range (Hayton et al. 2013). 
 By  providing  information  on  the  location  and
nature  of  functional  genetic  variation,
evolutionary analysis may help explain changes in
pathogen  tropism  (Sironi et  al. 2015).  Using
different  strategies,  we  investigated  the
evolutionary history of primate  BSG and  GYPA,
and of the Plasmodium ligands EBA175 and RH5.
Results  are  consistent  with  selection  acting  on
both primate genes, as well as on the PfRH5 gene
during P. falciparum speciation. 
Materials and Methods
Sequences and samples
Available  primate  sequences  for  BSG were
retrieved from the Ensembl website
(http://www.ensembl.org/index.html)  and
NCBI database (http://www.ncbi.nlm.nih.gov/).
BSG coding sequencing information for  Aotus
trivirgatus, Saguinus oedipus and Chlorocebus
aethiops was obtained by direct sequencing of
cDNA derived from OMK, EBV B95 UK and
COS1  cells,  respectively  (obtained  by  the
European  Collection  of  Cell  Cultures  ,
ECACC).  The  genomic  DNA  of   Colobus
guereza,  Ateles  fusciceps,  Pithecia  pithecia,
and  Lagothrix lagotricha was kindly provided
by  the  Gene  Bank  of  Primates,  Primate
Genetics (Germany) and used as a template for
BSG amplification  and  sequencing.  The
genomic DNA of one  Gorilla gorilla and two
Pan troglodytes were  obtained  from ECACC
and  used  to  amplify  and  sequence  the  BSG
coding  region.  This  procedure  was  meant  to
assess the presence of sequence errors or rare
variants  in  the  gorilla  and  chimpanzee
reference  genome  assemblies
(gorGor3.1/gorGor3  and  CSAC
2.1.4/panTro4). 
The  cDNAs/DNAs  were  amplified  by  PCR
(primer  sequences  are  listed  in  Table  S1,
Supporting information), and then treated with
ExoSAP-IT  (USB  Corporation  Cleveland
Ohio,  USA).  Purified  PCR  products  were
directly sequenced on both strands with a Big
Dye Terminator sequencing Kit (v3.1 Applied
Biosystems),  and  run  on  an  Applied
Biosystems  ABI  3130  XL Genetic  Analyzer
(Life  Technologies).  Sequences  were
assembled using AutoAssembler version 1.4.0
(Applied Biosystems), and manually inspected.
The obtained sequences have been submitted to
NCBI  database  (accession  numbers:
KR425477-KR425483,  KT358396-
KT358397).   A list  of  analyzed  species  and
their  accession  numbers  is  reported  in  Table
S2,  Supporting  information.
The  chimpanzee  and  gorilla  GYPA coding
sequences  were  obtained  from the  respective
reference  genomes  (gorGor3.1/gorGor3  and
CSAC  2.1.4/panTro4)  and  checked  against
GYPA sequences  obtained  by  Sanger
sequencing experiments (Baum et al. 2002; Xie
et al. 1997). The reference chimpanzee  GYPA
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sequence was identical to that previously obtained
by Baum and co-workers (Baum et al. 2002). As
for gorilla, the reference sequence was compared
to those obtained through cDNA sequencing (Xie
et  al. 1997):  minor  differences  were  detected,
which  were  in  all  cases  consistent  with  the
presence  of  polymorphisms  (Xie et  al. 1997;
Prado-Martinez et al. 2013) with the exclusion of
two  codons  (reference:  72S  and  81G;  all  other
sequences:  72P  and  81V).  These  were  thus
replaced  before  performing  ancestral  sequence
reconstruction (see below). 
For the analysis of positive selection in  RH5 and
EBA175,  Plasmodium sequences  were  retrieved
from  the  NCBI  database  (a  list  of  accession
numbers  is  provided  as  Table  S3,  Supporting
information) or  derived  from  previous  works
(Wanaguru et al. 2013b; Otto et al. 2014; Hayton
et al. 2008).
Evolutionary analyses
DNA  alignments  were  performed  with  the
RevTrans 2.0 utility,
(http://www.cbs.dtu.dk/services/RevTrans/, using
MAFFT  v6.240  as  an  aligner)  (Wernersson  &
Pedersen 2003), which uses the protein sequence
alignment  as  a  scaffold  to  construct  the
corresponding  DNA  multiple  alignment.  This
latter  was  checked  and  edited  by  TrimAl  to
remove alignment uncertainties
(http://phylemon.bioinfo.cipf.es/utilities.html,
with the  automated1 method) (Capella-Gutierrez
et al. 2009). Primate gene trees were generated by
maximum-likelihood  using  the  program phyML
with a GTR plus gamma-distributed rates model
(Guindon et  al. 2009).  For  analyses  using
Plasmodium sequences  were  used  previously
generated trees (Wanaguru et al. 2013b).
Positive  selection  in  primate  BSG gene  was
detected using the PAML (Phylogenetic Analysis
by Maximum Likelihood) package (Yang 2007).
The  site  models  implemented  in  the  codeml
program  were  developed  to  detect  positive
selection affecting only a few amino acid residues
in a protein: positive selection is characterized by
a  non-synonymous  substitution/synonymous
substitution rate ratio (dN/dS, also referred to as
ω)  >1. To detect selection, site models that allow
(M2a, M8) or disallow (M1a, M7, M8a) a class of
sites to evolve with ω >1 were fitted to the data
using the F61 model (frequencies of each of the
61 non-stop codons estimated from the data).
Positively selected sites were identified using
two  different  methods:  the  Bayes  Empirical
Bayes (BEB) analysis (with a cut-off of 0.90),
which calculates the posterior probability that
each codon is  from the site  class  of  positive
selection (under model M8) (Anisimova et al.
2002),  and  the  Mixed  Effects  Model  of
Evolution (MEME, with the default cut-off of
0.1)  (Murrell et  al. 2012),  which  allows  the
distribution of ω to vary from site to site and
from  branch  to  branch  at  a  site.  Only  sites
detected using both methods were considered
positively selected.
To  detect  positive  selection  in  RH5 and
EBA175 we applied the branch-site test  from
the  PAML  suite  (Zhang et  al. 2005) and
BUSTED  (branch-site  unrestricted  statistical
test for episodic diversification, Murrell et al.
2015),  which  is  implemented in  the HYPHY
package  (Pond et  al. 2005).  The branch-site
test  compares  a  model  (MA)  that  allows
positive  selection  on  one  or  more  lineages
(foreground lineages) with a model (MA1) that
does not allow such positive selection. Twice
the difference of likelihood for the two models
(ΔlnL)  is  then  compared  to  a  χ2 distribution
with  one  degree  of  freedom  (Zhang et  al.
2005).  Positively  selected  sites  can  be
identified through the BEB analysis.
BUSTED is  designed  to  detect  the  action  of
episodic positive selection that is acting on a
subset  of  branches  in  the  phylogeny  at  a
proportion  of  sites  within  the  alignment.  To
detect  selection  at  individual  sites,  twice  the
difference of the likelihood for the alternative
and  the  null  model  is  compared  to  a  χ2
distribution  (df=1);  we  considered  a  site  as
positively  selected  if  it  showed  a  p value  <
0.05.
To identify the action of recombination along
the gene alignment, we applied GARD (genetic
algorithm  recombination  detection)
(Kosakovsky Pond et al. 2006).
SLAC  (Kosakovsky  Pond  &  Frost  2005),
GARD and MEME analyses  were  performed
through the DataMonkey server (Delport et al.
2010) (http://www.datamonkey.org). 
Population genetics-phylogenetics analysis
Genotype data  from the Pilot 1 phase of the
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1000  Genomes  Project  were  retrieved  from the
dedicated  website  for  human  individuals  (1000
Genomes  Project  Consortium et  al. 2010).  SNP
genotype  informations  for  25  unrelated
chimpanzees  and  23  unrelated  gorillas  were
retrieved from a previous work (Prado-Martinez
et  al. 2013).  Coding  sequence  information  was
obtained  for  GYPA and  BSG.  For  BSG   the
ancestral  sequence  was  reconstructed  by
parsimony  from  the  human,  chimpanzee,
orangutan and macaque sequences; for GYPA, due
to the absence of an unambiguous orthologue in
orangutan  and  macaque  genomes,  the  ancestral
sequence  was  reconstructed  from  the  human,
chimpanzee, and gorilla sequences.
Analyses  were  performed  with  gammaMap
(Wilson et  al. 2011):  we  assumed  θ  (neutral
mutation rate per site), k (transitions/transversions
ratio),  and T (branch length) to vary among the
gene following log-normal distributions. For each
gene we set the neutral frequencies of non-STOP
codons  (1/61)  and  the  probability  that  adjacent
codons  share  the  same  selection  coefficient
(p=0.02). For selection coefficients we considered
a  uniform  Dirichlet  distribution  with  the  same
prior  weight  for  each  selection  class.  For  each
gene  we  run  100,000  iterations  with  thinning
interval of 10 iterations.
To  be  conservative,  we  declared  a  codon to  be
targeted by positive selection when the cumulative
posterior  probability  of  γ  ≥  1  was  >  0.75,  as
suggested (Quach et al. 2013).
Results
Natural  selection  at  the  primate  BSG and
Plasmodium RH5 genes contributes to species-
specific binding
To analyze the evolutionary history of  BSG,  we
obtained  coding  sequence  information  for  28
primate species either from public databases or by
sequencing  (see  methods).  These  sequence  data
allow sufficient power to detect positive selection
at  primate  genes  (McBee et  al. 2015).  The tree
shrew and colugo sequences were also included
(Table  S2,  Supporting  information). Notably,
sequencing  of  genomic  DNA  from  two
chimpanzees  and  one  gorilla  revealed  some
differences  compared  to  the  reference  BSG
sequences  (as  predicted  from  the  respective
genome  assemblies)  (Fig.  1A).  These  differing
positions were checked against genotype data
from 25 Pan troglodytes and 23 Gorilla gorilla
(Prado-Martinez et  al. 2013),  which  revealed
no polymorphism and were consistent with the
sequence data we obtained. Thus, the following
analyses  were  performed  using  these  newly
generated  sequences.  We  conclude  that  the
reference BSG sequences contain either  errors
or  rare  ploymorhisms/haplotypes.  DNA
alignments  were  generated  using  RevTrans
(Wernersson  & Pedersen  2003)  and screened
for the presence of recombination using GARD
(genetic  algorithm  recombination  detection)
(Kosakovsky Pond et al. 2006). This is because
recombination  can  be  mistaken  as  positive
selection. No breakpoint was detected. 
The  average  nonsynonymous/synonymous
substitution rate ratio (dN/dS, also referred to
as  ω)  was  calculated  using  the  single-
likelihood  ancestor  counting  (SLAC)  method
(Kosakovsky Pond & Frost 2005). dN/dS was
lower than 1 (ω =0.31, 95% CI = 0.29 - 0.34),
indicating  purifying  selection  as  the  major
driving force acting on BSG gene in primates.
This  finding  does  not  exclude  that  localized
positive  selection  acts  on  specific  sites  or
domains of the protein. To test this possibility
we  analyzed  the  BSG  alignment  using  the
codeml program  (Yang  2007;  Yang  1997).
Using  likelihood  ratio  tests  (LRTs),  codeml
compares models of gene evolution that allow
(NSsite models M2a and M8, positive selection
models) or disallow (NSsite models M1a, M7,
and  M8a  null  models)  a  class  of  codons  to
evolve with dN/dS > 1. In the case of BSG all
the neutral models were rejected in favor of the
positive  selection  models (Table  1). We next
applied  the  Bayes  Empirical  Bayes  (BEB)
analysis  (Anisimova et  al. 2002;  Yang et  al.
2005)  and  the  Mixed  Effects  Model  of
Evolution  (MEME)  (Murrell et  al. 2012)  to
identify  specific  sites  targeted  by  positive
selection in BSG; to be conservative only sites
detected using both methods were considered.
Two positively selected sites were identified in
the  extracellular  domain  (Table  1),  F27  and
H102  (Schlegel et  al. 2009).  Both  sites  are
located  at  the  direct  contact  interface  with
PfRH5  (Wright et  al. 2014)  (Fig.  1A-B);
consistently,  the  F27L  mutation  reduces  the
affinity of human BSG for PfRH5 (Wanaguru
et al. 2013b). Remarkably, some of the 
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Figure 1. Positive selection at BSG PfRH5 interface.  (A) Multiple sequence alignment of BSG. Alignment of a portion of BSG protein for a few
representative primate species is shown. The amino acid translation corresponding to the BSG coding regions inferred from the chimpanzee and gorilla
reference genomes are also shown in gray; amino acids that represent sequence errors or rare variants are shaded in yellow. Positively selected sites
identified by gammaMap or BUSTED are shown in red; residues identified with BEB and MEME are shown in green. Sites that interact with PfRH5 are
marked with a star. Black dots indicate basigin residues which, when mutated, affect PfRH5 affinity (Wanaguru  et al. 2013b). (B) Ribbon representation
(PDB ID: 4U0Q) of human basigin (white) in complex with PfRH5 (dark gray). Color codes are as in Figure 1A; residue W447 in PfRH5, as well as
BSG positively selected sites that interact with PfRH5, are shown in orange; residues involved in the interaction are shown in blue.
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sequence  errors/rare  variants  in  the  reference
genomes also correspond to codons that  map to
the binding interface with PfRH5. This is the case
of  Q164  in  chimpanzee  (P164  in  the  reference
sequence)  and  Q100  in  gorilla  (K100  in  the
reference). Based on the inferred Q100K change,
this  position  was  previously  indicated  as  a
determinant  of  species-specific  binding
(Wanaguru  et  al.  2013b)  (Fig.  1A).The  only
known ortholog of PfRH5 is the PrRH5 gene from
P.  reichenowi,  a  chimpanzee-infecting  parasite.
Evolutionary analysis of RH5 was thus performed
by including all  available  PfRH5 genes from 11
different  P.  falciparum strains  and  the  P.
reichenowi sequence  (Table  S3,  Supporting
information); the PfRH2b paralog was included to
anchor the phylogeny. 
Screening with GARD, identified a recombination
breakpoint at codon position 23. We thus omitted
the first 23 codons from the analysis. Evidence of
episodic selection along the branch leading to  P.
falciparum was searched for by using the branch-
site models implemented in  codeml (Zhang et al.
2005),  which  provided  statistically  significant
evidence  of  positive  selection,  but  detected  no
positively selected sites (Table 2). To validate this
result,  and  to  further  investigate  the  selection
pattern of RH5, we applied BUSTED (branch-site
unrestricted  statistical  test  for  episodic
diversification),  a  recently developed  method  to
detect  episodic  positive  selection (Murrell et  al.
2015).  This  analysis  confirmed selection  on  the
Plasmodium falciparum branch (Table 2, Fig. 2A).
The  implemented  maximum-likelihood  test
identified Y190 and W447 as positively selected
(Table  2).  W447  was  previously  shown  to
stabilize  the  interaction  between  PfRH5  and
human basigin (Wright et al. 2014) (Fig. 1B). 
The receptor-binding region of EBA175 is not a
selection  target  in  the  P.  falciparum lineage
The  evolutionary  history  of  PfEBA175 was
analyzed  by  retrieval  of  45  Laverania coding
sequences  of  the  receptor  binding  region  (RII)
(Wanaguru et al. 2013b)  (Fig. 2B and Table S3,
Supporting  information).  GARD  detected  no
breakpoint  and,  in  analogy  to  RH5,  episodic
positive  selection  was  searched  for  using  the
codeml branch-site  tests.  We  tested  both  the  P.
falciparum branch and the node which includes P.
falciparum and  P.  praefalciparum (the  closest
species  (Rayner et  al. 2011)).  The  analysis
didn't  provide  any  statistically  significant
evidence of  positive  selection;  similar  results
were obtained with BUSTED (Table 2).
Positive selection in primate lineages targets
residues  at  the  interaction  surface  with
parasite proteins
To gain insight into the more recent selective
events  in  specific  lineages,  we  applied  a
population  genetics-phylogenetics approach
(gammaMap (Wilson et al. 2011)) to study the
evolution of the BSG gene in Homininae. This
approach also allowed analysis of GYPA, which
belongs  to  a  multigene family that  expanded
through duplication events about 9-13 million
years ago (Ko et al. 2011). Therefore, orthologs
of  human  GYPA can  only  be  found in  the
chimpanzee and gorilla genomes. 
gammaMap jointly uses intra-species variation
and  inter-specific  diversity  to  estimate  the
distribution of selection coefficients (γ) along
coding regions. For humans we exploited data
from  the  1000  Genomes  Pilot  Project   for
Europeans  (CEU),  Chinese  plus  Japanese
(CHBJPT) and Yoruba (YRI) individuals (1000
Genomes Project Consortium et al. 2010). For
chimpanzees  and  gorillas,  we  used  SNP
information from 25 and 23 apes, respectively
(Prado-Martinez et al. 2013). 
Analysis of the overall distribution of selection
coefficients  indicated  a  similar  evolutionary
pattern   for  both  genes  in  the  human  and
chimpanzee lineages (Fig. 3A). In these species
purifying  selection   drove the evolution  of  a
major  proportion  of  sites  in  BSG,  with  a
median γ in the range of -10 to -5 (moderately
deleterious,  Fig.  3A).  Conversely, GYPA
displayed  median  γ  values  of  5  to  10
(moderately beneficial,  Fig. 3A).   The gorilla
lineage  showed  opposite  patterns  at  the  two
genes with average γ values of 5 (moderately
beneficial)  and -5 (moderately deleterious) for
BSG and  GYPA,  respectively  (Fig.  3A).  We
next  used  gammaMap  to  identify  specific
codons  evolving  under  positive  selection
(defined  as  those  having  a  cumulative
probability  >0.75  of  γ  >  0)  in  each  lineage.
These codons may occur even if the majority
of  sites  evolve  under  selective  constraint.  In
fact,  in  BSG,  2  and  6  sites  were  found  to
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represent positive selection targets in chimpanzees
and  gorillas,  respectively;  no  positively selected
sites were found in the human lineage (Table S4,
Supporting information).  One positively selected
site in the chimpanzee (S163) and two (L27 and
K191)  in  the  gorilla  lineage  are  located  at  the
interaction  surface  of  human  BSG with  PfRH5
(Wright et  al. 2014)  (Fig.  1A-B).  In  particular,
residue 191 was shown to play an important role
in the interaction with PfRH5, as its mutation to
the  gorilla  counterpart  is  sufficient  to  confer
chimpanzee  BSG  the  ability  to  bind  PfRH5
(Wanaguru et  al. 2013b).  The  L27  residue  is
known  to  reduce  the  binding  of  PfRH5  with
human  basigin  when  mutated  to  the  gorilla
counterpart (Wanaguru et al. 2013b).
Liu et al. 2014; Krief et al. 2010; Pacheco et al.
2013; Boundenga et al. 2015). Although cases of
cross-species infection have been described - for
example, chimpanzees and bonobos can acquire P.
falciparum from  humans  (Krief et  al. 2010;
Pacheco et  al. 2013)  and  P.  billcollinsi infects
both gorillas and chimpanzees (Boundenga et al.
2015) -  Laverania infections display remarkable
host-specificity in the wild (Rayner et al. 2011).
Overall,  these  observations  suggest  that,  over
millions of years, primate hosts have co-evolved
with their parasites. Herein we show that natural
selection has shaped genetic diversity at the BSG
gene  in  primates  and  at  its  parasite-encoded
ligand,  PfRH5. The two BSG residues previously
shown to modulate the affinity of human BSG for
PfRH5 were found to represent targets of positive
selection either in the entire primate phylogeny or
in specific primate lineages. Likewise, one of the
two positively selected sites in PfRH5, W447, is
known  to  stabilize  the  interaction  with  human
BSG by packing into hydrophobic pockets on the
protein (Wright et  al. 2014).  In  PrRH5 position
447  is  occupied  by  a  polar  residue  (N447),
suggesting  very  different  properties  at  the
contact  surface.  The  evolutionary analysis  of
PfRH5  was  nevertheless  conducted  using  a
limited  number  of  sequences  and  one  single
ortholog. Under these circumstances, the power
to detect selection is limited, especially when
inference is extended both to the branch and to
the  sites  targeted  by  selection.  This  might
explain  why  the  branch-site  test,  which  is
robust  but  lacks  power  (Zhang et  al. 2005),
failed to detect positively selected sites on the
P.  falciparum branch  of  the  RH5 phylogeny.
Therefore, results from this analysis will need
to  be  validated  by  further  analysis,  and  the
sequencing of additional orthologs from other
Plasmodium species will be necessary to gain
full  insight  into  the  evolutionary  history  of
RH5. 
Basigin is a multifunctional protein with a role
in trophoblast function and in spermatogenesis,
two processes that may be targeted by natural
selection  in  primates  (Nielsen et  al. 2005).
Therefore,  although several  selected sites  are
located  at  the  PfRH5  binding  interface,  we
cannot exclude that the evolution of BSG was
driven  by  selective  pressures  unrelated  to
Plasmodium infection. 
Previous  analyses  indicated  that  positive
selection  in  primates  also  targeted  DARC
(Duffy  antigen/receptor  for  chemokines),
which is used by  P. vivax and  P. knowlesi for
erythrocyte invasion,  with most selected sites
located  in  the  region  interacting  with  the
parasite-encoded  ligand  (Demogines et  al.
2012).  On the one hand,  these data testify to
the  long-lasting  interaction  between
Plasmodium parasites  and  primates;  on  the
other hand, Laverania infection in great apes is
generally thought to result in no or very weak
pathology,  although  transitory  malaria-like
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symptoms  were  recently  described  in  a  young
chimpanzee  (Herbert et  al. 2015).  Also,  recent
evidence  indicated  that  parasite  detection
increases  during  pregnancy  in  Pan  troglodytes,
either  because  of  increased  susceptibility  or  of
higher  parasitemia  (De  Nys et  al. 2014).
Nevertheless,  it  is  presently  unknown  whether
Plasmodium infection  has  an  adverse  effect  on
pregnancy  outcome  in  chimpanzees  and,  more
generally,  if  Laverania imposed a fitness cost in
great  apes.   It  is  also  worth  noting  that  it  is
presently unknown which other Laverania species
carry a functional RH5 ortholog because the RBL
family  is  highly  dynamic  (Otto et  al. 2014).
Moreover, whereas the interaction between human
BSG and PfRH5 occurs  through protein-protein
contacts  (Wright et  al. 2014),  PfRH5  variants
from distinct strains display different affinity for
erythrocytes  of  New World  monkeys  depending
on the presence of surface sialic acids (Hayton et
al. 2013).  Hence,  it  is  not  clear  if  such  PfRH5
mutants depend on BSG for invasion or whether
they acquired the ability to exploit other cellular
receptors.  By  analogy,  other  field  strains  or
Plasmodium species may express RH5 molecules
or, more generally, RBL proteins with affinity for
host receptors distinct from BSG, as is the case for
PfRH4,  which  binds  human  CR1  (complement
receptor type 1). Whereas these points will require
further  investigation,  data  herein  suggest  that
BSG-binding  Plasmodium parasites  have  been
circulating for  a  long time  among wild  primate
populations and support  the notion that  positive
selection  at  the  BSG-RH5  interacting  partners
contribute to host shifts. With respect to the more
recent  events  that  led  to  the  emergence  of  P.
falciparum as  a  human  pathogen,  gammaMap
analysis suggests that its gorilla-infecting ancestor
encoded a functional  RH5 gene and exerted a
strong  selective  pressure  on  BSG.  Positive
selection at the gorilla BSG and at the parasite
RH5 genes most likely contributed to the shift
to  human  hosts.  It  is  worth  mentioning  here
that previous  in vitro assays that analyzed the
interaction between primate  BSG and PfRH5
used  expression  vectors  based  on  the
chimpanzee  and  gorilla  reference  genomes,
which  contain  either  sequence  errors  or  rare
variants (Wanaguru et al. 2013b). Whereas the
results  of  the  single-site  mutagenesis  remain
mostly valid (e.g. for sites F27L, E191K, and
the  H103  insertion),  in  some  cases  their
biological  significance  should be  revised;  for
instance  the  Q100K  substitution,  which
decreases PfRH5 binding affinity (Wanaguru et
al. 2013b),  does  not  correspond  to  the
replacement  of  a  human  residue  with  the
gorilla counterpart,  as most gorillas are likely
to  carry  a  glutamine,  as  well.  Most,
importantly, the binding affinity of PfRH5 for
the  wild-type  gorilla  and  chimpanzee  BSG
proteins should be re-evaluated. We found no
evidence  of  selection  for  EBA175 in  the  P.
falciparum and  praefalciparum lineages.  We
note that, due to limited sequence information
availability,  our  analysis  only coveredthe  RII
domain.  Recently,  Wanaguru  and  coworkers
(Wanaguru et  al. 2013a)  demonstrated  that
protein regions other than the RII domain are
important for interaction with GYPA. In fact,
binding  of  EBA175  to  GYPA is  thought  to
occur  in  two  steps:  after  a  sialic-dependent
recognition,  proteolytic  cleavage  generates  a
65-kD  EBA175  fragment  that  binds  the
glycophorin backbone (Kain et al. 1993). This
fragment includes a dimorphic region 
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Figure 2. Phylogenetic trees of  Laverania subgenus.   Phylogenetic tree of  (A) RH5 sequences from P. falciparum and P. reichenowi and (B)  the
receptor binding region (RII) of  EBA175  strains (Wanaguru et al. 2013b). Branches set as foreground lineages are marked with dots: red indicates
statistically significant evidence of positive selection.
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Figure 3. Analysis of selective pressure in the Homininae lineages. (A) Violin plot of selection coefficients (median, white dot; interquartile range,
black bar) for  BSG and  GYPA genes. Selection coefficients (γ) are classified as strongly beneficial (100, 50), moderately beneficial (10, 5), weakly
beneficial (1), neutral (0), weakly deleterious (−1), moderately deleterious (−5, −10), strongly deleterious (−50, −100), and inviable (−500). (B) Multiple
sequence alignment of GYPA exons 2-4. Sites with a cumulative probability >0.75 of γ > 0 are shown in red, glycosylation sites are marked with a black
dot. Orange dots indicated glycosylation sites which, when mutated, affect PfEBA175 binding (Salinas et al. 2014).
characterized by the presence of two alternative
and divergent amino acid sequences, the so-called
F- and C- segments  (after the strains they were
initially  isolated  from,  FCR3  and  CAMP,
respectively),  with different  size  and location in
the EBA175 coding region (Kain et al. 1993; Ware
et al. 1993).  PfEBA175 genes carrying either the
F- or C-segment alleles have been detected in all
P. falciparum isolates analyzed to date (Ware et
al. 1993; Cramer et al. 2004; Ahouidi et al. 2010),
although  it  is  presently  unknown  whether  the
encoded proteins display differential efficiency for
GYPA binding. Irrespective of the possible role of
this dimorphic region, these observations indicate
that selection may target EBA175 residues outside
the RII region and, if so, would go undetected in
our study. Also, the analyses we performed were
not devised to detect intra-species selection in  P.
falciparum. 
 Baum  and  coworkers  (Baum et  al. 2002)
previously  analyzed  30  PfEBA175 RII
sequences  isolated  in  Nigeria  from  infected
subjects and concluded that the region was a
target of diversifying selection, highlighting its
importance  for  erythrocyte  invasion  and,
possibly,  as  a  target  of  the  host  immune
response. Herein we did not analyze the recent
evolutionary  events  driving  diversity  in  P.
falciparum populations,  but  focused  on  the
changes that contributed to the emergence of P.
falciparum as a human pathogen. We conclude
that  changes  in  the  RII  region  of  EBA175
played  no  or  minor  role  in  determining  host
tropism,  in  line  with  the  observation  that
EBA175 orthologs from chimpanzee-restricted
Laverania parasites encode proteins that bind
human  GYPA  with  the  same  affinity  as
PfEBA175 (Wanaguru et al. 2013b). 
The binding of PfEBA175 to GYPA is sialic-
acid dependent and the parasite ligand engages
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several  sialoglycans  (Salinas et  al. 2014).  We
found GYPA to display several positively selected
sites in the three primate lineages we analyzed, in
line with previous analyses (Baum et al. 2002; Ko
et  al. 2011).  Selected  codons  also  included
glycosylation  sites  that  modulate  PfEBA175
binding affinity (Salinas et al. 2014), suggesting
that the selective pressure imposed by Laverania
parasites  contributed  to  shaping  diversity  at
GYPA.  Although  large  uncertainty  affects  time
estimates,  the  timing  of  the  glycophorin  gene
family  expansion  and  the  time  of  origin  for
Laverania species broadly correspond (Krief et al.
2010;  Pacheco et  al. 2013),  suggesting  long-
lasting interactions between parasite ligands and
primate  glycophorins.  Nonetheless,  GYPA   is
bound  by  several  other  pathogens  including
common viruses  and bacteria;  these also exploit
complex  sugars  for  binding  (Gagneux  &  Varki
1999). This observation led to the suggestion that
GYPA may act as  a decoy receptor  that attracts
pathogens  to  erythrocytes  where  infection  is
unproductive  due  to  the  absence  of  a  nucleus.
Other authors (Baum et al. 2002; Ko et al. 2011)
favored an “evasion” hypothesis as opposed to the
decoy function,  by placing the emphasis  on the
role of glycophorins as receptors for Plasmodium
parasites.  While these two views of glycophorin
evolution are not mutually exclusive and remain
difficult  to test,  we limit  our conclusions to the
observation that pathogens unrelated to Laverania
may have acted as selective pressures on  GYPA.
Finally,  we  note  that  gene  conversion  has  been
shown to contribute significantly to the shaping of
nucleotide diversity at glycophorin genes, due to
the  high  sequence  homology  among  family
members  (Ko et  al. 2011).  We cannot  therefore
exclude  that  a  portion  of  the  selected  sites  we
detected may indeed result from gene conversion
events rather than selection. 
In summary, data herein provide an evolutionary
explanation  for  species-specific  binding  of  the
PfRH5-BSG ligand-receptor pair and support the
view that natural selection at these genes underlies
the  host  shift  that  gave  rise  to  P.  falciparum,  a
major human pathogen. These observations are in
line with recent  in  vitro data   (Wanaguru et  al.
2013b)  and  exemplify how evolutionary studies
can  provide  insight  into  infectious  diseases
emergence  and  zoonotic  transmission  (Sironi et
al. 2015). 
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4. CONCLUSIONS
Evolutionary analyses and the identification of natural selection patterns in
different species, have manifold purposes. 
In the first study, for example, the availability of genetic information of other
primates and of preagricultural human population, allowed the opportunity
to  address  the  tempo  and  mode  of  evolution  for  genes  involved  in
carbohydrate digestion and absorption. In this case I found that some non-
coding  positively  selected  variants  identified  in  human  populations  are
“modern  alleles”  when  Neanderthals  and  Denisovans  are  taken  as  a
comparison,  but  not  as  modern  as  to  unequivocally  support  their
agriculture-driven  spread.  The  introduction  of  agriculture  might  have
spurred  the  frequency  increase  of  variants  that  were  already  weakly
adaptive in hunter-gatherers, resulting in a continuum rather than an abrupt
onset of selective events. These data have a relevance in explaining the
high prevalence of diabetes and obesity seen in modern populations. When
applied to the study of host-pathogen conflict, evolutionary analyses may
help  to  gain  insight  into  the  genetic  determinants  modulating  the
susceptibility to infectious diseases and the virulence of pathogens. In turn,
this knowledge may be translated into novel treatment strategies in terms of
molecular targets for drug development.
Inter-specific  and  population  genetic-phylogenetic  analyses  allowed  the
identification of specific regions and sites evolving under positive selection:
in  the  case of  ADAR genes  (genes involved  in  A-to-I  RNA editing),  for
instance,  I  found  that  most  positively  selected  sites  are  located  in  the
additional amino-terminal portion of the interferon-induced isoform of ADAR
(p150). One of these, in particular, is located within the nuclear exporting
sequence (NES). Cytoplasmic localization of ADARp150 may be relevant to
viral detection and binding, as well to stress responses. This confirms the
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idea that regions under positive selection are the ones directly related with
immune responses.
As for  MX2 (myxovirus resistance 2), five of the positively selected sites
were  located  in  an  unstructured  loop  (loop  4)  where  several  positively
selected sites were also detected in primate MX1 genes. In this letter case,
the positively selected sites explain species-specific difference in antiviral
activity against orthomyxoviruses. Interestingly, one of the positive selected
sites detected in MX2, S518, corresponds to a polymorphic position in the
pig coding sequence: amino acid variation at this residue was shown to
modulate  the  ability  of  the  porcine  MX2  protein  to  inhibit  vescicular
stomatitis  virus  replication,  supporting  the  hypothesis  that  positively
selected sites determine antiviral activity. 
This work also clearly shows how evolutionary analysis could be exploited
to identify novel host determinant of HIV-1 infection susceptibility. Indeed,
population genetic analyses on  MX2 demonstrated that  distinct  selective
events drove the frequency increase of two haplotypes in populations of
Asian and European ancestry: the Asian haplotype carries a susceptibility
allele for melanoma; the European haplotype is tagged by rs2074560, an
intronic variant. Because natural selection targets variants are expected to
entail a phenotypic effect, and given the role of MX2 as a HIV-1 restriction
factor,  I  investigated  whether  the  allelic  status  at  rs2074560  modulates
susceptibility to HIV-1 infection. Genotyping analyses performed on three
independent European cohorts of HIV-1 exposed seronegative individuals
with different geographic origin and distinct exposure route showed that the
ancestral  (G) allele protects from HIV-1 infection with a recessive effect.
The  same allele  is  associated  with  lower  in  vitro HIV-1  replication  and
increases  MX2  expression  levels  in  response  to  IFN-α.  Results  herein
establish, therefore, a possible target for therapeutic intervention in HIV-1
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treatment and prevention. They also show that evolutionary analysis can
identify susceptibility alleles for modern human mutations. 
Still in line with the tenet that natural selection targets functionally relevant
residues, position 230 in STING (stimulator of interferon genes) was found
to be positively selected in both the primate and bat phylogenies. This site
lies in  the flexible  loop that  acts  as  a lid  above the cyclic  di-nucleotide
binding pocket of the receptor. Substitutions at this site greatly affect the
response  to  natural  ligands  and  to  mimetic  drugs,  such  as  DMXAA.
Different  aminoacid  residues  at  position  230  were  also  shown  to  be
responsible for the species-specific differences in the induction of the type I
interferon pathway in response to DMXAA in human and mouse. DMXAA is
a mimetic drug showed promising antitumor effects in mice, but failed in
human clinical trials because the human protein does not bind to or signal
in  response  to  DMXAA.  Therefore,  evolutionary  analyses  of  immune
response genes may also provide valuable information on the molecular
determinants  underlying species-specific  infection  susceptibility  and  may
clarify the differential response to natural or synthetic molecules. 
Under a genetic conflict scenario whereby the host and the pathogen genes
evolve  within  binding  avoidance-binding  seeking  dynamics,  evolutionary
analyses  may  predict  host-pathogen  interaction  surfaces  at  the  single
amino  acid  resolution.  That  was  clearly  shown  in  the  analyses  of  the
evolutionary history of  the complement  system and of  bacterial-encoded
complement-interacting  proteins.  In  this  case,  evolutionary  analyses
predicted  host-pathogen  interaction  surfaces  at  the  single  amino  acid
resolution.  In  the  CFH-OspE  interaction  (Complement  factor  H   and
Borrelia  burgdorferi surface  protein,  respectively),  for  example,  both
partners are targeted by selection. In OspE, two positively selected sites
(V120 and I121) are located at the binding interface and this is the same for
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the  positively  selected  sites  in  CFH  (e.g.  S1196  interacts  with  S82  in
OspE).  Mutations  V120L and  I121A in  OspE,  as  well  as  T1184K  and
S1196P in  CFH,  led  to  a  misplacement  of  the  interactors  in  a  docking
analysis, strongly suggesting that they affect protein-protein interaction.
Studying  the  pattern  of  inter-species  evolution  may  provide  valuable
information on the differential susceptibility to infection within and among
species.  Primates  for  example,  show  marked  differences  in  the
susceptibility and severity of several viral infections including those caused
by HIV/SIV.  Moreover,  several  emerging and re-emerging viral  diseases
affecting  humans  originate  through  the  zoonotic  transmission  from  a
reservoir  animal  host:  evolutionary  analysis  help  identify  the  most  likely
reservoirs of zoonotic pathogens. Examples of pathogen spillover events
include Ebola virus and Plasmodium falciparum. 
Uncertainty still exists about the reservoir host(s) for filoviruses, and it  is
presently unknown whether the spillover is initiated from a direct contact
with  the  reservoir  or  rather  from  exposure  to  other  wild-life  that  also
contracted the infection from the reservoir. The exploration of the presence
and extent of positively selection in NPC1 (Niemann-Pick disease, type C1
membran protein), led to identify distinct codons targeted by selection in
different mammalian orders/superorders or clades, most of them within or
at the base of loops previously shown to be involved in the interaction with
filovirus glycoprotein (GP).  This  data indicate that  positive selection has
been driving the molecular evolution at the host-filovirus interaction surface
and  that  most  mammals  are  or  were  infected  by these pathogens;  the
filovirus reservoir(s) may thus belong to any mammalian order.
Plasmodium falciparum, the causative agent of most malaria-related deaths
in  humans,  instead,  originated  in  gorillas,  although  infection  is  now
restricted to humans. A population genetics-phylogenetics approach applied
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on basigin (BSG) gene, the erytrocyte cell-surface receptor of Plasmodium
falciparum reticulocyte-binding protein homologue 5 (PfRH5), detected the
strongest selection for the gorilla lineage, suggesting that gorilla-infecting
Plasmodium ancestor encoded a functional RH5 gene and exerted a strong
selective pressure on BSG. Positive selection at the gorilla BSG and at the
parasite RH5 genes most likely contributed to the shift to human hosts. In
particular, one of the positively selected sites (K191) is a major determinant
of PfRH5 binding affinity: its mutation to the gorilla counterpart is sufficient
to confer chimpanzee BSG the ability to bind PfRH5. This data demonstrate
that adaptive changes in BSG-RH5 interacting partners contributed to the
host  shift  that  gave  rise  to  P.  falciparum as  a  major  human pathogen.
Therefore, by providing information on the location and nature of functional
genetic  variation,  evolutionary  analysis  may  help  explain  changes  in
pathogen tropism.
Finally,  evolutionary  analysis  can  provide  information  on  possible
therapeutic  targets.  Investigation  of  Ebola  GP  sequences  identified
positively selected sites that resides within epitopes for antibodies: residue
484 is within the epitope for 14G7 antibody and site 39 is located within an
epitope  bound  by  the 16F6 antibody that  specifically  neutralizes  Sudan
strains. Furthermore, one pair of co-evolving sites (309 and 509) was also
detected.  Residue  509  is  at  the  direct  contact  interface  with  the  KZ52
antibody  isolated  from  a  human  survivor  of  Ebola  infection,  whereas
residue 309 is located in the glycan cap, a region bound by neutralizing
antibodies.  It  is  worth noting  that  mutations  at  the  flanking 508 residue
affect  the  binding  of  three  different  antibodies  against  EBOV  GP,  and
Q508R escape mutants are associated with lethality in monkeys treated
with a combination of three neutralizing mAbs (ZMAb). These results point
to the host humoral immune response as a major selective pressure on
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filovirus GP. 
Because promising treatment strategies for filovirus infection are based on
antibody combinations, evolutionary studies suggest from one hand caution
in their use, since antigenic variability should pose a serious concern to
their effectiveness in the long-term. On the other, they identify in the less
variable regions the most likely targets for these treatments.
In conclusion, these works highlight the importance of applying evolutionary
approaches. Indeed, evolutionary analyses can provide information not only
on the past adaptive events that shaped human-specific traits, but also on
the  presence  and  location  of  functional  genetic  variants  with  particular
relevance to phenotypic diversity and, ultimately, to human health.
Moreover, the experimental design (based on the integration between inter
and intra-species analyses, and between host and pathogen's interacting
partners) used in my works may serve as a model for the analysis of other
host-pathogen interactors.
My  future  perspective  is  to  focus  on  host-pathogen  interactions,  the
strongest selective pressure. In particular I'm going to integrate evolutionary
analysis with the availability of an ever increasing number of mammalian
and pathogen genomes and with an increasing number of crystal structures
of interacting host and pathogen partners to search for selective pressures
acting on host and emergence pathogen interactions.
I  also  envisage  experimental  validation  of  the  results  from evolutionary
analysis using the two hybrid system, a method used to assay for protein-
protein interactions and protein-DNA interactions. The final aim is to clarify
the  mechanisms  underling  the  susceptibility  to  and  the  severity  of  the
diseases caused by emergence pathogens, as well as to provide a list of
proteins/regions that may be targets for therapeutic preventive strategies.
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